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"... Hence, whenever it is necessary to sift wheat and barley or
other Kinds of grain to be ground in the mill, or to measure it when
corn-merchants convey it hither and thither, the men who sift and
measure are so plagued by this kind of dust that when the work is 
fini shed they heap a thousand curses on the i r ca11i ng. The throat, 
lung, and eyes are keenly aware of serious damage; the throat is choked 
and dried up with dust, the pulmonary passages become coated with crust 
formed by the dust, and the result is a dry and obstinate cough; the 
eyes are much inflamed and watery; and almost all who make a living by 
sifting and measuring are short of breath and cachectic and rarely 
reach old age; in fact they are liable to lapse into orthopnea and 
finally dropsy. The dust moreover is so irritating that it excites 
intense itching over the whole body, of the sort that it is sometimes 
observed in nettle rash."
Thus, did Rammazini describe the health hazards of cereal grain 
workers in 1713**. Although pulmonary symptoms associated with 
exposure to grain dust have been known for centuries, the mechanism by 
which grain dust exerts its harmful effect is unknown. New insights 
into the nature and extent of the health problems created by grain dust 
have been provided by several epidemiologic'1-8 and clinical 
studies®»^,12,14-23 0f grain workers. The consequences of
symptomatic, recurrent, long-term exposure, however, have not been 
established with certainty.
During exposure to grain dust up to 75 % of grain workers 
frequently experienced symptoms of cough, expectoration, wheezing, 
chest tightness, eye and nasal irritation2-7. From 6 to 33 % of 
grain workers also experienced one or more episodes of "grain fever" 
characterized by malaise, chills and fever occurring during or several 
hours following exposure2-**. With the exception of coughing and 
wheezing, which occurred significantly more frequently among smokers, 
these effects were independent of age, length of employment and smoking 
habits6.
Symptoms of chron i c resp i ratory d i sease were a I so common among 
grain workers2-®. These symptoms included persistent cough27-4^, 
phlegm35-53%j wheezing^4- *̂ ,̂ or dyspnea on ef fort^®~4^.
Approximately one-third of the grain workers had chronic bronchitis or 
evidence2-® of airways obstruction as detected by spirometry. The 
MMF, FEF2 5 _7 5 % were the most common abnormal individual tests of lung 
function, occurring in almost one-half of the workers who smoked and a 
quarter of the workers who had never smoked. Decreases in FEV-j and 
FEV-j/FVC were found in approximately one-fourth of the workers who 
smoked and infrequently in workers who had never smoked. In all the 
studies reported, cigarette smoking was the predominant host factor in 
grain workers with obstructive lung disease. Moreover, the chronic 
bronchitis and chronic airways obstruction found in grain workers 
closely resembled that encountered in cigarette smokers. Because of 
the general lack of appropriately matched comparison populations in the 
reported epidemiologic studies, it is difficult to assess the 
contribution of grain dust to the obstructive lung disease
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seen in grain workers. The studies of Becklake6, and sore recent 
information by Dosman9, and Broder24 suggest that the effects of 
dust and smoking are additive, if not synergistic.
Grain dust is a complex mixture of husk particles, cellulose hairs 
and spikes, starch granules, spores of fungi, insect debris, pollens, 
rat hair, and approximately 5 X mineral particles10. The mean 
particle size of the airborne dusts may be less than 5m. Particles 
of this size can cause small airways and alveolar reactions, as well as 
upper airways injury.
In workers exposed to wheat dust a reduction in ventilatory 
capacity was observed within 30 minutes of starting work11. In 
addition, Warren, Cherniak and Tse12 reported immediate and late 
asthmatic reactions in some subjects exposed to an inhalation challenge 
with grain dust extract. More recently, Chan-Yeung has confirmed these 
results and has further shown that disodium cromoglycate given before 
the challenge inhibited the immediate bronchial reaction; 
beclomethasone dipropionate failed to prevent the immediate bronchial 
reaction, but inhibited the late asthmatic reaction. Half of the
workers studied had a marked degree of bronchial reactivity to
methacholine. Chan-Yeung's findings34 suggest that grain dust asthma 
may have an allergic basis. Results from several surveys2*6 have
shown that wheez i ng and abnorma I I ung funct i on were more preva I ent 
among atopic workers and workers with positive immediate skin tests to 
grain dusts. Thus, as with cigarette smoking, allergy and exposure to 
grain dust may operate as independent or interdependent factors in the 
development of respiratory disorders in grain workers. As in the case 
of grain workers6, a survey of the general population in Arizona13 
revealed a significant correlation between wheezing in adults and
cutaneous reactivity to a variety of common allergens, suggesting that 
atopic status might predispose the individual to the development of
chronic obstructive airways disease13. Conversely, Gerard6
demonstrated that non-atopic grain buyers who were nonsmokers from
non-atopic famiIies showed no increase in bronchial reactivity to
extracts of cereal grains, their common fungal contaminants or 
histamine and are not likely to develop lung disease as a result of
grain handling. However, evidence suggests that grain handlers are a 
self-selected group. The most sensitive individuals are likely to seek 
other employment early because of pulmonary symptoms.
Grain dust and its contaminants contain many allergens that are 
potent sensitizers in man10»14“21. Reactions to grain dust 
components have been described during many phases in the handling of 
grain, e.g., harvesting22, local storage17»19, grain 
elevators4»6»12, and processed material16»20»21. In isolated
instances, the agent in grain dust that was responsible for the 
reaction observed in individual workers appeared to be debris of a 
grain weevil (Sitophilus granarius)15»16, a grain mite (Glycophagus 
destructor)17, a specific fungus14»19 or a specific component of 
grain (Appendix 23). In general, the role of these agents in the 
respiratory disease of grain workers is unknown.
Grain dust contains a wide variety of fungi and bacteria2^-27, 
including several species of Aspergillus, Pénicillium, Mucor,
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Pullalaria and Thermophi11ic bacteria. These microbial agents can 
induce a variety of immunological reactions in the lung including a 
Type I (allergic) and a Type III (immune complex) reactions14. The 
clinical correlates of these reactions include asthma, allergic 
bronchopulmonary aspergiIlosis29 and Farmer’s Lung29. Except in 
isolated individuals, the immunological mechanism evoked by grain dust 
has not been identified. It was suggested9 that grain fever is a 
Type III (immune complex) reaction similar to that seen in various 
forms of hypersensitivity pneumonitis. In the reported studies, 
hypersensitivity pneumonitis or its sequelae, chronic diffuse 
interstitial fibrosis of the type seen in Farmer's Lung, was not 
established with certainty. Also, doPico found no correlation between 
a history of grain fever and the presence of serum precipitins to 
fungi, grain or grain dust®. Whether or not hypersensitivity 
pneumonitis or its sequelae cause workers to leave the industry is 
unknown.
Emmanuel has described mycotoxicosis90, a condition occurring in 
farmers exposed to massive concentrations of fungal spores. This 
syndrome resembles grain fever since there is no evidence of a Type III 
(immune complex) reaction and no chronic respiratory sequelae. 
Although the immunological mechanisms active in mycotoxicosis and grain 
fever are unknown, it was reported that airborne grain dusts activate 
complement by the alternative pathway, and that endotoxin can be 
recovered from all dust samples. Airborne grain dusts might be 
expected to elicit respiratory pathophysiology by a dose-dependent 
inflammatory response produced as a result of endotoxin or direct 
activation of the complement alternative pathway.
It is possibIe that grain dust may cause acute and chronic 
respiratory abnormalities by a direct irritant effect. Irritant 
receptors have been identified in the mucosa of bronchial airways31. 
Stimulation of these receptors in experimental animals with impulses 
going through the vagal pathways, led to hyperpnea and 
bronchoconstriction92. Vagal stimulation has also been shown to 
cause increased secretion of the bronchial mucous glands. It is thus 
conceivable that chronic non-specific stimulation of the bronchial 
irritant receptors by grain dust may lead to pathologic changes in the
bronchial airways and mucous glands which are the basis for the chronic
respiratory symptoms and abnormalities present in the majority of grain 
workers. The picture of chronic cough and phlegm, obstructive airways 
disease, episodes of tightness in the chest, fever and bronchial
reactivity to grain dust extracts are similar to byssinosis and mill 
fever. Other similarities to byssinosis were observed such as airflow 
limitation in nonsmoking grain workers which appeared to be detectable 
at the level of the small airways4*5. This suggests that the target 
for inhaled grain dust may be similar to inhaled cigarette smoke or 
cotton dusts. The MZ phenotype with intermediate alpha^-antitrypsin 
deficiency did not seem to be a significant host factor for the chronic 
obstructive lung disease found in grain workers9.
No information is available concerning cumulative dust exposures or 
dose-response relationships in any of the reported studies. Dust
concent rat i ons i ns i de gra i n elevators vary great Iy. Ava iIabIe
measurements' of dust2*5-' varied from 10 mg/m3 in some of the modern
Page 8
elevators in Vancouver7 to 600 mg/m3 in some elevators in 
Montreal5. The reason for the wide range of dust concentrations is 
unclear. However, the terminal elevators in Vancouver generally handle 
grain that has been partly cleaned during its transport from the 
prairies. There nay also be qualitative differences in the types of 
gra i n hand I ed by each e I evator. These quant i tat i ve and qua I i tat i ve 
differences probably account for the generally lower prevalence of 
respiratory disease and grain fever reported by Chan-Yeung7»34_
Population at risk. The exact number of workers exposed to grain 
dust is unknown since so many occupations are involved including 
fanners, grain elevator operators in small and large terminal elevators 
and workers in flour, feed and seed Bills. The total population at 
risk in Canada was estimated at 100,00c34. In the United States 
there are an estimated 500,000 grain elevator workers. The proportion 
of the more than 2 million farmers at risk is unknown. However, Wan 
and Wright35 analyzed disability data from a survey conducted by the 
Bureau of Census and reported that U.S. farmers and farm managers had 
the highest prevalence of disabling respiratory diseases of any 
occupational group— a rate of 21.8/100,000.
Grain dust has also been identified as a community air pollutant 
capable of causing epidemics of asthma35»37.
STUDY I. HEALTH STATUS OF A CROSS SECTION OF GRAIN HANDLERS WITHIN A 
SINGLE GEOGRAPHIC AREA.
The health status of grain handlers was evaluated by comparing the 
prevalence and characteristics of clinical, physiological, 
immunological, radiological, serological blood and urine parameters of 
310 grain handlers with 239 city services workers (named controls) from 
the same geographic area.
1. MATERIALS AND METHODS 
Population
1a. Grain Handlers
The 310 grain handlers that were studied represented 78Z of the 397 
total available working and acceptable workers (Table 1) from eight 
elevator companies, of Wisconsin and Minnesota State grain inspectors, 
and Wisconsin and of Minnesota longshoremen. Grain handlers from the 
elevator companies were members of Local 118 of the Grain Millers
Association, the longshoremen were members of the International
Longshore Association (ILA) and the state inspectors were members of
the American Federation of State, County and Municipal Employees 
(AFSCME).
Workers were notified and asked to participate in the study by 
fliers, posted notices, union stewards, and general meetings with
investigators. The purpose of the study was explained verbally and in 
writing. The management of each company was notified, the studies were 
explained to them and all agreed to permit their workers to participate 
without loss of personal income.
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Compan ies absorbed the cost of temporary decreased manpower. 
Overall, the elevator operations and productivity did not appear to be 
significantly altered due to proper scheduling and coverage. For the 
cross sect i onaI study, subj ects were cons i dered acceptabIe to 
participate if they were year round workers (defined as 9-12 months per 
year for grain handlers or 8 months per year for longshoremen); had 
worked for longer than one year; and were working at the time of the 
survey. The longshoremen accepted were those identified by the 
sh i pIoad i ng manpower compan i es as gra in sh i pIoaders excIus i veIy. 
Workers on sick leave were studied, when possible, but their data was
not included in the comparisons of group data analysis. Workers who
refused to participate (N=51) on the first contact were contacted at
least once more. Approximately 50% of the workers who initially 
refused, agreed to participate on the second contact. Thirty-nine 
workers agreed to participate but later, for reasons beyond their 
control, did not. One woman was studied but the data were not included 
in the group analysis.
1b. City Workers (Control Workers)
For the comparison population (called control population), subjects 
were recruited from outside workers of the cities of Superior and 
Duluth and from the Power and Light Company of Duluth, Minnesota. The 
arrangements were made with the cooperation of the mayors of these 
cities, city management officials, management of the Power and Light 
Company, and union (AFSCME) representatives.
Eligible workers were those whose work day was spent on outdoor 
functions at least 50% of the time. The job classifications included: 
engineers and bridge operators, street maintenance, water and gas 
(maintenance, meter readers, etc.), parks and zoo maintenance, sewage 
and sanitation maintenance and operations, building maintenance, 
airport mechanics and operators. Three hundred and eighty-six of 478 
eligible city workers (Table 2) were contacted and informed of the 
nature of the study by fliers, general meetings, posters, or by
department supervisors. Initial refusals were recontacted by 
supervisors and/or project coordinators. Two hundred and thirty-nine 
consented to participate and were studied (Table 2). The differences 
between the total eligible (N=478) and non-contacted (N=92) were 
explained by sex, vacation or sick leave, departments or divisions
where management preferred services not be disturbed, failure to 
contact. The differences between those contacted (N=386) and not 
tested (N=147) were mostly due to refusals. The 239 city workers 
represent 62% of the contacted workers. This lower participation among 
city workers as compared to grain handlers may be explained by lack of 
motivation or other factors. Age, height, weight and smoking habit
information were obtained from the non-participant workers. Their mean 
age was 44 % 12 years, height 172.3 % 6.5 cm, weight 83.3 % 13 
kg, 49% smokers, 31% ex-smokers and 20% nonsmokers.
The characteristics of the test and control populations are 
presented in Table 3. All city workers and 99% of the grain workers 
were white males. Among grain workers there were one black, one 
h i span i c and two Amer i can Ind i ans. TabIe 3b shows the IeveI of
education in both groups. The distribution of smoking habit, height
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and weight by age groups are presented in Tables 4a and 4b. The
characteristics of the smoking habits are presented in Table 5. Past
histories of occupational exposure to puInonary irritants are shown in 
Table 6. Because the Superior-Duluth city service workers are exposed 
to environmental city contamination with small amounts of grain dust 
that could sensitize them, it was decided to study the skin reactivity 
to aero-allergens and grains in 100 city service workers from a city 
where no grain dust exposure is known to occur, i.e., Madison, Wl. 
One-hundred and three aiale volunteers were studied from the Madison Gas 
and Electric Company. The mean age of this group was 38 % 10 years.
History
The history was obtained by a standard self-administered 
questionnaire (Appendix IV), reviewed for completeness by two trained 
interviewers who also assisted in the completion of the questionnaire
when required. Additional histories were obtained by the physicians
who reviewed the questionnaire and obtained a detailed history of grain 
fever and any other relevant health information.
Work history was filed using a job coding (Appendix III) which 
classified jobs by the type of hazard, site where job was performed and 
descriptive job title.
It became immediately apparent that not enough information could be 
obtained on grain fever because of the structure of questions 046 and 
047. The answers to these two questions were therefore not entered in 
the workers files. Instead, an interpretation of the answers to 
questions 46 and 47 was made by the examining physician, with 
additional information as explained in Appendix V.
Examination
Physical examinations were performed by one of three physicians 
following a standard procedure for heart and lung auscultation and 
liver palpation (Appendix VII).
Pulmonary Function Studies
Pulmonary function studies were performed using standard equipment 
and following acceptable clinical procedures as described in Appendix 
VIII. Included were FEV-j, FVC, MMF, Vmaxso, Vmaxjç, CV N2/L, 
D|_c0 i V50He02 and VisoV. These tests were considered abnormal when: 
FEV-j/FVC< 70%; FEV-j and Dlco <80% of predicted; MMF, Vmaxgg and
Vmax75<1.65 SO; and N2/L and CV <1.65 SO. (1.65 SD was chosen since 
the abnormality on these tests is undirectional.)
Immunologic Evaluation
a) Antigen preparation (Appendix X).
b) Immediate skin reactivity to common allergens: fungal 
antigens, mites, insects, grain extracts, airborne grain dust extracts 
and settled dust extracts were done by a prick test using commercial 
antigens or antigens prepared in our laboratory as explained in 
Appendix X and Appendix XI. These were considered positive if a wheal 
of 3 mm or greater developed 20 minutes following the prick.
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c) Delayed hypersensitivity to PPD, mumps, Candida, Streptokinase- 
Streptodornase and Tr ichophyton was determ i ned us i ng commerc i a IIy 
available antigens injected intradermally (.02 cc). Intraderma I skin 
tests were considered positive when: PPD, 5TU was 10 mm or greater
induration; SKSD, Trichophyton and Candida were 5 mm or greater 
induration and mumps 15 mm or greater erythema.
d) Serum precipitating antibodies were analyzed by techniques 
described in Appendix XII.
e) Immunoglobulins IgE, IgG, IgA and IgM were determined by 
techn i ques descr i bed i n Append i x XIII.
HemogIobuIin, hematocrit, urinalysis and blood chemistries
Methods for the determination of pseudocholinesterase, serum SGPT, 
serum creatinine and gamma GT are described in Appendix IX and for 
AIpha^-antitrypsin levels in Appendix XIII.
Chest Roentgenograms
Roentgenographic examinations of the chest complied with the 
specifications published in the Federal Registry, Vol. 28, No. 144, 
July 27, 1973. The posterior-anterior views were taken at Memorial 
Hospital, Radiology Department, Superior, Wisconsin. At the end of 
each test i ng day one of the pr i nc i paI i nvest i gators (GdP) rev i ewed a 11 
of the radiographs for quality and abnormalities that would require 
re-examination or recommendation to the patient of the need for further 
medical attention, e.g., bilaterial hilar adenopathy in subject #719. 
Workers with severe kyphoscoliosis or cardiomegaly would have been 
excluded in the group pulmonary function analysis. The PA chest 
roentgenographs were later read and interpreted independently by two 
physicians (a radiologist (M.E.P.) and a pulmonologist (H.D.). There 
was 95% agreement in the readings. The disagreements were on minor 
issues of questionable clinical or physiological significance, e.g., 
whether a single nodule was calcified or not, etc. When disagreements 
occurred, the roentgenographs were re-exam i ned and the f i nal read i ngs 
agreed to by the two readers and a principal co-investigator (GdP.). 
The reading form for the chest roentgenograms is contained in Appendix 
XVI.
The levels of circulating immunoglobulins (G,A,M,E) were determined 
by the standard timed Hancini technique (Appendix IX) using frozen 
serum samples from 307 grain workers and 237 city services workers.
The reproducibility of the immunodiffusion system was insured by 
the following protocol: The same lot of immunodiffusion plates was 
used to test both grain workers and controls for IgG, IgA, IgM and IgE 
levels. Accuracy control (internal standard) was included on each 
plate and a three point protein reference curve was included on every 
third plate.
Quality control data indicated a 2.5% variation in the values of 
the internal control from plate to plate. Plots of the squared
diameter of the precipitin rings (ordinate) obtained from the protein 
references against their respective concentrations (abscissa) on linear 
graph paper yielded an intercept ordinate of 11 % 2.5 mm3.
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2. RESULTS
2a SYMPTOMS (ANALYSIS OF QUESTIONNAIRE)
The analysis of symptoms or symptom complexes was made with 
the following objectives in mind:
1) To determine if the prevalence of acute and chronic
respiratory symptoms; eye, nose, throat, skin and joint symptoms; 
diseases or conditions diagnosed by a physician; and family histories 
of certain diseases among grain handlers were different than expected 
for people residing in the same geographic area with similar labor 
backgrounds, age, sex, smoking habits and socioeconomic status.
2) To determine the relative importance of the effects of 
cigarette smoking and grain handling on the prevalence of respiratory 
symptoms.
3) To determine if the prevalence of symptoms in grain
handlers was related to job classification, place or length of 
employment.
4) To determine the prevalence and characteristics of the
symptom complexes presented by grain handlers on exposure to grain dust 
and to pesticides.
5) To determine the relationship, if any, of acute and
chronic symptoms with lung function or immunologic parameters of the 
individual (see Section I-2a b c Correlations).
Definitions
Determination of chronic bronchitis followed the currently accepted 
definition of chronic expectoration for two or more years. Using this 
definition the diagnosis of chronic bronchitis can be made from the 
answers to the questionnaire. The combination of answers that may
represent this definition, however, has not been standardized We 
used primarily question 14E—  qreater than two years— as an indication 
of chronic bronchitis. In addition, we have used other combinations 
that may define the presence of chronic bronchitis and these are 
presented in Table 7.
Occupational asthma may be defined as wheezing and/or chest 
tightness when exposed to the working environment or the result of or 
aggravated by, exposure to the work environment. One may add to the 
definition: the association of cough and/or dyspnea also brought on or
aggravated by exposure to the work environment, and/or the relief or 
improvement of these symptoms when away from work or when on vacation. 
Answers to questions that may be used to categorize four definitions of 
occupational asthma are explained in Table 8. Dyspnea on exertion. 
Grade 1: when hurrying on level ground or walking up a slight hill.
Grade 2: when walking on level ground with people of own age.
Grade 3: having to stop walking when walking on level ground at others 
pace. Grade 4: having to stop walking when walking at own pace.
Objective 1. (refer to Tables 9-11 and Appendix VI)
Overall respiratory symptoms and symptom complexes, as well as
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symptoms of eye, nasal and throat irritations on exposure to the 
working environment were higher among grain handlers than controls 
(Table 9 and Appendix VI). Personal histories of pulmonary, 
cardiovascular, kidney and liver disease, diabetes or dermatitis 
diagnosed by a doctor and a family history of pulmonary disease were 
similar in the two occupational groups (Tables 10 and 11).
Usual cough and expectoration (Q 13 and 14).
There were significant differences between grain workers and 
controls (P < .001) in the prevalence of cough and expectoration: first 
thing in the morning, at other times during the day, four to six times 
a day at least four days a week (Q 13 & 14 a,b,c), at least three 
months of the year and for greater than two years (Q13 & 14 d,e). Of 
the 194 that had some type of cough, 175 had it for more than two 
years. There were 116 who did not have "usual" cough. Two hundred and 
sixty-six of the 310 grain workers had some type of expectoration; 151 
had it for more than two years. The prevalence of chronic bronchitis 
as defined in Table 8 was significantly higher among the grain workers 
than the controls. The prevalence of chronic bronchitis I was 46% in 
grain handlers and 18% among city workers. The incidence of chronic 
bronchitis was 35% in nonsmoking grain workers.
Cough and/or expectoration in relation to work (Q 15-18)
The cough or expectoration was worse on work days in a greater 
percentage of the grain workers (73%) than in controls (18%) (P < 
.001). Seventy-nine % of the controls noted no difference in cough or 
expectoration between work days and weekends. Only 27% of the grain 
workers noticed no difference between work days and weekends (Q 15).
Eighty-two % of grain workers felt their cough and/or phlegm was 
better on vacation (Q 16), whereas only 28% of controls reported
improvements in cough or phlegm (P < .01).
Cough and/or expectoration brought on or aggravated by exposure to 
grain dust, other dusts, gases or fumes at work (Q 18) was also
significantly higher among the grain workers than controls. The 
aggravation of cough and/or expectoration by barn dust was also higher 
among the grain workers than controls (P < .001). There was no
difference in the prevalence of symptoms aggravated by house dust,
weather or other factors.
Wheezing and/or chest tightness (Q 21-36).
The prevalence of wheezing and/or chest tightness (Q 21a) was 
higher (P < .001) in the grain workers (65%) than among controls
(42%). These significant differences were also apparent in all smoking 
categories between grain workers and controls and between smokers and 
nonsmokers i n both occupat i ona I categor i es. Note that 57% of the 
nonsmoker grain workers complained of wheezing and/or chest tightness.
The controls appeared to have a greater prevalence of "only 
wheezing" and "mainly wheezing" (0 22) than the grain workers, who had 
a greater prevalence of "both wheezing and/or chest tightness." 
However, the prevalence of "only chest tightness" or "mainly chest 
tightness" was not different between the two occupational groups.
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The onset of wheezing during 0-15 years of age was greater among 
controIs than among gra i n workers. Among the other age groups the 
onset of wheezing was not significantly different (Q 23).
Wheezing and/or chest tightness related to work exposure.
The prevalence of wheezing at work while performing their job (Q 25) 
was higher among grain workers (82.5%) than among controls (50%) (P < 
.001). The average frequency of wheezing and/or chest tightness during 
work appeared to be higher among the grain workers than controls. The 
prevalence of wheezing "at least once a day" and "a few tines a nonth" 
was significantly higher (P < .001) among the grain workers than
controls. The prevaIence of wheezing "a few tines a week" was 
significantly higher among controls (26% vs. 21%) (P < .05). The 
prevalence of wheezing and/or chest tightness occurring "a few tines a 
year" or "ever" was not different between the two occupational groups. 
It would appear that smokers in both groups (grain and controls) were 
more likely to have nore frequent wheezing than the nonsmokers. That 
is, they were nore likely to have it "daily" rather than "a few tines a 
nonth." There was only a small percentage (5% of the grain workers and 
14% of the controls) that had wheezing only "once."
Among the grain workers who had wheezing at work, 60% reported 
wheezing was usually worse any day of the week at work, 15% reported 
wheezing the first day of the work week and 25% clained no difference 
between the first day or any day of the week. None of the grain 
workers felt worse on the weekend. Among the controls, 76% answered 
that the day of the week nade no difference, 20% claimed that wheezing 
was worse any day at work and 4% reported wheezing on the first day of 
work. None of the controls answered that wheezing was worse on 
weekends (Q 27).
The prevalence of wheezing and chest tightness that was better
while on vacation or off work was significantly different and higher in 
grain workers (88%) than controls (20%) (P < .001). Most of the
controls (78%) felt that their wheezing remained the same on vacation 
or when not working (P < .001). There were two controls who felt worse 
on vacation.
The prevalence of occupational asthma, wheezing and/or chest 
tightness brought on or nade worse by exposure to grain dust, other
dusts, fumes or gases at work was significantly higher among grain
workers than controls (P < .001). The differences were also
significant between grain workers and controls in the three smoking 
categories. Significant differences were also observed when other 
comb i nat ions of quest ions were used to i nd icate occupat iona I asthma
(Table 6b).
Nocturnal dyspnea (0 33)
The prevalence of wheezing (0 33a) that awakened a subject from 
sleep was higher in grain workers (20%) than controls (10%). There was 
no difference in the prevalence of this symptom among the three smoking 
categories of each occupational group (Q 33a). The frequency of 
individual episodes of nocturnal wheezing (0 33b) was not different 
between grain workers and controls.
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Wheezing and/or chest tightness relation to time of the year (Q 34)
The prevalence of wheezing with no specific relation to the time of 
the year was similar in grain workers and controls. Controls who 
noticed seasonal variation reported the predominance of wheezing in 
January (28/40 or 70%). In the grain workers, the highest prevalence 
was found during January (32%) followed by April (16%), May (11%), June 
(11%), August and September.
Wheezing with dyspnea (Q 36)
The prevalence of attacks of wheezing with shortness of breath was 
higher among grain workers than controls (P <0.001) (0 36).
Dyspnea (Q 37-42)
The prevalence of ever having shortness of breath (Q 37), Grade 1 
(Q 38) or Grade 2 (0 39) dyspnea was significantly higher in grain 
workers than controls (P < 0.001, P < 0.01, P < 0.05, respectively). 
There were no differences for dyspnea on exertion for Grade 3 (Q 40) 
and Grade 4 (Q 41). The number of years they had shortness of breath 
was not different between the two occupational groups (Q 42).
Dyspnea while performing work (Q 43-44)
The prevalence of shortness of breath while performing work (Q 43) 
was higher in grain workers (36%) than controls (11%).
Chest illnesses (0 63)
The frequency of chest illnesses and their interference with normal 
activities was similar in grain workers and controls (Q 63a, b).
Disease or conditions diagnosed by a doctor (0 64-67)
Except for the prevalence of allergic rhinitis, which was higher in 
the controls than grain workers, the prevalence for the diseases or 
conditions indicated in Table 10 was not different between the groups.
Family history (immediate blood relatives) (0 74)
The prevalence of lung diseases shown in Table 11 in blood 
relatives of the grain workers and controls were not different.
Objective 2
Role of cigarette smoking.
A. Analysis of prevalence of symptoms by smoking categories.
Considering that the proportion of smokers, ex-smokers and 
nonsmokers was similar in grain workers and controls, the significantly 
higher prevalence of respiratory symptoms in grain handlers must be due 
to a significant effect of grain handling independent of smoking. To 
confirm this assertion and further evaluate the effects and possible 
interaction of cigarette smoking on symptom prevalence, we compared and 
analyzed the prevalence of symptoms or symptom complexes between grain 
workers and controls for each smoking category and between smokers and 
ex-smokers, ex-smokers and non-smokers, and non-smokers and smokers for 
each occupational group. (Table 9 and Appendix XI).
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The significant differences were analyzed by chi-square analysis. 
Overa11 the symptoms were more prevaIent among gra i n workers than 
controls in every smoking category (Table 9). For example (Table 12), 
the prevalence of chronic bronchitis among grain workers who smoke was 
higher than controls who smoke (57% vs. 30%) (P < .001), and higher 
among nonsmoking grain workers than nonsmoking controls (35% vs. 10%) 
(P < .001). Actually the prevalence of chronic bronchitis in
nonsmoking grain workers was higher (35%) than in controls (30%) who 
smoked.
The prevalence of “occupational asthma I" was also higher among 
grain workers who smoke (67%) than smoking controls (13%) and higher in 
nonsmoking grain workers (50%) than nonsmoking controls (11%). The 
prevalence of symptoms among nonsmoking grain workers was higher than 
among controls who smoke.
In grain workers, the prevalence of chronic cough and 
expectoration, chronic bronchitis, wheezing and/or chest tightness was 
h i gher i n smokers than nonsmokers or ex-smokers, but there were no 
d i fferences i n symptoms between nonsmokers or ex-smokers. The 
prevalence of nocturnal wheezing, dyspnea on exertion and "chest 
illness" was not significantly different between smoking categories 
(Table 12).
In grain handlers the prevalence of wheezing and/or chest tightness 
and cough and/or expectoration on exposure to the work environment 
("occupational asthma II") was significantly higher among smokers than 
nonsmokers and ex-smokers. The prevalence of dyspnea at work and grain 
fever was not different in smoking categories.
2b. A quantitative analysis of the relative effects of smoking and 
grain handling on symptom prevalence.
In order to quantitate the effects of smoking during grain dust 
exposures we analyzed the data using a log-linear model. We found that 
the effects of smoking and grain handling were both highly 
statistically significant and independent. Factors, or quantities, by 
which grain handling or smoking increased the odds (risk) of having a 
specific symptom or symptom complex are presented in Table 13. 
Overall, the effects of grain handling were greater than the effects of 
smoking. For example, the grain handler had four and a half times 
greater r i sk of hav i ng chron i c bronch i t i s than a non-gra in handIer 
regardless of the smoking habit. Smoking, independent of grain
handling, increased the odds of having chronic bronchitis by a factor
of three. Grain handling also increased the odds of having
occupational asthma II by a factor of five to 10, regardless of the
smoking habit and smoking by a factor of three regardless of grain 
handIing.
Objective 3
To study the effects of job categories and length and place of 
employment on symptom prevalence among grain handlers, we used logistic
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regress ion anaIys i s adj ust i ng for age, smoking hab i t and Iength of 
employment. Prevalence by smoking habits have been presented in Table 
9 and by age groups in Table 14. Only eye and nasal symptoms were 
related to age. We found that wheezing, dyspnea, nasal symptoms on 
exposure to grain dust and usual cough first thing in the morning were 
positively related to length of employment (Table 15). Eye symptoms on 
exposure, chronic bronchitis as previously defined and grain fever were 
not related to length of employment (Table 15). In Table 15, the
percent of prevalence was not adjusted for age or smoking. The P value 
indicates the significance of the relation between length of employment 
and prevalence of symptoms obtained from the used in the log-linear 
model adjusting for age and smoking. The job categories used in the 
analysis are presented in Table 16. Overall there were no significant 
d i fferences i n the preva I ence of symptoms among the var i ous j ob 
categories adjusting for age, smoking and length of employment (Table 
17). Table 18 shows those symptoms in which there were significant 
differences in prevalence between jobs ranked using the z values from 
the regression analysis. We found the highest prevalence among 
weighers and longshoremen and the lowest among inspectors.
The prevalence of wheezing and dyspnea on exposure was 
significantly different among elevator companies, but other symptoms
were not different (Table 19). We ranked the relative prevalence of 
symptoms adjusting for age, smoking, and length of employment among the 
companies from one to eight (Table 20). One corresponded to the 
company with the lowest prevalence; eight to the highest. The score 
value resulted from adding all the rank values for each symptom. 
Companies 1, 7, 5 and 4 appeared to have the highest prevalence, 
whereas 2 and 8 had the I owest. When we ana I yzed a 11 other symptoms or 
symptom complexes and ranked them, we obtained similar results. The 
overall ranking, considering symptoms which were found to be 
significantly different or not found to be significantly different 
among the companies is indicated in parenthesis. The relatively more 
symptomatic populations appeared to be in companies 1, 7, 5 and 4 who
had fewer symptoms than in companies 8 and 2.
Objective 4
The characteristics of the symptoms and symptom complexes (Table 9, 
8, and Appendix VI) developed by the grain workers on exposure to grain 
dust were as follows:
Respiratory symptoms on exposure
Cough and/or expectoration brought on or aggravated by exposure to 
grain dust was present (Q 18a) in 200 of 310 grain workers or 65%, and 
it was significantly higher among smokers (75%) than nonsmokers (52%); 
the symptoms were equally prevalent among ex-smokers and nonsmokers. 
The grain dusts that were most likely to bring on or aggravate cough 
and/or expectoration were durum wheat (55%) and barley (48%). Next 
were spring wheat (25%), rye (27%) and oat (21%). Least likely were 
corn (4%), soybean (5%), sunflower and others (1.6%). The frequency of 
cough and/or expectoration on exposure to grain dust, regardless of the 
smoking category, was daily (77%), a few times a week (18%) and a few 
times a month or a few times a year (3.2%).
The frequency of wheezing at work was determined in grain workers.
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Most subjects (59%) reported that wheezing occurred once a day, a few 
tines a week or a few times each nonth; another 16% reported that 
wheezing occurred once a year.
Wheezing/or chest tightness brought on or nade worse by exposure to 
grain dust was reported by 59% of the grain workers. Durum wheat and 
barley were reported to be the most common inducer of symptoms foilowed 
by spring wheat, rye and oats. The onset of wheezing and/or chest 
tightness was reported to occur: during work (70.5%), after work
(11.5%) or during and after work (16%). Only three workers claimed 
wheezing before going to work. Of those who felt that wheezing started 
or got worse during work, 19% of 156 reported that it started 
¡■mediately and 81% of 156 reported that wheezing started a few hours 
Iater. In the Iatter group, the workers reported that wheez i ng 
developed: 2 hours after starting work (42%), 4 hours after starting 
work (16%), the first hour of a work shift (14%) and 3 hours after 
starting work (14%). Only 6% of the workers felt the symptom develop 
during the fifth or sixth hour of work.
Some grain workers did report that wheezing and/or chest tightness 
occurred after the work shift. The symptom was likely to occur during 
the first hour after work (34%) or in the second hour (20%). However, 
some individuals had reactions 5, 6, 8, 9, 10 or nore hours later.
Shortness of breath during or after exposure to grain dust was 
clained by 49% of the grain workers. The prevalence of this symptom 
was higher among smokers than nonsmokers. The dusts that were nost 
likely to bring on this symptom were durum wheat, barley, spring wheat, 
rye and oats. The dusts least likely to induce shortness of breath 
were soybean, corn, linseed, sunflower and beets. The workers reported 
that shortness of breath occurred: during work (82%), either during or
after work (12%) or after work (6%). Of the subjects who reported 
shortness of breath at work, the onset occurred: 5 hours after
starting work (66%), within 2 hours after starting work (50%) or 
immediately after starting work (33%). The few workers who developed 
shortness of this breath after work reportedly noticed it between one 
and three hours after work.
Grain fever syndrome (Table 21)
A detailed history was obtained on the 121 workers who reported 
fever and/or chills on exposure to grain dust. We concluded that a 
syndrome compatible with grain fever was present in 99 of the grain 
workers who compIa i ned of fever on exposure (82%). AI though the 
history was questionable, an additional 16 workers nay have had grain 
fever. In the remaining 6 workers, we could not exclude the
possibility that the synptoms of grain fever were evoked by an upper
respiratory tract viral infection or other infectious processes.
The prevaIence of grain fever was similar in the three smoking 
categories. All subjects included in the grain fever group (N=115) had 
episodes of "a flu-like" syndrome with the sensation of fever, chills
or chilliness, nyalgia, arthralgias, malaise, warmth in the face with
or without respiratory symptoms. Most of the workers (73%) recalled no 
associated respiratory symptoms with the grain fever and a smaller 
proportion of workers recalled cough, wheezing., or dyspnea associated
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with the grain fever. In subjects who developed respiratory symptoms, 
the symptoms developed during or after work and improved in a few hours 
or by the next working day. These episodes were usually associated 
w i th heavy exposure to gra i n dust on that day. I n 96 of the 115 
workers, the number of grain fever episodes was ascertained. Forty-two 
percent of the workers had fewer than 10 episodes, whereas a small 
number of workers (16%) reported numerous episodes (Table 21). Workers 
reported that the grain fever usually occurred during work (32%), after 
work (35%), or during and after work (33%). Most of the workers (83%) 
indicated that grain fever occurred on any day of the week, whereas 17% 
i nd icated that gra i n fever occurred the f i rst day at work after a 
weekend or vacation. When grain fever occurred on the first day of 
work, the symptoms were usually worse.
Eye, nose and throat symptoms on exposure at work (Q 48a, b, c - 
Appendix XI)
Grain workers (98%) reported symptoms of eye irritation on exposure 
to grain dust. After exposure, grain workers also reported a stuffy 
nose (99%) or a sore throat (52%). Durum wheat and barley were the 
most likely inducers of these symptoms, followed by rye, spring wheat 
and oats.
Skin pruritus (049 - Appendix XI)
On exposure to grain dust, pruritis (itching of skin) was reported 
by 63% of the grain workers. The most common inducer of skin pruritis 
was barley, followed by wheat, oats and rye dust.
Health problems caused by pesticide exposure at work (Table 22)
One hundred and sixty-eight of the 294 grain workers who reported 
being exposed to pesticides at one time or another during their work 
life, reported health problems associated with pesticide exposure 
(Table 22). The most common symptoms were: headache (37%), dizziness 
(28%), weakness (21%), nausea (21%) and trouble breathing (16%). 
Blurred vision, stomach pains, diarrhea, fainting and cramps occurred 
in fewer than 5% of the workers. Nineteen of the 167 (11%) who 
answered 0 61 and 0 62 had to seek medical attention, and twenty-eight 
(17%) could not continue regular work assignments on the day of 
exposure. Exposure to phostoxin, carbon tetrachloride, malathion and 
methyl bromide were reported by the workers. There were, however, many 
instances in which the workers could not identify the pesticide. 72% 
had fewer than 10 symptomatic exposures to pesticides. A small number 
(16%) reported 20 to 100 symptomatic exposures to pesticides.
2a. RESULTS OF PHYSICAL EXAMINATION (Tables 23 and 24)
Physical examination revealed no chest configuration differences 
between gra i n workers and controIs (TabIe 23). There was no 
significant difference between grain workers and controls in 
auscultation of the heart or in the presence of hepatomegaly. However, 
the liver was more frequently palpable in the grain workers than 
controls.
Auscultation of the chest detected rhonchi or wheezes diffuse or 
localized, in 43% of the grain workers and 16% of the city workers (p < 
.005). The differences were also significant in each smoking category 
(Table 24). Once again, one should notice that 35% of the nonsmokers 
among the grain handlers had expiratory wheezes.
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There was no difference in the incidence of abnormal diastolic 
blood pressures in grain workers and controls. Thirty-nine (13%) grain 
workers and 25 (10%) controls had diastolic pressures higher than 90 
■mHg; 4 (1%) grain workers and 6 (3%) controls had diastolic pressures 
above 100 MiHg. Systolic pressures above 150 mmHg were found in 8% of 
grain workers and 13% of controls.
CONCLUSIONS
1) Clinical findings
Grain handlers had a higher prevalence of respiratory symptoms 
and s i gns (rhonch i) than comparabIe non-grai n handIi ng c i ty serv i ce 
workers from the same geographic area (Table 7-9, 12, 24) whether or 
not they smoked. The effects of grain handling on prevalence of 
respiratory symptoms were highly significant, independent and usually 
greater than those of smok i ng (Tab I e 13). The preva tence of work 
related respiratory symptoms adjusted for age and smoking habit was 
also positively related to place (Tables 19, 20) and length of
employment (Table 15). The data suggested variable environmental 
working conditions among elevators and perhaps an accumulative 
respiratory effect due to recurring exposures to grain dust.
Grain workers suffer from:
a) acute and chronic airways reactions (occupational asthma and 
chronic bronchitis) induced by exposure to grain dust with varying 
degrees of cough, expectoration, wheezing and/or chest tightness and 
shortness of breath. Durum wheat and barley grain dust were the most 
common inducers of symptoms. During the work shift, wheezing and/or 
chest tightness occurred immediately after starting work or within two 
hours. In late reactors, wheezing occurred within two hours after 
leaving work. Very late reactions were not reported.
Wheezing and dyspnea on exposure were related to length of 
employment. This may indicate either increased sensitization to the 
allergens present in the environment or the bronchial mucosa being 
rendered more hyperactive by the recurrent non-specific inflammatory 
reactions of the airways by grain dust. The place of employment was 
found to affect the prevalence of symptoms. The highest prevalence of 
symptoms were found in companies 1, 7, 5 and 4 and the lowest in 
companies 2 and 8.
b) A grain fever syndrome (Table 21) is characterized by a 
short-term febrile illness (flu-like syndrome) that may be associated 
with respiratory symptoms. It usually occurs during work or shortly 
after work. It is related to exposure to high concentrations of dust 
any day of the work week and not necessarily the first day at work or 
the first day of the week. There was, however, a small percentage of 
workers who had a single episode of grain fever the very first time at 
work and not again. The workers stated that in the last three years, 
because of the improvement in the work i ng cond i t ions, gra i n fever 
occurred less frequently. Some workers had grain fever a few hours 
after work, compatible with allergic pneumonitis. However, none of 
these episodes were severe enough to require medical attention, and we 
lack radiographic proof of allergic pneumonitis. Furthermore, the 
symptoms tended not to recur unless very high concentrations of dust
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were again present. Although we cannot deny that in some instances the 
grain fever syndrome may be a manifestation of allergic alveolitis, we 
have not found the typical history and radiographic changes of allergic 
alveolitis in these workers.
c) Acute recurrent conjunctivitis and rhinitis during exposure to 
grain dust occurred in most grain workers.
d) Skin pruritis occurred mostly on exposure to barley dust.
e) Pesticide exposure caused temporary disabling symptoms.
The long-term effects of recurrent symptomatic or asymptomatic 
exposures to pesticides are unknown. But we have encountered several 
former grain handlers with chronic neurological defects attributable to 
pesticide exposure.
Section I - Results 2b
2b. PULMONARY FUNCTION STUDIES
Lung function evaluations served the following purposes:
1) To determine if there was a difference in puImonary 
function between grain handlers and people residing in the same
geographic area with similar labor backgrounds, age, sex, smoking 
habits and socioeconomic status.
2) To determine the relative effects of cigarette smoking and 
gra i n handIi ng on Iung funct i on.
3) To determine the prevalence of abnormal lung function and 
the patterns of dysfunction among grain handlers.
4) To determine if job category, place or length of
employment had an effect on lung functions among grain handlers.
5) To determine the prevalence, if any, of abnormal lung 
function and patterns of dysfunction among grain handlers.
Objectives 1 and 2
The results of the pulmonary function studies by age and smoking 
groups are presented in Table 25 for the grain workers and Table 26 for 
the controls. The mean values for all lung functions (Table 27) were 
significantly different when grain handlers and city workers were 
compared by the unpaired t-test. There were no differences in the mean 
FEVf and FVC of workers tested either on the same day of exposure one 
or more than 2 days after the last exposure. MMF means were different 
(P < .05) between those tested the same day and those tested more than
two days from the last exposure (Table 28).
The effects of grain handling, age, height and smoking habits on 
lung function were analyzed by multiple regression analyses (Table
29). Age had a significant effect on all lung functions except 
Vmax5 Q. The effects of grain handI¡ng were significant on all 
measures except CV. Smoking had an effect on all lung functions. The 
combined effects of grain handling and smoking were additive, but not 
synergistic when tested for interaction.
Objective 3
The prevalence of abnormal lung functions, except FVC, was higher
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among grain workers than controls using chi-square analysis (Table
30). Airway obstruction, defined as FEV-j/FVC < 70%, was present in 
16% of grain workers and 7% of control workers. If abnormal MMF, 
VmaxgQ and Vmax7 5  are considered to indicate airways obstruction, 
then IMF detected airways obstruction as often as FEV<|/FVCf whereas, 
Vmaxgo and Vmax7 5  detected a higher proportion of abnormalities in 
both grain workers and controls. Abnormality in the distribution of 
ventilation (CV, N2/L) may also reflect airways dysfunction but is 
affected by the parenchymal recoil status. Grain workers had a higher 
prevalence of abnormality in distribution of ventilation (CV, N2/L) 
than controls. N2/L, although it detected a higher percentage of 
workers with dysfunction than FEV-j/FVC, also detected a higher 
percentage of abnormalities among the controls. The prevalence of 
abnormal D|_co was higher in controls than grain workers and higher in 
smoker controls than smoker grain workers. The percentage of abnormal 
function tests other than D|_qq in nonsmoker grain workers tended to 
be higher than that of nonsmoker controls, however, the differences 
were statistically significant only for MMF and Vmaxjjg. The 
prevalence of abnormal functions was consistently higher among smoking 
grain workers than non-workers and reached statistical significance for 
WF, VmaxgQ, Vmax7 5 , N2/L. More severe airways obstruction, 
i nd i cated by an FEV-j /FVC < 60% was not more preva I ent among gra i n 
handlers (4%) than among controls (3%) and there were only 3 grain and 
3 control workers with FEV-j /FVC less than <50%.
To determine the relative importance of cigarette smoking and grain 
dust exposure on lung function, we analyzed the ratios of their 
regression coefficients from the regression analysis (Table 31). A 
ratio of 1 indicates that smoking and grain exposure had the same 
effect on lung function. Values greater than 1 indicate a greater 
effect of smoking. For example, smoking had a 44% greater effect on 
FEV-j than grain handling. Smoking had a much greater effect on 
D|co and CV whereas flows at low lung volumes were close to 1 or even 
lower. Hence, the effects of smoking were the same or greater than 
grain exposure for all lung functions except Vmaxtjo. The reasons for 
the latter are not clear.
In addition, to further quantitate the effects of smoking and grain 
dust exposure, we analyzed these data using a log-linear model. Both 
grain handling and smoking significantly and independently increased 
the odds of having airways obstruction by two and one-half times (odds 
factor = 2.6 for grain handling and 2.7 for smoking). That is, a grain 
handler had two and a half times greater risk of having airways 
obstruction than a non-grain handler regardless of their smoking 
habit. Smoking, independent of grain handling, also increased the odds 
of airways obstruction 2.5 times.
Objective 4
Lastly, to study the effects of type, place and length of 
employment, we also used multiple regression analysis to adjust for age 
and smoking. We found no significant differences in lung functions 
between the six job categories, places of employment and length of 
employment (Tables 32 and 33).
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CONCLUSIONS
Grain dust exposure had an adverse effect on lung function (Tables 
25-27, 29-31). The effects of grain dust on airways function was 
highly significant, and the overall effect was the same or of a smaller 
magnitude than that of smoking. Although there were more grain workers 
with mild airways obstruction than controls, moderately severe or 
severe airways obstruction was equally prevalent in both. The effect 
of gra i n hand I i ng appeared to be on the a i rways and not on the 
parenchyma. However, the high prevalence of abnormal . N2/L 
which nay reflect parenchymal injury needs further evaluation. There 
was no correlation between lung function and job category, place or 
length of employment (Tables 32 and 33).
Section I - Results 2c
2c. SKIN TESTS-IMMEDIATE HYPERSENSITIVITY
A. Analysis'of Prevalence of Positive Reactions in the Grain 
Workers and Control from Duluth Metropolitan Area and Controls from the 
Madison, Wisconsin Area (Tables 34 and 35).
Common AIlergens
The prevalence of positive skin tests to oak pollen or timothy 
grass in the grain handling population was lower than observed in the 
control population from the same geographic area. Moreover, the 
prevalence of 1 or more positive skin tests to common allergens was 
lower in the grain handling population (Tables 34 and 35) than in the 
Superior-Duluth city workers.
Superior-Duluth city workers had a higher prevalence of positive 
skin tests to oak pollen than Madison workers. Moreover, more of the 
subjects from the Superior-Duluth area had positive skin tests to 1 or 
more common allergens.
Conclusion
The lower prevalence of atopy in grain workers (1 or more positive 
skin tests) than city workers from the same geographic area suggests 
that the aore "allergic" individuals tend to avoid the grain dust 
environment or leave the industry.
Fungal Antigens
There was a very low prevalence of positive skin tests reactions 
to fungal extracts. No differences were found between the occupational 
groups. However, the skin test reagents were not representative of the 
fungi and flora we found in the airborne dust of grain elevators (See 
Dr. Smalley's subcontract report).
Insects and Mites
There was a higher prevalence of skin test reactivity to mixed 
grain mites and mixed grain beetles in grain workers when compared to 
Duluth city workers. Skin test reactivity to grain beetles among the 
grain workers was higher than in the Madison workers.
ConeIus i on
As expected, a higher proportion of grain workers reacted to grain 
mites and insects commonly found to contaminate cereal grain. The 
prevalence of reactivity is similar to that we found in 1974 with 
common house insect extracts.
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Grain Antigens
The prevalence of positive skin tests to whole grain antigens was 
low in the test and control populations. The prevalence of positive 
skin tests to small seeds was different when the city workers were 
compared to Madison workers or when the Madison workers were compared 
to grain workers. There was, however, no difference in skin test 
reactivity to small seeds when grain workers were compared to city 
workers.
Conclusions
The low prevalence of positive reactions nay be due to low 
antigenicity of grain, extracts tested at sub-optimal concentrations, 
or the loss of antigenic components during extraction procedure.
Airborne Dust
The prevalence of positive skin tests to durum and spring wheat 
dusts was higher in the grain workers when compared to the city workers 
and the Madison workers. The city workers had a higher prevalence of 
positive reactions to durum wheat, corn, rye, oats and sunflower seeds 
when compared to Mad t son workers. The preva I ence of the sk i n
reactivity to barley was not different in the grain workers and city 
workers. However, the grain workers had a higher prevalence of skin 
test reactivity to barley than the Madison workers. When considering 
the preva I ence of sk i n test react i ons to one or more of the dust 
antigens, there was no difference between grain workers and city 
workers. There was, however, a significant difference between 
Duluth-Superior city workers and Madison workers. Similar differences 
were observed when the grain workers were compared to Madison workers.
Conclusions
The increased frequency in skin test reactivity to wheat dust
extracts reflects the higher exposure of grain workers to wheat dusts. 
City workers, however, also seem to be exposed to environmental 
contamination with several types of grain dusts based upon comparisons 
with the Madison workers.
Settled Dust
The prevalence of skin test reactivity to settled dust was similar 
in grain worker and Duluth/Superior city workers but both were
significantly higher than Madison workers.
B. Analysis of the Intensity and Degree of Skin Hypersensitivity 
in the Three Occupational Groups using the Total Sum of Wheal
Reactions (Fig. 1).
Figure 1 presents the distribution of sums of all wheal 
reactions for each group of antigens. The mean wheal reaction for each 
group is indicated with a horizontal bar. The mean wheal reaction for 
common atopic allergens in control workers was greater than in grain 
workers. There were no significant differences in mean wheal reactions 
to the other antigens between the three occupational groups.
C. Prevalence of Grain Dust and Insect-Mite Reactivity among
Atopic Grain Workers and Controls (Table 37).
The prevalence of skin reactions to grain dusts and insects or
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mites was significantly higher among atopic individuals (grain or 
control) than among non-atopic individuals.
ConeIus i ons
Not surprisingly, atopic workers are store likely to become 
sensitized to antigens extracted from grain dust and the insects or 
nites which are commonly found in cereal grains.
2a, b, c RELATIONSHIPS BETWEEN SYMPTOMS, PULMONARY FUNCTIONS AND SKIN 
REACTIVITY.
2a, b. RELATIONSHIPS BETWEEN SYMPTOMS AND PULMONARY FUNCTION.
The relationships were analyzed by: i) multiple regression
analyses using the lung function value as the dependent variable and 
se1ected i ndependent var i abIes: symptoms, symptoms compIexes, age,
height, and smoking habit; and ii) comparisons of abnormal lung 
function in symptomatic and asymptomatic grain workers.
i) Results of Multiple Regression Analysis
The relationships between acute and chronic symptoms or symptom 
complexes are presented in Table 38. There was a significant negative 
relationship between symptoms on exposure to grain dust and tests of 
ventilatory function (FEVj/FVC, MMF, VmaxgQ, Vmax75 >. There was 
also a significant and negative relationship between chronic cough 
first thing in the morning and the FEV-|/FVC and MMF. Chronic 
bronchitis phlegm the first thing in the morning, wheezing at night, 
grain fever, and chest illness did not correlate with pulmonary 
functions as tested.
Among controls, there was a negative relationship between 
FEVVFVC and chronic bronchitis, wheezing at night and dyspnea on 
exert i on.
i i) ResuIts of ReIat ionsh i p between Symptoms and AbnormaI PuImonary 
Functions. The Prevalence of Abnormal Lung Function in Grain Workers 
with and without Selected Symptoms (Table 39).
A h i gher proporti on of workers w i th chron i c bronch i t i s had 
airways obstruction as measured by FEVj, FVC, MMF and Vmaxejo. A 
higher proportion of workers with respiratory symptoms (cough, wheezing 
or dyspnea) on exposure to grain dust had abnormal FEV-j/FVC, MMF, 
Vmaxgo and Vmax7 5  N2/L and DLlcq. There was no correlation 
between the history of grain fever or wheezing at night and abnormal 
pulmonary function. Workers with dyspnea on exertion had a higher 
prevalence of abnormal FEVj/FVC, MMF, Vmaxgg, FVC and Dlcq.
Conclusions
Clinico-physiological correlation. Grain workers with symptoms on 
exposure to dust had lower values of ventilatory function than workers 
without symptoms on exposure regardless of smoking habits (Table 38, 
39). This suggests that such symptomatic workers are at a higher risk 
of developing airways dysfunction and possibly non-specific bronchial 
hypereactivity. The prevalence of chronic bronchitis with airways 
obstruction was higher in grain workers than controls, regardless of 
smoking habits. In addition, chronic bronchitis with airways
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obstruction was related to length of employment. These findings 
suggest that chronic grain dust exposure may result in chronic 
obstructive pulmonary disease.
2b, C. RELATION BETWEEN PULMONARY FUNCTION AND SKIN TESTS.
This analysis was done by: i) multiple regression analysis
adjusting for age, height and smoking habit (Tables 40a and 40b), and 
ii) comparing prevalence of abnormal lung function tests in positive 
and negative skin reactors (Table 41a and 41b).
i) Multiple Regression Analysis - Grain Workers.* (Table 40a).
There were negative relationships between the total mean wheal
diameter for common allergens and grain dust antigens and FEVj/FVC, 
FEV|, FVC, MMF, VmaxgQ and Vmaxyg. Using skin tests in the 
categorical way (positive or negative skin tests), there were also 
negative relationships between reactivity to common atopic allergens 
(CAA), airborne dust extract, durum wheat, fungi and settled dust 
extracts and FEVj, MMF, Vmaxgg and Vmax7 5  (Table 40a). We found 
no consistent relationship between reactivity to insects and mites, and 
barley or to one or more grain antigens and pulmonary function. There 
was no relationship between skin test reactivity and pulmonary function 
in the control group (Table 40b), except for vital capacity with total 
wheal for common allergens and total wheal for grain and grain dust 
antigens and with reactivity to barley, grain and settled dust antigens.
ii) The prevalence of abnormal lung function in positive and 
negative skin reactors is shown in Tables 41a-b. The prevalence of 
abnormal FEV|/FVC, MMR, Vmax^Q and N2/L were not different between 
atopic and non-atopic grain workers or between reactors and 
non-reactors to insect and mite antigens. There was, however, a 
difference in the prevalence of abnormal lung functions in reactors and 
non-reactors to fungal antigens. An abnormal Vnaxgo was more 
prevalent in reactions to airborne grain dust. Among the controls 
(Table 41b), there were no significant differences between reactors and 
non-reactors.
Conclusions
The results of the regression analysis indicate that grain workers 
with atopy or skin reactivity to grain dust antigens are more likely to 
have lower lung function values than non-reactors to common allergens 
or grain dust antigens. The clinical significance of these findings is 
not clear since abnormal lung function is not more prevalent among 
atopic individuals or skin reactors.
2a, c. RELATIONSHIP BETWEEN SYMPTOMS AND SKIN REACTIVITY.
The relationship between the prevalence of symptoms on exposure to 
grain dust and chronic symptoms and skin reactivity to allergens are 
presented in Table 42.
The data demonstrated that: 1) dyspnea on exposure to grain dust
was more frequent among those grain workers with positive skin 
reactivity to fungal antigens and to grain antigens, and 2) nasal 
symptoms on exposure to grain dust were more frequent among those 
workers with positive skin reactivity to grain antigens, barley and 
oats antigens. Overall, there were no significant correlations between
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acute symptoms on exposure to gra i n dust, chron i c symptoms, gra i n 
fever, and symptom complexes and skin reactivity to common allergens or 
specific allergens.
Sect i on I
2c. SKIN TESTS - DELAYED HYPERSENSITIVITY (Table 43).
There was no difference in the prevalence of positive PPD tests in 
grain workers and controls. The prevalence of skin reactions to 
Candida and numps was higher in city workers. Conversely, the 
prevalence of positive skin tests to Trichophytin and SK/SD was higher 
in grain workers. Overall, the prevalence of positive tests (2 or more 
of positive tests) was not significantly different between groups.
2d. SERUM PRECIPITATING ANTIBODIES
The prevalence of precipitins are shown in Table 44. City workers 
had a greater frequency of precipitins to Trichoderma, T. vulgaris 
(Greer or Hollisteir strains), T. sacchari or to one or «ore extracts 
(#1-33). Conversely, grain workers had a greater frequency of 
precipitins to durum wheat and rye. The grain workers also had an 
increased frequency of precipitins to airborne dusts from durum wheat, 
barley, rye, oats and sunflower seeds.
Relationships between Serum Precipitins and Pulmonary Function.
To evaluate the relationship, we used the prevalence of abnormal 
functions:
FEV1/FVC ratio < 70%, Vmaxsp < 1.65 SD, N2/L > 1.65 SD and DLC0 
< 80% in subjects with positive or negative precipitins to one or more 
of the following:
I) Fungal, bacterial, and pigeon sera antigens 1-33 (Table 44)
2) grain dust antigens labeled 42-52 (Table 44)
3) grain, grain dust, insects or mites 34-55 (Table 44)
4) Thermoactinomycetes #17-20 and #27-33 (Table 44)
5) Aspergillus fumigatus #5-10 (Table 44)
There was a significantly higher prevalence of airways obstruction 
(FEV|/FVC < 70%) among grain handlers with precipitins to A.
fumigatus. A higher prevalence of abnormal slope III or N2/L was 
observed in grain workers and controls with serum precipitins to one or 
■ore fungal antigens. There was no relationship between the presence 
of precipitins and abnormal VmaxgQ, Vmax7 5 , arK* 0L.
Relationship between Symptoms and Precipitins 
The prevaIence of symptoms on exposure or gra i n fever were not 
d i fferent i n gra i n workers with or w ithout prec i p i t i ns as descr i bed 
above.
Conclusions
7) Serum precipitating antibodies. City workers had a greater 
prevalence of precipitins to Trichoderma, T\ vuIgaris, T^ sacchari and 
to one or more fungi than grain workers (Table 44). Conversely, grain 
workers had a greater prevalence of precipitins to durum wheat, rye, 
and airborne dusts of wheat, barley, rye, oats and sunflower and to one 
of the settled dusts than controls. The larger prevalence of
Page 28
precipitins to some grain dusts among grain workers was not surprising, 
yet they did not correlate with increased prevalence of symptoms or 
abnormal lung functions. Hence, the data infer that the respiratory 
reactions to grain dusts are not precipitin-mediated and that grain 
fever is not a manifestation of allergic alveolitis type III reaction. 
Serum precipitins reflect host response to antigens but not necessarily 
the presence of disease or abnormal pulmonary dysfunction. The reason 
for the greater prevalence of fungal precipitins among city workers is 
not clear.
Section I
2e RESULTS - BLOOD CHEMISTRIES, URINALYSIS, HEMOGLOBIN
The mean values for pseudochoI inesterase , SGPT and creatinine were 
higher among grain workers (Table 45). The elevated values observed, 
however, were not high enough to indicate significant parenchymal liver 
disease. When the prevalence of abnormal values (larger than the 
highest range value for the laboratory) was considered, there was a 
difference only in GGT values.
Follow-up studies of abnormal liver function tests were attempted, but 
the returns from patients and physicians were not high. Hence, the 
data were inconclusive.
The presence of protein in urine was more frequent among grain 
workers when compared to controls.
Discussion - Liver Function Screening
SGPT
Alanine amino transferase (SGPT). The determination of SGPT is a 
sensitive indicator of minimal hepatocellular injury. Elevated levels 
nay precede other evidence of viral hepatitis by several weeks. The 
levels may remain elevated following the return to normal of other 
laboratory parameters which are sensitive indicators of persistent 
hepatitis. Like other indices of necrosis, the transaminases are 
inferior to alkaline phosphatase and other cholestatic indicators in 
detecting infiltrative liver disease or cholestatic injury. The SGPT 
analysis contributes significantly to the differential diagnosis of 
hepatobiliary disease: as a general rule, levels greater than ten
times the upper normal limits favor acute hepatic cellular injury, 
lesser elevations favor chronic cell injury, cholestasis or 
infiltrative liver disease. There are, however, a number of important 
exceptions. Alcoholic liver disease (severe, acute alcoholic 
hepatitis) is characterized by transaminase levels less than ten times 
normal. On the other hand, extremely high values (in excess of ten 
times normal) may occur in early cholestatic injury due to extra 
hepatic obstruction. Although the transaminases are sensitive indices 
of cell injury, the diagnostic accuracy of these determinations are 
limited by a lack of a specificity. SGPT is widely distributed in the 
body, but it is predominantly confined to the liver making it more 
specific than SGOT.
GGT
Gamma glutamyl transpeptidase (GGT) predominates in renal and 
hepatobiliary tract tissue and was shown by histochemical methods to be 
located in the endothelial cells of a variety of tissues. However,
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serum GGT it is believed to originate in the hepatobiliary system. It 
is regarded as the most sensitive of the cholestatic indicators but has 
also been reported to be significantly elevated in virtually all 
hepatocellular conditions, especially in alcoholic liver disease and 
infiltrative hepatobiliary disease. Since GGT is absent from bone and 
placenta tissue, children, adolescents, pregnant patients and patients 
with bone disease show normal or only slightly elevated GGT values. A 
number of reports demonstrated that GGT was elevated in neurological 
disease, post-myocardial infarction, alcoholic patients without other 
evidence of liver disease and patients receiving enzyme-inducing drugs 
(e.g., ant i convuIsants). Th i s suggests that the eIevated GGT IeveIs 
should be interpreted with caution. As with SGPT, slightly elevated 
levels (i.e., siightly above the range of normal) are less organ 
spec i f i c than h igh abnormaI vaIues, but other organ parenchymaI 
reactions cannot be excluded from consideration. For the purpose of 
screening for liver disease, the values did not reach levels (T500) 
which were indicative of liver disease. Abnormal or elevated GGT 
values were found in 64 or (21%) of the grain workers and 31 (13%) of 
the controls. The elevated gamma GT rarely correlated with elevated 
SGPT or choI inesterase.
Choi inesterase may be an indicator of chronic liver disease but few 
abnormal values were found in this study. The frequency of abnormal 
values was not different in grain workers and controls.
CONCLUSION
We did not detect significant differences in the frequency of overt 
liver disease between grain workers and controls. We used three 
screening methods to detect liver disease. The questionnaire included 
a quest i on: "has a phys i c i an ever d i agnosed Ii ver d i sease i n the
patient?" There was no significant difference in the answer to this 
question between grain workers and controls. Second, in the physical 
examination the presence of hepatomegaly was determined. There was no 
significant difference between the two groups, although the prevalence 
of a palpable liver was different between the two groups. Third, the 
serum enzymes (SGPT< GT and cho I inesterase were not abnormal in the 
grain workers or controls).
Although the findings are inconclusive, we did find a higher number 
of abnormal values for GGT, a higher mean value of SSPT, and more 
paIpabIe Ii vers among gra i n workers. S i nee gra i n workers are 
occasionally exposed to hepatotoxic grain fumigants we recommend 
further prospective studies on the potential hepatotoxicity of grain 
fumigant exposure.
Renal function screening
There were few abnormal creatinine levels (Table 45) in grain 
workers and controls, but the mean value (t-test) was significantly 
higher among grain workers than controls (Table 46). The urinalysis 
revealed no differences in the frequency of blood, glucose and protein 
the urine when grain workers were compared to city workers. There was, 




II) Renal disease screening. The results of the renal function 
screening tests were inconclusive (Tables 45, 46). We would recommend 
further prospective studies on the potential renal morbidity of 
pesticide exposure.
Hemoglobin - hematocrit
The hemoglobin was evaluated: I) to detect the presence of
polycythemia or anemia and 2) for correction of diffusion values if 




The chest-roentgenogram changes found in grain workers and controls 
are shown in Table 47. The prevalence of abnormal findings was small 
and Most changes, with a few exceptions, were of m i nor clinical 
significance. One control subject showed bilateral hilar adenopathies 
compatible with lymphoma or sarcoidosis. Another control had evidence 
of coronary bypass surgery and a third subject had a questionable 
paratracheal node (which in re-examination with other views could not 
be delineated). Among the grain workers there were three workers with 
small blebs, one with Marked hyperinflation compatible with emphysema, 
one with a rib resection from a negative exploratory thoracotomy and a 
worker with bilateral calcified pleura thickening. The apical 
thickening and costophrenic angle pleural thickening was Mi ni ma l .  
There were no cases with diffuse bilateral interstitial infiltration 
or fibrosis. Old healed rib fractures, degenerative changes of the 
thoracic spine, basilar bands of fibrosis or plate atelectasis were 
More commonly seen among grain workers.
Conclusion
Grain dust exposure does not appear to be associated with any specific 
roentgenograph i c abnormaIi ty.
2g. lanunoglobulin Levels
The levels of IgG and IgA observed in grain workers differed 
significantly from the city workers (Table 48), whereas the levels of 
IgH were sinilar in both groups. Since it was conceivable that 
differences in age, smoking habit, place of employment or length of 
employment introduced an inherent bias into the data, the test and 
control groups were further subdivided.
Table 49 shows the immunoglobulin levels when the test group (grain 
workers) and controls (city workers) were grouped on the basis of 
smoking habits. The levels of IgG were significantly higher in the 
grain workers when compared to city workers in each of the three 
smoking habit categories. Hence, the data suggest that the increased 
levels of IgG observed in the grain workers were not a reflection of 
saoking habit. Conversely, only ex-smoking and nonsmoking grain 
workers demonstrated elevated serum IgA levels when compared to control 
values. The data suggest that grain dust normally enhances the levels 
of serum IgA but that the response was blunted by smoking.
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When the same data were grouped with respect to age, the following 
data were obtained: Grain workers between the ages of 31 to 50 years
demonstrated elevated IgG levels (Table 50). There was no statistical 
difference in IgG levels when other age groups were considered.
Statistical differences in IgA levels were only observed when grain
workers between the ages of 4I to 50 years were compared to controls.
Since it was conceivable that length of employment influenced the
data, the test and control iamunoglobulin levels were subdivided with
respect to length of employment (Table 51). Both IgG and IgA were 
elevated in the grain workers working in the elevators from I0.6 to I5.5 
years. Increased levels of IgA were also observed in grain workers 
working fewer than 5.5 years in the industry. However, there was no 
relationship between IgA levels and place of employment. Increased 
levels of IgG (Table 52) were observed in workers in elevators I and 8.
The levels of circulating IgE were also ascertained in serum samples 
obtained from grain workers and controls using commercially available 
immunodiffusion plates. The lowest level of sensitivity of this system
is 600 I.U. Only four of the 307 grain workers tested had IgE levels
above 600 I.U. (1,000-4,000 I.U.) Similarly, only two of the 235 city
workers tested had IgE levels above 600 l.u.
Data from the IgE determinations should be interpreted with caution. 
Recent data from our laboratories, using radioimmunoassays for 
determination of IgE levels, suggest that the level of IgE in normal 
serum is below 50 I.U./ml. Serum from highly allergic individuals 
contains between 300-600 I.U. and, rarely,levels above 900 I.U. Hence, 
the immunodiffusion method for determining IgE levels is not sensitive 
- enough to detect increases in serum IgE occurring between 100-600 I.U.
CONCLUSION
Grain dust exposure enhances the levels of serum IgA and IgG, an 
effect which appears to be blunted by smoking (significantly in the case 
of IgA).
2h. ALPHA]-ANTITRYPSIN (AAT) LEVELS
The levels of alpha<|-antitrypsin in serum samples from grain 
workers and controls were determined by the timed Mancini technique 
(Appendix XIII). The reproducibility of the system was insured through 
the use of the protocol outlined under the section on Materials and 
Methods.
There was no stat i st i ca I d i f f erence when the AAT I eve Is in gra i n 
workers (mean + SD = 296 + 5 ag/dl) were compared to controls (mean + SD 
= 308 + 6 mg/dl). When smoker grain workers were compared to smoker 
controls there was a significant decrease in the AAT levels observed in 
grain workers (Table 53). No significant differences were observed when 
other smoking categories were compared.
When the test group and controls were grouped by age, the AAT levels 
were significantly depressed in grain workers between the ages of 21 to 
30 years and 41 to 50 years (Table 54a). Uni ike the iamunoglobulin 
levels, there was no relationship between length of employment and AAT 
levels (Table 54b).
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Since it has been shown that subjects heterozygous for the AAT 
deficiency gene (Pi phenotype MX) have serum levels of AAT that are 
roughly 60% of the normal levels, we selected sera from the nine grain 
workers wi th AAT I eve I s less than 60% of the noma f va I ues for 
phenotyping and trypsin inhibitory capacity (TIC) neasurements. These 
studies were performed by Dr. Richard Talamo of Johns Hopkins 
University. None of the city workers exhibited intermediate AAT levels 
by the Mancini test.
The data show that three of the grain workers (#232, #239 and #240) 
had the heterozygous MZ phenotype and ¡«paired TIC (Table 55). Another 
three subjects had the MZ phenotype and normal trypsin inhibitory 
capacity. The remaining three subjects had the MZ phenotype and normal 
TIC. Because of the small number of heterozygotes found in this study, 
we did not do statistical correlations with symptoms or lung function, 
but the review of these six subjects did not reveal any consistent 
abnormalities. Of the three subjects with MZ phenotype, one (#332) had 
a slightly decreased D^co and abnormal CV and N2/L but no evidence of 
airways obstruction. He had many years of chronic productive cough and 
wheezing. He also had elevated SGPT and GGT of unknown etiology. One 
of the three with MS (#52) had an FEVj/FVC of 74% which may reflect 
some aild degree of airways obstruction at his age.
2i. MULTIPLE REGRESSION ANALYSIS OF THE EFFECT OF GRAIN DUST EXPOSURE 
ON imUNOGLOBULIN AND ALPHA]-ANT I TRYPSIN LEVELS (TABLE 56).
As will be seen in Table 57 grain dust exposure has a highly 
significant positive effect on the levels of IgA, and IgG (p < 0.005) 
but not on IgM. Length of employment and/or age is also positively 
related to levels of IgA and IgG with a significant relationship
present for smoking (p < 0.05). Unfortunately it is not possible to 
separate the confounding effects of age and length of employment on 
iamunoglobulin levels.
Conversely, grain dust exposure has a significant negative effect 
(p < 0.025) on the level of a I pha-| -anti trypsin (AAT). Length of
employnent (p < 0.0005) and/or age (p < 0.001) and smoking (p < 0.0005) 
on the other hand show a highly significant positive relationship to
the level of AAT. In this case age appeared to be a better predictor
than length of employment.
Since grain dust exposure appeared to have a significant effect on 
the iamune system which conceivably could in turn be related to the 
disease syndromes encountered in grain workers, we analyzed the
relationship between chronic bronchitis, occupational asthma, grain 
fever and other symptoms, as well as skin test reactivity, tests of 
pulaonary function, and the level of iamunoglobul ins. Using an
unpaired t test we found no statistically significant relationships 
between levels of immunoglobulins on AAT and skin test reactivity or 
symptoms. However, the levels of IgA, IgG and IgM were consistently
higher in subjects who showed skin test reactivity to antigens from
airborne grain dust, fungi, insects and aites. A siailar trend was 
seen when comparing symptomatic with non-symptomatic workers for IgA 
and less consistently for IgG.
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The results of a similar analysis of iamunoglobulin levels in 
relation to abnormal tests of pulmonary function are seen in Table 57. 
Significant association was found between abnormal FVC, VmaxgQ, DL 
and IgA and between abnormal FVC and IgG. Also a significant 
association was found between abnormal N2/Ly DL and AAT. Once again 
subjects with abnormaI puImonary function had, with two exceptions, 
consistently higher levels of IgA and IgG.
CONCLUSIONS
Chronic exposure to grain dust appears to stimulate the immune system
as reflected by its positive effect on serum IgA and IgG which increase
wi th age and/or length of employment. The mechan i sm i nvoIved i n 
producing these increases is unclear but may be an adjuvant effect. 
This may also explain the consistently higher levels of immunoglobulins 
in subjects who show skin reactivity to antigens found in grain dust. 
Evidence regarding any relationship of this effect on the immune system 
to the disease syndromes encountered in grain workers is conflicting. 
There is no relationship between immunoglobulin levels and acute or 
chronic symptoms of lung disease. On the other hand, workers with
abnormal lung function have significantly higher levels of IgA and/or 
IgG. These findings merit further study.
Chronic exposure to grain dust appears to be associated with a 
decrease in the level of AAT. Smoking on the other hand is associated 
with a decrease in the level of IgA and IgG and an increase in AAT.
The significance of the association between abnormal N2/L, DL and AAT
is unclear. However, these tests may reflect an inflammatory reaction 
in the small airways (bronchiolitis) related to chronic grain dust
exposure. These findings also merit further investigation.
STUDY II. WORK SHIFT STUDY 
Materials and methods
Population
We studied 248 grain workers and 192 controls (city services 
workers). They represented 88% of the 283 grain workers and 80% of the 
239 controls previously surveyed (see Study I). The 27 longshoremen 
were not asked to participate in the work shift study.
The character i st i cs of the test and cont ro I popu I at i ons are 
presented in Table ll-la and b. The following parameters were 
evaluated:
1) Symptoms during the shift and the workers' subjective appraisal
of the dust exposure were obtained at the end of the work shift on a
standard form.
2) PuImonary funct i ons stud i es before and after the sh i f t 
included: FEV|, FEVC, Vnaxgo, Vmax75 . All of these values were
obtained using a rolling bar Ohio 840 spirometer with the techniques 
described in Appendix VIII.
3) Blood studies before and after the shift included: a) 
Ieukocyte count and d i fferent i aI count, b) serum compIement and 
complement activation measured studied as described in Appendix XIII 
and XIV.
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4) Oral temperature were taken at 700-800 hours, 1100-1200 hours, 
1500-1600 hours and 2000 hours.
5) Environmental studies: airborne total and respirable dust
levels were measured on each of 209 grain workers and in a sample of 63 
controls using personal dust samplers as described in Appendix XV.
6) Mycological studies: Airborne dust from personal samplers was 
analyzed for fungi as described in a separate report.
Medications taken by subjects during the day of study included: 
subject #9 - "Tedral," #7 - "Contac," #21 - "Robitusin," #242 - "Cough 
drops" and #233 - "Dristan."
RESULTS
Dust exposure. Of the 248 gra i n workers, 197 (79.4%) reported
exposure to either wheat, barley or oats. Other exposures included 
sunflower seeds, corn and rye. Total dust levels in grain workers by 
elevator and job category are presented in Table II-2.
Symptoms during work.
Twenty-five % of the grain workers claimed they had worn a mask 
during at least part of that day. The incidence of respiratory 
symptoms (cough, expectoration, wheezing and dyspnea), nasal stuffiness 
and eye irritation (Table II-3) were higher in grain workers than 
controls.
The incidence of symptoms during work shifts in grain handlers by 
smoking categories and subjective appraisal of dust exposure is shown 
in Table 11-4. Wheezing and/or chest tightness were more common among 
smokers than nonsmokers, whereas throat symptoms were more common among 
nonsmokers.
Grain workers who reported a normal or average exposure to dust 
during the work shift had a higher incidence of cough and phlegm when 
compared to workers exposed to less than average dust concentrations. 
Workers exposed to higher dust concentrations (more than average) had a 
higher incidence of dyspnea, wheezing, eye and nasal symptoms when 
compared to workers exposed to average or less than average dust
concentrations. Most symptoms were more common among workers who 
reported a heavy exposure to dust some time during that day (p <0.05). 
Incidence of respiratory symptoms by company and job category are shown 
on Table 11-5.
Leukocyte count and serum complement
The leukocyte count and serum complement levels before and after 
work shifts are presented in Tables 11-6 and 11-7. The data show that
the total white blood cell counts were not different when pre- and
post-samples were compared (Table 11-6). The differential white blood 
cell count suggests that there were slight shifts in leukocyte
subpopulations during a work shift. Grain workers had slight increases 
in the percentage of segmental neutrophiles and decreases in 
lymphocytes when compared to controls.
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There were no changes in the mean C3 levels during the work shift 
in either the grain working or control population (Table 11-7). 
Moreover, there was no evidence of classical or alternate complement 
pathway act i vat i on. However, six of 191 cont roIs demonst rated 
activation of the alternate complement pathway at pre- and post-shift 
intervaIs. This may represent fauIty on-site specimen handIing in 
DuIuth/Super i or.
Cons i derat i on was a I so g i ven to i nd i v i dua I changes i n tota I C3 
levels within the grain workers and city workers. Using the standard 
deviation from the pre-shift city workers (28 mg X) as the base, we 
considered a significant increase or decrease in C3 levels to be 2 
standard deviations (56 mg X) from the population mean. Using this 
criterion to analyze the C3 data, seven of 248 grain workers decreased 
their C3 levels significantly as compared to three of 191 city 
workers. Conversely, nine of the grain workers increased C3 levels by 
more than 53 mg%. None of the city workers increased C3 levels by the 
same value.
There were no correlations between increases or decreases in 
complement levels and changes in pulmonary function tests, white blood 
counts or symptoms. Moreover, there was no relationship between 
changes in complement levels and activation of complement by either the 
classical or the alternative pathway.
Body temperature
Values are presented in Table 11-8. There were no differences in 
body temperature (800, 1200, 1600 and 2000 hour values) between the
grain workers and the controls.
Pulmonary function studies
The pulmonary function studies were performed before and after the 
work shift (Tables 11-9 and 11-10). Analysis of the pre- and 
post-shift values indicated that no significant acute effects on lung 
function occurred during the work shift (Table 10). On the other hand 
when the data were expressed as X difference in pre- and post-values 
(Table 9), the FVC, Vmaxgo and Vmax7 5  *n grain workers were 
significantly different from controls (p < 0.05). The difference was 
due to a slight increase in function in the controls and an average 
slight decrease or lesser increase in function in grain workers. Also 
the actual differences in pre- and post-shift VmaxgQ and Vmax7 5  
were slightly positive in controls and slightly negative in grain 
workers (Table 11-9).
The changes in lung function, before and after a work shift, were 
also evaluated by multiple regression analyses using the actual 
pre-post-shift lung function difference or X differences as the 
dependent variable. The independent variables were grain handling, 
age, height, current smoking and ex-smoking. This analysis indicated 
that grain handling had a significant adverse or negative effect on 
pre-post-shift X differences in lung function independent of the 
effects of cigarette smoking (Table 11-11).
To evaluate the possible clinical significance of changes in 
pulmonary funotion, we studied the incidence of post-shift reduction in
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function of varying severity that sight be considered an abnormal 
response to the environment (Table 11-12a). Although the numbers of 
workers were small, there was a consistently higher number of grain 
workers with pre-post reductions in pulmonary functions when compared 
to city workers having no abnormal lung function changes. The
characteristics of the 14 subjects with pre-post shift difference in
FEV|(>I5%) are presented in Table 12b. The mean age (48.4 years) was
higher than the population mean, and the mean length of employment was
15.8 years. Only 2 of the 14 were nonsmokers. Four had a history of 
chronic bronchitis and one subject had asthma. Nine of the 14 had 
complained of cough or wheezing on exposure. All subjects were exposed 
to wheat, barley and/or sunflower seeds. The total dust levels varied 
between .5 and 9.3 mg/m3. Ten of the 14 had pre-existing airways 
obstruction. Three were atopic and 5 had skin reactivity to grain dust 
antigens.
These data suggest that a decline in FEVj greater than 15% over a 
work shift can occur at average total dust levels lower than 10 mg/m3 
in grain workers with pre-existing airways obstruction, regardless of 
smoking habits (smokers or ex-smokers).
Relationship between Symptoms during Work and Lung Function Changes
There was no difference (chi square analysis) in the X change of 
pre-post values when subjects with respiratory symptoms or fever were 
compared to subjects without symptoms (Table II-I3).
Relationship between Symptoms of Pulmonary Function Changes during 
the Work Shift and Skin Hypersensitivity
The incidence of respiratory or nasal symptoms was not different 
between atopic (wheal reaction V 3 mm to one or more common 
allergens) and non-atopic workers or between grain dust skin reactors 
and non-reactors.
Also using pre-post mean values for pulmonary function tests, there 
were no d i fferences when atopic and non-atopic subjects or gra i n 
reactors and non-grain reactors were compared.
Relationship between Total Dust Level and Presence or Absence of 
Symptoms during Work Shift
Workers with respiratory symptoms (cough, expectoration, wheezing 
or dyspnea) during the work shift were exposed to a higher mean total 
dust level than workers who did not claim symptoms on the shift studied 
(Table II-I4).
The incidence of symptoms by dust level categories is shown in 
Table 11 — 15a. Few significant differences between grain workers and 
controls are seen at dust levels below 10 mg/m3. At levels above 10 
mg/m3 there is a significantly higher incidence of cough, dyspnea, 
fever, eye and throat symptoms among grain workers. It should be 
noted, however, that relatively low dust levels were encountered during 
this study. Sixty-seven X of the measured values were below 2 mg/m3 
and 86% were below 5 mg/M3. Only 7X of the values were between 5-I0 
ng/m3 and 7X were above 10 mg/M3. Compared with the conditions that 
existed prior to 1974, this is a remarkable achievement on the part of 
the grain companies to control grain dust in their elevators. During
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this study only 4% of the measured dust levels exceeded the current 
nuisance dust standard of 15 mg/ai3. On the other hand the relatively 
small number of workers exposed to grain dust levels above 5 mg/m3 
limited our ability to establish a clear cut dose-response 
relationship. Since control workers could be considered as having zero 
grain dust exposure, we repeated the analysis using the entire cohort 
of city workers (N=I92). The results are shown in Table 15b. As will 
be seen in this table, grain workers experience a significant excess of 
cough and expectoration even at dust levels 5 mg/m3.
Relationship between Total Dust Level and Workers1 Subjective
Estinat ion of Dust Exposure
There was a significant relationship between total dust level and 
workers' subjective estimation of dust levels (Table 11-14).
Relationship between Total Dust Level and Pre-Post Shift 
Differences in Lung Function Tests
Relationships were studied by multiple regression analyses using 
pulmonary function (FEV-j, FVC, VmaxgQ or Vmaxyc) as the dependent 
var i abIe and dust IeveI, age, he i ght, smok i ng and ex-smoki ng hab i t as 
independent variables. In the grain workers (Table 11-16) there was a 
significant negative relation between dust level and pre-post shift % 
changes in FVC, VmaxgQ and Vmax7 5  (P < 0.05) adjusted for the
effects of age, height and smoking habit (Table 11-16). In controls 
there was no relationship between the dust level and changes in 
pulmonary function using any test.
The negative effect of grain dust on tests of airways flow and
vital capacity appears to be dose related.
Relationship between Dust Levels and Pre-Post Shift Difference in 
Leukocyte Count and C3 Complement Level
By regression analysis, pre-post shift changes in leukocyte count 
or in C3 complement level were considered dependent variables and dust 
IeveI» age and smoking as independent variabIes. In the controIs there 
was no relationship found between total dust levels and changes in 
leukocytes or C3 complement levels. In grain workers there was a 
positive relationship between total dust level and the pre-post shift 
difference in leukocyte count (P < 0.05), but no relation between
compIement I eveI changes and dust IeveIs. Gra i n dust exposure thus
appears to induce a leukocyte response that is dose related.
Conclusions
Exposure to grain dust during a work shift has a dose related acute 
adverse effect on the worker. The effects, which are largely on the
respiratory system, are seen at relatively low dust concentrations. 
When compared with city workers, grain workers show a significant 
excess of cough and expectorat ion dur ing a work sh i f t at dust 
concentrations below 5 mg/m3. In addition, the susceptible workers 
(i.e., those with pre-existing airways obstruction) can experience 
significant declines in ventilatory function at dust levels below 10
mg/m3. Because of the smal I proportion of workers (14%) who were
exposed to dust concentrations above 5 mg/m3 during this study, it was 
difficult to establish an exact dose-response relationship between dust 
concentrations and ventilatory function. There seems to be Iittle
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doubt, however, that dust concentrât ions beIow the current nu i sance 
dust standard of 15 ng/n3 can have an adverse acute effect on 
ventilatory function. The grain companies are to be congratulated on 
the remarkable decrease in dust levels that has been achieved since 
1974. During this study 86% of the dust neasurements were below 5 
ng/n3 and 93% below 10 vg/n3. Further studies should include peak 
values of dust concentrations as well as tine-weighted averages, since 
workers' symptoms and changes in lung function nay be related more to 
peak concentrations than average concentrations of dust during an 
8-hour shift.
STUDY III PROSPECTIVE 3 YEAR FOLLOW-UP (1974-1977)
The purpose was to detemine changes in pul nonary function in grain 
elevator workers who had been previously studied.
Materials and Methods
We studied 172 of the 293 year-round grain workers who were studied 
in 1974. One hundred and twenty-one subjects were not included in the 
study or analysis because of the following reasons:
1) Thirty-two subjects were working in the elevators but refused 
or could not participate.
2) Thirteen subjects were laid off and unavailable.
3) Twelve subjects had retired at ages 62 to 65 except one who had 
retired earlier because of a stroke residual.
4) Thirteen subjects were on vacation, 8 were on sick leave, 8 had
changed jobs and noved away from the area and 3 had been transferred to
management.
5) Three had died (2 heart attacks and 1 car accident).
6) The status of 29 workers was unknown.
The characteristics of the population studied are shown in Table 
l l l - l .
Pulmonary Function Studies (see appendix VIII)
Pulmonary function studies included forced expiratory volume in I 
sec (FEV|), forced vital capacity (FVC), and nean forced expiratory 
flow during the middle half of the FVC (MMF), all recorded on a 13.5 
liter Collins spirometer. The FEVj and FEF 25-75% were measured from 
the largest of three acceptable FVC tracings, and all volumes were
corrected to BTPS. The instantaneous naxinal expiratory flows after 
exhalation of 50 and 75 X of the FVC (Vmaxcjo and Vnaxyg,
respectively) were neasured using a rolling bar spirometer and were 
displayed on an X-Y recorder. The average of 3 reproducible naxinal 
expiratory flow volume curves was used.
Diffusing capacity of the lung for CO (Dijpo) was neasured by the 
single-breath nethod of Ogilvie and associates4'3*/
Predicted values for FEV-j, FVC, and MMF, Vmaxjjg, Vmax7 5  were 
obtained from the data of Knudson et al.17; Dlcq from Ogilvie and 
co-workers14. These nethods were used in the 1974 study.
The changes in puImonary function over 3 years were evaIuated
independently and also by the status of their smoking habit including: 
smoker who remained smoker; smoker who became ex-smoker; ex-smoker who
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remained ex-smoker; nonsmoker who remained nonsmoker. Three ex-smokers 
who resumed smoking and 4 nonsmokers, who became smokers and then quit, 
were excluded from analysis.
Other information on these subjects was obtained as described under 
Material and Methods - Study I.
The current status of their respiratory symptoms was obtained on a 
standard form. Changes in smoking habit were obtained from the 
standard questionnaire.
Results
Symptoms. The symptoms reported by workers in 1977 are shown in 
Table 111-2. Most workers (72-84%) reported that their respiratory 
symptoms remained about the same, but 9-25% were better or had symptoms 
less often. A small percentage felt their symptoms were worse (Table 
111-3).
Pulmonary function changes. There were no significant changes in 
FEV| and FVC, but there were significant changes in MMF, Vmax^Q and 
Vmax7 5 , both actual and when corrected for age by using the changes 
in % predicted values (Table 111-4).
Similar results were detected in the different smoking categories 
(Tables 111-5-8).
The yearly mean decrement (Table 111-9) in FEV* and FVC was 
similar to that expected from published data (Knudson, et al.), but the 
yearly mean decrement in FFM, VmaxgQ and Vmax7 5  was greater than 
expected.
There were no differences between the 3 year changes in atopic and 
non-atopic individuals, between skin reactors to grain dust and 
non-reactors, between those with chronic bronchitis and those without, 
or between workers with and without occupational asthma I (Table 
111- 10).
CONCLUSION
This study is seriously faulted by the poor level of participation 
(59%) of workers previously studied in 1974. However several tests of 
lung function (MMF, VmaxgQ and Vmax7 g) showed a yearly mean 
decrement that was greater than expected, which is probably indicative 
of the chronic effect of grain dust on ventilatory function.
STUDY IV BRONCHIAL CHALLENGE STUDY
IDENTIFICATION OF GRAIN DUST CONSTITUENTS WHICH CAN INDUCE 
PULMONARY REACTION
This study was undertaken to identify the constituent of grain dust 
responsible for grain handlers' symptoms and to determine a site of 
action in the lung. Host factors which may influence or contribute to 
this process were also assessed.
Material and Methods
Subjects: The subjects for the study were II grain handlers from
northern Wisconsin and Minnesota who had respiratory symptoms on
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exposure to durum wheat dust at work. Symptoms included cough, 
wheezing, chest tightness and expectoration. The workers were all men 
with a Mean age of 38 and an age range of 27-59 years.
Skin tests: Subjects were tested for atopic diathesis by prick
test using six common allergens: ragweed, feathers, oak, cat,
Altemaria and timothy grass. The subject was considered atopic if he 
developed a 3 mm or greater wheal at 20 minutes to three or more of 
these allergens. Intradermal tests were used to detect immediate skin 
test reactivity to extracts of durum wheat, airborne durum wheat dust, 
molds, grain mites, grain weevils or grain beetles. These extracts 
were prepared from material collected from the workers' environment. 
Subjects were termed positive skin reactors if an 8 mm or greater wheal 
was raised at 10 minutes to an injection of 1000 PNU per ml or less of 
extract.
Precipitating antibody: serum precipitating antibodies against
durum wheat, airborne durum wheat dust, molds and insects were measured 
by the immunodiffusion method of Ouchterloney.
Spirometry: Spirometry was performed on an Ohio 840 rolling bar
spirometer. The FEV| and MMF were measured from the largest of two 
acceptable FVC tracings, and all volianes were corrected to BTPS. The 
instantaneous maximal expiratory flows after exhalation of 50 and 75% 
of FVC (Vinaxgo and Vmax7 c) were measured from 2 reproducible 
maximal expiratory efforts which were displayed on an X-Y recorder and 
then averaged. Diffusing capacity of the lungs for CO (D^^q) was 
measured by the single breath method of Ogilvie and associates. Before 
entering the study, each subject was tested for pre-existing airways 
obstruction. Subjects 40 years of age or under were termed obstructed 
if the FVCj/FVC % was less than 70%, and subjects over 40 years of 
age were termed obstructed if the FEV|/FVC % was less than 75%.
Preparation of challenge material: The preparation of extracts
used for skin tests and bronchial challenge is described in Appendix 
X. Twenty-four hours prior to the challenge, the lyophilized extracts 
were resuspended in sterile, non-pyrogenic coca buffer with 3.0% human 
serum albumin to effect a final concentration of 100,000 PNU/ml. The 
resuspended extracts were fiItered through a millipore fiIter (pore 
size .22mm), placed in sterile needle vials and tested for sterility on 
nutrient agar and Sabouraud's agar plates incubated at room temperature 
and 37°C. If the plates showed no growth after 24 hours, the 
resuspended extracts were diluted into additional needle vials using 
sterile coca buffer with 3.0% NSA to effect final concentrations of
100,000 PNU/ml, 50,000 PNU/ml, 10,000, 5,000, 1,000, 50 and 1.0 PNU/ml.
Bronchial challenge: Subjects were tested on 4 or 5 consecutive
days. Each day a challenge was performed using a different extract: 
durum wheat, durum wheat dust, grain mites or grain insects. A 
Rosenthal dosimeter powering a #42 Devi Ibis nebulizer was used to 
administer the extracts. Five vital capacity inspirations were taken 
slowly by the subject and then held for 5 seconds at each concentration 
of extract. This maneuver was repeated at gradually increasing 
concentrations of extracts until either a drop in FEV| of at least 
20% was noted or the maximum concentration (100,000 PNU/ml) of antigen
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was g i ven. PuImonary funct i on test i ng was performed before 
administration of antigen, 10 minutes after administration of antigen 
at each concentrâtion, and at frequent intervals thereafter up to 24 
hours.
Temperature: During each bronchial provocation, oral temperature
was measured hourly.
Laboratory tests: Blood samples were drawn for white blood cell
counts and for complement (C3) measurements at 20 minutes, 4, 8 and 24 
hours. Complement was measured by the method described in Appendix XII.
Methachoi ine provocation: Non-specific bronchial reactivity was
measured using Methachoiine inhalation by the method recommended by Chi 
and co-workers. Us i ng the dos i meter techn ique, NethachoIi ne was 
administered in increasing concentrations from 2.5 mg/ml to a maximum 
concentration of 25 mg/ml. The test was terminated when > 20% decrease 
from the baseline FEV| was noted, or if no response was elicited, 
with the maximum concentration. The results were expressed as the 
concentration of Methachoi ine producing a 20% decrease in FEVj (Pc20) 
calculated from a dose-response curve.
Challenge after sodium cromoglycate: One capsule of sodium
cromoglycate was administered, via a spinha 1er, 10 minutes prior to 
challenge.
Results
Bronchial provocation challenge: Five of the It subjects showed a
decrease in FEV| (> 20%) in response to bronchial provocation with 
extracts of durum wheat (IV-Fig. I). These 5 were termed airways 
reactors. The other 6 showed no significant diminution in FEVj when 
challenged with these extracts and were termed non-reactors (IV-Fig. 2).
Type of response: One subject responded to extracts from both
durum wheat and airborne durum wheat dust. In this subject the airways 
response occurred within 10-20 minutes (IV-Fig. I). The other 4 
subjects showed only late responses to durum wheat extract.
Methachoiine response: Methachoiine inhalation produced a positive
test in 4 of the 5 airways reactors and in two of the 6 non-reactors 
(Table IV—I>» However, the Pc 20 was lower in the positive airways 
reactors.
Contribution of airways obstruction: Pre-existing airways
obstruction was present in 4 of the 5 airways reactors and 3 of the 6 
non-reactors (Table IV-I). However, the obstruction was more severe in 
the reactors. Four of the 5 airways reactors were ex-smokers and one 
subject was a smoker. Of the 6 non-reactors, the 2 smokers were 
obstructed and 1 of the 2 ex-smokers was obstructed. The 4 airways 
reactors who had pre-existing airways obstruction responded to 
Methachoiine inhalation while the non-reactors with pre-existing 
airways obstruction showed no response.
Effect of sodium cromoglycate: Four of the 5 airways reactors were
pre-treated with sodium cromoglycate and challenged with extract of
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durum wheat. The n airways response was blocked by pre-treatment in 
all four subjects (Fig. IV-3).
Sk i n test: One of the 5 a i rways reactors and 2 of the 6
non-reactors were atopic. There was no correlation between positive 
skin tests (CAA, insects, mites, durum wheat, durum wheat dust, and 
aspergillus species) and a positive bronchial challenge (Table IV-2).
Precipitating antibody: One of the 5 airways reactors had serum
prec i p i tat i ng ant i bod i es d i rected to the durum wheat extract and 
positive bronchial response to durum wheat. Five subjects showed serum 
precipitins against extracts which did not induce a bronchial response.
Diffusing capacity: There was no significant change seen in the
dLCO-
Blood tests: There was no change in leucocyte counts or levels of
serum complement in airways or non-airways reactors after challenge.
Small airways measurement: If a decrement of 35% in MMF, Vmaxgq
and Vmax7 5  is used as the criterion of detecting airways obstruction, 
then these tests were no »ore sensitive than FEV| in detecting the 
acute airways response induced by durum wheat. However, in some 
instances Vmax/c revealed an airways response which was not reflected 
in the FEV], which suggested a small airways reaction (Fig. IV-4).
Extracts of durum wheat i nduced an a irways response i n gra i n 
handlers. This response was not duplicated by extracts of A^ fumigatus 
or grain insects, grain mites or grain weevils. The airways response 
was not related to either the atopic status of the individual or the 
presence of precipiting antibodies in the serum.
CONCLUSION
Durum wheat induces an airways response in grain handlers. The 
effect of inhaled durum wheat appeared to be on the large airways 
without parenchymal or systemic reactions and without complement 
consumption. This response can be inhibited by sodium cromoglycate.
Study V - Grain Fever Syndrome 
Purpose
This study was designed to delineate the clinical, physiological 
and immunological events which occurred during episodes of grain 
fever. It also intended to answer several questions:
K) Does f,gra in fever" deveIop dur ing and/or after exposure to 
grain dust? Can saline extracts of barley induce grain fever?
2) What individuals are more likely to develop "grain fever," 
grain handlers previously exposed to grain dust or individuals not 
exposed to grain dust (controls)? Atopic individuals? Skin reactors 
to grain dust extract of grain, i.e., barley, fungal mite or insect 
antigens? Bronchial hyperreactors to methachoiine? Individuals with 
pre-existing airways obstruction? Individuals with precipitating 
antibodies to airborne grain dust or precipitins to fungal antigens?
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3) Does fever develop in all subjects with symptoms described as 
"grain fever?"
4) Do respiratory symptoms occur with "grain fever?"
5) Is there an airways response? Are there parenchymal reactions?
6) Is the complement system activated during these reactions? By 
the alternate or classical pathway?
7) Is there a blood leukocyte response?
Materials and Methods
Subjects
We studied 6 grain handlers with history of recurrent episodes of 
"grain fever" detected during the health survey and 6 asymptomatic 
healthy adults without occupational history of grain handling. The 
characteristics of these 12 individuals are summarized on Table V-l. 
The 6 gra i n handIers compIa i ned of respi ratory symptoms and eye 
irritation during exposure to high concentrations of grain dust. Three 
subjects had a history of productive cough for more than 2 years, 3
were smokers and 3 were nonsmokers. All had worked in the grain
industry for I to 30 years with a mean of 13 years. The controls were 
unemployed, nonsmoking men. One of the controls had some chest 
tightness on heavy exercise, a second a history of hay fever and a 
third a history of some wheezing with colds in childhood.
InhaIat»on Cha11enge
Dur i ng the i nhaIat i on cha11enge we stud i ed symptoms, body 
temperature, blood leukocyte count and differential counts, FEV|/FVC, 
MMF, Vmaxgo, Vmax7 5, DLCO and complement changes (total C3) and
act i vat i on of class i caI or a11ernate compIement pathway. The 
Methachoiine inhalation tests were administered as recommended by the 
Asthma and Allergy Disease Center Report for standardization of 
bronchial challenge procedures. The Pc20 (the provocation 
concentration which will cause a fall in FEV| of 20%) was calculated 
from the last two points on the log dose-response curve. On the first 
day, or control day, no inhalation material was given, but measurements 
were taken at regular intervals. On the second day, baseline values 
were obtained, and the subjects were exposed to airborne grain with 
dust in an environmental chamber. The subjects manually created dust 
aerosols similar to levels which provoked episodes of grain fever. 
Each subject was tested at f requent i ntervaIs for 24-48 hours to
provoke an episode of grain fever.
Respirable dust concentrations were determined using a 37 
millimeter diameter acrylic filter with an 0.8 micron pore size (DA 
800, Gelman). All f i Iters were pre-weighed to the nearest .001 
milligram. Prepared filter cassettes with cellulose backup pads were 
then capped and securely placed into a 10 milliliter nylon cyclone 
assembly, attached by .75 meter long tygon tubing to personal sampling 
pumps equipped with pulsation- flow dampers (Model G, MSA). Pumps were 
periodically monitored over the exposure time to insure a flow-rate of
1.7 liters per minute + .1 liter per minute. Air sampling was stopped 
when the subjects were removed from the chamber for testing. Based on 
the actual exposure time, the time-weighted average respirable dust 
levels were calculated considering the actual time of exposure, which 
varied between 60 m i nutes and 120 mi nutes. Any change i n the 
parameters measured was compared to a baseline established earlier. On
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the third day, if the subject was still symptomatic and/or leukocytosis 
persisted and/or FEV| had not returned to the pre-challenge baseline 
level + 10%, the subject was tested at regular intervals. Eight of the
12 subjects were observed for 48 hours. If the subject returned to
baseline levels, he was tested, on the third day, with saline extract 
of barley (Appendix X). Each subject was challenged with increased 
concentrations of barley using a dosimeter-powered Oeviblis nebulizer 
until a decrease of 20% in FEV| occurred or a dose of 100,000 PNU/ml 
was reached. To establish a safe initial dose for inhalation challenge
wi th barIey extract, -intradermaI sk in tests were performed. The
dilution at which an 8 m  wheal reaction was obtained was used as the 
initial challenge dilution. No skin test was done with a dose greater 
than 1000 PNU.
Skin testing (See appendix XI)
Precipitating antibodies (See appendix XII)
Complement (See appendix XIII & XIV)
Grain dust concentration (See appendix XV)
Results
A significant change in experimental parameters was considered to be:
1) Blood leukocyte counts (WBC) above 10,500 per am3 
(leukocytosis).
2) Increased oral temperature 37.8 C (fever).
3) C3 complement levels »ore than 38 mg % from baseline.
4) A decrease > 20% in FEV], FVC and DLC0 when compared to 
baseline values. No change greater than 10% was observed during the 
control day.
5) A decrease > 35% in MMF, VmaxgQ and Vmax7 5  when compared to 
baseline values.
Precipitins
None of the 12 subjects had precipitins to grain dust or fungal 
antigens.
Skin tests:
Two of the grain workers and 4 controls had positive prick skin 
tests to 2 or more common allergens and were considered atopic 
individuals. Three grain workers and 1 control had positive prick skin 
test to airborne grain dust antigen. No skin reactivity to barley was 
observed in the test or control group.
Hethocholine Challenge
Methochotine bronchial hyperreactivity was observed in 2 grain 
workers and 2 controls. Pre-existing airways obstruction defined as an 
FEVj/FVC less than 70% was observed in 1 grain worker. The pulmonary 
function studies done on these subjects before the challenge are 
presented in Table V-1.
Airborne grain dust challenge
Respirable dust concentrations, time averaged for each individual, 
are presented in Table V-l. The mean respirable dust concentration was 
84 mg/n3.
Symptoms
All subjects became symptomatic during exposure. In some
instances, the symptoms lasted longer than 24 hours but no greater than
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36 hours. The most common complaints were "flu-like” symptoms: malaise,
myalgias, tiredness, feverish feeling, chills and flushed face. These 
symptoms were observed in all grain workers and in 3 of the controls. 
These symptoms varied in intensity and were particularly marked in 7 of 
the 12 subjects. The symptoms were very mild in 2 of the 12 subjects. 
Seven of the I2 workers had headaches; none complained of eye irritation. 
The following symptoms were also observed: nasal symptoms (4/I2), throat
burning (5/I2), cough (I2/I2), wheezing or chest tightness (9/I2) and 
shortness of breath (9/I2). Using baseline comparisons, 10/I2 subjects 
(5/6 controls and 5/6 grain workers) developed leukocytosis (>11,700 per 
■m3: range 11,000-24,300). The average increase in the leukocytes was
11,000 per mm3. In one additional subject the white count increased by 
3,300 but remained below 9,000. Body temperature rose above 37.8C in 6 
of the 12 subjects (5/6 grain workers and 1/6 controls), 2 to 40 hours 
after exposure.
Pulmonary Function
Airways obstruction (decline in FEV-j = 20%) developed in 4 of 6 
grain workers and 5 of the 6 controls (Table V-l). Diffusing capacity 
also decreased in two controls within 24 hours after exposure. T-test 
analysis of the changes in FEV-j between the baseline and immediate 
post-exposure values revealed a significant (P <0.05) change for grain 
workers and controls (Fig. V-l). After challenge, the maximum changes in 
FEV| occurred: 1 hour (I), 2 hours (4), 4 hours (4), 6 hours (I), 8
hours (I) and 24 hours (I) later. Two of the controls showed a marked 
decrease in FEV*j after an improvement from the initial decrease at the 
28th hour. The changes in FVC for the group by t-test analysis was also 
significant in the grain workers, the controls and both groups together 
(Fig. V-2). For the MMF the paired t-test showed significant change for 
the 12 subjects analyzed together (p <0.001) (Fig. V-3) and for the 
controls (p <0.01), but it was not significant for the grain workers 
alone. VmaxgQ showed significant differences between baseline and 
control and the grain workers (p <0.01), the controls (p <0.02) and in 
both groups (p <0.001) (Fig. V-4).
The changes i n I eukocyte count by t-test on the group was a I so 
significant for the grain workers, controls and both groups together 
(P<0.02), (Table V-l).
The maximum leukocyte change was seen between 4 and 8 hours on most 
subjects and in 24 hours on 1 subject.
The changes in temperature in the grain workers was significant 
(P <0.05) by the t-test but was not significant for the controls or grain 
workers plus controls (Table V-l).
We analyzed the relationship between atopy and the development of 
airways reaction to dust exposure utilizing x2 analysis and it was 
not significant. Of the 6 atopic individuals, 5 developed a significant 
change in FEV] or airways obstruction (83%) and 1 (17%) did not. Of 
the non-atopic individuals 4 of 6 (57%) developed airways obstruction; 
but 2 of the 6 (33%) did not.
In those individuals with positive skin tests to airborne dust, 3
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of 4 (75%) developed airways obstruction, and 1 of the 4 did not. Of 
those with negative skin tests, 6 of 8 developed airways obstruction 
(75%); 2 of the 8 did not. Airways obstruction developed in 9 of 12 
subjects, 4 of which were non-atopic while 5 were atopic. Airways 
obstruction developed in 6 of 9 negative skin reactors to airborne 
grain dust; 3 of 9 reactors were reactors to the airborne dust.
Barley ChaIlenge
Inhalation of barley extracts reproduced grain fever syndrome in 1 
of 10. Six of 10 had leukocytosis with left shift, but 1 had fever 
over 37.8 C. One of 10 had a 20% or greater decline in FEV-|. One of 
10 had an increasing C3 level of 44.
Conclusions
Inhalation of high concentrations of airborne dust for 1 to 3 hours 
induces the grain fever syndrome lasting 24 to 36 hours. This syndrome 
is characterized by systemic reaction, facial warnth, headache, chills, 
nalaise, Myalgias, leukocytosis, left shift fever and is commonly 
associated with respiratory symptoms, throat and tracheal burning, 
chest tightness, dyspnea, cough, expectoration and airways 
obstruction. There is no evidence of parenchymal reaction.
These reactions occur in both grain workers and controls and are 
independent of previous exposure, atopic status, bronchial 
hypersensitivity, pre-existing airways obstruction or the presence of 
precipitins.
Our data do not support the hypothesis that grain fever is a type 
III allergic reaction since none had precipitins to grain dust, 
complement was not activated and changes in DLCO were not observed. 
This data nay suggest that grain fever is due to bacterial endotoxin or 
non-specific release of pharmacologically active substances from the 
lung after interactions between components of grain dust and lung cells.
Study I. Health Status of a Cross-section of Grain Handlers in the 
Twin Ports of Duluth and Superior.
The health status of grain handlers was evaluated by comparing the 
prevalence of clinical, physiological, immunological, radiological, 
serological, blood and urine parameters in 3I0 grain workers (test 
group) and 239 city service workers (controls) from the same geographic 
area. The control group was matched to the test group with respect to 
sex, age, height, weight and smoking habit.
All subjects were studied according to the following protocol:
1) a self-administered questionnaire reviewed for completeness by 
trained interviewers;
2) a physical examination performed by physician;
3) pulmonary function tests including FEV-j, FVC, MMF, Vmax^Q, 
Vmax7c, CV, N2/L, DLCO;
4) a chest roentgenograph, postero-anterior view;
5) skin prick tests for detection of immediate hypersensitivity to 
common allergens, fungal antigens, grain mites, grain insects, grain, 
airborne grain dust and settled grain dust;
6) intraderma I skin tests for delayed hypersensitivity to PPD, 
mumps, Candida albicans, Streptokinase-Streptodornase (SK/SD) and
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Trichophyton;
7) detection of serum precipitating antibodies directed toward: 
fungal antigens, bacterial antigens, pigeon sera, grain, airborne grain 
dust and settled grain dust;
8) the levels of circulating immunoglobulins (G,A,M,E);
9) blood hemoglobin and hematocrit;
10) urinalysis for protein, glucose and blood;
11) serum creatinine;
12) serum alanine aminotransferase (SGPT), gamma 
glutamyl transpeptidase (GGT) and pseudocholinesterase;
13) alpha]-antitrypsin levels.
Results and Conclusions from this Study
I) Clinical findings. Grain handlers had a higher prevalence of 
respiratory symptoms and signs (ronchi) than comparable non-grain 
handling city service workers from the same geographic area (Table 7-9, 
12, 24) whether or not they smoked. The effects of grain handling on 
prevalence of respiratory symptoms were highly significant, independent 
and usually greater than those of smoking (Table 13). The prevalence 
of work related respiratory symptoms adjusted for age and smoking habit 
was also positively related to place (Tables 19, 20) and length of 
employment (Table 15). The data suggested variable environmental 
working conditions among elevators and perhaps an accumulative 
respiratory effect due to recurring exposures to grain dust.
Grain workers suffer from:
a) acute and chronic airways reactions (occupational asthma and 
chronic bronchitis) induced by exposure to grain dust with varying 
degrees of: cough, expectoration, wheezing and/or chest tightness and
shortness of breath. Durum wheat and barley grain dust were the most 
common inducers of symptoms. During the work shift, wheezing and/or 
chest tightness occurred immediately after starting work or within 2 
hours. In late reactors, wheezing occurred within 2 hours after
leaving work. Very late reactions were not reported.
Wheezing and dyspnea on exposure were related to length of 
employment. This nay indicate either increased sensitization to the 
a11ergens present i n the env i ronment or the bronch i a I mucosa be i ng 
rendered more hyperreactive by the recurrent non-specific inflammatory 
reactions of the airways by grain dust. The place of employment was 
found to affect the prevalence of symptoms. The highest prevalence of 
symptoms were found in 4 companies and the lowest in 2 companies.
b) A grain fever syndrome (Table 21), characterized by a short-term 
febrile illness (flu-1 ike syndrome) that may be associated with
respiratory symptoms. It usually occurs during work or shortly after 
work. It is related to exposure to high concentrations of dust any day 
of the work week and not necessarily the first day at work or the first
day of the week. There was, however, a sma11 percentage of workers who
had a single episode of grain fever the first time at work and not 
again. The workers stated that in the last 3 years, because of the
improvement in the working conditions, grain fever occurred less
frequent ly. Some workers had grain fever a few hours after work,
compatible with allergic pneumonitis. However, none of these episodes 
were severe < enough to require medical attention, and we lack
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radiographic proof of allergic pneumonitis. Furthernore, the symptoms 
tended not to recur unless very high concentrations of dust were again 
present. Although we cannot deny that in some instances the grain 
fever syndrome nay be a manifestation of allergic alveolitis, we have 
not found the typical history and radiographic changes of allergic 
alveolitis in these workers.
c) Acute recurrent conjunctivitis and rhinitis during exposure to 
grain dust occurred in most grain workers.
d) Skin pruritus occurred nostly on exposure to barley dust.
e) Pesticide exposure caused temporary disabling symptoms
The long-term effects of recurrent symptomatic or asymptomatic 
exposures to pesticides are unknown, but we have encountered several 
forner grain handlers with chronic neurological defects attributable to 
pesticide exposure.
2) PuInonary function status. We concluded that grain dust exposure 
had an adverse effect on lung function (Tables 25-27, 29-31). The 
effect of grain dust on lung function was highly significant, and the 
overall effect was the same or of smaller Magnitude than that of 
smoking. Although there were nore grain workers with mild airways 
obstruction than controls, noderately severe or severe airways 
obstruct i on was equa I ly preva I ent i n both. The effect of gra i n 
handling appeared to be nostly on the airways. The high prevalence of 
abnormal W H2/L, indicating abnormal distribution of ventilation tine 
constants, needs further evaluation. Sinple, reproducible spirometric 
neasurements were sufficiently sensitive to detect the effects of grain 
dust exposure on lung function in the cross-sectional study. Other 
tests offer little or no advantage, but the potential usefulness in 
longitudinal studies needs to be further evaluated. There was no 
correlation between lung function and job category, place or length of 
employment (Tables 32, 33)®.
3) Clinico-physiological correlation. Grain workers with symptoms on 
exposure to dust had lower values of ventilatory function than workers 
without symptoms on exposure, regardless of smoking habits (Tables 38, 
39). This suggests that symptomatic exposure to grain dust results in 
lower ventilatory function and conceivably leads to non-specific 
bronchial hyperreactivity. It is also possible that grain workers have 
a pre-existing lower ventilatory function due to undiagnosed nild or 
non-symptomatic asthma or non-specific bronchial hyperreactivity, and 
exposure to grain dusts aggravates this condition. The prevalence of 
chronic bronchitis with airways obstruction was higher in grain workers 
than controls, regardless of smoking habits. In addition, chronic 
bronchitis with airways obstruction was related to length of 
employment. These findings suggest that chronic grain dust exposure 
nay result in chronic obstructive pulnonary disease.
4) Skin hypersensitivity (allergic). Atopy was nore prevalent among 
controls than grain workers (Table 35). The lower prevalence of atopy 
in grain workers nay inply that the nore "allergic" individuals tend to 
avo i d the gra i n dust env i ronment or I eave the i ndust ry. Th i s 
hypothesis could be tested in future longitudinal studies and a 
cross-sectional study of the "non-survival" population of grain workers.
The higher prevalence of positive skin test reactivity to insects
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and aites in grain workers suggested that the antigens used were more 
specific for the grain workers because the extracts were prepared with 
the grain insects and grain aites commonly found in elevators. Hence, 
grain workers would be nore likely to be sensitized. The low 
prevalence of positive reactions to grain antigens nay be due to a low 
allergenicity of the grain extracts; too low a concentration or loss of 
the antigenic component of grain during saline extraction. According 
to previous studies, however, the saline extractable fraction seemed to 
be the most allergenic of the wheat fractions.
The high prevalence of positive skin tests to airborne grain dusts 
observed i n gra i n workers suggests that a greater proport i on were 
sensitized to grain dust. Since some city service workers also had 
positive skin tests to airborne dust, the data suggest that air in the 
Duluth-Superior area was contaminated with dust from the grain 
elevators.
The prevalence of skin test reactions to grain dust and
insect/nites was significantly higher (by x2) in atopic grain 
workers and in atopic control workers than in non-atopic individuals. 
The data i npIy that atop i c i nd i v i duaIs are more Ii keIy to become 
sensitized to grain dust or insect-nite airborne particles than are 
non-atopic individuals (Table 37).
5) Skin hypersensitivity-symptoms correlation. Overall, there were no 
significant correlations between symptoms on exposure, chronic 
symptoms, grain fever, or symptom complexes and skin reactivity to 
common allergens or specific allergens. The exceptions were: a)
dyspnea on exertion was nore prevalent among grain workers with 
positive skin reactivity to fungal antigens and to grain antigens, b) 
Nasa I symptoms on exposure to gra i n dust were nore preva I ent among 
grain workers with positive skin reactivity to grains, barley and oats 
(Table 42).
6) Skin hypersensitivity-pulmonary function correlation. Grain 
workers with atopy or skin reactivity to grain dust were more likely to 
have lower airways function values. The clinical significance of these 
findings is not clear since abnormal lung function was not nore 
prevalent among atopic individuals or skin reactors to specific grain 
extracts (Tables 40, 41).
7) Serum prec i p i tat i ng ant i bod i es. C i ty workers had a greater 
prevalence of precipitins to Trichoderma, T, vulgaris, T. sacchari and 
to one or nore fungi than grain workers (Table 44). Conversely, grain 
workers had a greater prevalence of precipitins to: durum wheat, rye
and airborne dusts of wheat, barley, rye, oats and sunflower to one of 
the settled dusts than controls. The larger prevalence of precipitins 
to some grain dusts among grain workers was not surprising, yet they 
did not correlate with increased prevalence of symptoms or abnormal 
lung functions. Hence, the data inply that the respiratory reactions 
to grain dusts are not precipitin-nediated, and that grain fever is not
a Manifestation of allergic alveolitis type III reaction. Serum
precipitins reflect host response to antigens but not necessarily the 
presence of disease or abnormal pulmonary dysfunction. The reason for 
the greater prevalence of fungal precipitins among city workers is not 
clear.
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8) AI pha-j -Anti trypsin level (AAT). The levels of AAT in grain 
workers and controls were similar. Pi phenotyping of grain workers 
with AAT levels less than 60% of the normal values detected 3 MZ's with 
¡■paired trypsin inhibitory capacity (TIC) and 3 MZ's with normal TIC. 
These subjects showed no consistent abnomality in lung function 
(Tables 53, 55).
9) Chest roentgenograms. The prevalence of abnormal chest 
roentgenogram findings was small and most changes were of ainor 
clinical significance with a few exceptions (Table 47). There were no 
cases with diffuse bilateral interstitial infiltration or fibrosis.
10) Liver disease screening (SGPT, GGT, Choiinesterase). We did not 
detect differences in the frequency of overt liver disease between 
grain workers and controls (Table 45). Certain findings make us 
recommend that future prospective morbidity studies include evaluation 
of liver disease prevalence. In the questionnaire, the grain workers 
reported exposure to hepatotoxic pesticides. The liver was palpable in 
a significant number of grain workers. Moreover, the mean values for 
SGPT were elevated in grain workers. Grain workers had a greater 
number of abnormal values for GT.
11) Renal disease screening. The results of the renal function 
screening tests were inconclusive (Tables 45, 46). We would recommend 
further prospective studies on the potential renal morbidity of 
pesticide exposure.
12) Immunoglobulins. The levels of IgG and IgA observed in grain 
workers differed significantly from the city workers, whereas the 
levels of IgM were similar in both groups (Tables 48, 52). The data 
suggest that grain dust normally enhances the levels of serum IgA, but 
that the response was blunted by smoking. Elevated IgG and IgA levels 
were observed only in grain workers working in the elevators from 10.6 
to 15.5 years. Increased levels of IgA were also observed in grain 
workers working in the industry fewer than 5.5 years.
The place of employment influenced the level of circulating IgG. 
(Increased levels of IgG in elevators I and 8)
Only 4 of the 307 grain workers and 2 of 235 city workers tested 
had IgE levels above 600 I.U. Oata from the IgE determinations should 
be interpreted with caution. Using radioissnunoassays for determination 
of IgE, the level of IgE in normal serum is below 50 I.U./ml. Serum 
from highly allergic individuals contains between 300-600 I.U. Levels 
above 900 I.U. are rarely observed. Hence, the immunodiffusion method 
for determining IgE levels is not sensitive enough to detect increases 
in serum IgE occurring between 100-600 I.U.
Study II - Work Shift Study
Two hundred and forty-eight (248) grain workers and 192 controls 
(city service workers) were studied. The following parameters were 
evaluated: I) symptoms, 2) pulmonary functions (FEVj, FVC, VmaxgQ
and Vmax7 5 ) before and after the shift, 3) leukocyte count and 
differential, 4) serum complement C3 level and complement activation
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before and after the shift, 5) oral temperature at 7-800 hrs, 1200 hrs, 
15-1600 hrs and 2000 hrs, 6) total and respirable time average dust 
levels by personal sampler, 7) mycological studies described 
Whidden et al. "Microbial Flora and Fauna of Respirable Grain Dust 
from Grain Elevators."
Results and Conclusions from this Study
Exposure to grain dust during an 8 hour work shift appeared to have 
an adverse, dose-related, acute effect on the workers. This adverse 
effect is suggested by the following:
1) Grain workers reported more symptoms during work than city service
workers of similar age, height and smoking habit (Table II - 3).
2) Grain workers were exposed to a higher concentration of dust than 
city service workers (Table II - 2).
3) The incidence of respiratory symptoms was positively related to the 
workers' subjective estimates of dust levels and to time-weighted
average total dust concentration (Tables 11-4, 14).
4) Grain workers' subjective estimation of dust level correlated with 
the measured total dust concentrations (Table II - 14).
The incidence of respiratory symptoms was higher among grain
workers exposed to mean total airborne dust (time-weighted average 
concentration) of 13.9 mg/m3 when compared to grain workers exposed to 
4 mg/m3 or less. In the latter group of grain workers the incidence of 
symptoms was similar to that found among controls.
The negative effect of grain dust exposure on lung function also
tends to support the hypothesis that grain dust exposure has an adverse 
effect on the workers.
The negative effect of grain dust exposure on lung function was 
suggested by:
1) In a small number of subjects, a greater proportion of grain 
workers had a significant decrease in FEV-j (-15%), Vma xjjq and 
Vmax/g (-25%) (Table II - 12a).
2) There was a negative correlation between VmaxgQ and Vmax7 5  and 
total dust level. The higher the dust level the more negative the
change in function value (Table II - II).
3) There was a significant difference between the pre-post-shift lung 
function changes observed in grain workers and controls. The mean 
control group values tended to increase slightly during the day, 
whereas grain workers showed slightly negative changes (Table 11-9).
Overall, the acute effects of the dust concentrations found in this 
study on the lung function did not seem to be of clinical significance 
since there was no correlation between the presence of symptoms and 
pre-post-shift changes in function. This small, negative, acute effect 
may or may not have long-term effects such as a greater than expected 
yearly loss of function.
At the total dust concentrations these workers were exposed to we 
found no consistent systemic reaction, i.e., oral temperature, 
leukocyte count or serum complement level or activation of complement 
(Tables II -£-8).
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Study III. Prospective 3 Year Fol low-up Study
The pulmonary function parameters (FEVj, FVC, Vmaxijo, Vnax7 s 
and DLCO) studied in 1974 were compared with the values obtained in 
cross-sectional study performed in 1977.
Results and Conclusions
No def i n i te coneIus i ons as to the chron i c effects of recurrent 
grain dust exposure can be derived from this short-term follow-up study 
using tests of airways flow and diffusing capacity. The non-working 
grain handlers (left the industry, retired, laid-off) were not included 
in the evaluation. The results would be affected by those who had to 
stop work i ng because of resp i ratory d i sab i I i ty and were I ost to 
follow-up.
The mean decline in FEVj or FVC was no greater than that expected 
for aging alone. The results did show, however, a significant mean 
decline in other tests of airways flow— i.e., H1F, Vnaxgo and 
Vmax7 5 — which was greater than expected for age alone in any smoking 
category (Tables 111-4-10). Although nonsmokers showed a greater mean 
decline in flows at low lung volumes than smokers, a very small 
proportion of nonsmokers showed a decline in function greater than 
expected. This significant mean function (MMF, VmaxgQ and Vmax7 5 ) 
decline in nonsmokers suggests a grain dust effect independent of age. 
However, since the majority of those who showed a greater than expected 
(age related) decline in these functions were smokers, cigarette 
smoking probably has a greater adverse long-term effect on these
functions than grain dust exposure.
Study IV: Pulmonary Reaction to Grain Dust Constituent - Pilot Study
in the Identification of Etioloqic Agents
The pulmonary and systemic response to extracts of durum wheat,
durum wheat airborne dust and insects or mites was studied by
inhalation provocation tests on II grain workers with symptoms on 
exposure to grain dust.
Conclusions
Durum wheat, a constituent of grain dust, induced an airways
response in grain handlers (Figures IV-1,2). This response was
inhibited by sodium cromoglycate (Figure IV-3). The effect of inhaled
durum wheat appeared to be on the large airways without parenchymal or 
systemic reaction and without complement activation. The bronchial
reaction was not always related to the atopic status or acquired skin
hyperreactivity to grain or grain dust antigens. Our data suggest that
a type III allergic reaction does not play a role in the bronchial 
response to durum wheat extract. Moreover, the data ¡*ply a
nonimmunologic release of mediators, e.g., histamine, or type I
immediate IgE mediated allergic reactions are responsible for the 
reaction.
Study V: Grain Fever Syndrome
Clinical, physiological and immunological parameters were evaluated 
in 12 subjects (6 grain workers with grain fever and 6 nonsmoking, 
asymptomat i c controIs) after exposure i n a chamber to h i gh
concentration (>15 mg/m3) of grain dust to reproduce an environment.
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Workers considered this concentration of dust similar to that most 
likely to provoke an episode of grain fever at work. Results after 
challenge were compared to baseline and to control day results.
Conclusions
Inhalation of high concentrations of airborne grain dust for one to 
three hours induced the grain fever syndrome manifestation lasting 24 
to 36 hours. The syndrome was characterized by systemic reactions: 
facial warmth, headache, chills, malaise, myalgias, leukocytosis, left 
shift fever and by respiratory reaction: throat and tracheal burning,
chest tightness, dyspnea, cough, expectoration and airways 
obstruction. There was no evidence of parenchymal reaction.
The reactions occurred in both grain workers and controls and were 
independent of previous exposure, atopic status, bronchial 
hypersensitivity, pre-existing airways obstruction or the presence of 
precipitins.
Our data do not support the hypothesis that grain fever is a type 
III allergic reaction. None of the test subjects had precipitins to 
grain dust, complement was not activated and changes in DLCO were not 
observed. This data may suggest that grain fever is due to 
non-specific release of pharmacologically active substances from the 
lung after interactions between components of grain dust and lung cells.
Health Effects of Grain Dust Exposure Summary
Grain dust exposure can induce acute symptomatic reactions of the 
skin, conjunctiva, upper and lower airways (asthma) and systemic 
febrile reaction (grain fever syndrome). Grain fever could be induced 
by inhalation of high concentrations of respirable airborne dust (>20 
mg/m3) and was temporarily disabling. Respiratory symptoms were more 
likely to occur among workers exposed to a total dust time-weighted 
average concentration of 13.9 mg/m3. They also occurred among workers 
exposed to a mean total dust time average concentration of 4 mg/m3 and 
less, but overall the incidence of symptoms in that group of grain 
workers was similar to that in controls.
Gra i n dust exposure can i nduce chroni c expectorat i on (chron i c 
bronchitis) and dyspnea on exertion. The effect of grain dust exposure 
on symptom prevalence was of greater or the same magnitude as the 
effect of smoking. The acute physiologic pulmonary changes were 
significant (e.g., pre-post work shift FEV-j > 20%) at high
(time-weighted average) respirable dust concentrations (> 20 mg) but 
are infrequent at time average total dust levels below the current TLV 
of 15 mg/m3.
Recurrent daily exposure to low concentrations (assuming that 
time-weighted average dust concentrations at the elevator was TLV of 15 
mg/m3 or lower) may result in lower ventilatory function than expected 
for men of the same geographic area not exposed to grain dust. The 
adverse effect of grain dust exposure on lung function was of equal 
magnitude or smaller than that of cigarette smoking. The physiologic 
changes, however, were of small magnitude and may have no significant 
long-term effects on the worker's sense of well-being, working 
performance or longevity. On certain occasions, the acute symptoms on
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exposure at weighted average total dust levels below accepted TLV 
nuisance dust <15 mg/m3) appeared to affect workers' work performance 
and sense of well-being during and after work, thus affecting their 
quality of life.
It is reasonable to suspect that acute symptoms on exposure are 
more related to peak airborne dust concentrations rather than to 
time-weighted average levels. It is also conceivable that significant 
transient decreases in ventilatory function may occur during the work 
shift when high peak airborne dust concentrations occur. Hence, 
further studies are needed to determine the relationship between peak 
dust levels and the biological response. In addition, prospective 
studies are needed to determine the long-term effect of the : I)
recurrent adverse acute pulmonary adverse effects of grain dust 
exposure, 2) the grain fever episodes, and 3) the symptomatic pesticide 
exposure.
There was no evidence to suggest that grain dust can cause 
hypersensitivity pneumonitis.
The effects of grain handling and smoking on the lungs were
statistically significant, independent and additive. Although allergic 
predisposition must play an important pathogenetic role in some
individuals, acute asthmatic responses can be elicited regardless of 
the atopic status of the individual.
A component of grain dust, durum wheat, has been identified as an 
etiologic agent. The mechanism by which durum wheat or grain dust 
induces asthma is not known. The prevention of asthma to grain dust by
pre-treatment with sodium cromolyn suggests an allergic or
pharmacologically mediated histamine release. Further studies are 
needed to identify the fractions of d. wheat and other components of 
grain dust (e.g., barley, oats,, rye, insects, mites or fungi) capable 
of inducing asthmatic reactions and their mechanism of action.
HEALTH EFFECTS OF GRAIN DUST EXPOSURE 
Acute inflammatory reactions 
♦ skin irritation with pruritus 
+ Conjunctiva
I Upper airways: nasal passages, larynx, trachea 
I Lower airways: (asthma) + large airways 
o Alveoli (no evidence of alveolitis) Small 
airways (probable) but possible under 
certain conditions 
Acute systemic reaction (inflammatory? toxic?)
+ Grain fever syndrome 
Chronic respiratory effects
+ Chronic bronchitis without airways obstruction 
? Hyperreactive airways (probable)
? Chronic bronchitis with airways obstruction (probable)
? Loss of lung function greater than expected for age 
Toxic effects of pesticides 
+ Acute neurological and gastrointestinal 
? Chronic neurological disease from recurrent exposures 
(probable) 
o Hepatotoxicity or nephrotoxicity
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Other health effects: Unknown
+ There is evidence to support the cause-effect 
relationship with grain dust exposure 
? Cause-effect still debatable and nore information is needed. In some 
instances the cause-effect is highly probable.
0 No evidence of cause-effect or even that it ever occurred following 
grain dust exposure.
Based on the results of the studies described above we conclude
that grain dust exposure has an adverse effect on grain handlers.
We can conclude with certainty that: a) grain dust exposure can
induce acute reactions of the exposed mucosa of acute clinical 
significance as indicated by Studies I, II, IV and V, and b) exposure
to high dust concentrations have a definite negative physiologic effect 
on the airways and systemic response (leukocytosist fever) as
demonstrated by Study V.
At I ow dust concent rat i ons (Study 11) there i s a negat i ve 
physioIogic effect which, except for a few instances, is of sma11 
magnitude. The prognostic significance or long-term effect of this
small negative effect is not clear. The prospective pulmonary function 
data (Study III) would suggest that this effect may result in a yearly
loss of airways flow greater than expected for age. However, this may
only be significantly abnormal in smokers.
Our data (Study II) lend support to the workers' subjective 
correlation of acute respiratory response to dust level, since there
was a relationship between prevalence of symptoms on exposure and lung 
function changes and total dust levels. The recurrent exposure to
grain dust also appears to have definite chronic clinic effects related 
to length of exposure, but the chronic functional effects are less 
clear-cut. The higher prevalence of abnormal airways flow in grain 
workers and the greater than expected yearly loss of airways flow 
suggest a chronic negative functional effect. Whether or not this 
effect leads to early disability or decreased performance or affects an
1 nd i v i duaI's sense of we11-be i ng cannot be answered as yet. The 
long-tern effects of the acute pulmonary recurrent negative effects of 
grain dust exposure; grain fever episodes; and symptomatic pesticide 
exposure will have to be answered by prospective studies.
We found no acute or chronic evidence that suggests that grain dust 
exposure can cause hypersensitivity pneumonitis. The results of these 
studies allow us to make some conclusions about host factors that 
affect the response to grain dust and about the mechanism of action of 
grain dust.
Cigarette smoking: Cigarette smoking has an additive effeet on
gra i n hand I i ng in regard to the preva I ence of acute and chron i c 
resp i ratory symptoms, puImonary funct i on status and preva1ence of 
pulmonary function abnormalities. Although smokers are more likely to 
be affected by chronic grain dust exposure, acute symptoms on exposure 
can occur independently from smoking habit.
Allergic sensitization (as detected by immediate reaction to 
common or specific allergens): Overall, in this working (survival)
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population of grain workers, there was no relation between prevalence 
of symptoms or abnormal lung function and the atopic status of 
individuals. In addition, positive bronchial provocation challenge 
occurred regardless of the atopic status of individuals. There is 
evidence, hcwrever, that allergy nay play a role since there was a 
negative relation between lung function and skin test reactivity in 
Study I* The bronchial reaction seen in a subject in Study IV can be 
interpreted as being an immediate IgE type I allergic reaction in a 
"very atopic" individual. Hence, the lack of overall relation between 
skin sensitivity and respiratory response should not exclude the 
probability that in certain individuals the bronchial reaction is 
Mediated via an allergic mechanism. Also, it is likely that very 
atopic individuals with hyperreactive airways are unlikely to remain in 
this industry for long. This is suggested by the lower than expected 
prevalence of atopy to common allergens among the grain workers.
BronchiaI hyperreactivity: Bronchial hyperreactivity is likely to
predispose to bronchial reaction to grain dust, but Studies IV and V 
demonstrate that responses to durum wheat or high concentrations of 
airborne grain dust can occur in subjects without pre-existing 
hyperreactivity. Further studies on non-specific bronchial 
hyperreactive airways of the biologic response to airborne dust are 
needed. To determine if bronchial hyperreactivity is acquired or 
pre-existing; if it reverses once exposure is discontinued; and to 
establish the usefulness of Mecholyl test to detect high risk 
individuals before or during employment.
Pre-existing airways obstruction: Based on Study IV we conclude that
airways response to grain is more likely to occur in subjects with 
severe airways obstruction but according to Study V high concentrations 
of grain dust can induce bronchial reaction even if there is no 
pre-existing airways obstruction.
Alphai-Antitrypsin activity: No apparent relationship was found
between level of a I pha-j -anti trypsin and pulmonary response to grain 
dust.
Mechanism of action: We have shown that durum wheat saline extract,
durum wheat airborne dust saline extract and airborne grain dust from 
elevators can induce the bronchial reaction by mediator release, since 
their reaction can be blocked by sodium cromoglycate. An allergic IgE 
mediated type I reaction was apparent in one subject. We found no 
evidence that a type III precipitin-mediated reaction or complement 
activation plays a significant pathogenetic role (Studies II, IV and V).
Further studies are required to identify: the components of grain
dust responsible for the pulmonary reaction, their mechanism and site 
of action; the role of mediator release and complement activation in 
the pathogenesis of the airways reaction; and the role of host factors 
which can modify the responses to grain dust, i.e., non-specific 
bronchial hyperreactivity and allergic predisposition or sensitization.
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REF CC VAC SL TOTAL
ELEVATOR 1 37 35 95 2 0 2 1 40
ELEVATOR 2 23 22 96 1 0 1 0 40
ELEVATOR 3 17 12 71 1 4 1 1 19
ELEVATOR 4 81 49 60 15 17 4 4 89
ELEVATOR 5 18 17 94 1 0 2 2 22
ELEVATOR 6 21 17 80 4 0 1 2 24
ELEVATOR 7 44 39 89 3 2 4 1 49
ELEVATOR 8 37 24 65 10 3 1 2 40
ELEVATOR OPERATORS 278 215 77 37 26 16 13 307
STATE INSPECTORS 79 68 85 10 5 5 0 88
LONGSHOREMEN 40 27 68 4 8 0 0 39
TOTALS: 397 310 78 51 39 21 13 434
Working = At time of survey study.
CC * Unable to leave work to be tested, or not properly notified of examination 
time.
SL = Sick leave - 11 studied.
VAC * On vacation.
REF » Refused.
TABLE 2.




n % of C % of E
Duluth City 322 273 137 50% 43%
Duluth Power & Light Co. 92 59 59 100% 64%
Superior City 64 54 43 90% 67%
Total 478 386 239 81% 50%
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Mean age (years) 
Mean weight (kg) 









Live or work on
TABLE 3a
CHARACTERISTICS OF THE POPULATIONS
GRAIN HANDLERS CONTROLS
N « 310____________________P______________H - 239
40.8 + 12.4 (MS) 40.8 ± 11.5
84.1 + 14.1 (NS) 85.5 + 13.6














DISTRIBUTION OF SMOKING HABITS, HEIGHT, WEIGHT, AGE GROUP
GRAIN WORKERS



















20-29 47 53 177.1 78.3 19 22 178.1 82.2 22 25 179.4 83.5 88 177.9 80.4
30-39 35 67 178.5 84.8 9 17 177.3 81.5 8 15 176.2 83.4 52 177.9 84.0
40-49 42 52 175.9 83.7 20 25 177.0 87.7 19 23 175.3 89.5 81 176.0 86.1
50-64 29 33 174.8 78.2 44 49 176.3 86.3 16 18 176.0 84.5 89 175.7 83.3
20-64 153 49 176.7 81.2 92 30 176.9 85.3 65 21 176.9 85.5 310 176.8 83.3






DISTRIBUTION OF SMOKING HABITS, HEIGHT, WEIGHT, AGE GROUP
CONTROLS
____________Smoke« _________Ex-Smoker«  Nonsmokers________  ______All, Groups_______
Age Height Weight Height Weight Height Weight Height Weight
(years) (no,) (%)* (cm) (k*) (no)_ (%)* (cm) (kit) (no,) <*)* (cm) (kn) (no,) (cm) (kg)
20-29 26 52 176.8 81.7 7 14 177.3 81.0 17 34 179.9 85.6 50 177.9 82.9
30-39 35 45 176.8 83.9 22 29 176.2 84.2 20 26 175.8 83.1 77 176.4 83.8
40-49 29 56 174.5 84.5 13 25 179.4 98.2 10 19 175.1 91.4 52 175.8 89.2
50-64 16 28 174.6 79.7 26 45 174.6 86.7 16 28 172.4 83.3 58 174.0 83.8
20-64 106 45 175.8 82.9 68 29 176.3 87.5 63 27 175.9 85.1 237 176.0 84.8





SMOKING HABITS OF SMOKERS AND EX-SMOKERS
GRAIN CONTROL
SMOKER EX-SMOKER SMOKER EX-SMOKER
#153_________ £92________________#106___________ £70
#CIGARBTTES/ONLY n X n % n X n X
<14 15 10 14 15 15 14 8 11
15 - 25 78 51 43 47 45 43 32 46
>25 60 39 35 38 46 43 30 43
# PACK/YEARS
0 - 14.9 43 28 38 41 38 36 26 37
15 - 30 51 34 27 29 29 27 25 36
30.5 - 200 58 38 27 29 39 37 19 27
SMOKE/YEARS
<14.5 57 38 38 41 37 35 31 44
14.6 - 25.5 37 24 20 22 39 37 25 36
>25.6 58 38 34 37 30 28 14 20
INHALED SMOKE 147 97 102 96
AGE STARTED
0 - 2 0 134 91 83 90 98 93 61 87
21 - 301 13 9 8 9 8 7 9 13
>30 0 0 1 1 0 0 0 0
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TABLE 6
ggLBCTTO OCCUPATIONAL PAST HISTORIES IN CRAIN WORKERS ASP CONTROLS
Job (code) GRAIN WORKERS (310) 
LOE






(10) Ore loaders or 
Cement Mixing Operation 12 4 9.3 2-18 13 5 2.8 .25-10
(11) Metal work foundries 28 9 4 .5-14 25 10 3.5 .33-24
(12) Coke gas plant 3 1 9 5-11 1 0 .5 .5
(16) Faming 16 5 12.4 1-36 4 2 2.8 1-5
(20) Welding 12 4 .4.5 .3-14 17 7 4.3 .5-27
(22) Feed mill, grain mill 
Brewery
8 3 6.7 1-19 3 1 1.7 1-2
(7,9 ,6) Equipment operator, 
longshoremen, 
grain inspector 11 A 3 .25-7
Workers who had past history 77 25 55 23
LOE = Length of employment
TABLE 7
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PREVALENCE OF CHRONIC COUGH AND EXPECTORATION THAT HAY 
INDICATE PRESENCE OF CHRONIC BRONCHITIS
Grain Workers Controls
n X n X
Chronic Bronchitis:
I 14E > 2 Yrs 151 49 43 18
II Yes to 14C+14E > 2 Yrs 119 38 27 11
III 13 > 2 Yrs 132 43 37 14
IV Yes to 14D+14E > 2 Yrs 132 43 36 15
V Yes to 13A or B or C 193 62 67 28
VI Yes to 14A or B or C 165 53 51 21
VII Yes to 13A 109 35 37 15
VIII Yes to 14A 116 37 36 15
IX Yes to V or VI 194 63 67 14
COUGH AND PHLEGM:
13a. Do you usually cough first thing 
(Exclude clearing throat.)
in the morning? 1 . Yes 2. No
b. Do you usually cough at other times during the 
day or night? 1 . Yes 2. No
c. Do vou cough as much as 4-6 times 
more days out of the weeks?
a day for 4 or
1 . Yes 2. No
IF YES TO EITHER 13a. b OR c. ANSWER d AND e:
d. Do you cough on most days for as much as 3 months
of the year? 1. Yes 2. No (x)
e. For how many years have you had this cough?   Years (x)
Page 72
TABLE 7 (continued)
14a. Do you usually bring up phelpn from the chest
first thing in the morning? (Hot from the back 
of your nose. Count swallowed phlegm from the
chest.) 1. Tes 2. Ho
b. Do you usually bring up phlegm from the chest
at other times during the day or night? 1. Yes 2. Vo
c. Do you bring up phlegm like this as much as twice
a day, 4 or more days out of the week? 1. Yes 2. Vo
IF YES.TO EITHER 14a, b OR c, ANSWER d and e:
d. Do you bring up phlegm from the chest on most 1. Yes 2. Vo (x)
days for as much as 3 months of the year?
e. For how many years have you raised phlegm from 
the chest?  Years (x)
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TABLE 8
PREVALENCE OP WHEEZING AND/OR CHEST TIGHTNESS (W &/OR CT) 





n % n _ X
Occupational Asthma if:
I W &/or CT brought on or aggravated 
by exposure to dusts, gases or 
fumes at work (Yes to Q 28A or B 
or C) 183 59 31 13
II I and cough aggravated by or 
brought on by exposure to dusts, 
gases or fumes at work (Yes to 
Q 28A or B or C and Q 18A or B or C) 145 47 20 8
III II and dyspnea while performing 
job (Yes to Q 28A or B or C and 
Q 18A or B or C) 81 26 0 0
IV I and Wheeling better When off 
work or vacation (Yes to Q 28A 
or B or C and Q 35A) 167 54 13 5
V IV and episodes of Vheezing with 
dyspnea (Yes to Q 28A or B or C 
and Q 35A and Q 36) 72 23 2 1
Grain Handlers Onlv
VI W &/or CT while at %n>rk 
(Yes to Q 2SA) 165 53 - -
VII W St/or CT brought on or aggravated 
by grain dust (Yes to Q 28A) 183 59 - -
VIII W &/or CT and cough on exposure 
(Yes to Q 28A and Q 18A) 144 46 - -
IX VIII and dyspnea on exposure 
(Yes to Q 28A and Q 18A and 
Q 44A) 102 33
X W &/or CT on exposure and Wheezing 
better when off work or on vacation 
(Yes to Q 35A and Q 40) 165 53 - -
See Questionnaire (Appendix IV) for text of questions. 
Q = question.




« X El mmM X n U EXSMOKER « X n
P3 HONSMOKER 
« X u £4
TOTAL 0 310 100 153 92 «5
c 239 100 104 70 __
CHROMIC BROHCHITIS t 0 151 49 8» ST .05 40 43 K3 23 35 .005
(Q14 > 2 YRS) <■001 <.001 <.001 <.001
C 43 18 32 30 .001 5 7 MS ft 10 .005
CHROMIC BROMCHtTIS IX Q LU 3« 48 44 .100 30 33 ■S 21 3t .100
(Q14C > 2 m> <.001 <.001 <.001 <.001
C 27 11 21 20 .010 4 4 MS 2 3 .005
COUCH FIRST THIMC 1» 0 10« 35 75 49 .001 19 2L MS 15 23 .001k.n. «.001 #005 .001 .05
(Q13A) C 35 15 31 29 .001 1 1 .10 5 8 .005
PHLECN PI1ST THING IN 0 tu 37 71 4« .005 2ft 28 MS 19 29 .05
A.». <.001 .005 .001 .005
(QMA) C 3ft 15 28 2ft .001 3 4 MS 5 8 .005
dyspnea ov n m io i 0 HI 3« «5 42 MS 29 32 MS 24 37 MS
CRADB I <.01 .05 NS .005
<Q38> c •4 27 32 30 MS 25 3ft .001 7 11 .005
DYSPNEA 0» n m to i 0 23 7 11 7 MS 9 10 MS 3 5 ftS
CHADS II <.05 MS MS NS
<Q39) c a 3 3 3 MS 4 ft NS 1 2 NS
HX OF WHS8ZIM0 JUTO/OR 0 200 «5 110 72 .05 53 58 NS 37 57 .05
CH8ST TIGtmntSf <.001 .001 .05 .05
(Q21A) c 101 42 53 50 NS 29 41 NS 19 30 .05
WHEMZINO AT MIGHT 0 (1 20 34 22 MS 1ft 17 NS 11 17 NS
(Q33A) .005 .05 NS NS
c 24 10 12 11 NS 8 11 NS 4 ft NS
EPISODES OF WHESZINO 0 7ft 25 48 31 MS 20 22 NS 8 12 .005m  DYSPNEA .001 .001 .05 VS






El n EXSMOKER 
N X
El u NONSMOKER 
V %
El P4
TOTAL G 310 100 153 92 65
C 239 100 106 70 63
CH85T ILLNESS* C 123 40 60 9 NS 36 39 NS 27 42 NS
(63B, C or D) NS NS NS .05
C 78 33 42 0 NS 23 33 NS 13 21 .05
SYMPTOMS RELATED
TO WORK EXPOSURE
COUGH AMD/OR G 201 65 115 5 .005 52 57 NS 34 52 .001
EXPECTORATION .001 .001 .001 .001
(18A or B or C) C 41 17 28 6 .05 9 13 NS 4 6 .005
DYSPNEA AT WORK G 113 37 61 NS 35 38 NS 17 26 .1
(043) .001 .001 .001 .01
C 26 11 13 2 NS 8 11 NS 5 8 NS
"OCCUPATIONAL G 183 59 104 7 .01 45 50 NS 33 50 o u*
ASTHMA" I .001 .001 .001 .001
C 31 12 14 3 NS 10 14 NS 7 11 NS
"OCCUPATIONAL G 145 46 89 8 .005 35 38 NS 21 32 .001
ASTHMA" II .001 .001 .001 .001
C 20 8 12 1 NS 5 7 NS 3 4 NS
"OCCUPATIONAL G 81 26 48 1 NS 22 24 NS 11 17 .05
ASTHMA" III .001 .001 .001 .005
C 0 0 0 0 0 0 0
"OCCUPATIONAL G 167 54 95 2 .05 45 49 NS 27 42 .01
ASTHMA" IV .001 .001 .001 .001
C 13 5 8 8 NS 3 3 NS 2 3 NS
CRAIN EXPOSURE ONLY - TOTAL 310 153 92 65
COUCH (18A) G 200 65 114 5 .005 52 57 NS 34 52 .005
WHEEZING (28A) G 183 59 104 8 .01 46 50 NS 33 50 .05
DYSPNEA (44A) G 151 49 84 5 NS 47 51 .05 20 31 .005
*Cannot do usual activities bee s u m  of chest Illness nor then twice in lest 3 yeera . Page 
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Table 9 (cont.)
TOTAL El SMOKER El E2 EXSMOKER PI El MONSMOKER PI £4
N X N % N X N X
EYEBURNING (48A) G 242 78 123 80 NS 69 75 NS 50 77 NS
NASAL STUFFINESS (48B)G 246 79 126 82 NS 70 76 NS 50 77 NS
SORE THROAT (48C) G 161 52 88 58 NS 43 47 NS 30 46 NS
CRAIN FEVER G 99 32 47 31 NS 31 33 NS 21 32 NS
For definition of "Occupational Asthma" see Table 8 (Refer to Questionnaire - Appendix IV).
P - Significance of the difference In prevalence (x^ analysis). PI grain workers vs. controls: P2 smokers vs. 








N = 310 N - 239
N X 5 *
"Has your doctor ever told you 
you had...?*’
Bronchitis 53 17 36 15
Emphysema 6 2 2 1
Pleuresy 28 10 18 8
Tuberculosis - Lung 6 2 1 .5
Cancer of the Lung 0 0 0 0
Chest surgery 4 1 3 1
Chest injury 11 4 10 4
Sinus "trouble” 72 23 74 31
Farmer's Lung 0 0 0 0
Pneumonia or bronchopneumonia 68 22 60 25
Bronchial asthma 12 4 4 2
Heart "trouble** 20 6 15 6
High blood pressure 49 16 33 14
Allergic rhinitis - Hay fever 20 6 29 12**
Kidney "trouble" 24 8 15 6
Liver "trouble" or jaundice 17 5 13 5
Diabetes 6 2 11 5
"Have you ever suffered from...?"
Eczema in childhood 13 4 10 4
Skin rashes 92 30 72 30
Painful or swollen joints 96 31 72 30
♦Number and proportion of grain workers and controls who answered yes to 
questions 64, 65a, 66a, 67, 68, 69, 70a and 71a.
**P.05
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FAMILY HISTORY (IMMEDIATE - BLOOD RELATIVES)
TABLE IX
Grain Workers Controls
S - 310 
tf %
H * 239 
V %
Chronic bronchitis 15 5 9 4
Emphysema 16 5 18 8
Asthma 33 11 25 10
Hay fever 20 6 27 11
Cystic fibrosis 1 .5 0 0
Cancer of the lung 12 à 17 8
Fanner's Lung Disease 0 0 1
Other lung diseases 11 4 8 3
TABLE 12
PREVALENCE OF SELECTED SYMPTOMS OR SYMPTOM COMPLEXES 
IN GRAIN WORKERS AND CONTROLS AND BY SMOKING HABIT
Chronic Occupational Dyspnea Nocturnal
Bronchitis Asthma I at Work Asthma
% E *  E X P % E
Controls -■ nonsmokers (63) 10 11 8 6
] < .005 NS NS NS
Controls - smokers (106) 30 13 12 11
] NS <.001 <.05 NS
Grain worker nonsmokers (65) 35 50 26 17
] <.005 < .05 .1 NS
Grain worker smokers (153) 57 67 40 22





FACTORS BY WHICH GRAIN EXPOSURE OR SMOKING 
INCREASE THE ODDS* (RISK) OF 




Chronic Bronchitis (I) 4.4 2.9
Chronic Bronchitis (II) 4.9 2.3
Occupational "Asthma” (I) 4.6 1.9
Occupational **Asthma** (II) 9.9 2.8
Nocturnal Asthma 2.2 1.8
*See text for explanation.
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TABLE 14









N % N % 5 * N %
Chronic Bronchitis (I) 
(135) 31 35 18 35 43 53 43 48 NS
Cough on Exposure 
(200) 55 63 35 67 52 64 58 65 NS
Occupational Asthma VII 
(183) 47 53 31 60 51 63 54 61 NS
Dyspnea on Exposure 
(151) 35 40 27 52 41 51 48 54 NS
Eye Sx on Exposure 
(242) 78 89 44 85 60 74 60 67 .05
Nasal Sx on Exposure 
(246) 76 86 42 81 64 79 64 72 .05
Grain Fever 
(99) 22 25 16 31 29 36 32 36 NS
Cough in A.M. 
(109) 31 35 13 25 30 37 35 39 NS
Expectoration in A.M. 
(116) 30 34 14 27 34 42 38 43 NS
Wheezing at Night 
(50) 10 11 5 10 18 22 17 19 NS
Chronic Bronchitis 
+ FEV1/FVC70X pred. 
(31) 2 2 1 2 11 14 17 19 .05
Occupational 
Asthma X 
(69) 14 16 13 25 21 26 21 24 NS
Occupational 
Asthma IX 
(97) 21 24 17 33 28 35 31 35 NS
Chest Illnesst 
(123) 39 44 19 37 34 42 31 35 NS
( ) Number of subjects with the symptom.
fCannot do usual activities because of chest illness more than twice in last 3 
years.
♦Significance of the differences in symptom prevalence between age groups adjusting 
ft)? (smoking and length of employment by regression logistic analysis.
TABLE 15
PREVALENCE Of SYMPTOMS BY LENGTH OP EMPLOYMENT CATEGORIES
Length of Employment 
in Years
Chronic Bronchitis (I) 
(135)**
Cough on Exposure 
( 2 0 0 ) * *
Occupational Asthma VII 
(183)**
Dyspnea on Exposure 
(151)**
Eye Sx on Exposure 
(242)**






Expectoration in A.M. 
(116)**





5.5 5.6-10.5 10.6-15.5 15.6-20.5 2 20.6-25.5 25.6-30.5 30.6 Pf
M-93* M»77*
M S  I S










21 23 29 38




50 65 25 78
45 58 26 81
37 48 23 72
65 84 27 94
61 79 28 88
16 50
30 39 12 38
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PREVALENCE OF SYMPTOMS BY LENGTH OF EMPLOYMENT CATEGORIES (CONTINUED)
Length of Employment 5.5 5.6-10.5 10.6-15.5 15.6-20.5 20.6-25.5 25,6-30,5 30.6 P+
N-93* H«77* N»32* N-45* N«22* N-30* N»ll* ___
H t N S N X  N X  N X N X  N X
Occupational 
Asthma X
(69)** 13 14 14 18 11 34 8 18 9 41 11 37 3 27 .02
Occupational 
Asthma IX
(97)** 17 18 26 34 14 47 12 27 10 45 12 40 5 45 NS
Chest Illness
(123)** 34 37 31 40 17 53 16 36 8 36 15 50 2 18 NS
*Number of workers in category
**Number of workers with symptom.
fSignificance of the differences in relative prevalence between length of employment 




GRAIN WORKERS - JOB CATEGORIES 
CODE ~ W
06 Inspectors (94)
02 Annex Hen N
03 Laborers ? (90)
04 Transport j
05 Haintenance (41)
07 Operators Outdoors (31)
09 Longshoremen (29)
01 Weighers (20)
08 In House Firemen* ( 5)
♦Included in all analysis except when using 
job categories because of small number.






































Cough on Exposura 200 53 56 59 66 29 71 23 74 20 69 15 75 MS
Occupational Asttwa VIZ 1S3 47 SO 50 56 26 63 19 61 22 76 16 80 MS
Dyspnaa on Exposura 151 38 40 45 50 21 51 15 48 17 59 13 65 MS
Eya Sx on Exposura 242 69 72 (9 77 33 80 25 81 27 93 IS 75 MS
Maaal Sx on Exposura 246 78 83 66 73 32 78 24 77 26 90 17 85 .03
Grain Pavar 99 30 32 20 22 13 32 11 35 18 62 6 30 N8
Cough In A.M. 109 32 34 30 33 17 41 10 32 9 31 10 50 MS
Expactoratlon in A.M. 116 31 33 32 36 18 44 11 35 14 48 9 45 MS
Whaaclng at Might 50 14 IS 8 9 9 22 4 13 7 24 7 35 MS
Chronic Bronchitis 
♦ FEVx/FVC70t prad. 31 9 10 7 8 6 15 4 13 2 7 3 IS M8
Occupational 
Aattaa X 69 13 14 20 22 13 32 7 23 4 14 10 50 .05
Occupational 
Aathaa IX •7 17 18 31 34 16 39 10 32 12 41 10 50 MS
Chast Illnass 123 29 31 42 47 22 54 10 32 6 21 12 60 .01





JOBS BASKED BY RELATIVE PREVALENCE OF SYMPTOMS*
Inspectors Indoor
06 02-0*
Eye Symptoms 1 2
"Occupational Asthma VII” 1 3
Chest Illnesst 2 4
Score 4 9
Rankins X 3
Maint. Outdoor Longshoremen Weighers
05___ 07 09______  01
5 3 6 4
5 4 2 6
5 3 1 6
15 10 9 16
5 4 3 6
♦Prevalence significantly different among jobs, adjusting for age, smoking and 
LOE.
fChest illness affecting usual activities.
Highest rank value * highest relative prevalence of symptoms. Jobs are ranked 
using the z value from the regression analysis.
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TABLE 19




































ough on Exposure N 25 13 7 32 13 12 27 10
X 71 59 58 65 76 71 69 42 NS
heezing on Exposure N 27 9 4 31 13 10 26 7
ccupational Asthma VIIX % 77 41 33 63 76 59 67 29 .01
yspnea on Exposure N 22 10 2 30 6 8 24 7
X 63 45 17 61 35 47 62 29 .02
ye Symptoms on Exposure N 29 17 7 36 15 16 33 15
X 83 77 58 73 88 94 85 63 NS
ose Symptoms on Exposure N 31 14 8 37 13 13 34 16
X 89 64 67 76 76 76 87 67 NS
rain Fever N 9 1 5 15 4 4 16 6
X 26 5 42 31 24 24 41 25 .05
ough in a.m. N 14 7 3 20 11 8 9 4
X 40 32 25 41 65 47 23 17 NS
hlegm in a.m. N 17 61 4 14 9 6 13 7
X A9 27 33 29 53 35 33 29 NS
heezing at Night N 1A 2 1 5 3 1 6 3
X AO 9 8 10 18 6 15 13 NS
hronic bronchitis + FEV]/ N 6 1 1 6 1 1 2 3
VC 70% X 17 5 8 12 6 6 5 13 NS
ccupational Asthma X N 14 3 1 14 6 4 11 4
X 40 14 8 29 35 24 28 17 NS
occupational Asthma IX N 15 5 1 21 6 5 16 4
X 43 23 8 43 35 29 41 17 .05
liest Illness (C-D-E) N 15 6 5 19 10 5 13 3
X 43 27 42 39 59 29 33 13 NS
liest Illness (C-D) N 18 8 2 26 8 7 20 6
X 51 36 17 53 47 41 51 25 NS
P* - significance of differences in relative prevalence of symptom analyzed by regression 
nalysis adjusting for age, smoking and LOE.
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TABLE 20
RANKING OF COMPANIES BY RELATIVE PREVALENCE OF SYMPTOMS 
ADJUSTED FOR AGE, SMOKING AND LENGTH OF EMPLOYMENT
I II III IV V VI VII VIII
Grain Fever 2 1 7 6 4 3 8 5 P<.05
Occupational Asthma VII 8 2 3 5 6 4 7 1 P<.01
Dyspnea on Exposure 6 4 1 7 3 5 8 2 P< .02
Subtotal Score 16 7 11 18 13 12 25 8
Rating (6) (1) (3) (7) (5) (4) (8) (2)
Cough on Exposure 7 2 3 5 6 4 8 1
Eye Sx on Exposure 6 4 1 3 7 8 5 2
Nose Sx on Exposure 7 1 2 4 6 5 8 3
Chronic Bronchitis 5 4 8 1 7 3 2 6
Early Cough 5 2 3 6 8 7 4 1
Early Phlegm 7 1 5 2 8 4 6 3
Wheezing at Night 8 2 3 4 6 1 7 5
Wheezing and SOB 8 1 2 7 5 4 6 3
Chest Illness* 6 3 5 7 8 2 4 1
Chest Illnessf 6 3 1 7 5 4 8 2
CB and AO** 8 2 1 7 3 4 5 6
Subtotal Score 73 25 34 53 69 46 63 33
Rating (8) (1) (3) (5) (7) (4) (6) (2)
Total Score 89 32 45 71 82 58 88 41
Overall Rating (8) (1) (3) (5) (6) (4) (7) (2)
*Much to a great deal.
**Chronic bronchitis + airways obstruction 
tunable to do usual activity two or more times in last 3 years.
Rating highest value « highest adjusted prevalence. Companies are ranked by 
the z value from the regression analysis for each symptom.
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TABLE 21
GRAIN FEVER SYNDROME (GRAIN HANDLERS) 
N-115 (16 questionable)





Fever and/or "chills'* noticed: N % of 115
During work 37 32
After work 40 35
Either during or after work 38 33
Mostly noticed on: N X of 115
First day of work 15 13
Any day of the week 95 83








PESTICIDE EXPOSURE AND RELATED 
HEALTH PROBLEMS IN GRAIN HANDLERS (N=310)
Exposed (ever) 294 95










































Unable to do regular job because 
of symptoms:
Had to be taken to doctor:
28
19
17 *(of 167 that answerer
11 *(of 167 that answerec












Type of pesticide: (of 168 that answered!


























Chest Configuration N X  N X
Normal 309 100 233 98
Kyphoscoliosis* 1 2 1
Pectum Excavatum 0 3 1
Auscultation Posterior Chest
Normal 178 57 201 85
Ronchi (See table) 131 43** 37 16
Rales Bilateral 100 32** 30 13
Unilateral 31 10** 7 3
Cardiac Auscultation
Normal 278 90 216 91
Murmur 15 5 14 6
Arrhythmia 6 2 3 1
Other 10 3 5 2
Abdomen N=305 11=238
Not palpable 171 56 184 77
Palpable* 132 43** 51 21
Hepatomegaly 2 1 3 1
(span 14 cm)
reported as mild
On deep inspiration at rib costal margin, mid-clavicular line. 
P<.005 - Significance of the differences between grain workers and 




Total Smoker Ex-Smoker Vonsmoker
N X N X N X N X
Bilateral
Grain Workers 100 32 55 36 28 17 17 26
*  *  *  *
Controls 30 13 20 19 7 10 3 5
Localized
Grain Workers 31 10 18 12 8 9 6 9
* * *
Controls 7 3  3 3  4 6 0 0
Both
Grain Workers 131 43 73 48 36 26 23 35
*  *  *  *
Controls 37 16 23 22 11 16 3 5











RR3ULT8 OF PULMONARY FUNCTION STUDIES IN GRAIN-SMOKERS, 
EX-SMOKERS AND VONSMOKERS, BY AGS GROUP
Age Years
20-29 30-39 40-49 50-62 All Aga Groups
Smoking
Grouv P mean mean 9P mean sp P mean sp N mean 8D
Smoker (47) 4484 606 (35) 4202 657 (42) 3393 677 (29) 3052 590 (153) 3849 853
Ex-smoker (19) 4587 376 ( 9) 4175 963 (20) 3825 523 (44) 3190 782 ( 92) 3713 877
Nonsmoker (22) 4726 592 ( 8) 4239 358 (19) 3799 531 (16) 3443 750 ( 65) 4079 782
All (88) 4567 564 (52) 4203 672 (81) 3595 638 (89) 3191 723 (310) 3857 853
Smoker 5437 750 5244 797 4565 726 4188 728 4917 892
Ex-smoker 5549 461 5469 1240 4790 585 4330 702 4793 866
Nonsmoker 5694 796 5032 625 4731 734 4881 901 5033 920
All 5525 711 5250 857 4660 695 4311 747 4904 891
Smoker 82 5 80 6 73 9 72 9 77 8
Ex-smoker 82 5 76 10 79 6 72 11 76 10
Nonsmoker 83 6 84 9 80 7 76 7 81 7
All 82 5 80 8 76 8 73 10 78 9
Smoker 276.9 61.4 250.4 68.5 171.8 74.0 142.1 54.5 216.4 85.0
Ex-smoker 285.0 50.1 230.1 79.0 233.2 82.5 158.7 77.7 207.9 89.0
Nonsmoker 299.6 69.4 288.7 91.7 220.2 51.0 185.9 71.0 247.1 82 .0
All 284.3 61.4 252.7 74.5 198.3 76.1 158.2 70.6 220.3 86.5
Smoker 4.94 1.25 4.35 1.28 3.18 1.53 2.86 1.31 3.93 1.59
Ex-Smoker 5.28 1.45 4.08 1.51 4.16 1.48 3.08 1.47 3.87 1.68
Nonsmoker 5.17 1.63 4.69 1.63 4.12 ¿88 3.52 1.39 4.40 1.50
All 5.07 1.39 4.35 1.36 3.64 1.46 3.09 1.41 4.01 1.61
Smoker 1.98 .60 1.49 .52 .99 .45 .75 .30 1.36 .69
■x-smoker 2.11 .73 1.51 .53 1.23 .45 .87 .43 1.27 .70
Nonsmoker 2.26 .94 2.06 .90 1.40 .29 1.05 .49 1.69 .84






RKSULT8 OF PULHOVARY FUNCTION STUDIS3 III GRAIN WORKERS-SMOKERS, 
EX-8HOKBR8 AND NONSMOKERS , BY AGS GROUP
Agi, Yuri
Smoking
20-29 30-39 40--49 50-62 All Aga Groupa
l u t Group If naan W Jl naan sp naan sp If naan sp N naan 8Q
cv Snokar (45) 13 5 (32) 15 5 (41) 19 5 (29) 21 6 (147) 17 6
Bx-snokar (19) 13 7 ( 9) 17 4 (20) 19 5 (39) 21 7 ( 87) 18 7
Nonsmoksr (22) 10 4 ( 7) 16 7 (18) 18 5 (15) 21 3 ( 62) 16 7
All (86) 13 5 (48) 15 5 (79) 19 5 (83) 21 6 (296) 17 6
am2/l Snokar (45) 1.32 .83 (33) 1.39 .84 (41) 2.16 1.15 (29) 3.43 2.11 (148) 1.98 1.48
Rx-snokar (19) .96 .55 < 9) 1.26 .91 (20) 1.33 .65 (39) 2.54 1.90 ( 87) 1.79 1.52
Nonsmoker (22) .86 .28 ( 8) .85 .54 (19) 1.17 .57 (15) 1.67 .82 ( 64) 1.14 .64
All (86) 1.13 .70 (50) 1.28 .68 (80) 1.72 1.03 (83) 2.70 1.92 (299) 1.75 1.40
DLCO Snokar (40) 35.6 5.6 (32) 34.4 5.9 (40) 30.8 5.0 (28) 27.9 6.0 (140) 32.4 6.3
Bx-smoker (17) 39.3 4.3 < 9) 37.4 4.7 (19) 36.1 5.4 (44) 30.6 5.4 ( 89) 34.2 6.2
Nonanokar (14) 41.1 6.7 ( 7) 38.0 5.0 (17) 35.2 3.4 (U) 33.8 6.0 ( 54) 36.7 6.0
All (71) 37.6 5.9 (48) 35.5 3,* (76) 33.1 5.3 (88) 30.3 6.0 (283) 33.8 6.4
( ) paranthaala - if not ititid N • N of ibovt function
TABLE 26
RESULTS OF PULMONARY FUNCTION STUDIES III CONTROLS-SMOKERS, 
EX-SMOKERS AMD NONSMOKERS, BY AGE GROUP
As«i Yatra
20-29 30-39 40-49 50-62 All As« Groups
Smoking
T»»t Grout) | mesn SP v wm%n SP If mesn sp V siesn SD mean SP
FEVj Smoker (26) 4566 648 (35) 4282 572 (29) 3721 654 (U) 3209 778 (106) 4036 792
Ex-smoker ( 7) 4408 420 (22) 4310 477 (13) 4055 461 (26) 3356 710 ( 68) 3907 717
Nonsmoker (17) 4635 717 (20) 4404 570 (10) 4058 602 (16) 3605 348 ( 63) 4208 689
All (50) 4567 640 (77) 4232 541 (52) 3869 614 (58) 3384 659 (237) 4045 750
rvc Smoker 5507 794 5245 684 4667 720 4547 643 5045 801
Ex-smoker 5020 511 5298 541 5133 493 4477 792 4924 725
Nonsmoker 5560 917 5360 644 4929 759 4512 497 5136 816
All 5464 814 5290 629 4834 696 4506 671 5034 745
PEVj/ Smoker 82 6 81 5 79 7 70 13 79 8
PVCX Ex-smoker 88 4 81 6 78 5 74 11 78 9
Nonsmoker 82 5 82 3 81 5 79 5 81 4
All 83 5 81 5 79 6 74 10 79 8
MMP Smoker 288 64.5 274.8 70.7 223.5 72.8 160.1 90.1 246.7 84.6
Ex-smoksr 317.7 50.2 272.4 82.2 235.7 60.2 180.5 81 234.9 88.1
Nonsmoker 289.1 72.2 270.9 53.4 276.4 66.5 222.6 52.0 264.4 64.6
All 292.5 65.1 273 69.4 236.7 70.4 186.5 79.4 248 81.3
VMX50 SsM>ker 5.49 1.35 5.26 1.55 4.47 1.42 (16) 3.21 1.69 (106) 4.79 1.6<
Ex-smoker 6.36 1.02 5.12 1.52 4.35 1.34 (25) 3.54 1.50 ( 67) 4.51 1.61
Nonsmoker 5.22 1.55 5.08 .98 5.06 .95 (15) 4.48 1.29 ( 62) 4.97 1.24
All 5.52 1.40 5.17 1.40 4.55 1.32 (56) 3.70 1.56 (235) 4.76 1.51
VMX75 Smoker 2.25 .71 1.93 .69 1.44 .65 (16) 3.21 1.69 (106) 1.71 .7<
Ex-smoker 2.61 .62 1.90 .63 1.42 .38 (25) 1.00 .43 ( 67) 1.55 . 7 2
Nonsmoker 2.19 .75 2.01 .57 1.61 .53 (15) 1.25 .46 ( 62) 1.81 .6<






RESULTS OF PULMONARY FUNCTION STUDIES IN CONTROLS-SMOKERS, 
EX-SMOKERS AND NONSMOKERS, BY AGE GROUP
Age, Years
Smoking 20-29 30-39 40-49 50--62 All Axe Groups
Test Group N mean SD N mean SD N mean SD N mean SD N mean SD
CV Smoker (25) 13 5 (35) 14 3 (28) 17 4 (14) 22 6 (102) 16 5
Ex-smoker ( 7) 11 3 (22) 14 3 (13) 18 4 (23) 22 5 ( 65) 18 6
Nonsmoker (16) 10 3 (IB) 15 4 (10) 17 3 (14) 19 4 ( 58) 15 6
All (48) 12 4 (75) 14 3 (51) 18 3 (51) 21 5 (225) 16 5
&N2/L Smoker 1.32 .55 1.21 .60 1.87 .96 (15) 3.38 2.32 (103) 1.73 1.31
Ex-smoker 1.12 .46 1.11 .43 1.23 .48 (23) 1.69 .76 ( 65) 1.34 .63
Nonsmoker .84 .31 1.00 .31 1.19 .64 (14) 1.44 .71 ( 58) 1.10 .54
All 1.13 .51 1.13 .49 1.57 .86 (52) 2 .11 1.59 (226) 1.46 1.02
DLco Smoker (25) 32.7 6.2 (30) 30.4 6.2 (20) 31.1 7.3 (13) 21.6 6.7 ( 88) 29.9 7.4
Ex-smoker ( 5) 30.7 5.5 (21) 32.8 6.3 (11) 32.9 5.2 (21) 27.9 5.7 ( 58) 30.9 6 .1
Nonsmoker (16) 39.8 9.1 (20) 32.5 6.7 ( 7) 37.0 5.9 (14) 27.9 7.0 ( 57) 34.0 8.6












t u 2 /
D^ ml CO/m/Torr
RESULTS OF PULMONARY FUNCTION STUDIES 





































































♦Significance of the difference by unpaired t-test.
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TABLE 28
Pulmonary Function Test Values 
in Relation to Last Exposure to Grain Dust
PEVx FVC MMF
Last Exposure X SD X SD X SD
Same day of testing 3902 + 813 4938 + 866 225.7 + 85
Day before testing 3711 ± 948 4827 ± 975 200.7 + 88
> 2 days before testing 3842 + 891 4768 + 877 227.6 + 86*
♦Significantly different from KMF mean of "same day tested** by unpaired 
t-test.
TABLE 29
MULTIPLE REGRESSIONS OF RESULTS OF PULMONARY FUNCTION TESTS WITH SMOKING AND GRAIN 
HANDLING HISTORY, HEIGHT AND AGE OF GRAIN WORKERS AND CONTROLS. RELATIVE CONTRIBUTIONS (t>) 
OF THE INDEPENDENT VARIABLES AND SIGNIFICANCE OF THE CONTRIBUTION(p)
GRAIN PREVIOUS
TEST HANDLING SMOKING SMOKING AGE HEIGHT
b P b P b P b P b P
FEVX -172 .0002 -248 .0000 -119 .03 -41 .0000 103 .0000
FVC -139 .009 -137 .04 - 55 NS -33 .0000 140 .0000
FEVx*pvC - 1.3 .04 - 3.2 .0001 - 2.0 .025 - 3.3 .0000 - .13 NS
MMF - 24.1 .0000 - 29.5 .0001 - 13 NS - 4.0 .0000 4.4 .0000
Vmax^O - 7.2 .0000 - 35 .02 .10 NS - 0.07 .0000 .06 .004
Vniax7^ .25 .0000 .27 .0000 .13 .03 - .04 .0000 .03 .003
CV .62 NS 1.4 .01 1.4 .01 .30 .0000 .06 NS
a n2/l .23 .02 .79 .0000 .25 .05 .05 .0000 .06 .0005
d lco 3.13 .0000 - 4.58 .0000 - 1.77 .02 - .23 .0000 .88 .0000
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Prevalence of Abnormal Lung Functions
TABLE 30
ALL  SMOKERS_______ EX-SMOKERS KONSMOKERS
N X P1 N X p 1 N X PX N X P1 P*
FEV^/FVC % <70 G (310) 51 16 (153) 28 18 (92) 17 18 (65) 6 9 <.1 NS
<.001 <.05 NS NS
C (237) 16 7 (106) 9 8 (68) 6 9 (63) 1 2 <•1 NS
HMF<1.65SD G (310) 60 19 (153) 33 22 (92) 23 25 (65) 4 6 <♦01 NS
Of Predicted <.001 < .005 <.001 <.05
C (237) 12 5 (106) 9 8 (68) 3 4 (63) 0 0 <.05 <.05
Vma*50 <1.65SD C (310) 130 42 (153) 68 44 (92) 43 47 (65) 19 29 <.05 NS
of Predicted <.001 <.001 <.05 <.01
C (235) 46 19 (106) 21 20 (67) 19 25 (62) 6 3 <.1 NS
W ™  <1.6580 G (310) 153 49 (153) 83 54 (92) 51 55 (65) 19 29 <.001 NS
of Predicted <.001 <.001 <.05 NS
C (235) 68 29 (106) 31 29 (68) 25 37 (63) 12 19 NS NS
CV<1.65SD G (296) 43 15 (147) 20 14 (87) 17 20 (62) 6 10 NS NS
<.001 NS <.01 NS
C (225) 12 5 (102) 7 7 (65) 3 5 (58) 2 3 NS NS
AN2/L>1.65SD G (299) 101 34 (148) 67 45 (87) 24 28 (64) 10 16 <.001 <.01
of Predicted <.01 NS NS NS
C (226) 51 23 (103) 35 34 (65) 12 18 (58) 4 7 <.001 <.05
FVC <80% G (310) 17 5 (153) 10 7 (92) 5 5 (65) 2 3 NS NS
of Predicted <.1 NS NS <.05
C (237) 6 3 (106) 4 4 (68) 2 3 (63) 0 0 NS NS
DLCO<BO X G (283) 22 8 (140) 14 10 (89) 6 7 (54) 2 4 NS NS
of Predicted <.005 <.01 NS NS
C (203) 33 16 20 23 (58) 9 16 -157? 4 7 <.05 NS
() Total tested with each test on each category. P^Grain vs. Control Workers.
P2 Smokers vs. Vonsmokers. P3 Smokers vs. Ex-smokers. Values <.05 are considered not significant. jp
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RATIOS* OF THE EFFECT OF SMOKING TO THE EFFECT 











♦Ratio of the regression coefficient for smoking and 
grain handling from the multiple regression analysis 
that included ex-smoking, age and height as the 
other independent variables.
TABLE 32
PULMOEARY fVWCTI0E8 0» ORAI» W0RKKR8 BY JOB CATEGORIES
(0«) (02, 03, 04) (05) (07) (09) (01)
V-94 i-90 «-41 B-31 *-29 »-20
Heen 1 80 Heen.. 1 8D Neen 1 80 Heen 1 SO Keen 1 SD _ Meen 1 8D
PBVj «1 4017 763.5 3393 960.8 3631 726.0 3734 835.6 3703 851.4 3328 596.8
X  Predicted 99.5 12.7 99.7 19.7 97.8 16.4 98.2 15.7 96.5 15.6 94.3 18.8
rvc ml 5054 783.4 5081 1010.7 4663 816.0 4714 912.0 4714 778.6 4324 514.5
% Predicted 101.« 11.9 103.1 16.6 100.3 15.1 99.7 13.9 99.8 9.6 97.6 14.2
PEVj/FVC X 78.6 8.06 77.6 9.11 76.9 9.99 78.2 7.76 75.8 9.59 76.2 9.59
MMPt/mln. 299.6 86.3 277.8 87.8 206.9 83.7 209.8 76.7 216.4 98.4 190.0 74.4
X  Predicted 76.1 25.3 76.3 27.9 73.6 28.2 73.3 24.2 74.8 29.9 70.7 28.3
vmex*°l/tec 4.17 1.60 4.01 1.60 3.90 1.56 3.58 1.44 4.02 1.67 3.65 1.38
X  Predicted 67.2 25.6 65.2 26.1 64.3 25.8 26.3 61.6 23.8
W 7 5 1 / m c 1.58 .85 1.48 .78 1.23 .52 1.20 .67 1.37 .70 1.16 .57
X  Predicted 48.2 25.4 45.6 22.3 40.1 17.6 36.8 19.7 42.7 20.6 39.5 20.3
cv % 16.3 6.08 16.1 6.55 18.5 6.76 18.6 6.82 17.9 6.12 19.2 4.93
X  Predicted 116.4 35.9 119.9 40.9 114.8 55.8 119.4 32.6 109.6 36.7 114.1 26.0
M r2 / t 1.53 .97 1.69 1.50 1.96 1.80 1.65 .98 2.05 1.90 2.35 1.40
X  Predicted 137.5 80.7 150.9 120.1 165.1 142.8 142.6 78.7 168.5 143.1 195.8 110.8
DlCO 35.3 5.8 34.1 6.2 32.2 5.4 32.1 8.2 33.9 6.7 31.5 6.0
X  Predicted 113.6 18.9 111.0 19.7 104.0 16.1 105.6 25.4 104.5 20.6 101.8 15.6 Page 
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TABLfc 33

























FrVj 4340 794 3946 800 3585 842 3406 709 3520 747 3555 743 3267 587
% Predicted 103.2 12.7 100.2 18.1 94.1 15.4 92.3 17.8 94.6 15.0 98.3 18.6 95.0 13.6
FVC 5319 883 4905 860 4711 963 4565 808 4619 729 4767 746 4287 607
X  Predicted 103.8 12.9 100.4 15.7 99.0 13.5 98.2 13.9 99.2 9.8 104.7 16.0 98.3 9.3
FEVj % FVC 81.1 6.33 79.5 9.0 75.0 8.6 73.6 9.8 75.1 9.6 73.5 7.9 75.0 8.3
MMF 261.8 79.9 238.0 80.2 193.1 84.5 172.9 70.4 198.1 88.8 180.2 78.7 172.7 76.1
X  Predicted 84.7 23.1 80.1 25.7 67.3 27.6 62.4 25.7 70.8 28.4 65.9 27.3 66.2 29.3
W 5 0 4.63 1.49 4.28 1.50 3.37 1.57 3.32 1.30 3.48 1.24 3.45 1.63 3.18 1.60
X  Predicted 74.6 23.0 69.8 25.7 55.1 25.6 56.0 24.2 56.0 17.9 55.8 25.4 51.5 22.2
W 5 0 1.85 .84 1.56 .71 1.04 .51 1.08 .43 1.09 .46 1.00 .41 1.01 .65
X  Predicted 55.4 24.0 49.0 22.8 32.3 15.6 35.4 15.8 33.5 13.7 32.4 14.3 34.6 21.8
CV 14.15 6.03 16.02 6.17 18.5 6.82 18.9 5.08 19.5 4.62 21.9 6.23 21.3 2.60
X  Predicted 121.2 50.2 118.4 38.1 114.0 34.6 111.0 31.7 112.2 25.3 117.1 34.9 107.7 16.7
Slope 1.27 .72 1.53 1.18 1.95 1.14 2.48 2.14 2.00 1.51 2.07 1.66 2.59 1.58
X  Predicted 122.1 65.1 139.1 99.4 164.8 92.5 202.9 165.0 168.3 119.4 164.8 125.2 215.0 129.8
DlCO 36.5 6.17 33.5 6.27 31.5 7.23 32.5 5.37 34.7 4.70 31.7 6.88 31.3 4.94
X  Predicted 119.2 19.0 109.0 18.7 98.7 20.0 103.9 18.6 109.4 12.5 100.0 20.0 99.5 14.2
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TABLES 34/35 



























- 286 93.8 VS
+ 19 6.2
- 281 92.1 .001
+ 2 4  7.9
- 294 96.4 .01
+ 11 3.6
- 291 95.4 .005
+ 14 4.6
- 293 96.1 .001
+ 12 3.9
- 301 98.7 .005
+ 4 1.3
1:20 w/v
- 292 95.7 VS
+ 13 4.3
- 297 97.4 .1
+ 8 2.6
- 303 99.3 .05
+ 2 .7
- 297 97.4 NS
+ 8 2.6
- 298 97.7 NS
+ 7 2.3
- 302 99.0 NS
+ 3 1.0






















































To one or more
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TABLE 34/35
PREVALENCE OF WHEAL REACTION 3 mm OR GREATER









- 286 93.8 NS 214 91.1 NS 94 91.3 NS
Ragweed + 19 6.2 21 8.9 9 8.7
_ 286 93.8 195 83.8 91 88.3
Timothy Grass + 19 6.2 .001 40 17.0 12 11.7
_ 288 94.4 NS 216 91.9 NS 96 93.2 NS
Feathers + 17 5.6 19 8.1 7 6.8
_ 292 95.7 .01 211 89.8 .05 100 97.1 NS
+ 13 4.3 24 10.2 3 2.9
— 287 94.1 .1 211 89.8 NS 97 94.2 NS
+ 18 5.9 24 10.2 6 5.8
- 298 97.7 NS 224 95.3 NS 99 96.1 NS
+ 7 2.3 11 4.7 4 3.9
To one or more 46 15.1 .05 51 21.7 .05 13 12.6 NS
FUNGAL ANTIGENS
_ 288 94.4 NS 221 94.0 NS 96 93.2 NS
A. Fumigatus + 17 5.6 14 6.0 7 6.8
— 294 96.4 NS 221 94.0 NS 97 94.2 NS
Pénicillium + 11 3.6 14 6.0 6 5.8
_ 300 98.4 NS 228 97.0 NS 102 99.0 NS
Mucor Sp. + 5 1.6 7 3.0 1 1.0
_ 299 98.0 NS 229 97.4 NS 103 100.0 NS
Cladosporium Sp. + 6 2.0 6 2.6 0
_ 295 96.7 NS 231 98.3 NS 100 97.1 NS
Altemaria Sp. + 10 3.3 4 1.7 3 2.9
- 295 96.7 NS 232 98.7 NS 101 98.1 NS
Rust + 10 3.3 3 1.3 2 1.9
- 297 97.4 NS 231 98.3 NS 101 98.1 NS
Smut + 8 2.6 4 1.7 2 1.9
To one or more 35 11.5 NS 29 12.3 NS 12 11.7 NS
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TABLE 34/35
PREVALENCE OF ERYTHEMA REACTION 5 ran OR GREATER
Grain Workers 
n=305 










































































































To one or more











































To one or more
Significance of the difference between grain and city workers X2. 
Significance of the difference between city and MDN workes X2. 
Significance of the difference between grain and MDN workers x2.
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TABLE 34/35
PREVALENCE OF WHEAL REACTION 3 mm OR GREATER
Grain Workers 
n=305 






















































































































































To one or more 46 15.1 NS 36 15.3 .1 8 7.8 .05
Significance of the difference between grain and city workers X2.
Significance of the difference between city and MDN workes X2.
Significance of the difference between grain and MON workers X2 -
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TABLE 34/35
PREVALENCE OF ERYTHEMA REACTION 5 ran OR GREATER
Grain Workers 
n=305 








- 264 86.6 NS 209 88.9 NS 90 87.4 NS
Mites Mixed + 41 13.4 26 11.1 13 12.6
- 264 86.6 NS 211 89.8 NS 95 92.2 NS
Beetles Mixed + 41 13.4 24 10.2 8 7.8
- 267 87.5 NS 209 88.9 NS 89 86.4 NS
Weevils + 38 12.5 26 11.1 14 13.6
To one or more
Grain 100 ,000 PNU/ml
- 296 97.0 NS 229 97.4 NS 99 96.1 NS
Wheat Durum ♦ 9 3.0 6 2.6 4 3.9
- 300 98.4 .1 225 95.7 NS 100 97.1 NS
Wheat Spring + 5 1.6 10 4.3 3 2.9
- 298 97.7 NS 227 96.6 NS 99 96.1 NS
Barley + 7 2.3 8 3.4 4 3.9
- 296 97.0 NS 225 95.7 NS 99 96.1 NS
C o m + 9 3.0 10 4.3 4 3.9
- 303 99.3 .005 223 94.9 NS 101 98.1 NS
Rye + 2 .7 12 5.1 2 1.9
- 301 98.7 NS 228 97.0 NS 102 99.0 NS
Oats + 4 1.3 7 3.0 1 1.0
- 296 97.0 NS 228 97.0 NS 98 95.1 NS
Sunflower + 9 3.0 7 3.0 5 4.9
- 289 94.8 NS 219 93.2 NS 100 97.1 NS
Small Seeds + 16 5.2 16 6.8 3 2.9
- 305 100.0 NS 234 99.6 NS 103 100.0
Soybean + 0 1 .4 0
To one or more
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TABLE 34/35
PREVALENCE OF WHEAL REACTION 3 mm OR GREATER
Grain Workers 
n=305 








— 259 84 .9 .05 213 90.6 NS 95 92.2 .1
Mites Mixed + 45 15.1 22 9.4 8 7.8
260 85.2 215 91.5 NS 96 93.2 .05
Beetles Mixed + 45 14.8 .05 20 8.5 7 6.8
266 87.2 NS 210 89.4 NS 93 90.3 NS
Weevils + 39 12.8 25 10.6 10 9.7
To one or more 69 22.6 .05 36 15.3 NS 15 14.6 .1
Grain
— 296 97.0 NS 231 98.3 NS 101 98.1 NS
Wheat Durum + 9 3.0 4 1.7 2 1.9
_ 299 98.0 NS 228 97.0 NS 102 99.0 NS
Wheat Spring + 6 2.0 7 3.0 1 1.0
_ 300 98.4 NS 228 97.0 .1 103 100.0 NS
Barley + 5 1.6 7 3.0 0
_ 297 97.4 NS 228 97.0 NS 101 98.1 NS
C o m + 8 2.6 7 3.0 2 1.9
_ 300 98.4 NS 227 96.6 NS 102 99.0 NS
Rye + 5 1.6 8 3.4 1 1.0
— 300 98.4 NS 229 97.4 NS 103 100.0 NS
Oats + 5 1.6 6 2.6 0
__ 293 96.1 NS 228 97.0 NS 100 97.1 NS
Sunflower + 12 3.9 7 3.0 3 2.9
_ 285 93.4 NS 221 94.0 .05 102 99.0 .0?
Small Seeds + 20 6.6 14 6.0 1 1.0
_ 305 100.0 235 100.0 103 100.0
Soybean + 0 0 0
To one or more 38 12.4 NS 28 11.9 .1 6 5.8 .1
INDIVIDUAL SUM OF WHEAL REACTIONS
COMMON ALLERGENS INSECTS -  MITES
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INDIVIDUAL SUM OF WHEAL REACTIONS
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PREVALENCE OF GRAIN DUST AND INSECT-HITE REACTIONS 








Atopic Grain Workers (46) 37** 80 31** 67
Non-atopic (259) 44 17 38 15
Atopic Controls (51) 24** 47 13* 25
Non-atopic (184) 24 13 23 12
*P = .05 by X2 for the difference between atopic and non-atopic.
**P = .001
TABLE 38. REGRESSION COEFFICIENTS (b) AND T RATIOS (t) OP THE SIGNIFICANT* RELATIONS BETWEEN 
ACUTE AMD CHRONIC SYMPTOMS AVD LOTW FUNCTION ADJUSTED FOR AGE, HEIGHT, SMOKING HABIT
MULTIPLE REGRESSION ANALYSIS*
FEVi
FVC FITi FTC IMF *»«50 ¥ ^ 7 5  CV An2/L DL
v i M i n  m / n i t b n o  a c  i n - l J
Chronic Bronchitis
■ J 1 U ------- ***—
Cough First Thing -2.51 -16.70
in A.If. -2,7 - 2.0
Phlegm First Thing
in A.M.
Dyspnea on Exertion -1.85 -170.8 -130.0
-2.0 -2.7 -1.7
Wheezing at Night
Cough on Exposure -3.07 -137.8 -19.11 -0.487 -  .140
- 3.4 - 2.4 -2.4 -3.0 -2.2
Occupational -1.63 -130.8 -0.305 -0.167 0.272
Asthma I - 1.8 - 2.0 -1.9 -2.7 +1.9
Dyspnea on Exposure -144.9 -0.264 -0.109
- 2.3 -1.7 -1.8
Occupational -1.79 -116.5 -0.275 -0.120 0.281
Asthma II - 2.0 - 1.8 -1.7 -1.9 >2.0
Occupational -172.9 -164.7 0.331
Asthma IV - 2.2 - 1.9 +  1.9
Crain Fever
Chest Illness
CONTROLS df fn-l> 237 237 237 237 235 235 225 226 203
Chronic Bronchitis -3.50 - 25.7 0.550
-3.10 - 2.2 +3.53
DyBpnmm on Bxertlon -1.99 0.275
-1.99 +2.02
Wheezing at Night -3.72 -0.631
-2.63 -2.10
occupational Asthma II
*P < .05 when t > 1.66 sing one tall area of t distribution and > 200 degrees of freedom
(P <  .05 When t >  1.9 using two tail)
♦Multiple regression an lysis using lung function test value as the dependent variable and symptom,
















W >  
<1.65 8D 
(296)
PREVALENCE OP ABNORMAL LUNG FUNCTION IN 











Dypsnea on Exposure 
Yes No P*




» X 'I X 
N-99 N-211
12 6 5 5 NS 13 7 A 3 NS 16 9 3 2 <.005
92 66 38 35 <.1 89 49 41 32 <.005 76 50 54 34 <.005 44 46 B6 41
105 53 48 44 NS
P*
41 20 10 9 <.01 37 20 14 11 <.05 31 21 20 13 <. 1 20 20 31 1 5 NS
5 12 6 NS
47 29 13 12 <.05 45 25 15 12 <.01 37 25 23 14 <.05 22 22 38 18 NS
NS





30 15 13 14 N8
N-183 N-113 N-151 N-145 N-99 N-197




N-200 N-96 N-183 N-110 N-151 N-148 N“99 N-209






N-99 N-169 N-114 N-143 N-140
3 <.05 17 10 5 4 <.1 14 10 8 6 NS
N-92 N*191
10 11 12 6 NS Page 
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TABLE 39 (COW'D.)
Chronic Bronchitis Cough First Thing In A.M. Uhaatlng at Might Dyspnea on ExartIon
Abnormal Yas Mo P« Yaa Mo P* Yas Mo_ P* Yas  MO _ P*
rvmism JL  J L  J L  Jl_ J L J L  J L  JL J L  - i-  J L  J L  J L  J L  J L
W-13S M-17S i d » l  8 - liI  f c l i l  fc lS i !=*£ f c i i i
31 23 20 11 <.01 25 23 26 13 <.05 9 15 42 17 MS 30 25 21 11 <.001
IS 6 6 11 5 MS 5 8 12 5 MS 12 10 5 3 <.005























18 13 25 16
  62 5 <.01 49 45 81 40 M8 32 52 98 39 <.1 56 47 74 39 MS
 36 78 45 <.1 56 51 97 48 MS 36 59 117 47 <.1 66 56 87 45 <.1
«■109 M-187 M-61 M»235 M-118 M-178
IS 15 14 28 15 MS 12 20 31 13 MS 14 12 29 16 MS
E=m fciii Bam g -m e-m fein
Am2/l
<1.65 8D 48 36 52 32 MS 46 42 54 28 <.05 22 36 78 33 MS 47 40 53 29 MS
(299)
Eilli feliS «-105 ««178 M-£7 M-226 H-108 M-175
Dl CO
80% 13 10 9 6 MS 13 12 9 6 .05 6 11 17 7 MS 15 14 7 4 .005
(283)
¿significance of diffaroneo in provalenco of abnormal lung function» in ttorkers with and without symptoms. u
MS ■ Mot significant. ®
TABLE 40«
REGRESSION COEFFICIENTS (b) AMD A T RATIOS (t) FOR THE SIGNIFICANT*
RELATIONS OF SKIN REACTIVITY TO COMMON OR 8PECIFIC ANTIGENS AND PULMONARY 











Dust Grain Mitas Fungi
Sattlad
Dust
FEVj/ b - .064 - .049 -1.83 - 3.77 - 2.44
FVC t “1.95 -1*73 -1.73 - 2.74 - 1.98
FEVx b -6.08 -5.24 -183.7 -170.3 -161.6 -268.5 -240.5
t 2.61 -2.57 - 2.40 - 1.92 - 2.25 2.71 2.73
FVC t -1.75 -1.77 - 1.94 - 1.76 - 1.96
MMP b - .67 - .549 - 17.9 - 14.49 - 30.1 - 23.3
t -2.39 -2.26 - 1.69 - 1.69 - 2.55 - 2.21
Vm a i50 b - .014 - .010 .404 .364 .703 - .412
t -2.49 -2.10 - 2.16 - 2.08 - 2.92 - 1.91
"MAX” b - .005 - .004 - 1.89 - 1.71 .213 .178
t -2.23 -2.26 - 2.59 - 2.49 - 2.23 - 2.09
6N2/L b
t
DL b - 1.87 - 1.57
t - 1.98 - 1.83
*P < .05 When t > 1.66 using ona tsll area of t distribution snd > 200 dagraas of fraadom (P < .05 when t >
1.98 using two tail)
t Multiplo regretsion analysis using lung function tast valúas as tha dapandant varlabla and skin reactivity, aga,
halght, and smoking as indapandant varlabias.
** Common allargano.




REGRESSION COEFFICIENTS (b) AMD A T RATIOS (t) FOR THE 8IGMXFICAMT*
RELATIONS OF SKIN REACTIVITY TO COMMON OR SPECIFIC ANTIGENS AMD PULMONARY 
FUNCTION ADJUSTED FOR AGE, HEIGHT, SMOKING HABIT U8XNG MULTIPLE REGRESSION AMALYSISt
(CONTROLS)
Total Total
Wheal Wheal Durum Airborne Insects Settled









FVC b 3.52 5.73 3.60 110.9 .198 186.0 212.0
t 2.12 2.49 2.51 1.67 2.03














*P < .OS when t > 1.66 using on« tail irit of t distribution and 200 degrees of freedom (F<.05 When t
1.98 using two tsil)
t Multip1« regression analysis using lung funetion test values as the dependent variable and skin reactivity, age, 
height, and smoking as independent variables.
** Comon allergens.




PREVALENCE OP ABNORMAL FUNCTION IN POSITIVE 
AND NEGATIVE SKIN REACTIONS
GRAIN WORKERS (305)
Abnormal FEVj/FVC Abnormal MMF < 1.65 SO Abnormal, V50 < 1.65 SD Abnormal AN2/L > 1.65 !
ALL S EX NS ALL S EX NS ALL S EX NS ALL S EX NS
N N X N % N % N X N % N X N X N X N X N X N % N % N X N X N X N X
+ 46 8 17 3 7 5 11 0 9 20 3 7 6 13 0 20 43 6 13 7 15 7 15
Common NS NS NS NS
Allergens -259 42 16 24 9 12 5 6 2 49 19 28 11 17 6 4 2 108 42 60 23 36 14 12 5 79 31 54 21 17 7 8 3
Airborne + 81 12 15 6 7 6 7 0 14 17 4 5 10 12 0 _ 34 42 16 20 14 17 4 5 35 43 23 28 10 12 2 2
Dust NS NS <.001 NS
40 18 22 10 12 5 6 3 44 20 27 12 13 6 4 2 40 18 19 8 17 8 4 2 82 37 51 23 23 10 8 4
Insects + 69 14 20 6 12 6 9 0 14 20 7 10 7 10 0 . 30 43 16 23 10 14 4 6 23 33 16 23 5 7 2 3
Mites NS NS NS NS
-236 36 15 19 8 11 5 6 3 44 19 24 10 16 7 4 2 98 42 50 21 33 14 15 6 74 31 47 20 19 8 8 3
+ 35 11 31 4 11 7 20 0 16 46 6 17 10 29 0 24 69 11 31 11 33 2 6 17 49 9 26 7 20 1 3
Fungi <.05 <.001 <.001 <.05
-270 39 14 23 9 10 4 6 2 42 16 25 9 13 5 4 2 104 39 55 20 32 12 17 6 80 30 54 20 17 6 9 3
+Positlve to ona or more antigens of the group of antigens.
^Percentage of skin reactions or nonreactions with the abnormal function for each smoking category. 
S * Smoker; EX ■ Ex-smoker; NS - Nonsmoker.
PREVALENCE OF ABNORMAL FUNCTION IN POSITIVE 
AND NEGATIVE SKIN REACTIONS
CONTROL (235)
TABLE 41b


















ALL S EX 











+ 51 1 2 1 2 0 0 2 4 2 4 0 0 9 18 5 10 3 6 1 2 3 6 9 18 3 6 1 2
Common NS NS NS NS
Allergens -184 15 8 8 4 6 3 1 1 10 5 7 4 3 2 0 37 20 16 9 16 9 5 3 38 21 26 14 9 5 3 2
Airborne + 48 3 06 0 2 4 1 2 1 2 0 6 13 2 4 2 4 2 4 14 29 6 13 5 10 3 6
Dust NS NS NS NS
-187 17 9 9 5 8 4 0 - 11 6 9 5 2 1 0 40 21 19 10 17 9 4 2 54 29 37 20 14 7 3 2
Insects + 36 2 6 0 2 6 0 1 3 0 1 3 0 3 8 0 3 8 0 11 31 8 22 3 8 0
Mites NS NS <.1 NS
-199 36 15 19 8 11 5 6 3 44 19 24 10 16 7 4 2 98 42 50 21 33 14 15 6 74 31 47 20 19 8 8 3
+ 29 2 7 1 3 1 21 0 _ 2 7 2 7 0 0 8 28 4 14 2 7 2 7 7 24 5 17 1 3 1 3
Fungi NS NS NS NS
-206 14 7 8 4 5 2 1 0 10 5 7 3 3 1 0 38 18 17 8 17 8 4 2 44 21 30 15 11 5 3 1
+Positive to one or more antigens of the group of antigens.
^Percentage of skin reactions or nonreactions with the abnormal function for each smoking category. 
S ■ Smoker; EX - Ex-smoker; NS - Nonsmoker.
TABLE 42
Skin
PREVALENCE OF SYMPTOMS XN POSITIVE AND NEGATIVE SKIN REACTORS - (GRAIN WORKERS)
Reaction CAA ABD X-M Fungi Grain SD D Wh Barley Oats Rye
+ 46 4-81 +69 +35 +38 446 +65 +27 +12 +17
Total No. - 259 224 -236 270 -267 259 -240 -278 -287 -288
n X n X n X n % n X n % n % n % n X n %
Chronic Bronchitia + 21 46 39 48 32 46
- 127 49 109 49 116 49
Cough on Exposure + 32 70 55 68 45 65 27 77 27 71 30 65 43 66 20 74 11 61 14 82
- 165 64 142 63 152 64 170 63 170 64 167 64 154 64 177 64 186 65 183 64
Occupational + 30 65 55 68 45 65 26 74 27 71 31 67 44 68 19 70 9 50 12 71
Asthma X 150 58 125 56 135 57 154 57 153 57 149 58 136 57 161 58 171 60 168 58
Dyspnea on Exposure + 27 59 44 54 34 49 24 69 25 66 28 61 37 57 16 59 10 56 10 59
- 121 47 104 46 114 48 124 46* 123 46* 120 46 111 46 132 47 138 48 138 48
Nasal Sx on Exposure + 38 83 66 81 56 81 30 86 37 97 40 87 57 88 27 100 18 100 17 100
- 199 77 171 76 181 77 213 79 206 77* 203 78 186 78 216 78* 225 78* 226 78
Grain Fever + 19 41 25 31 21 30
- SO 31 74 33 78 33
Cough First Thing + 16 35 29 36 29 42
in A.M. - 90 35 77 34 77 33
Wheezing at Night + 11 24 17 21 15 22
- 50 19 44 20 46 19
Occupational + 12 26 20 25 13 19
Asthma IV - 56 22 48 21 55 23
Occupational + 25 54 44 54 37 54
Asthma 11 - 118 46 99 44 106 45
*Signifleant (P < .05) by X*; CAA ■ Common Allergan®; ABD - Airborne Grain Dust; oo


























(Tinne Tests) 34 14 15 10 NS
SK/SD 
(4 u/lu) 
(Varidase) 164 71 89 57 <.01 Lederle 500-283 20000 U SK 40 U SK 4 U
Humps skin 
test antigen 
(0.1 ml) 104 45 95 61 <.005 Lilly OH544A 1.0 ml 0.1 ml
Trichophyton 
1:1000 w/v 90 39 28 18 <.001
Hollister-
Steir H9701702 1:10 w/v 1:10 1:1000
Candida (Monilia) 
Albions Antigen 
(10 PNU) 28 12 50 32 <.001
Hollister-
Steir 6108934 10,000 PNU 100 PNU 10 PNU
To 2 or More 134 58 104 6 7 NS
*A11 dilutions prepared in sterile Coca's non-allergenic buffer.
Tests were considered positive «/hen induration was: >5.0 mm for SK/SD, Trichophyton and Candida; >10 mm for PPD or 
Erythema, >15 mm for mumps and after 48 hours of .1 cc of solution injected intradermally.
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TABLE 44


























Aerobasidium 2 .6 0 0
Altemaria 0 0 0 0
Aspergillus clavatus 1 .3 0 0
Aspergillus falvus 0 0 0 0
Aspergillus fumigatus (1) 5 1.6 0 0
Aspergillus fumigatus (5) 1 .3 8 3.4
Aspergillus fumigatus (6) 0 0 1 .4
Aspergillus fumigatus (8) 0 0 0 0
Aspergillus fumigatus (9) 0 0 0 0
Aspergillus fumigatus (1022) 1 .3 1 .4
All Aspergillus fumigatus 5-10 0 0 0 0
One or more Aspergillus fumigatus 5-10 7 2.2 10 4.0
Aspergillus niger 1 .3 1 .4
Candida Albicans 2 .6 2 .8
Cephalosporium 1 .3 3 1.3
Fusarium 3 .9 5 2.1
Ho rmodendrum 5 1.6 5 2.1
House dust 4 1.2 6 2.5
Micropolyspora faeni (Greer) 3 .9 4 1.7
Micropolyspora faeni (Karsh) 0 0 0 0







N Z N X
20. Koldy hay 87 27.8 78 33.1
All micropolysport faeni and hay 17*20 0 0 0 0
On* or more micropolysport Cseni or hay 17-20 89 29.0 82 34.0
21. Mucor 0 0 2 .8
22. Penicillium casei 1 .3 1 .4
23. Panicillium rubrum 7 2.2 5 2.1
24. Phoma 3 .9 9 0
25. Pigeon aara 0 0 2 .8
26. Trichodarma 3 .9 14 5.9
27. Themoaccinomy cates candidus (Kosky) 5 1.6 0 0
28. Thermoactinomycetes candidus (UW) 4 1.2 0 0
29. Thermoactinoatycetes vulgaris (Grear) 1 .3 34 14.4
30. Thermoactinomycetes vulgaris (H/S) 7 2.2 25 10.6
31. Thermoactinomycates vulgaris (Marsh) 6 1.9 4 1.7
All Thermoactinomycetes vulgaris 0 0 1 0
One or more Thermoactinomycetes vulgaris 11 3.5 38 16.0
32. Thermoactinomycetes sacchari 2 .6 45 19.1
33. Thermoactinomycetes viridans 15 4.8 6 2.5
One or more of above 1*33 115 37.0 133 56.0
34. Wheat Durum 11 3.5 2 .8
35. Wheat Spring 14 4.4 0 0
36. Barley 10 3.2 3 1.3
37. Corn 14 4.4 15 6.4
38. Rye 11 3.5 2 .8





N  X N X
*- o • Sunflower seeds 3 .9 7 3.0
41. Smell seeds 21 6.7 11 4.7
One or acre of above 34-41 38 12.0 28 12.0
42. Wheat durum dust 25 8.0 2 .8
43. Wheat spring dust 21 6.7 0 0
44. Barley dust 14 4.4 3 1.3
45. Corn dust 21 6.7 15 6.4
46. Kyt dust 17 3.4 2 .8
47. Oats dust 25 8.0 6 2.5
48. Sunflower seed dust 7 2.2 0 0
49. Soybean dust 0 0 0 0
50. Settled dust I 94 30.1 59 25.0
51. Settled dust 11 21 6.7 12 5.1
52. Settled dust III 30 9-6 11 4.7
One or more 42-52 115 37.0 70 29.0
53. Mites nixed 4 1.2 1 • 4
54. Beetles mixed 3 .9 0 0
55. Weevils nixed 0 0 2 .5
One or «ore 53-55 7 2.2 3 1.0




G * Grain___________ C - Control Workers






Cholinesterase G 308 10.9 3.68 7 2 5
(4-16 |i/l) } -2.21* NS
C 234 11.6 2.99 10 4
GGT G 205 21.7 13.1 64 21 .05 6
(Upper breath) } 1.15 } -
(30 v/l> C 232 20.0 20.8 31 13
Creatinine G 305 1.20 .22 3 1 59
(0.4-19 ml/l) } 8.92* } NS
C 232 1.05 .14 0 —
SGPT G 302 25.3 15.2 8 3 30
(10-50 y/l) } 8.23* } HS
C 234 15.6 10.9 5 2
HGB GMX G 306 16.1 1.14
} .931
C 192 16.0 1.03
HCTX G 306 47.5 2.84
} 6.54*
C 192 45.8 2.53
**P < .01




Grain Worker Control Worker
H-303 N-231
H Z * Z
Blood 6 2 5 2
Giocosa TO 4 1 1
>2♦ 0 0 5 2
Protein TO 29 10 8 3.5
>!♦ 10 3 6 3 •
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TABLE 47










Normal 264 90 218 93
Rib fracture (old) 12 4 5 2 NS
Degenerative spine changes 16 5 5 2 <.1
Scoliosis (mild) 2 1 5 2
Other 3* 1
Heart
Normal 292 100 236 100
Questionably enlarged 1 0
Enlarged
Lungs
Normal 279 95 225 95
Nodule(s) calcified 2 1 6 3
Nodule(s) non-calcified 4 1 2 1
Mass (>2.5 cm) 0 0 2* 1
Reticulonodular pattern 0 0 0 0
Band atelectasis or fibrosis 5 2 1 0
Blebs 3 1 1
Hyperinflation 1 0 0 0
Pleura
Normal 280 95 228 96
Apical thickening 2 1 3 1
Costophrenic angles-unilateral 9 3 4 2 NS
-bilateral 1 1** 0
Post thoracotomy changes 1+ 0 2++ 1
*One rib fibrodysplasia, one pectus excavatus, one mild old fracture of clavicle. 
+One bilateral hilar mass, probably lymphoma, one paratracheal node.
**One grain worker and one control with calcification of pleura.
^One grain worker and one control rib resection from thoracotomy, one control 
mid-sternal sutures from mid-stemotomy for coronary bypass.
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TABLE 48









Grain Workers 307 1587 ± 27 266 + 6 156 ± 4
Controls 235 1436 ♦ 23** 238 + 6** 151 ♦ 5
*Results expressed as Mean ± Standard Error of the Mean 
♦♦Statistically significant (p < 0.05) between grain workers and controls
with Students t test.
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LEVELS OF IMMUNOGLOBULINS (G,A,M)* IN SMOKING, EX-SMOKING AND 





















1514+36 1384±36*Ä 1687±35^ 1427±35^ 1631162 1532±45*A
ISA
mg/di
24618 236±10 288+12 238111#* 280115 241±12^*
IgM 148+7 151±7 163±8 14318 16719 16019
♦Results expressed as the Mean ± Standard error of the Mean 
♦♦Statistically significant (p < 0.05) with Students T test using comparisons 
of means between grain workers and controls in each smoking category.
TABLE 50
THE LEVELS OF IMMUNOGLOBULINS (0,A,M)* IN AGE GROUPED GRAIN WORKERS AND CONTROLS
<20 21<-30 31--40 41--50 51--60 61-70
Years Years Years Years Years Years
Grain Grain Grain Grain Grain Grain
Workers Controls Workers Controls Workers Controls Workers Controls Workers Controls Workers Controls
(N-2) (N-2) (N«97) (N-58) (N-44) (N-72) (N-50) (N-48) (N-71) (N-44) (N-12) (N-ll)
IRC
mg/dl
1531+722 1591+298 1475+42 1445+44 1533+77 1377+35** 1695+54 1401+59** 1658+55 1538+55 1579+03 1496+96




170+86 133+28 170+08 164+10 143+10 138+07 147+08 163+14 158+10 149+09 149+20 135+16
*Results expressed as the Mean + Standard Error of the Mean.
^Statistically signifleant (P < 0.05) using Students t-test comparing the mean values of grain workers and controls in each 
age group.
TABLES 51
THE LEVELS OF IMMUNOGLOBULINS (G,A,M)* BY LENGTH OF EMPLOYMENT 
IN AGE GROUPED GRAIN WORKERS AND CONTROLS





















IgG mg/dl 1535149 1428140 1537151 1419149 17801103 1289152** 1559161 1512159
IgA mg/dl 248112 214110** 257114 248114 2981 17 244114** 274115 237117
IgM mg/dl 171± 9 157110 157110 1541 9 1541 11 155112 156110 156111





















IgG mg/dl 1578181 1459170 1748191 16541190 15461158 1690192 16731242 14211134
IgA mg/dl 279123 298122 295120 2281 41 2501 27 264127 2841 17 2681 90
IgM mg/dl 135114 121i 1 136111 1321 22 1231 23 135114 1981 34 1081 34
*Results expressed as Mean + Standard Error of the Mean.
^Statistically different (P < 0.05) using Students t-test of comparisons between mean levels of grain workers and 
controls in each age group or length of employment group.
TABLE 52






























1587+27 1737+95** 1612+101 1288+05 1560+56 1566+157 1556+30 1632+94 1714+122**
IgA
mg/dl
266+06 266+16 273+17 301+04 264+16 278+39 286+30 264+21 281+25
XgM
mg/dl
156+04 147±13 186±20 162+24 158+09 143+15 133+15 160+80 153+22
*Results expressed as mean ± standard error of the mean.
^Statistically significant (P < 0.05) of the difference between mean level of the grain workers 
and the mean level for each elevator company.
TABLE 53
ALPHAx-ANTITRYPSIN (AAT) LEVELS* IN 
SMOKERS, EX-SMOKERS AND NONSMOKERS






















mg/dl 306 + 7** 329 + 7 284 + 8 302 ± 10 292 + 10 281 + 12 296 + 5 308 + 6
*Results expressed as Mean ± Standard Error of the Mean.
**Statistically significant (P < 0.05) using Students t-test.
TABLE 54a











































253+49 345+23 270+08 302+9** 297+13 288+10 306+8** 342+17 315+10 312+12 331+32 317+16
*Results expressed as the Mean ± Standard Error of the Mean.
**Statistically significant (P < 0.05) using Students t-test.
Page 135
TABLE 54b
LEVELS OF ALPHAi-AHTITRYPSIH* IN CHAIN WORKERS AND CONTROLS GROUPED 






























284+8** 306+8 288+10 288+12 298+15 304+14 305+12 314+12
20.6-25 .5 25.6-30.5 30.6-35 .5 35.6
Years Years Years Years
Grain Grain Grain Grain
Workers Controls Workers Controls Workers Controls Workers Controls
(N=22) (N*17) (N=30) (N=9) (N*9) (N=7) (N=2) (N=3)
314+14 343+35 305+14 353+20 353+40 326+54 417+33 322+54
Results expressed as Mean + Standard Error of the Mean. 
Statistically significant (P < 0.05) using Students t-test.
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THE TRYPSIN INHIBITORY CAPACITY AND ALPHA}-ANTITRYPSIN (AAT) 




T.I.C.* %** Pi Type Age
(Yrs)
Smoking
18 1.40 118.6 H
52 .92 77.9 MS 27 EX
98 1.30 110.0 H
133 1.36 115.2 If
143 1.27 107.9 MS 30 S
210 .94 79.6 MS 21 VS
232 .63 55.5 HZ 36 VS
239 .72 61.5 HZ 31 S
240 .81 68.6 HZ 28 Ex
♦Trypsin inhibitory capacity expressed as mg of trypsin inhibited per ml of 
serum.
«♦Percentage of normal standard pool.
TABLE 56












FEVj/FVC + 51.0 286.2 96.7 1540.4 458.4 144.2 76.1 306.4 77.8
<70% - 25.9 262.1 113.7 NS 1596.8 469.7 NS 158.6 78.9 NS 294.4 83.7 NS
FVC + 17.0 331.4 138.1 1815.1 540.3 151.3 76.5 331.5 83.1
<80% - 293.0 262.2 108.6 <.025 1574.3 460.5 <.05 156.6 78.7 NS 294.3 82.4 NS
+ 130.0 285.0 108.8 1608.8 515.7 150.4 74.9 306.0 74.9
<1.65 - 180.0 252.3 111.4 <.025 1572.3 430.2 NS 160.6 80.9 NS 289.3 80.3 NS
MMF + 60.0 290.2 104.1 1641.6 510.2 147.3 76.0 315.0 81.6
<1.65 - 250.0 260.3 112.4 NS 1574.8 457.0 NS 158.4 79.1 NS 292.0 82.6 NS
vmax75 + 153.0 277.8 114.1 1621.3 520.1 156.8 84.9 303,8 84.8
<1.65 - 157.0 254.5 107.6 NS 1554.6 408.6 NS 155.8 71.9 NS 289.1 80.3 NS
CV + 43.0 283.3 132.7 1534.2 434.8 158.3 70.0 289.7 83.0
<1.65 - 267.0 263.2 107.4 NS 1596.3 472.9 NS 156.0 79.9 NS 297.4 82.8 NS
&N2/L + 100.0 260.7 105.0 1616.0 142.2 142.2 86.5 321.1 92.4
<1.65 - 210.0 268.5 114.4 NS 1574.2 468.5 <.05 163.0 73.7 <.05 284.6 75.2 <.005
DL + 22.0 333.8 120.8 1655.1 547.8 137.9 74.0 343.0 72.9
<80% - 288.0 260.8 109.1 <.01 1582.4 461.5 NS 157.7 78.8 NS 292.8 82.5
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REGRESSION COEFFICIENTS (b) T RATIOS (t) AND SIGNIFICANCE <p) IN MULTIPLE REGRESSION OF 
IMMUNOGLOBULIN (A,G,M) AND ALPHA}-ANTITRYPSIN (AAT) LEVELS ON GRAIN DUST EXPOSURE, 
SMOKING HABIT, AGE AND/OR LENGTH OF EMPLOYMENT (LOE)
Ag« Smoking
Ex-
Smoking Grain LOE Smoking
Ex-
Smoking Grain
(b) 1.237 - 20.8 2.2 28.63 1,735 -19.8 -5.4 28.34
IgA (t) 2.5 - 1.86 .18 3.20 4.63 - 1.8 - .44 3.22
(p) .01 .05 NS .005 .0001 .05 NS .005
(b) 4.55 >132.8 -46,0 157.6 3.99 -134.5 -27.5 NS
IRC (t) 2.99 - 2.97 - .93 4.4 2.01 - 2.99 - .56 157.6
(p) .005 .005 .005 .0001 .025 .005 NS .0001
(b) - .394 - 15.07 - 7.48 6.30 -1,150 - 15.67 - 7.79 7.07
IgM (t) -1.41 - 1.84 - .82 .96 -3,19 - 1.93 - .87 1.09
(p) .0001 .05 NS NS .0001 .005 .05 NS
(b) 1.586 32.37 -2.96 -15.83 1,578 31.94 3.21 -15.99
AAT (t) 5.26 3.65 - .30 - 2.23 3,97 3.56 .33 -2.23
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20-29 36 SO 178. S 78.8 16 22 178.2 81.6 20 28 179 82 72 178.5 80.4
30-39 27 63 178.9 84.3 9 21 177.3 81.5 7 16 177 82 43 178.3 83.3
40-49 33 51 173.0 82.4 17 26 176.6 87.7 15 23 175 90 65 17S.5 85.5
50-64 22 32 174.6 77.8 34 SO 176.8 87.9 12 18 173 81 68 175.4 83.4
20-64 118 48 176.9 80.9 76 31 177.1 85.8 54 22 176.3 84 248 176.8 83.1
TABLE II«lb

























20-29 22 52 176.9 81.3 6 14 178.4 94.1 14 33 179.6 84.3 42 178.0 82.7
30-39 26 43 176.4 83.3 17 28 176.5 85.3 18 30 175.2 82.7 61 176.0 83.7
40-49 25 60 17S.1 84.7 11 26 179.4 95.6 6 14 177.8 94.3 42 176.6 88.0
50-64 14 30 174.6 76.8 19 40 175.3 87.7 14 30 172.6 84.1 47 174.3 83.4




MEAN TOTAL DUST LEVELS AND RESPIKABLE DUST LEVELS 
JOB CATEGORY, COMPANY AND WEEK
TABLE I1-2
Total Dust Level Total Dust Level
H x U S D Range n % n X
>10 mg/m3 >15 mg/m3
GRAIN WORKERS
All Samples 209 3.29 6.95 .03-54.98 15 7.2 9 4.3
Company*
1 36 2.81 5.39 .196-30.18 2 5.6 1 2.8
2 17 3.17 5.25 .03-20.16 2 11.8 1 5.9
3 5 9.48 16-59 .73-38.95 1 20.0 1 20.0
4 46 3.78 7.95 .14-39.12 4 8.7 3 6.5
5 17 1.72 2.18 .27- 8.29 0 0 0 0
6 18 4.95 12.52 .22-54.08 2 11.1 1 5.6
7 32 4.24 5.81 .23-32.62 3 9.4 1 3.1
8 32 1.70 3.52 .18-20.19 1 3.1 1 3.1
9t 6 .45 .30 .20- 1.03 0 0 0 0
Job Category
01 21 1.55 1.33 .27- 5.47 0 0 0 0
02 9 11.75 12.72 .79-38.95 4 44.4 3 33.3
03 35 4.27 7.96 .18-36.08 4 11.4 2 5.7
04 14 2.98 2.89 .22-10.30 1 7.1 0 0
05 43 4.18 9.85 .196-54.08 2 4.7 2 4.7
06 56 1.24 1.24 .03- 6.72 0 0 0 0
07 25 4.10 7.13 .14-30.18 4 16.0 2 8.0
08 6 1.05 1.20 .41- 3.47 0 0 0 0
02,03,04 58 5.12 8.42 .18-38.95 9 15.5 5 8.6
Week
10/10 37 4.38 8.76 .14-39.12 4 10.8 3 8.1
10/17 22 2.73 4.65 .03-20.16 2 9.0 1 4.5
10/24 41 1.64 3.27 .18-20.19 1 2.4 1 2.4
10/31 24 4.87 10.87 .23-54.08 3 12.5 1 4.1
11/7 20 4.63 7.03 .43-32.62 2 10.0 1 5.0
11/14 43 2.60 4.97 .20-30.18 2 4.6 1 2.3
11/27 22 3.48 8.19 .27-38.95 1 4.5 1 4.5
CONTROLS
All Samples 65 .60 .56 .09- 2.56 0 0 0 0
♦Company where elevator operator or state inspector worked the day tested, 
tother - not specified on dust level report from NIOSH.
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TABLE 11-3
INCIDENCE OF SYMPTOMS DURING SHIFT STUDY







Cough 119 48 61 32 <•001
Expectoration 93 38 36 19 <-001
Wheezing* 30 12 17 9 <.001
Dyspnea 29 12 10 5 <.050
Fever 13 5 6 3 U.S.
Eye Sxt 29 12 10 5 <.050
Stuffy Nose 91 37 48 25 <.010
Throat Sx** 15 6 13 7 N.S.
One or More Sx 163 66 81 42 <.001
♦Wheezing and/or chest tightness 
fEyes burning, watering or itching 
♦♦Throat sore or burning
INCIDENCE OP 8YMPT0N8 DURING WORK SHIFT IN ORA» HANDLERS IT 8N0KINQ CATEGORIES AND SUBJECTIVE APPRAISAL OP DUST EIPOSUM
YULI 11-4
Subjactive Apfralaal of Dost Ixpoaura1
laaa Than Nor« Than Expoaura Heavy 
Symptom All Smokor Exomokar Nonsmokor Avaras« Avaraga Averoge Yes No
(248) 1118) (7«) (54) <70 (158) (14) (48) (200)
V % 1 % V % ■ t I % N « N 1 N % N %
Cough 119 41.9 66 55.9 28 36.8 25 44.2 44 37. St 44 40.5 11 78 5 30 42.5** 89 44.5
Kxpeetoratlon 93 37.5 51 43.2 26 34.2 16 29.6 32 42.1 54 34.1 7 50 0 30 62.5** 63 31.5
Wheeling ond/or 
Ch**ot Tightness 30 12.0 17 14.4 11 14.4 2* 3.7 10 13.1 19 9.4 S 33 7* 14 29.1** 16 8.0
SOB 29 11.6 19 16.1 6 7.8 4 7.4 8 10.S 16 10.1 5 35 7* 15 31.2** 14 7.0
Fever 13 5.2 S 4.2 5 4.5 3 5.5 8 lO.St 4 2.5 1 7 1 4 8.3 9 4.5
Eye Symptoms 29 11.6 14 11.8 7 9.2 8« 14.8 9 11.8 13 8.2 7 SO o* 14 29.1«* 15 7.5
Stuffy Nos« 91 36.6 42 95.5 23 30.2 26 48.1 27 35.5 55 34.8 9 64 2 * 23 47.9 68 34.0
Throat Symptofcs 15 6.0 6 5.0 1 1.3 8 14.8 7 9.2 8 5.0 0 4 8.3 11 5.5
Ono or Nor«
Symptom« 113 45.7
*8lg»lfleantly dlfforont Ineldoneo batman «vanga and mora than average P < .05. 
fstgnifleant ly dlfforont prevalence between average and l«sa than «voraga P < .05.
**p valua < .05 - Significant d Iff «ranca between MyaaM and "no."
•P < .05 - Significant d If faranca between vumomokera and smokers.
Total dost laval x ± 1 8D ■ 14 ± 12 for "mara than average"
4 k  8.4 for "average"
1.1 i 4 for "lass than average"
Iq M  ulned by pool »hift answers to "In your opinion, tha amount of duat you were exposed to today was a) average, b) lass 






OrCIDEHCE OF RESPIRATORY SYMPTOMS* BY JOB CATEGORY 
AND PLACE OF EMPLOYMENT
Job 1 2 3
COMPANY 





■ ff=34 *>21 H=6 *=44 V=>17 H=14 N=31 H=19 H=62 H X
01 19 5 0 0 2 1 1 1 1 0 11 58 95
02-03-04 73 3 4 1 18 4 4 7 2 0 43 59 81
05 37 6 3 1 4 3 1 3 3 0 24 65 90
06 83 3 1 1 5 0 0 1 2 36 49 56 94
07 25 2 1 0 4 4 1 4 1 0 17 68 81
08 5 1 0 0 0 0 0 0 0 0 1 20
Total in 
Shift Study 248 20 9 3 33 11 7 16 9 36 145 58
X with 
Symptoms 59 43 50 75 71 50 52 47 58
X Studied 
of Study I 97 95 50 90 100 82 79 79 91
* Cough on expectoration or wheezing or dyspnea during the shift.
** X of the workers studied in Study I that participated in Study II.
Page 147
TABLE II - 6
LEUKOCYTE COUNT AND DIFFERENTIAL COUNTS 
BEFORE AND AFTER A WORK SHIFT 
IN CRAIN WORKERS (G) AND CONTROLS (C)
Difference
Pre-Shift Post-Shift Pre-Post Shift
■jf *5D T  ±5D T  ±SD
Total number G 6.9 1.7 7.8 1.5 .91 1.2
per s*3
C 6.8 1.7 7.8 1.8 .99 1.15
Neutrophils G 53.5 9.9 59.1 8.1 6.4 9.9
Segmented Z Total
C 55.9 9.2 58.5 9.8 2.6 9.2
Neutrophils G .75 1.13 .37 .98 - .42 1.44
Banda Z Total
C 1.43 1.74 .39 .90 -1.06 1.87
Eosinophils G 2.9 2.4 2.4 2.2 - .62 2.6
Z Total
C 2.9 2.1 1.8 1.9 -1.06 2.5
Basophils G .49 .73 .02 .16 -  .50 .74
Z Total
c .43 .67 .01 .07 -  .41 .67
Lymphocytes c 41 .5 9.7 37.6 8.3 -  4.5 9.7
Z Total
c 38.7 8.8 39.2 9.8 .46 9.2
Monocytes c .75 1 . 10 .21 .88 -  .55 1.32
Z Total
c .6 7 .91 .13 .42 -  .54 1.05
The range for leukocyte counts from grain workers «a»: pre-shift 4.2*14.7 and 
post-shift 4.7-14.1. The range of leukocyte counts from control city workers 
was: pre-shift 3.9-12.2 and post-shifc 3.2-14.5*
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TABLE II - 7 





Pre--shift Post--shift Pre--shift Post-shift
Total C3* 
(B1A/B1C) ng/l 106 ± 29 104 ± 33 101 ± 2 8  98 ± 23
Range mg/I 66 - 266 58 - 294 54 - 256 51 - 167
Activation 
Classical Pathway 0 0 0 0
Activation 
Alternate Pathway 0 0 0 0
♦Results expressed as the Mean ± 1 SD.
TABLE II - 8 
BODY TEMPERATURE DURING DAY OF SHIFT STUDY
800 Hr« 1200 Hr« 1600 Hr« 2000 Hra
Crain Workers 
x 4 1 SD (245) 97.7 * .9 (244) 98.3 4 1.1 (245) 98.2 4 .9 (212) 98 .3  4 .8
Range 96.0 -  99.8 96.0 - 104.2 96.0 - 100.0 96.0 - 102.2
Controls 
X 4 1 SD (191) 97.9 * .9 (167) 98.6 * .8 (191) 98.5 * .8 (167) 98.6 4 .7
Range 96.0 -  100.4 96.2 - 100.2 96.4 - 100 .6 96.8 - 100 .0
Page 150
PULHONARY FUNCTION BEFORE AND AFTER WORK SHIFT 
n r  CttATW WORKERS <G) n=241 AND CONTROLS (C) n=191









P*x ± SD x ± SD x ± SD x 1 SD
FEVi G 3474 828 NS 3466 868 -8.0 271 -.25 9.31
ml VS NS
C 3874 746 <.05 3911 718 36.3 236 1.41 8.25
FVC G 4725 917 <.02 4679 948 -46.3 280 -.95 6.45
ml VS <.05
C 4830 776 HS 4827 730 -2.8 265 .25 5.80
Vmax50 G 3.70 1.47 VS 3.65 1.52 -.06 .65 -1.05 17.7
L/sec <.05 <.01
C 4.54 1.60 vs 4.60 1.55 .06 .40 3.62 17.5
Vmax^ G 1.34 .66 vs 1.32 .65 -.03 .31 .15 23.4
L/sec <.001
C 1.66 .72 <.001 1.74 .72 .08 .24 8.0 22.5 <.001
P* Significance of pre-post differences in grain workers versus city workers.
P Significance of pre versus post values in grain workers and in controls by paired t tests.
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PULMONARY FUNCTION CHANGES DURING WORK SHIFT IN GRAIN WORKERS (G) 
AND CONTROL WORKERS (C) BY SMOKING CATEGORY
TABLE 1 1 - 1 0
Smoker Ex-smoker Nonsmoker
Pre Post Diff P1 Pre Post Diff P2 Pre Post Diff p3
mean mean mean mean mean mean mean mean mean
±1SD ±1SD +1SD ±1SD ±1SD ±1SD ±1SD ±1SD ±1SD
FEYi G 3473 3481 -.92 3395 3352 -43.4 3576 3601 31.3
ml +859 +865 ±280 +819 ±897 +253 ±773 +815 ±271
C 3795 3835 40.1 3837 3870 32.7 4040 4003 33.4
±846 +809 ±289 +601 +592 ±206 ±678 ±860 ±153
FVC G 4732 4695 -48.1 4623 4582 -41.5 4835 4771 —47 .6
ml ±943 ±978 301 ±883 ±949 ±278 ±920 ±879 +234
C 4804 4807 3.5 4782 4783 .74 4919 4812 -17.1
±813 +801 +169 ±693 ±603 ±396 ±790 +991 +235
FEV}/ G 73.2 73.8 73.2 72.6 74.2 75.3













Vmax^0 G 3.61 3.59 -.03 3.60 3.54 -.05 4.05 3.99 -.08
L/sec ±1.51 ±1.53 ±.66 +1.42 +1.54 ±.56 +1.41 +1.51 ±.79
C 4.46 4.43 -.03 <.02 4.43 4.62 .19 4.77 4.77 .09
±1.64 ±1.62 ±-44 +1.77 ±1.71 ±.59 +1.32 +1.35 + .48
Vmax^5 G 1.31 1.26 -.06 1.26 1.25 -.01 1.54 1.55 .02
L/sec ±.63 ±.57 ±.28 + .59 + .66 ±.32 + .77 + .73 ±•35
C 1.65 1.67 .02 <.01 1.55 1.68 .13 1.78 1.88 .13 <•02
±.78 ±-74 ±.21 ±. 68 ±.71 ±.22 + - 64 ±.71 + .29
By unpaired t-test: P* smokers vs. ex-smokers; P2 ex-smokers vs. nonsmokers;
P3 smokers vs. nonsmokers. Blanks: no significance
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TABLE II - 11
MULTIPLE REGRESSION ANALYSIS USING PRE-POST-SHIFT PERCENT DIFFERENCE 
IN LUNG FUNCTION AS THE DEPENDENT VARIABLE AND GRAIN HANDLING, AGE 
HEIGHT, SMOKING AND EX-SMOKING AS INDEPENDENT VARIABLES
Independent Variables 
Grain Previous
Handling Age Height Sacking Smoking
FEVi - .0162 - .00038 .0004 .0017 - .0124
-1.88 -1.01 ♦.24 ♦ .16 -1.03
FVC - .0118 - .00041 -.0004 - .0005 ♦ .0035
-1.96* -1.55 -.38 1 • o ♦ .41
*MAX50 - .0486 -.00007 .00009 - .0104 ♦ .0142
-2.84* - .10 .29 1 » * .61
VMAX75 - .0801 .0016 .0023 - .0653 - .0186
-3.62* -1.67 .56 -2.36*
0
 •1
b ■ regression coefficient 
*P < .05 (evo tail)
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TABLE II - 12*
NUMBER OF WORKERS WITH PRE-POST SHIFT REDUCTIONS 





FEV} £ 10% 26 0
£ i 5 X 14 I
£20% 4 0
£ 3 0 X 2 0
rvc > 2 oz 2 1
V|«x50 £  *5X 13 1
£ 3 5 X 5 1
£ 5 0 % 3 0
V mAX’5 >2 5% 23 4
1  35% 13 0
£  50% 3 0
TABU XI 12b
c H A M c m im c t  or w * . 1» w w c w  m n  n i- to s t  m a rt % p im w w c i > m _____________
8X During Exposed to RV J Dost
History • Shift on 8hlft_ yyg Post XA Pro Post Pro Post Level






C M  Crsln 
Dust
Ho. * a t/> U M  5  Ü 5  Ö .....
30 43 11 n 23 03 0 X X X X tunflower 91 3.55 2.9 -17 HA HA 48 44 5.9 HA HA
Wheat 55 2.45 2.0 -14 HA HA 120 94 .8 — —
28 51 25 tx 82 01 ♦ X X X X Vhest' Ijre 
Herley
44 1.45 1.0 -34 • • z 4.5 88 80 1.4 --
43 39 ? IX 23 Wheet 53 2.52 1.7 -32 • * r 8.4 114 112 1.0 -- —
43 48 22
Bsrler
«0 2.13 1.8 -14 G • f 7.4 150 134 1.5 -- --
54 35 13 n 18 04 Asttwe X X X X Sunflower 54 2.50 2.1 -14 9 8.4 70 70 2.1 * ♦
10 39 1« 8 28 03 0 0 X 0 X Hot Speelfled 43 3*33 2.4 -11 12.0 12.0 120 128 1.0 « ♦
90 44 18 ■ 0 04 0 0 0 0 0 tunflower 90 3.18 2.4 -17 3>9 4.4 98 98 1.« -- ...
IS 43 2 KX 8 03 Whest 89 3.09 2.5 -18 9 * X 8.4 114 294 3.3 - -
3* 51 5 n
iirlif
48 2.24 1.8 -17 9 ♦ m - ♦
21 49 29 8 • 04
Sunflower
43 2.47 2.1 -18 9 ft ̂ 5.8 87 91 HA - -
92 58 29 KX 31 03 0 0 0 0 0 Vhest A
Sunflower
42 3.00 2.3 -23 9 • • 7.4 95 90 9.3 . +
100 51 44 2.10 1.7 -19 HA HA 142 I U 1.8 » ♦




TABLE II - 13
CHANCE IN PULMONARY FUNCTION DURING WORK SHIFT IN GRAIN WORKERS 




FEVi#o * A Pr«-Poat-Stiift - .5 .08 NS
FVC X * Pr«-Po#t*Shifc *1.4 -.4 NS
V ^ j S O  X A Prm-Poit-Shift -1.6 4.9 MS
*MAX75 * 4 Fr«-Po«t-Sbl£t - .67 6.0 NS
*B y
♦♦Cough «ttd/or «xp€ccor«cioo «nd/or vh««tio| and/or dyiptMi.
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TABLE II - 14
RELATIONSHIP OF TOTAL DUST LEVELS TO SYMPTOMS 
DURING WORK AND SUBJECTIVE ESTIMATION OF DUST EXPOSURE
During Shift Symptom N Total Dust Level 
(ag/s^)
' S  * 1SD
P
Respiratory Symptoms:
Yss 122 4.11 8.16
<.05
No 87 2*14 4.54
fivir: Yts 9 2.30 3.10
NS
No 200 3.33 7.07
Eyt or S a u l  Symptom:
Yea 82 3.72 7.45
NS
No 127 3.01 6.62
Subjective Estimation 
of Dust Exposure:
Less than Average 134 1.84 3.92
<.01
Average 62 4.21 8.62
<.001
More than Average 13 13.87 11.78
Heavy at Any Time 
That Day:
Yea 42 10.08 12.92
<.001
No 167 1.58 2.15
P ■ significance by unpaired t-eest.
TABLE II - 15«













































0-5** (179) 80 45 63 35 22 12 17 9 100 56 8 4 10 6 64 36 7 4 104 58
P NS <.1 NS NS NS NS NS <.05 NS NS
5-10 (15) 6 40 8 53 1 7 I 7 10 67 0 5 33 5 33 1 7 11 73
P NS <.05 NS NS NS NS <.05 NS NS NS
10-15 ( 6) 4 67 4 67 2 33 3 50 4 67 1 17 3 50 3 50 2 23 4 66
NS <.05 NS <.005 NS <.01 <.005 NS <.05 NS
>15 ( 9) 8 89 6 67 2 22 4 44 8 89 0 4 44 4 44 0 8 89
<.01 <.01 NS <.005 <•05 NS <.005 NS NS <.05
Controls 
(63 J
0-5* 25 40 15 24 7 11 5 8 29 46 I 2 6 10 14 22 5 8 32 51
*60 out of 63 had dust livila fros 0 to 2 n g f w ?
**141 out of 179 had dust lavils froa 0*2 sig/a^
P ■ significance of the difference between grain workera to controls J
TABLE It - 15b













































0-5** (179) 80 45 63 35 22 12 17 9 100 56 8 4 10 6 64 36 7 4 104 58
P <.05 <.001 NS NS <•001 NS NS <.05 NS <.005
5-10 (15) 6 40 8 33 1 7 I 7 10 67 0 5 33 5 33 1 7 It 73
P <.1 <•003 NS NS <.03 NS <.001 NS NS <.05
10-15 ( 6) 4 67 4 67 2 33 3 30 4 67 1 17 3 30 3 50 2 23 4 66
<.I <•003 <.03 <.001 NS <.1 <.001 NS <.05 NS
>15 ( 9) 8 89 6 67 2 22 4 44 8 89 0 4 44 4 44 0 8 89
<.001 <.001 NS <.001 <.003 NS <.001 NS NS <.01
Controla 
(192)
0-5* 61 32 36 19 17 9 10 3 71 37 6 3 10 3 48 25 13 7 81 42
*60 out of 63 had duat levels froa 0 to 2 ag/a*
**141 out of 179 had dust ltvil« froa 0*2 ag/a^






MULTIPLE REGRESSION ANALYSIS USING PRE-POST SHIFT PERCENT DIFFERENCE IN LUNG 
FUNCTION AS THE DEPENDENT VARIABLE AND TIMED WEIGHTED TOTAL DUST CONCENTRATION, 
AGE, HEIGHT, SMOKING AND EX-SMOKING AS INDEPENDENT VARIABLES





Age Height Ex-smoking Smoking
FEV b .096 .096 - .27 -2.07 -.45
X A Pre/Post Shift t 1.03 -1.73 -1.07 -1.11 -.26
FVC b - .153 - .063 - .155 -1.72 -2.0
X A Pre/Post Shift t 2.3* -1.59 - .86 -1.28 -1.62
vmax50 b - .42 - .148 - .277 .41 .82
X A Pre/Post Shift t -2.43* -1.44 - .59 .12 .26
vmax*5 b - .537 - .037 - .618 1.44 -3.62
X A Pre/Post Shift t -2.36* -.28 -1.0 .32 - .86
b » regression coefficient 
t = t ratio
* = b .05 (using two tail analysis)
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DISTRIBUTION OF SNOKINO HABITS, HEIGHT AND WEIGHT BY AGB GROUP (FOLLOW-UP STUDY)



















20-29 19 56 177.4 80.6 S 15 182.0 81.4 2 6 173.3 74.9
30-39 23 68 180.2 85.8 2 6 181.9 90.7 3 6 177.0 81.6
40-49 25 48 176.3 82.8 10 19 178.0 89.6 9 17 176.1 92.1
50-64 19 37 172.7 76.0 14 27 176.9 95.7 10 19 173.0 81.5
20-64 86 50 176.8 81.6 31 18 178.4 91.1 24 14 174.8 84.9
Smokor« »1974 Bx-mokars - 1974 VonBrook*ra - 1974
Ex-smok*rs -1977 Smokors - 1977 Ex-«mok*r* - 1977 All Groups
As*
(Y**ri) (no.) (%) (cm) (ks) (no.) (%) (cm) (ks) (no.) (%) (cm) (ks) (no.) (cm) (ks)
20-29 7 21 176.4 81.6 0 0 0 0 1 3 172.7 81.0 34 177.6 80.6
30-39 5 15 17S.3 77.3 1 3 178.4 86.0 0 0 0 0 34 179.2 84.4
40-49 6 12 175.9 78.6 1 2 177.8 73.4 1 2 172.7 83.3 52 176.4 85.1
50-64 6 12 170.4 76.1 1 2 175.3 75.6 2 4 185.1 95.9 52 174.1 83.1




SYMPTOMS REPORTED IN 1977 
BY THE 177 GRAIN WORKERS FOLLOWED SINCE 1974
TABLE II1-2
N %
Cough in a.m. 66 37
Chronic Bronchitis 82 46
Cough on Exposure 119 67
Wheezing on Exposure 113 64
Dyspnea on Exposure 98 55
Grain Fever 53 30
Eye symptom on exposure 139 79
Nasal symptom on exposure 140 79
PULMONARY FUNCTION











x * 1 SD
P
FEVj ml 177 *829 846 3801 860 - 29 * 323 NS
X Predicted 98 18 99 18 .1 ±  8.6 NS
FVC ml 177 4903 914 4838 913 - 64 * 429 <.02
X Predicted 101 15 101 15 - .2 *  9.8 NS
MMF L/min 165 252 81 228 74 - 24 * 39 <.001
X Predicted 87 27 78 23 -9.4 i 14.4 <.001
t a x  50 L/aec 170 4.5 1.6 4.0 1.5 - .5 * 1.0 <.001
X Predicted 73 26 65 24 -7.8 * 16.6 <.001
Vh «x 75 122 1.8 • 6 1.6 .5 - . 2 *  .4 <.001
X Predicted 56 18 49 17 -6.8 ± 12.1 <.001
D^ml/CO/min /mnHg 168 32.0 6.1 33.3 6.2 1.3 ±  4.2 <.001
X Predicted 104 19 107 19 2.9 1 14.1 <.01
TABLE III - 5
PULMONARY FUNCTION






T  t  1 SD
1974-1977 
Difference 
JT t 1 SD
P
FEVj ml 07 3905 956 3808 953 33 305 NS
X Predicted 95 19 96 18 .8 8.3 NS
FVC ml 87 4887 1000 4870 979 - 16 429 NS
X Predicted 99 16 100 16 .6 10.3 NS
MMF L/min 80 249 83 227 81 - 22 38 <.001
X  Predicted 84 27 76 23 -9.1 14.3 <.001
Vm «x 50 L/»*c 84 4.3 1.6 3.9 1.6 - .4 1.0 <.01
X Predicted 69 25 63 24 -6.3 16.9 <.0t
VMax 75 L/ « c 56 1.8 .6 1.6 .3 - .2 .4 <.001
X Predicted 55 18 49 18 -5.9 12.9 <.001
D^ml/CO/nin /mmHg 83 30.8 5.4 31.7 6.0 .9 3.4 <.02
X Predicted 102 16 103 17 1.4 11.4 NS
TABLE III - 6
P1JL80NARY FUNCTION











ff t l SD
P
FEV| ml 32 3878 791 3793 815 85 1 316 NS
Z Predicted 99 19 99 19 - 1.8 * 7.9 NS
FVC ml 32 5073 862 4891 886 - 184 4 342 <.005
X  Predicted 103 IS 102 14 - 3.0 i 7.1 <.01
MHF L/min 29 247 68 224 68 -22.7 * 33.1 <.001
% Predicted 86 23 78 25 - 9.1 ±  11.7 <.010
•
vMex 50 W«te 30 4.6 1.6 3.9 1.4 - .8 4 1.1 <.01
X Predicted 73 27 63 24 -11.5 4 17.0 <.001
Vm «x 75 22 1*6 •7 1.4 .5 - .4 * .5 <.001
Z Predicted 37 22 44 17 -12.6 4 15,6 <.01
D^Ml/CO/Min /nNg 31 33.7 7.3 36 6 ♦ .5 4 5.9 NS
Z Predicted 110 24 n o 19 .1 4 20.0 NS
TABLE III - 7
PULMONARY FUNCTION
CRAIN WORKERS - SMOKERS 1974-1977 (FOLLOW-UP STUDY)
1974-1977
N 1974 1977 Difference P
7  t  1 SD J  t  1 SD x t  1 SD
FEVj ml 26 3784 ± 702 3784 ft 650 ♦ .3 399 NS
X  Predicted 102 * 14 105 * 15 1.5 10.5 NS
FVC ml 26 4697 ft 883 4700 1 805 3.6 529.3 NS
X  Predicted 101 ft 16 104 ft 16 2.4 11.7 NS
MMF L/min 26 261 ± 94 224 ± 68 - 37 43 <.001
X  Predicted 94 £ 30.1 82 ft 22 -11.8 14.9 <.001
^M*x 50 L/**c 25 4.8 ft 1.5 4.1 ft 1.3 - .7 .9 <.01
X  Predicted 80 ft 26 69 ft 22 -11.3 16.7 <.01
W  75 L/*«c 21 1.7 ± »6 1.5 ft .6 - .1 .2 <.02
X  Predicted 55 ft 20 51 ft 19 - 3.9 7.3 <.05
D^ml/CO/min /mmHg 24 33*5 ft 5.5 36 ft 5 2.6 4.2 <.01
X  Predicted 109 t 20 116 ft 20 7.2 13 <.02
TABLE III - 8
ttfLHONARY FUNCTION 
CRAIN WORKERS - SMOKERS 1974, EX-SMOKER-1977 (FOLLOW-UP STUDY)
N 1974 







IT t I SD
P
FEV| ml 24 3904 * 732 3873 891 -28.8 313 NS
X Predicted 101 * IS 102 19 - .1 9.0 NS
FVC ml 24 4974 * 798 4920 932 -54.3 399 NS
X Predicted 103 * 13 104 13 - .3 9.1 NS
MMF L/min 22 264 ± 77 242 63 - 22 45 <.05
X Predicted 91.8 t 28 84 20 - 9.8 18.5 <.05
*M«x 50 L^»«c \
23 4.3 * 1.3 4.3 1.4 - .3 .7 NS
X Predicted 73 * 23 70 23 - 4.4 15 NS
VMa* 73 W*«e 18 1.8 ± .3 1.6 .5 - .2 .3 <.01
X Predicted 58 * IS 31 14 -  6.1 9.0 <.01
D^ml/CO/min /mnNg 22 30.S * 3.8 33 6 ♦ 2.8 4.3 <.01
X Predicted 10S * 19 112 18 ♦ 8.3 15 <.02
TABLE III - 9
YEARLY DECREMENTS IN LUNG FUNCTIONS TESTED 
IN ALL GRAIN WORKERS AND BY SMOKING CATEGORIES
Yearly

















FEVx, L - .029 - .029 i .323 - .033 i .305 - .085 ± .316 +.003 ± .399 -.028 ± .313
FVC, L - .025 ^ .064 ± .429 .016 ± .429 - .184 t .342 + 3.6 i .529 -.054 ± .399
MMF, L/min -1.86 24 ± 39 - 22 ± 38 - 22.7 t 33.1 - 37 ± 43 - 22 ± 45
Vmax50, L/sec - .015 - .5 ± 1.0 - .4 ± 1.0 .8 ± 1.1 - .7t .9 - .3 ± .7
Vmax7^, L/sec - .012 - .2 ± .4 - .02 ± .4 .4 t .5 - .1 ± .2 - .2 ± .3
dl co - .166 1.3 ± 4.2 .9 ± 3.4 .5 ± 5.9 + 2.6 i 4.2 + 2.8 i 4.3
^Expected yearly mean decrement In men (>25 years old) from Knudson et al.
Page 170
PROSPECTIVE STUDY 
PULMONARY FUNCTION CHANGES IN SKIN REACTORS AND NON-REACTORS 
AND IN WORKERS WITH OR WITHOUT CHRONIC BRONCHITIS OR OCCUPATIONAL ASTHMA
TABLE III - 10
All Workers
Airborne 





Mean (±1 SD) 
n=177















Mean (±1 SD) 
n=108 n=69 
(+) (-)
FEVx X  Pred 97.7 97.7 97.8 97.3 97.9 93.7 99.9 94.5 102.8
1974 ±17.7 ±14.6 ±18.2 ±12.7 ±19.5 ±18.8 ±16.7 ±19.5 ±12.9
1977 98.7 96.7 98.9 96.9 99.3 95.9 100.2 95.4 103.7
±18.1 ±16.1 ±18.6 ±12.5 ±20.1 ±18.7 ±17.6 ±19.7 ±13.8
Diff .07 -1.42 .34 -1.22 .60 1.52 -.73 .30 -.28
±8.6 ±6.8 ±8.4 ±6.7 ±8.8 ±9.2 ±8.3 ±9.1 ±8.0
MMF % Pred 86.9 85.6 87.4 81.7 89.5 81.9 89.4 83.4 91.9
1974 ±27.2 ±29.9 ±27.1 ±22.7 ±29.1 ±26.6 ±27.2 ±27.7 ±25.8
1977 78.4 77.5 78.7 75.3 79.9 74.0 80.6 76.0 81.8
±23.3 ±23.6 ±23.4 ±21.7 ±24.0 ±24.0 ±22.8 ±24.2 ±21.8
Diff -9.4 -8.2 -9.8 -7.5 -10.5 -8.4 -9.9 -8.1 -11-4
±14,4 ±13.1 ±14.5 ±10.3 ±15.7 ±11.6 ±15.7 ±14.2 ±14.6
vMax50 * Pred 72,8 68.9 73.5 70.1 74.0 68.8 74.9 68.8 79.1
1974 ±26.0 ±24.2 ±26.4 ±23.3 ±27.2 ±29.3 ±24.0 ±26.9 ±23.4
1977 65.0 65.4 65.0 61.7 66.5 62.0 66.5 61.7 70.2
±23.7 ±23.8 ±23.8 ±21.9 ±24.5 ±25.5 ±22.7 ±24.7 ±21.2
Diff -7.8 -3.5 -8.6 -8.4 -7.4 -6.8 -8.4 -7.1 -8.9
±16.6 ±16.4 ±16.7 ±12.5 ±18.3 ±18-3 ±15.8 ±18.4 ±13.5
VMax75X Pred 55.5 52.3 56.0 55.2 55.5 50.8 57.6 54.1 57.3
1974 ±18.4 ±21.1 ±18.1 ±15.4 ±19.8 ±18-4 ±18.1 ±18.1 ±18.8
1977 48.7 49.3 48.6 48.1 49.0 45.2 50.2 47.1 50.7
±17.0 ±20.4 ±16.4 ±12.6 ±18.5 ±14.7 ±17.8 ±17.1 ±16.9
Diff -6.8 -3.1 -7.4 -7.2 -6.5 -5.6 -7.3 -7.0 -6.6
±12.1 ±9.7 ±12.8 ±12.6 ±12.4 ±11.4 ±12.5 ±13.7 ±9.9
No significant changes in lung function (1974-1977) were found between positive or negative skin 
reactors or workers with or without chronic bronchitis or occupational asthma by unpaired t-test.








Characteristics of Grain Handlers Tested ...................................  1
Relationship between Skin Reactivity to Common and Specific
Allergens and Bronchial Reactivity to Specific Allergens ................... 2
FIGURE
NUMBER
Bronchial Challenge with D. Wheat Extracts -
Airways Reactors . . . . .  .................................................. 1
Bronchial Challenge with D. Wheat Extracts -
Airways Non-reactors ........................................................  2
Challenge with D. Wheat Extract After
Pre-treatment with Sodium Cromoglycate........................................3
Bronchial Challenge with D. Wheat Extracts
Subject #266 ...................................................................4
TABLE IV - 1 
CHARACTERISTICS OF GRAIN HANDLERS TESTED
Pulmonary Function Testa 
Pre-challenge Percent Predicted
Job Cigarette Smoking
Subject Age Years pack-yra Status FEVi FVC FEVj/FVC Vftux SO vMax 75 ^lCO PCjo
Reactors
1 59 7 25.5 Ex 66 106 49 23 31 105 2.5
2 51 25 32.5 Ex 50 83 48 19 29 187 2.5
3 35 13 18.0 Ex 43 71 49 16 16 122 2.S
4 48 18 28.9 S 75 111 54 33 33 124 2.5
5 28 7.5 19.5 Ex 104 114 74 72 54 103 Neg
X 44 14 35.0 68 97 55 33 33 128
i-reactora
6 33 10 18.0 S 94 107 70 54 52 78 Neg
7 34 9 21.2 s 102 117 70 61 46 95 Neg
8 30 5 8.7 Ex 102 96 78 97 88 97 Neg
9 27 3 13.5 Ex 90 96 75 67 66 95 9.6
0 46 23 0 NS 94 101 75 63 59 139 16.0
1 28 8 0 NS 101 119 69 68 67 82 Neg
l 33 10 10.0 97 106 73 68 63 98
S - Smoker; Ex« Ex-smoker; NS » Nonsmoker.




RELATIONSHIP BETWEEN SKIN REACTIVITY TO COMMON AND SPECIFIC 
ALLERGENS AND BRONCHIAL REACTIVITY TO SPECIFIC ALLERGENS






AF Insect or DW ADW 
Mite
Bronchial Challenge 




3 + ♦ + ■f + +
— +
♦
4 - + + - + + + -
5 - + + - + + + + -
6 + + + - + + - -
7 - + + - + - + - -
8 + - - - + + - -
9 - + + - + - - -
10 - - - - - + - -
11 — — - — — - — — —
CAA - Common Allergens
AF - Aspergillus Fumigatus
DW - Durum Wheat
ADW - Airborne Durum Wheat Dust
* F E V I.O
Bronchial Challenge With D. Wheat Extracts 
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Challenge With D. Wheat Extract After 












Baseline and Post-Challenge with Grain
Dust Results of Selected Parameters........................................  1
FIGURE
NUMBER
Change from Baseline on Control Day - and After
Exposure to Airborne Grain Dust - FEVi X Change.......................  1
Change from Baseline on Control Day -and After
Exposure to Airborne Grain Dust - FVC X Change.......................  2
Change from Baseline on Control Day - and After
Exposure to Airborne Grain Dust - MMF X Change.......................  3
Change from Baseline on Control Day - and After
Exposure to Airborne Grain Dust - D^CO X Change........................ 4
Change from Baseline on Control Day - and After
Exposure to Airborne Grain Dust - Vgj^SO X Change........................ 5
Change from Baseline on Control Day - and After
Exposure to Airborne Grain Dust - Vjy^j75 X Change........................ 6
BASELINE AMD POST-CHALLENGE WITH GRAIN DUST RESULTS Of SELECTED PARAMETERS
TABLE V - 1
Skin Prick 
Teat Baa* Reaplr.






















81 48 Yea - - 70 - 86.7 - 3 - 6 - 4 -75 - 6 +44 38 0* 14.3* 79 -
82 47 Yea - ♦ 70 10 44 -35* -73* -55* -40* -12 - 5 37 2 11.7* 70 -
56 30 No - - 83 - 86.7 -12 - 3 -31 -29 -41* ♦16 39 0* 24.3* 82 ♦
84 27 Yea - - 84 - 23 -27* -16 -43* -29 -51* -17* 38 4* 21.0* 81 -
23 57 No + + 61 .75 23 -27* -29* -55* -36* -50* -21* 36 9 8.6 66 -
32 29 No + ♦ 81 - 38.6 -25* -15 -40* -44* -38* +17 38 9* 17.6* 86 -
84 29 No + - 85 1.56 164 -23* -11 -36* -37* -35* + 7 36 4 8.8 77 -
83 27 No - 82 25 143 -37* - 6 -33 -37* -35* - 2 37 8* 24.3* 78 -
81 25 No + - 94 - 90.1 -27* -13* -58* -54* -53* +14 37 2 19.0* 83 -
85 26 No + ♦ 98 - 164 -11 -11 -25 -29 -21 -13 36 9 14.6* 80 -




No 88 90.1 -50* -39* -70* -67* -26 +15 37 4 22.0* 83
Footnoteet CAA « comaon allergens, + • atopy - 2 or more positive reaction* to ragweed, grata, traa altarnarla, eat hair or 
feathers; Airborne grain dust extract, + * wheal 3«m; Temp ■ temperature; WBC * laukocyta count; PMN*a - 
neutrophils; C3 - C3 level total aerum complement, t Mecholyl teat negative (-) if no FEVj decrease 
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APPENDIX I
Privacy Act of 1974 - Comments
The study we have performed as a non-government organization under 
contract with a Federal agency adhered to the Privacy Act of 1974, which 
requires that the government: 1) maintain no secret files on individuals; 2)
inform people at the time it is collecting information about them why this 
information is needed, and how it will be used; 3) assure that personal 
information is used only for the reasons given, or seek the person's 
permission when another purpose for its use is considered necessary or 
desirable; 4) allow people to see the records kept on them; and 5) provide 
people with the opportunity to correct inaccuracies in their records.
In this study all completed forms, computer output, back up tapes and 
related documents trill be maintained in locked cabinets on secure premises. 
All subjects will be assigned a study number upon signature of the informed 
consent. Only in a single file will the subject's name, social security 
number and study number be present in an unscrambled form. In most files only 
the subject number will be used. In those cases where the subject's 
identification is needed for specific tests such as the subject's physical 
exam record, code work scrambled identifiers will be used. In certain 
processers these scrambled words are replaced by asterisks upon printing, 




Privacy Act of 197A - Comments
ALOSH will receive one sealed copy of the list of subjects by name, social 
security number and study number. All samples will be transferred by subject 
number and sample number with a sample number list identifying the source and 
details pertinent to that sample. At study completion, ALOSH will specify in 
writing which subject records are to have identifying data purged prior to 
transfer.
All subjects, prior to signing the consent form, were informed of their 
rights under the Privacy Act and that the Medical Ethics Code applied to all 
their medical Information to protect their privacy. Medical information was 
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OMB Ho. 68-S77027 
Exp. 7-79______
HIOSH/UNIVERSITY OF WISCONSIN HUMAN SUBJECTS RESEARCH PARTICIPANT DOCUMENT
I . PROJECT DESCRIPTION
1. Project Title and Number: Disease Prevalence & Health Hazards of
Grain Handlers; NIOSH Project VKCR21132.
2. Sponsor and/or contractor: National Institute for Occupational
Safety and Health, Morgantown, West Virginia 26505 and University of 
Wisconsin, Madison, Wisconsin 53706.
3. Purpose and Benefits:
This study will be divided into two parts: Part A —
Determination of General Health Status and Biological Response to the 
Working Environment; and Part B —  Determination of Response to 
Specific Environmental Agents. The participant may limit his 
willingness to cooperate to either Part A or Part B or he may elect 
to participate in both of these studies.
Part A : Determination of General Health Status and Biological
Response to the Working Environment
This study is designed to define the presence and extent of
health hazards associated with occupational exposure to grain dusts. 
However, in order to determine the uniqueness of the effect of the 
exposure to grain dust it is necessary to evaluate what the health 
status is of other working people not exposed to grain dust. 
Therefore, to participate in this study you do not necessarily have 
to be associated with the grain industry.
During the course of the study, our examinations may identify 
diseases or conditions (which may or may not be related to grain 
handlers) which should have further medical attention or treatment. 
With your permission, we will notify you and your private physician 
of such findings so that they can be taken care of. This is one way 
in which you may personally benefit from the tests. In addition, all 
workers may benefit from the study if it is found that present 
precautions against occupational disease are inadequate, and that 
improved preventive measures should be taken.
Part B : Determination of Response to Specific Environmental Agents
This study is designed to identify the agent that may cause a 
lung reaction to grain dust in sensitive individuals. Grain dust 
contains not only grain particles but also particles of insects and 
molds to which some people may react. If the agent causing your 
problem can then be recognized, steps can be taken to prevent or 
reduce its effects on your health. However, in order to determine if 
only sensitive individuals will react, it is also necessary to do 
this study on people who have not shown reaction to grain dust. In 
this case the participant will not derive any direct benefit from the 
study.
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II. CONSENT TO PARTICIPATE
I, ________________________________________ , age _________ , hereby voluntarily
agree to cooperate in the above named study and to undergo the tests listed 
in Attachment A as follows:
(Indicate your willingness to cooperate in either Part A or Part B or both 
studies by writing "YES" or "NO” in the space provided.)
Part A: ____________________
Part B:
The studies have been discussed with me and I have been given a copy of the
document. I understand that:
1. The procedures and tests to be followed are as stated in Attachment A 
with those procedures which are experimental so identified.
2. Attendant discomforts and risks are as noted in Attachment A and, except 
as noted, are minimal and provision has been made for any necessary 
medical care, and I have been told what to do if I have any reaction.
3. Benefits are as indicated in the Purpose and Benefits section in Part X.
4. If alternative procedures advantageous to me are available, they are 
specified in Attachment A ; and if they become available during the 
project, the procedure most advantageous for me will be indicated and 
used or an explanation will be given to me as to use of any other 
procedure.
5. My inquiries will be answered by the examining personnel, by the Project 
Director, Dr. John Rankin, University of Wisconsin, Department of 
Preventive Medicine, Rm. 101, 504 H. Walnut Street, Madison, Wisconsin 
53706, (608-263-2881); or by the Project Officer, Dr. Pervis C. Major, 
NI0SH, 944 Chestnut Ridge Road, Morgantown, West Virginia 26505 
(304-291-4256).
6. I am free to terminate my consent and to discontinue participation in 
the project at any time without prejudice to myself.
7. My identity and my relationship to any information (1) disclosed by me 
in completing any project questionnaire, and (2) reported by me or 
derived from me during my participation in the above named project shall 
be kept confidential and trill not be disclosed to others without my 
written consent except as required by law and except that such 
information will be used for statistical and research purposes in such a 
manner that no individual can be identified. 1 understand that if any 
information is found out concerning me that can endanger the health and 
safety of others, this information will be given to the proper authority.
8. If any of my medical records are required for purposes of this project, 
a separate written consent for release of the records will be requested 
from me.
9. There will be questions that I trill be asked to answer, and my inquiries 
concerning the questions will be answered by the examining personnel, by 
Dr. John Rankin (608-263-2881), or by Dr. Pervis Major (304-291-4256).
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10. A report of any significant information from the study that specifically 
concerns me, including medical information, will be furnished by the 
project officer or his designated representative to me or to my 







(Name, title and signature)
III.REQUEST AND AUTHORIZATION FOR RELEASE OF INFORMATION
I__________________________________ , hereby request and authorize the Project
Director to inform the following physicians whose names and addresses I have 
entered below of any significant findings from the above named study
concerning me. (Do not leave blank. Write "NO" where you do not wish to
give a name and address.)
1. My personal physician(s): Dr.__________________________________________
Street:__________________________________________________________________
City:_____________________________________________________________________




IV. The "Medical Health Surveillance of Grain Handlers'* questionnaire is required 
under Part A of this study and it will constitute this Part IV as a separate
attachment to be retained by the Project Director. A copy of the
questionnaire is not retained by the participant.
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A. Project Title and Number: Disease Prevalence & Health Hazards of Grain 
Handlers; HIOSH Project VKCE21132.
B. Procedures and tests which involve human subjects in conduct of this project 
are as follows:
The examination will be divided into two parts: Part A —  Determination of
General Health Status and Biological Response to the Working Environment; and 
Part B — Determination of Response to Specific Environmental Agents. The 
participant may limit his willingness to cooperate to either Part A or Part B 
or he may elect to participate in both of these studies.
PART A :
The procedures and tests that you will be asked to do are part of a 
physical examination which consists of: (1) Filling out a questionnaire
which contains a series of questions Which will be reviewed with you later by 
a trained interviewer. These questions will be about your work history, your 
use of tobacco, possible health problems, and your family history; (2) your 
height and weight will be measured and recorded; (3) x-rays of your chest 
will be made; (4) breathing tests will be made to determine if there is any 
increased resistance in your air passages; (5) blood and urine will be 
collected and analyzed; and (6) allergic skin tests will be done with common 
allergy testing agents (e.g.. ragweed) and with specific agents related to 
the grain industry (e.g., wheat). Reactions to skin tests look like a hive 
and may give some local discomfort and itching. None of these tests is 
experimental, all are widely used during medical examinations and usually 
cause no discomfort to the health of participants.
Occasionally, the breathing tests may cause some temporary chest 
discomfort and coughing. Some pain, as you may feel with a pin prick, may be 
associated with the blood collection and skin tests.
One tube (20 ml) of blood will be drawn from an arm vein before and after 
a work shift. The blood will be analyzed for white cell counts, globulins, 
complement, enzymes, creatinine and precipitins against common molds and 
grains. A sample of your blood will be frozen and transferred to the 
National Institute for Occupational Safety and Health (NIOSH), Morgantown, 
West Virginia, where they may elect to perform additional blood tests or 
repeat those performed in this study.
Urine will be collected and analyzed for protein, sugar, and blood.
There will be no direct costs to you for these tests.
Qualified professional personnel and proper medical supplies will be 
available to treat-any unforeseen reaction such as fainting. There are no 
alternative procedures to those noted above which will permit you to 
participate in the study. You may, of course, refuse to take any of them 
without incurring any penalty.
PART B:
ATTACHMENT A
This part of the study will be done in a hospital. Each individual will
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be exposed to a spray-mist of a solution made from substances obtained from 
either grain, mite, or insects and/or molds to which he has shown to be 
allergic in the skin test. He will be tested before, immediately after the 
exposure, and at regular intervals over a 24-hour period.
The tests will include the assessment of symptoms, temperature, White 
blood count, and standard breathing.
The individual may develop fever, cough, wheezing and/or shortness of 
breath which may be rapidly improved by available standard medication. Some 
temporary chest discomfort and coughing may come with the breathing tests and 
some pain, as a pin prick, may be associated with the collection of the blood 
sample.
Although the tests used to evaluate the effects of the exposure are not 
experimental, the exposure to the material is experimental. However, to 
assure that no untoward reactions will occur, only those individuals who are 
commonly exposed to these materials at work and Who have shown they have 
reacted to them (as indicated by the positive skin tests to these materials) 
will be selected as the test population. Only those individuals who are 
non-reactive (as indicated by negative skin tests to these materials) will be 
selected as controls.
C. Rights Under the Privacy Act of 1974 Title 5 United States Code, Section 552 
(a) (e) (3).
The information required to be given to me under the Privacy Act of 1974 is 
as follows:
(1) Authority for collecting information is the Occupational Safety and
Health Act 1970, Section 20 (29 USC 669).
(2) The principal purpose or purposes for which the requested information is 
intended to be used is for accurate assessment of the participants* 
general and occupational health status and is being solicited for
specific epidemiological analysis and/or as stated in Section I, Item 3.
(3) The anticipated routine use Which may be made of the solicited
information is in developing criteria and programs for a safe and 
healthful place of employment or as published in the Federal Register, 
Vol. 41, Ho. 240, #0146.00, pp. 54223-54225, Monday, December 13, 1976.
(4) I do not have to furnish any information I do not wish to. Nothing 
happens to me as a result of my not providing information, Whether all or 
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EXPLANATION :
Questions 46 and 47 in the grain handlers* questionnaire were independently 
verified by clinically experienced physicians. This verification was facilitated 
throush the use of a work sheet (see Appendix V), citing two headings (questions 
46 and 47) which differ only in form and not substance from questions 46 and 47 
as originally presented. It is important to note that the form adopted on the 




ALL THE INFORMATION OBTAINED FROM THIS STUDY WILL BE KEPT CONFIDENTIAL.
Please answer the questions by circling the number of the best answer or by 
filling in a blank with a number or word. If uncertain or in doubt, circle No.
EXAMPLE: Do you live or work on a farm? 1. Yes 2. No
If you desire help in answering a question, please put a ( ) in front of the 
question number. You will be helped with these questions by a member of our 
personnel.
1. Name (Last) (First) (MI) 3. Phone Number 4. Social Security #
AREA CODE (___) *(optional. see below)
-   / / / - / / / - / / / / /
2. Current Address (Number, street or 5a. Birthdate 5b. Age (last birthday)
rural route, city or town, county, (mo, day, year)
state, zip code) _________________________________________
6. Sex
1. / / Male 2. / / Female
7. Ethnic Group or Ancestry
1. / / White, not of Hispanic Origin
2. / / Black, not of Hispanic Origin
3 . / / Hispanic
4. / / American Indian or Alaskan Native
5. / / Asian or Pacific Islander
6. / / Other:
8. Marital Status 9a. Height 9b. Weight
1. / / Married 3. / / Divorced (cm) (kR)
2. / / Widowed 4. / / Never
Married / / with shoes / / with clothing/
street shoes
10. What was the highest grade of / / with boots / / with clothing/
regular school you completed? safety shoes
/ /
/ / bare feet / / in underwear
(For example: completion of 11. Do you live or work on a farm?
high school is 12.)
1. Yes 2. No
♦(Furnishing your Social Security number is voluntary. Your refusal to provide 
this number will not affect any right, benefit, or privilege to which you would be 
entitled if you did provide your Social Security number. Your Social Security 




12. List all jobs, occupations or type of work you have held or done through life and state 


























(CHECK APPROPRIATE ANSWER AFTER EACH QUESTION. WHEN IN DOUBT, ANSWER NO.)
COUGH AND PHLEGM:
13a. Do you usually cough first thing in the 
morning? (Exclude clearing throat)
b. Do you usually cough at other times 
during the day or night?
c. Do you cough as much as 4-6 times a day 
for 4 or more days out of the week?
IF YES TO EITHER 13a, b OR c, ANSWER d AND e:
d. Do you cough on most days for as much 
as 3 months of the year? 1. Yes 2. No (x)
e. For how many years have you had this cough?   Years (x)
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14a. Do you usually bring up phlegm from the
chest first thing in the morning? (Not 1. Yes 2. No
from the back of your nose. Count 
swallowed phlegm from the chest.)
b. Do you usually bring up phlegm from the chest 
at other times during the day or night?
c. Do you bring up phlegm like this as much as
twice a day, 4 or more days out of the week?
IF YES TO EITHER 14a, b OR c, ANSWER d AND e:
d. Do you bring up phlegm from the chest
on most days for as much as 3 months
of the year?
e. For how many years have you raised 
phlegm from the chest?
IF YOU NEVER HAD COUGH OR PHLEGM, GO TO Q 21.
15. When is your cough worse?
1. Yes 2. No 
1. Yes 2. No
1. Yes 2. No (x)
Years (x)
a. On workdays (x)
b. On weekends 
when not working
c. I notice no 
difference
1. Yes 2. No 
1. Yes 2. No 
1. Yes 2. No
16. Is your cough and/or phlegm better, 
the same or worse when on vacation 
or not working?
a . Better





17a. Is your cough and/or phlegm worse 
at different times of the year?
1. Yes 2. Vo (x)
Go to Q 18
.IF YES TO 17af CIRCLE THE MONTHS IN WHICH YOU HAVE BEEN HOST TROUBLED.
b. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
1 2 3 4 4 6 7 8 9 10 11 12
Is your cough and/or phlegm brought on 
by or made worse by exposure to:
a. Grain dust at work? 1. Yes 2. NO
b. Other dusts at work? 1. Yes 2. No
c. Gases or fumes at work? 1. Yes 2. No
d. House dust or fumes in the home? 1. Yes 2. No
e. B a m  dusts, silage or hay? 1. Yes 2. No
f. Weather changes? 1. Yes 2. No




.IF YES TO GRAIN DUST AT WORK, ANSWER Q 19:. 
(Otherwise, Go to Q21a.)
19. In your opinion, which grain dusts are cost likely 
to bring on cough and/or phlegm, or make it worse? 
(May circle more than one.)
(Specify)
(x)
a . Durum wheat g. Soybean
b. Spring wheat h. Linseed
c. Rye i. Sunflower seed
d . Oats j . Beets
e. Barley k. Malt
f. Corn 1. Other
(Specify)
20. When you are working regularly, how frequently
(on the average) have you experienced cough and/ 
during work?
a. Usually at least once a day.
b. Only a few times each week.
c. Only a few times each month.
d. Only a few times each year.





WHEEZING AMD/OR CHEST TIGHTNESS:
21a. Have you ever noticed any wheezing 
and/or tightness in your chest?
IF YES TO 21a, ANSWER b AND c:.
1. Yes 2. Vo (x)
Go to Q 37
b. Do you get this only with colds?
c. Do you get this even When you don*t 
have a cold?
1. Yes 2. Ho
1. Yes 2. Vo
(x)
(x)
IF YOU HAVE HEVER NOTICED WHEEZING AHD/OR TIGHTNESS IN YOUR CHEST, SKIP Q 22 







Which of these symptoms have you 
experienced: Wheezing, chest
tightness or both? a. Only Wheezing
b. Only chest tightness
c. Mainly wheezing
d. Mainly chest tightness
e. Both wheezing and chest 
tightness
At What age did your wheezing 
and/or chest tightness first occur?
At What age did wheezing and/or 
chest tightness last occur?
Do you have wheezing and/or chest 
tightness at work While you are 
performing your job?
When you are working regularly, 
how frequently (on the average) 
have you experienced wheezing 
and/or chest tightness during 
work?
Is your wheezing and/or chest 






(If you are still 
having these, put 
your present age.)
1. Yes 2. Ho
Go to Q 28
a. Usually at least once a day.
b. Only a few times each week.
c. Only a few times each month.
d. Only a few times each year.
e. Only a few times ever.
f . Only once.
a. First day back at work.
b. Any day(s) at work.
c . Weekends, when not working.





28. Is your wheezing and/or chest tightness 
brought on by or made worse by exposure
to :
a. Grain dust at work? 1. Yes 2. No
b. Other dusts at work? 1. Yes 2. Vo
c. Gases or fumes at work? 1. Yes 2. Vo
d. House dust or fumes in the home? 1. Yes 2. Vo
e. B a m  dusts, silage or hay? 1. Yes 2. Vo
f. Moldy or musty b a m  dusts, 
silage or hay? 1. Yes 2. Vo
S- Contacts with animals? 1. Yes 2. Vo
h. Plants, pollens or weeds? 1. Yes 2. Vo
i. Weather changes? 1. Yes 2. Vo
Other exposures 1. Yes 2. Vo
(Specify)
 IF TBS TO GRAIN DUST AT WORK. ANSWER Q 29 THROUGH 32: ______________________
(Otherwise, Go to Q 33a.)
29. In your opinion, which grain dusts are most likely to (x)
bring on wheezing and/or chest tightness or make it 






f. C o m
30. When is your wheezing and/or chest 
tightness most likely to start or 
get worse? (Circle only one)
31. If it starts or gets worse 
during work, how soon after 
the beginning of the work 
shift does not happen?
32. If it starts or gets worse
after work, how many hours  hours after
after work does this happen?
g . Soybean
h. Linseed













b. ___________ hours after
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33a. Does wheezing and/or chest tightness 
ever wake you up from your sleep?
(x)
1. Yes 2. Ho
IF YES TO 33a, ANSWER b:
b. How often does this happen? (x)
A. Almost every night.
B. A few times each month.
C. A few times each year.
D. A few times ever.
E. Only once.
F. Hever.
34a. Is your wheezing and/or chest (x)
tightness worse at different 1. Yes 2. Ho
times of the year?
Go to Q 35
 IF YES TO 34a, CIRCLE THE MONTHS IH WHICH YOU ARE HOST TROUBLED BY
WHEEZIHG AND/OR CHEST TIGHTNESS
b. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Vov Dec (x)
1 2 3 4 5 6  7 8 9  10 11 12
35. Is your wheezing and/or chest 
tightness better, the same or 
worse when on vacation or not 
working?
36. Have you ever had 2 or more 
attacks of wheezing that has 
made you feel short of breath?
SHORTNESS OF BREATH:
37. Have you ever been troubled by 
shortness of breath?
38. Are you troubled by shortness
of breath When hurrying on level 
ground or walking up a slight hill?
39. Do you get short of breath walking 
with other people of your own age 
on level ground?
40. Do you have to stop for breath 
While walking at your own pace 
on level ground?
41. Do you get short of breath dressing 





1. Yes 2. Ho (x)
1. Yes 2. Ho
1. Yes 2. Ho
1. Yes 2. Ho
1. Yes 2. Ho 
1. Yes 2. Ho
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.IF TES TO Q 38, 39, 40 OS 41, ANSWER Q 42:
42. For how long have you had this shortness (x)
of breath?  Tears
43. Do you get short of breath while 
at work, perforating your job?
44a. Do you get short of breath during 
or after exposure to grain dust?
1. Tes 2. Vo
1. Yes 2. Vo (x)
Go to Q 45a
IF YES TO Q 44a, ANSWER b, c, d AND e:
b. In your opinion, which grain dusts are most 
likely to bring on shortness of breath or 







F. C o m
G. Soybean
H. Linseed





c. When is your shortness of breath 





C. Either during or after work
d. If it starts during work, how soon 
after the beginning of the work 
shift does this happen?
(x)
A. Right away 
OR
B. hours after
If it starts after work, how many 
hours after work does this happen?
(x)
hours after
IF IN YOUR WORK YOU ARE EXPOSED TO GRAIN DUST. PLEASE ANSWER THE NEXT WORK
QUESTIONS, IF NOT» GO TO Q 50.
FEVER AND/OR CHILLS (SHIVERING):
45a. Have you ever had fever and/or 
chills during exposure, or after 
being exposed to grain dust?
b. If yes to 45a, did you have:
(x)
1. Yes 2. Vo





E. Both fever and chills?
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46. When have you noticed the fever 
and/or chills? (Circle only one.)
IF IT STARTS AFTER WORK:
47a. About how many hours after work 
did this (these) happen?
b . About how many hours did this 
(these) last?
c. How many times in your work life 
as a grain handler have you had 
fever and/or chills after work?
d. When have you experienced this 
fever and/or chills?
e. If on the first day back to work, 
how long had you been off work?
A. During work.
B. After work.




A. On first day back to work.
B. Any other day at work.
C. On either the first day back 




48. During exposure to grain dust have 
you ever had:
a. Eyes burning, watering or itching?
b. Stuffy nose?
c. Throat sore or burning?
 IF YES TO Q 48a, b OR c, ANSWER d:___
d. In your opinion, which grain dusts are most 
likely to bring on these symptoms or make them 
worse? (May circle more than one.)
(x)
1. Yes 2. No
1. Yes 2. No
1. Yes 2. No
(x)
A. Durum wheat G . Soybean
B . Spring Wheat H. Linseed
C. Rye I. Sunflower seed
D. Oats J. Beets
E. Barley K. Malt
F* C o m L. Other
(Specify)
49a. During or immediately after exposure to grain
dust, have you ever had itching on your skin? 1. Yes 2. No (x)
Go to Q 50
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IF YES TO 49a, ANSWER b AHD c:
b. How many tines in a year is this
likely to happen?   times (x)
c. In your opinion, which grain dusts are most
likely to bring on the skin itching? (Hay (x)
circle more than one.)
A. Durum wheat G. Soybean
B. Spring wheat H. Linseed
C. Rye I. Sunflower seed
D. Oats J. Beets
E. Barley K. Halt
F. C o m  L. Other _______________________________
(Specify)
TOBACCO SMOKING
50. Have you ever smoked cigarettes?
(If you have smoked less than 20 packs 
of cigarettes in your lifetime, check No.)
51a. Do you now smoke cigarettes?
(Answer "yes" if you currently smoke or if 
you stopped smoking within the last month.)
IF YOU SMOKE REGULARLY NOW:
b. Do you inhale the cigarette smoke?
c. How old were you When you began to 
smoke cigarettes?
d. How many cigarettes do you usually 
smoke each day at the present time? 
(Please give best estimate: one pack
contains 20 cigarettes.)
e. What is the usual number of cigarettes 
you have smoked per day since you began 
to smoke? (Please give best estimate: 
one pack contains 20 cigarettes.)
f. If there have been periods when you 
abstained from smoking, please enter 
total years of abstinence from smoking. 
(If less than one year, do not fill in.)
1. Yes 2. No
Go to Q53a
1. Yes 2. No
Go to Q 52a











IF YOU HAVE COMPLETED THIS SECTION, GO TO Q 53a.
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52a. Did you used to smoke cigarettes? 1. Yes 2. No (x)
_IF YOU DO HOT SMOKE CIGARETTES REGULARLY NOW, BUT USED TO_ 
SMOKE THEM: (If you have not smoked at least 20
packs of cigarettes in your lifetime, check here: /____/
b. how old were you when you began 
to smoke cigarettes?
c. How old were you when you stopped 
smoking cigarettes regularly?
d. What was the usual number of cigarettes 
you smoked per day? (Please give best 
estimate: one pack contains 20 
cigarettes.)
e. If there have been periods when you 
abstained from smoking, please enter 
total number of years of abstinence 
from smoking. (If less than one 






53a. Do you now smoke pipes or cigars?
b. Do you usually inhale when you smoke 
either pipes or cigars?
PESTICIDES:
54. Have you ever been exposed to 
pesticides?
55. During or immediately after exposure 
to pesticides, have you ever had any 
health problems or symptoms?
1. Yes 2. No
Go to Q 54
1. Yes 2. No (x)
1. Yes 2. No
Go to Q 63a
1. Yes 2. No (x)










IF YES TO Q 55, ANSWER THE NEXT QUESTIONS,
Where did this (these) exposures 
happen?



















How many days did these 
problems last?
How many times have you 
had these problems?
Have you ever been ill following 
the exposure to pesticides that 
you couldn't do your regular job?
Have you ever had to go or be taken 
to a doctor or hospital because of 
these problems?


























1. Yes 2. No










THE NEXT SET OF QUESTIONS IS ABOUT ILLNESSES YOU HAVE HAD OR HAVE CURRENTLY. 
WHEN RECORDING AGE, WRITE IN THE YOUNGEST AGE AT WHICH THE ILLNESS OCCURRED.
63a. During the past 3 years, how much trouble 
have you had with illnesses such as chest 





E. A great deal
Cx)
b. During the past 3 years, how often were 
you unable to do your usual activities 





D. More than 5 times
64. Has a doctor ever told you that you had any 
of the following: AGE
a. Bronchitis (or bronchial trouble) 1. Yes 2. No
b . Emphysema 1. Yes 2. No
c. Pleurisy 1. Yes 2. No
d. Tuberculosis of the lung 1. Yes 2. No
e. Cancer of the lung 1. Yes 2. No
f. Chest surgery (including heart surgery) 1. Yes 2. No
g. Chest injury 1. Yes 2. No
h. Sinus trouble 1. Yes 2. No
i. Farmer's Lung Disease 1. Yes 2. No
65a. Has a doctor ever said you had:
Pneumonia or broncho-pneumonia? 1. Yes 2. No
Go to Q 66a
IF YES TO 0 65a. ANSWER b AND c:
b. How many times have you had pneumonia? Times (x)
c . Your age (or ages) when this (these
happened? Years (x)
66a. Has a doctor ever said you had 1. Yes 2. No
bronchial asthma?
Go to Q 67
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 IF YES TO 66a, ANSWER b, c AND d:_____________________________________ _____
b . How old were you when your asthma started? ____ Age (x)
started
c. Do you still have asthma? 1. Yes 2. No (x)
d. If no, how old were you when your ____ Age (x)
asthma stopped? stopped
67. Has a doctor ever told you that you 
had any of the following?
a. Heart trouble
b. High blood pressure
c. Allergic reaction in your nose, 
such as hay fever
d. Kidney trouble
e. Liver trouble or jaundice
f. Diabetes
68. Have you ever had a serious skin 
rash in infancy (eczema)?
69. Have you ever suffered from skin 
rashes?
70a. If yes, have you ever suffered from 
skin rashes lasting longer than 2 
weeks?
 IF YES TO Q 70a, ANSWER b:






71a. Have you ever suffered with painful 
or swollen joints?
1. Yes 2. Ho
1. Yes 2. Ho
1. Yes 2. Ho
1. Yes 2. Ho
1. Yes 2. No
1. Yes 2. Ho
1. Yes 2. Ho
1. Yes 2. No
Go to
1. Yes 2. Vo
Go to Q 71a
(x)






Go to Q 72
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_IF YES TO Q 71a, AHSUER b AND c:.










1. Yes 2. No
(x)
(x)
72. Do you have frequent "chills” with 
fever, sweating and perhaps shaking?
73. Do you have swelling of both ankles?
74. Has any member of your immediate family 







f. Cancer of the lung
g. Fanner's Lung Disease
h. Other lung disease
(Specify)
75a. Have you ever had a chest x-ray 
in the past?
 IF YES TO Q 75a, ANSWER b and c:.
1. Yes 2. No
1. Yes 2. No
1. Yes 2. No
1. Yes 2. No
1. Yes 2. No
1. Yes 2. No
1. Yes 2. No
1. Yes 2. No







c. Have you ever been told you had an 
abnormal chest x-ray?
(City)
1. Yes 2. No 
1. Yes 2. No
RELATIVE
1. Yes 2. No
in 19
in 19




Are you taking any drugs or
medications? (Prescribed or not) 1. Yes 2. Bo
If yes, please list the medications
here: ______________________________
ID f ___
When was the last time you were
exposed to your working environment? a. Today
b. Yesterday
c. 2 days ago
d. ______  days ago
(Date) (Signature)
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HEALTH STATUS OF GRAIN HANDLERS
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Location Date of Interview
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Physician's Verification Work Sheet 
Re: Questions 46 and 47
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Physician's Verification Work Sheet 
Re: Questions 46 and 47
The following questions are designed to verify self-administered responses to 
questions 46 and 47 listed in Appendix IV - Questionnaire.
Physician's Name:_____________________________  Date: __________________________
46a. Are the participant's signs and symptoms compatible with a diagnosis of: 
(Circle only one)
/__ __/ A: Grain fever
/____/ B: Questionable grain fever
/____/ C: Not grain fever
b. How many episodes of grain fever did the participant experience during 
his/her work life?
/ / 0-9 / / 10-19 / / 20-99 / / 100-300
c. When did the participant notice the episode (fever and/or chills)?
(Circle only one)
/___ / A: During work
/___ / B: After work
/___ / C: Either during or after work
d. When did the participant experience an episode (fever and/or chills)?
/___/ A: On first day back to work
/___/ B: Any day of the week
/___ / C: Any day of the week but predominantly (or worse) first
day back to work
e. If episode was experienced on the first day back to work, how long 
had he/she been off work (days)?
/ 7 1-7 / 1 8-30 / 7 31-180 / / 181-300
APPENDIX V Page 1 of 2
APPENDIX T
47. Associated respiratory symptoms:
/___/ A: Hone or not registered
I___ / B: Cough and/or expectoration
/___ / C: Tightness and/or wheezing
APPENDIX VI
Questionnaire Analysis
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The answers to the individual questionnaires were entered into our 
computer file. Prevalence of symptoms or "conditions" were obtained by simple 
statistical analysis to determine the proportion of workers with the symptoms,
e.g., cough in the morning or "condition,** e.g., age, lived on a farm, had 
chest illness often. The significance of the differences in prevalence of 
symptoms or "conditions" between grain workers and controls was done using 
Chi-Square analysis. The questions analyzed by Chi-Square are indicated by # 
by the question number. This analysis compares the proportion of grain 
workers with or without the symptom with the proportion of controls with or 
without the symptom. More detailed analysis is described in the text of the 
report from page ___ to page ___ and Tables ____ .
To simplify the table, key words and/or abbreviations were used to 
describe each question. For the proper interpretation and for understanding 
this table the reader should read the complete text of the question from the 
questionnaire (Appendix IV).
In addition, the following clarifications are provided:
Grain = Grain workers (see text for definition)
Control = City services workers (see text for definition)
Smoker = Current cigarette smoker = yes to Q Sla
Nonsmoker = Never smoked * no to Q 50
(See Questionnaire for details on smoking)
Ques = Question number
# = Chi-Square analysis result reported here
Description = See text of each question on questionnaire (Appendix IV)
Code s Y » yes; N * no (see Questionnaire for details)
NR = Number of workers from which proportion (%) were obtained. NR varies 
depending on question, e.g., one may want to know what proportion of 
all workers (NR=300) interviewed had wheezing at work or how many of 
those workers with wheezing on exposure (NR=183) had it during work.
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CUT = Number of positive answers to question or number of workers that 
selected a particular choice of answers to multiple choice questions.
% = Refers to percent of NR
"C+E" = Indicates positive answer to questions C and E
"18ABC+28ABC" = Indicates positive answer to questions 18A or B or C and 
28A or B or C.
+ or * by CNT/Total = Indicates P < .05 by Chi-Square analysis on
questions tested marked # or those questions with 
no symbol by CNT number indicates no significant 
difference between grain and control workers.
Q ■ chi-square don«; C
U ♦ - p<.05;9- pC.001; 0
* Blank ■ not slunlfleant D
_S ______DESCRIPTION__________ E
I
II Live/work on farm Y
QUESTIONNAIRE AMALYSI8 - TOTAL AMP ALL SMOKING HABITS_______________________________________
G R A I N  C O N T R O L S
TOTAL______ SMOKER BI-SH_______ NONSM TOTAL_______ SMOKER EX-SM_______NONSM
MR, CNT % HR,, CUT L  BL. CUT % NRj. CNT % NR^ CNT %_ NR^ CNT % NRj_ CNT % NIL. CNT
307 359 11 151 14 9 92 12 13 64 9 14 239 2 1 106 2 2 70 - - 63 -
# Cough: 
13
Flrtt thing In a.m. A 310 1099 35 153 75 49 92 19 21 65 15 23 239 37 15 106 31 29 70 1 63 5 8
Other times B 310 1739 56 153 104 68 92 42 46 65 27 42 239 57 24 106 43 41 70 10 63 7 11
x4-6/d > 4x/wk C 310 1329 43 153 75 49 92 34 37 65 23 35 239 38 16 106 28 26 70 7 63 5 8
Most days/3 months D 310 1439 46 153 85 56 92 34 37 65 24 37 239 47 20 106 35 33 70 10 63 5 8
Cou&h more than 2 yrs B 310 1759 56 153 104 68 92 45 49 65 26 40 239 58 25 106 44 42 70 10 63 7 11
I Cough: Yean
0-2 187 29 16 64 18 28
3-5 187 55 29 64 19 30
6-10 187 50 27 64 13 20
11-20 187 29 16 64 9 14
21-51 187 24 13 64 5 8
Phlegm:
#
First thing In a.m. A 310 1169 37 53 71 46 92 26 8 65 19 29 239 36 15 106 28 26 70 3 4 63 5 8
Other times B 310 1379 44 53 77 50 92 36 9 65 24 37 239 30 13 106 22 21 70 S 1 63 3 5
x4-6/d > 4x/wk C 310 1289 41 53 72 47 92 33 6 65 23 35 239 30 13 106 23 22 70 5 7 63 2 3
Most days/3 months D 310 1409 45 53 84 55 92 33 6 65 23 35 239 39 16 106 30 28 70 6 9 63 3 5
Cough more than 2 yrs B 310 1519 49 53 88 57 92 40 3 65 23 35 239 43 18 106 32 30 70 5 7 63 6 10




u o  —----------------------------------------------------------------------------------------------- ----------------------------
B D TOTAL______ SHOKER EX-SH______ WOMSH TOTAL_______ SMOKER EX-SH_______NONSH____
S DESCRIPTION__________ E gL. CRT % HSx CRT %_ K L  CRT 5 CRT % NRj. CRT %_ NR,. CNT % NEt CKT % NRj. jCNT
Phlegm: Years
0-2 159 24 15 50 15 30
3-5 159 39 25 50 13 26
6-10 159 36 23 50 15 30
11-20 159 39 25 50 5 10
21-50 159 21 13 50 2 4




Workdays A 192 140* 73 114 7B 68 48 40 83 30 22 73 67 12 18 51 10 20 9 1 11 7 1 14
Weekends B 192 1 1 114 1 1 48 0 0 30 0 0 67 2 •2 51 2 4 9 0 0 7 0 0
No Difference C 192 51* 27 114 35 31 48 8 17 30 8 27 67 53 79 51 39 77 9 8 89 7 6 86
#
16
Cough and/or phlegm 
on vacation:
Better A 207 170* 82 116 95 81 54 47 87 35 28 80 78 22 2B 56 15 27 12 3 25 10 4 40
Same B 207 37* 18 118 23 20 54 7 13 35 7 20 78 56 72 56 41 73 12 9 75 10 6 60
Worse C 207 0 0 118 0 0 54 0 0 35 0 0 78 0 0 56 0 0 12 0 0 10 0 0
I Cough and/or phlegm made 
18 worse by exposure to:
Grain Dust A 310 200* 65 153 114 75 92 52 57 65 34 52 239 1 .5 106 0 0 70 0 0 63 1 2
Other Dust B 310 67* 22 153 38 25 92 13 14 65 16 25 239 25 10 106 IB 17 70 4 6 63 3 5
Q C 0 I A I I C O N T R O L S
Ü 0 -----------------------------------------------------------------------------------------------
E D TOTAL_______SMOKER EI-SM______ HOHSH TOTAL________SMOKER BX-SH_______NOMSH
_S DESCRIPTION__________  f CNT %  gR^ _CNT NFj. CNT % RRj. CNT % NRj. CNT X. N ^  CNT 5 NRj. _CNI %  NR^ CNT
18 CONTINUED
Gases or Furnas C 310 58 19 153 33 22 92 14 15 65 11 17 239 31 13 106 20 19 70 7 10 63 4 6
House dust D 3X0 14 5 153 7 5 92 3 3 65 4 6 239 6 3 106 4 4 70 1 1 63 I 2
B a m  dust B 310 239 7 153 10 7 92 7 8 65 6 9 239 1 .5 106 1 1 70 0 0 63 0 0
Weather F 3X0 34 11 153 13 8 92 9 10 65 12 18 239 31 13 106 20 19 70 5 7 63 6 1
Other G 310 19 6 153 11 7 92 3 3 65 5 8 239 14 6 106 12 11 70 1 1 63 1 2
§ 18 ABC + 28 ABC 310 1459 46 153 89 58 92 35 38 65 21 32 239 20 8 106 12 11 70 5 7 63 3 4
19 Which grain dusts bring 
on cough and/or phlegm:
Durum Wheat A 200 172
Spring wheat B 200 77
Rye C 200 84
Oats D 200 65
Barley B 200 150
C o m F 200 13
Soybean G 200 17
Linseed H 200 3
Sunflower X 200 5
Beets J 200 1
Malt K 200 0





a iR A 3: h C 0 H T R 0 L S
D TOTAL SMOKBR BX-SM HOHSN TOTAL SMOKBR BX--SM HOHSN
DESCRIPTION E HR. CUT X HR. CUT X NRr CHT X HR. CHT X HR. CHT 1 HR. CHT X HR. CHT X HR. CHT X
Cough and/or phlegm
freqtjence:
Once a day A 199 153 77 113 83 74 52 42 81 34 28 82 1 1 100 0 0 0 0 0 0 1 1 10
Pew times week B 199 35 18 113 22 20 52 9 17 34 4 12 1 0 0 0 0 0 0 0 0 1 0 0
Few times month C 199 5 3 113 5 4 52 0 0 34 0 0 1 0 0 0 0 0 0 0 0 1 0 0
Pew times year D 199 4 2 113 3 3 52 1 2 34 0 0 1 0 0 0 0 0 0 0 0 1 0 0
Few times ever B 199 2 1 113 0 0 52 0 0 34 2 6 1 0 0 0 0 0 0 0 0 1 0 0
Only once F 199 0 - 113 0 0 52 0 0 34 0 0 1 0 0 0 0 0 0 0 0 1 0 0
Wheezing and/or chest 
Tightness: Y 310 200* 65 153 110 72 92 53 58 65 37 57 239 101 42 106 53 50 70 29 41 63 19 30
§ Wheeze only
21 With colds Y 200 33* 17 110 19 17 63 7 13 37 7 19 101 46 46 53 22 42 29 13 45 19 11 58
B
# Symptoms : 
22
Only Wheezing A 200 22+ 11 110 11 10 53 7 13 37 4 11 100 20 20 53 11 21 28 2 7 19 7 37
Only chest tightness B 200 37 19 110 15 14 53 12 23 37 10 27 100 19 19 53 12 23 28 4 14 19 3 16
Mainly wheezing C 200 13+ 7 110 10 9 53 2 4 37 1 3 100 14 14 53 8 15 28 4 14 19 2 11
Mainly chest tightness D 200 38 19 110 16 15 53 12 23 37 10 27 100 17 17 53 9 17 28 7 25 19 1 5




Q C O U X I  C O N T R O L S
u 0 ---------------------------------------------------------------------------------------------------------
I D TOTAL______ SHOES* K1-8H______ MOMSH TOTAL________SMOKER CT-SM_______MOWSM
- I  DESCRTPTJOW__________ 8 EBi. J0H & H U  _££E EEt. S S L % U± S S L lt J&j. SS L ^  U*. SS L S m . S S L Z  SSL  * _
23- Total Yaara of wheezlnt 
24
0-5 200 85 43 110 44 40 53 18 34 37 23 62 100 47 47 53 31 59 28 10 36 19 6 32
6-10 200 45 23 110 33 30 53 6 11 37 6 16 100 12 12 53 5 9 28 3 11 19 4 21
11-15 200 34 17 110 16 15 53 12 23 37 6 16 100 11 11 53 7 13 28 3 11 19 1 5
16-20 200 11 6 110 7 6 53 3 6 37 1 3 100 10 10 53 4 8 28 2 7 19 4 21
21-25 200 9 5 110 4 4 53 4 8 37 1 3 100 5 5 53 2 4 28 2 7 19 1 5
26-30 200 7 4 110 2 2 53 5 9 37 0 0 100 10 10 53 3 6 28 6 21 19 1 5
31-70 200 9 5 110 4 4 53 5 9 37 0 0 100 5 5 53 1 2 28 2 7 19 2 11
23 Aga Whaeslng first 
occurred:
0-15 199 10+ 5 110 5 5 52 5 10 3 0 0 98 17 17 52 4 8 27 19 19 8 42
16-25 199 69 35 110 35 32 52 17 33 3 17 46 98 26 27 52 16 31 27 22 19 4 21
26-35 199 53 27 110 37 34 52 11 21 3 5 14 98 25 26 52 14 27 27 33 19 2 11
36-45 199 40 20 110 23 21 52 8 15 3 9 24 98 18 18 52 13 25 27 15 19 1 5
46-55 199 23 12 110 9 8 52 10 19 3 4 11 98 11 11 52 5 10 27 7 19 4 ?l






G R A I N C O N 1 T R 0 L S •
K D TOTAL SMOKER EX-SM N0NSM TOTAL SMOKER EX--SM NONSM
S DESCRIPTION E NR. CNT 1 NR. CNT % NR. CNT % NR. CNT % NR. CNT X NR. CNT X NR. CNT % ÜJL CNT
24 Age wheeze first occur:
15-25 200 23 12 110 13 12 53 3 6 37 7 19 100 10 10 53 6 11 28 1 4 19 3 16
26-35 200 52 26 110 30 27 53 12 23 37 10 27 100 35 35 53 18 34 28 9 32 19 8 42
36-45 200 35 18 110 25 23 53 15 9 37 5 14 100 26 26 53 16 30 28 9 32 19 1 5
46-55 200 60 30 110 34 31 53 16 30 37 10 27 IOC 18 18 59 9 17 28 3 11 19 6 32
56-70 200 30 15 110 8 7 53 17 32 37 5 14 100 11 11 53 4 8 28 6 21 19 1 5
#
25 Wheezing at work Y 310 165+ 53 153 91 59 92 45 49 65 29 45 239 50 21 106 26 25 70 14 20 63 10 6
OF Y21A Y 200 165+ 83 110 91 83 53 45 85 37 29 78 100 50 50 53 26 49 28 14 50 19 10 53
# Wheezing frequence: 
26
Once a day A 165 469 28 91 28 31 45 14 31 29 4 14 50 6 12 26 4 15 14 2 14 10 0 0
Few times/week B 165 34+ 21 91 14 15 45 15 33 29 5 17 50 13 26 26 10 39 14 2 14 10 1 10
Few times/month C 165 509 30 91 27 30 45 9 20 29 14 48 50 11 22 26 5 19 14 2 14 10 4 40
Few times/year D 165 26 16 91 16 18 45 7 16 29 3 10 50 13 26 26 5 19 14 5 36 10 3 30
Few times/year E 165 9 6 91 6 7 45 0 0 29 3 10 50 6 12 26 1 4 14 3 21 10 2 20
Only once F 165 0 0 91 0 0 45 0 0 29 0 0 50 1 2 26 \ 4 14 0 0 10 0 0
#
27 Wheezing worse:
First day at work A 165 259 15 91 14 15 45 8 18 29 3 10 50 2 4 26 2 8 14 0 0 10 0 0
Any day at work B 165 999 60 91 54 59 45 28 62 29 17 59 50 10 20 26 5 19 14 4 29 10 1 10
Weekends C 165 0 0 91 0 0 45 0 0 29 0 0 50 0 0 26 0 0 14 0 0 10 0 0
Makes no difference D 165 419 25 91 23 25 45 9 20 29 9 31 50 38 76 26 19 73 14 10 71 10 9 90





R D TOTAL______ SMOKER EX-SM_______HONSM______TOTAL________SMOKER______EX-SM______ NOHSH
S DESCRIPTION
m
E U l _ÇNI 5 NR. CNT 3L SE¿. CNT % BEi. _£NX % NR, CNT %_ MEj. CNT % HEi. CNT % NR. CNT %
28 Wheezing made worse:
Crain Dust A 310 183* 59 153 104 68 92 46 50 65 46 50 239 5 2 106 2 2 70 0 0 63 3 5
Other Dust B 310 48 15 153 25 16 92 13 14 65 10 15 239 24 10 106 11 10 70 9 13 63 4 6
Gases or fumes C 310 53+ 17 153 27 18 92 16 17 65 10 15 239 20 8 106 9 8 70 7 10 63 4 6
House dust D 310 9 3 153 5 3 92 2 2 65 2 3 239 12 5 106 2 2 70 7 10 63 3 5
Barn dusts E 310 14 5 153 4 3 92 5 5 65 5 8 239 5 2 106 2 2 70 2 3 63 1 2
Moldy/musty b a m F 310 22+ 7 153 8 5 92 7 8 65 7 11 239 6 3 106 3 3 70 2 3 63 1 2
Contact with animals G 310 4 1 153 1 1 92 2 2 65 1 2 239 5 2 106 2 2 70 2 3 63 1 2
Plants H 310 7 2 153 3 2 92 2 2 65 2 3 239 12 5 106 3 3 70 4 6 63 5 8
Weather 1 310 34 11 153 14 9 92 13 14 65 7 11 239 37 15 106 17 16 70 13 19 63 7 11
Other J 310 11 4 153 4 3 92 3 3 65 4 6 239 14 6 106 8 8 70 6 9 63 0 0
NA 310 124 40 153 49 32 92 44 48 65 31 48 239 179 75 106 78 74 70 48 69 63 53 8
29 Grain dusts bring on 
wheezing:
Durum wheat A 183 168 92
Spring wheat B 183 76 42
Rye C 183 82 45
Oats D 183 55 30
Barley E 183 129 75
C o m F 183 10 5








G R A I N C O N T R O L S
c D TOTAL SMOKER EX-SM NONSM TOTAL SMOKER EX-SM NONSM
S DESCRIPTION C NR. -ÇNI * NR. CNT %_ NRj, _£MX % NR. CNT % NRj. ÇNI X NR. ÇNÎ X NR. CNT X NR^ CNT
29 Continued
Linseed H 183 2
Sunflower I 183 4
Beets J 183 2
Halt K 183 0
Other L 183 3
30 Wheezing most likely
to start:
Before work A 183 3 2 104 2 2 46 1 2 33 0 0
During work B 183 129 71 104 70 67 46 35 76 33 24 73
After work C 183 21 12 104 12 12 46 4 9 33 5 15
Either during/after D 183 30 16 104 20 19 46 6 13 33 4 12
31 Wheezing during work
Right away A 156 30 19 88 16 18 41 6 15 27 8 30
Hours After B 156 126 81 88 72 82 41 35 85 27 19 70
3IB# Hour Wheeza start
during work:
1 127 18 14 73 9 12 35 5 14 19 4 21
2 127 53 42 73 30 41 35 16 46 19 7 37





Q C O K A I M  C O N T R O L S
u 0 ----------------------------------------------------------------------------------------------
R D TOTAL______ SWOCTR KI-SH_______HONSH TOTAL________SMOKER EX-SH_______NONSM
______DESCRIPTION__________ E NRj. CNT % gBi CNT NR*, CNT % NR^ CUT % NRj. CNT NR^ CNT X NRj. CNT X NR*. CNT %
31B CONTINUED:
4 127 20 16 73 13 18 33 3 9 19 4 21
5 127 8 6 73 4 6 35 4 11 19 0 0
6 127 10 8 73 7 10 35 1 3 19 2 11
7 127 0 0 73 0 0 35 0 0 19 0 0
8 127 0 0 73 0 0 35 0 0 19 0 0
31B Whaaza 0 hours bafora
start:
0-2 127 71 56 73 39 53 35 21 60 19 11 58
3-4 127 38 30 73 23 32 35 9 26 19 6 32
5-6 127 18 14 73 11 15 35 5 14 19 2 11
7-8 127 0 0 73 0 0 35 0 0 19 0 0
8-20 127 0 0 73 0 0 0 0 19 0 0
32 Whatza aftar work-# hrs
1 35 12 34 21 8 38 6 2 33 8 2 25
2 35 7 20 21 3 14 6 2 33 8 2 25
3 35 2 6 21 0 0 6 0 0 8 2 25
4 35 4 11 21 4 19 6 0 0 8 0 0
5 35 1 3 21 1 5 6 0 0 8 0 0
6 35 5 14 21 2 10 t 2 33 8 1 13
7 35 0 0 21 0 0 6 0 0 8 0 0
Page 
228
q  c 0 H  I I  C O N T R O L S
u o    — ------------------------------
B D TOTAL_______SHOOT Kl-SH______ NONSM TOTAL________SMOKER EX-SM_______NONSH
S ______DESCRIPTION__________ E NRj. CNT X NRj. CNT %_ NRj. CNT X Ngj. CNT % NRj, CNT %_ NRj. CNT % NR*. CNT % NRV CWT X
32 CONTINUED:
8 35 1 3 21 0 0 6 0  0 8 1  13
9 35 1 3 21 1 5 6 0  0 8 0  0
10 35 1 3 21 1 5 6 0  0 8 0  0
>10 35 1 3 21 1 5 6 0 0 8 0 0
33A Wheezlng-wake up Y 20 61 30 111 34 31 52 16 31 38 11 29 101 24 24 53 12 23 29 8 28 19 4 ?l
 (See Below)__________ _______________________________________________________________________________________________________
33B Wheezing wake up-
how often:
every night A 60 6 10 33 4 12 16 2 13 11 0 0 24 3 13 12 1 8 8 0 0 4 2 50
few times/month B 60 21 35 33 11 33 16 5 31 11 5 45 24 8 33 12 4 33 8 4 50 4 0 0
few times/year C 60 23 38 33 11 33 16 6 38 11 6 55 24 8 33 12 5 42 8 2 25 4 I 25
few times/ever D 60 8 13 33 7 21 16 1 6 11 0 0 24 5 21 12 2 17 8 2 25 4 1 25
only once E 60 2 3 33 0 0 16 2 13 11 0 0 24 0 0 12 0 0 8 0 0 4 0 0
never r 60 0 0 33 0 0 16 0 0 11 0 0 24 0 0 12 0 0 8 0 0 4 0 0
34A Wheeze worse time/year Y 195 64 33 110 36 33 49 12 25 36 16 44 106 10 38 57 20 35 29 15 52 20 5 25
34B Wheeze-months worse
January 01 62 20 32 35 11 31 12 4 33 15 5 33 40 8 20 20 18 90 15 8 53 5 2 40
February 02 62 1 2 35 0 0 12 0 0 15 1 7 40 1 3 20 1 5 15 0 0 5 0 0
March 03 62 3 5 35 3 9 12 0 0 15 0 0 40 2 5 20 0 0 15 2 13 5 0 0
April 04 62 10 16 35 6 17 12 2 17 15 2 13 40 2 5 20 0 0 15 2 13 5 0 0





Q C G R A I N  C O N T R O L S
U 0     —
E D TOTAL______ SMOKER EX-SM______ MONSM TOTAL________SMOKER______EX-SM_______NONSM
_S DESCRIPTION__________ g CNT % KEi. CNT %_ ®Ll CNT % gR* CNT % NJL. CNT ¡»L CNT % NRi. JMt % MJLl CNT %
34B CONTINUED
May 05 62 7 11 35 4 11 12 1 8 15 2 13 40 4 10 20 1 5 15 1 7 5 2 40
Juna 06 62 7 11 35 5 14 12 1 8 15 1 7 40 0 0 20 0 0 15 0 0 5 0 0
July 07 62 2 3 35 1 3 12 1 8 15 0 0 40 0 0 20 0 0 15 0 0 5 0 0
August 08 62 5 8 35 1 3 12 2 17 15 1 13 40 0 0 20 0 0 15 0 0 5 0 0
Saptember 09 62 5 8 35 3 9 12 1 8 15 1 7 40 1 3 20 0 0 15 1 7 5 0 0
October 10 62 1 2 35 0 0 12 0 0 15 1 7 40 2 5 20 0 0 15 1 7 5 0 0
November 11 62 1 2 35 1 3 12 0 0 15 0 0 40 0 0 20 0 0 15 0 0 5 1 20
Dacember 12 62 0 0 35 0 0 12 0 0 15 0 0 40 0 0 20 0 0 15 0 0 5 0 0
35 Wheezing on vacation:
Better A 196 1729 88 109 98 90 51 46 90 36 28 78 101 20 20 53 13 25 29 4 14 19 3 16
Same B 196 249 12 109 11 10 51 5 10 36 8 22 101 79 78 53 38 72 29 25 86 19 16 84
Uorae C 196 0 0 109 0 0 51 0 0 36 0 0 101 2 2 53 2 4 29 0 0 19 0 0
36 Wheeze 2 or more I 196 769 39 109 48 44 52 20 39 35 8 23 101 17 17 53 7 13 29 7 24 19 3 16




U 0  — ---------------------------------------------------------------
E D TOTAL______ SMOKER EX-SM______ NOHSM TOTAL_______ SMOKER______EX-SM_______NONSH
s DESCRIPTION E NR. CNT * NR. CNT t NR. <?NT * NR. CNT X NR. la i- NR. CNT % CNT % NR. CNT X
37
Shortness of breath: 
SOB ever 37 310 1759 56 153 97 63 92 49 53 65 29 45 239 90 38 106 48 45 70 30 43 63 12 19
38 SOB slight hill 38 310 118+ 38 153 65 42 92 29 32 65 24 37 239 64 27 106 32 30 70 25 36 63 7 U
39 SOB other people/ 
level ground 39 310 23+ 7 153 11 7 92 9 10 65 3 5 239 8 3 106 3 3 70 4 6 63 1 2
40 SOB own pace/level 40 310 4 1 153 3 2 92 1 1 65 0 0 239 3 1 106 1 1 70 2 3 63 0 0
41 SOB dressing/walking 
about house 41 310 7 2 153 4 3 92 2 2 65 1 2 239 5 2 106 3 3 70 2 3 63 0 0
42 How many years had SOB 
0-5 145 77 53 84 43 51 32 12 38 29 22 76 71 42 59 36 19 53 26 14 54 9 9 IOC
6-10 145 43 30 84 30 36 32 10 31 29 3 10 71 14 20 36 9 25 26 5 19 9 0 0
11-15 145 14 10 84 5 6 32 5 16 29 4 14 71 7 10 36 6 17 26 1 4 9 0 0
16-20 145 8 6 84 5 6 32 3 9 29 0 0 71 7 10 36 2 6 26 5 19 9 0 0
71-25 145 1 1 84 1 1 32 0 0 29 0 0 71 1 1 36 0 0 26 1 4 9 0 0
26-50 145 2 1 84 0 0 32 2 6 29 0 0 71 0 0 36 0 0 26 0 0 9 0 0
43 SOB at work Y 310 113 37+ 153 61 40 92 35 38 65 17 26 239 26 11 106 13 12 70 8 11 63 5 8
44A SOB to grain dust Y 310 151 49 153 84 55 92 47 51 65 20 31
"d0)oon
hou>
q C G R A I N  C O N T R O L S
u 0 - --------------------------— —  ------------------- —-----------------------------------------------------------------------------------------------------------
E D TOTAL______ SMOKER El-SH_______NONSM TOTAL________SMOKER EX-SM_______NONSM
_S _ DESCRIPTION__________ g gfL. CNT * CNT %_ NRj. CNT % Mx. CNT * NRj. CNT NRj. CNT % NR̂ . CNT % NR*. _CNT
44B SOB grain dust worse:
Du turn A 151 136 90 84 77 92 47 42 89 20 17 85
Spring B 1S1 71 47 84 45 54 47 18 38 20 8 40
Rye C 151 69 46 84 34 40 47 25 53 20 10 50
Oats D 151 47 31 84 27 32 47 12 26 20 8 40
Barley B 151 99 66 84 50 60 47 33 70 20 16 80
C o m r 151 5 3 84 4 5 47 1 2 20 0
Soybean G 151 16 11 84 11 13 47 4 9 20 1 5
Linseed H 151 1 1 84 0 47 1 2 20 0
Sunflower I 151 4 3 84 1 1 47 1 2 20 2 10
Beets J 151 0 0 84 0 47 0 20 0
Malt K 151 0 84 0 47 0 20 0
Other L 4 3 84 47 2 4 20 1 5
44C SOB when worsa:
During work A 149 122 82
Aftar work B 149 9 6
Either C 149 18 12
44D SOB start during work:
Right away A 143 48 34




Q C G R A I N  C O N T R O L S
u o --- .—  ------------------------------------------------------------------- — — — ---- - ------
E D TOTAL______ SMOKER EI-SM______ MOMSH TOTAL________SMOKER EX-SH_______NONSM
S DESCRIPTION__________ E NR^ _CNT % NRj. CMT *_ NR*. CNT % M j. CNT % M j. _QN1 L  HEi CNT % NR^ CNT X NRj. _CNT Xj,
44D SOB start during work/ 
hours:
0-1 95 19 20
2-3 95 47 50
4-5 95 24 25
6-7 95 5 5
8-9 95 0 0
44B SOB start after work/ 
hours :
0-1 20 7 35 10 3 30 4 3 75 6 1 17 2 1 50 1 0 0 0 0 0 1 0
2-3 20 11 55 10 6 60 4 1 25 6 4 67 2 1 50 1 1 100 0 0 0 1 0
4-5 20 1 5 10 1 10 4 0 0 6 0 0 2 0 0 1 0 0 0 0 0 1 0
6-7 20 1 5 10 0 0 4 0 0 6 1 17 2 0 0 1 0 0 0 0 0 1 0
8-9 20 0 0 10 0 0 4 0 0 6 0 0 2 0 0 1 0 0 0 0 0 1 0
10-11 20 0 0 10 0 0 4 0 0 6 0 0 2 0 0 1 0 0 0 0 0 1 0
12-13 20 0 0 10 0 0 4 0 0 6 0 0 2 0 0 1 0 0 0 0 0 1 0
14-20 20 0 0 10 0 0 4 0 0 6 0 0 2 0 0 1 0 0 0 0 0 1 0
45A Fever and/or chills Y 310 121 39 153 60 39 92 40 44 65 21 32
45B Fever and/or chills, T 123 1 1
Which:
Only favar A 123 28 23
Only chills B 123 9 7
Mostly fever C 123 15 12
Mostly chills D 123 3 2





Q C 0 1 1 1 1  C O N T R O L S
U 0 .----------------------------------------------------------------------------------------------
E 0 TOTAL______ SMOKER El-SM______ HONSM TOTAL________SMOKER EX-SM_______MOMSM
_S ______DESCRIPTION__________ f CUT % NRj. CWT £_ gR^ CNT % WR^ CUT X MRj. CNT %_ JlRj. CNT % NRj. CNT % NR^ CWT X
46A Grain Fever?
Grain Fever A 310 99 32 153 47 31 92 31 33 65 21 32
Questionable G.F. B 310 16 5
Not G.F. C 310 6 2
46B Grain Fever Episodes
0-9 96 40 42
10-19 96 22 23
20-99 96 18 19
100-300 96 16 17
46C Grain Fever Noticed:
During work A 115 37 32
After work B 115 40 35
Either C 115 38 33
46D Grain Fever day:
First day A 115 15 13
Any day B 115 95 83
Any day/worse 1st C 115 5 4
46E # Days off work before
grain fever:
1-7 16 2 13
8-30 16 5 31
31-180 16 3 19







G R A I N C 0 N T R 0 L S
D TOTAL SMOKER EX-SM NONSM TOTAL SMOKER EX-SM NONSM
8 DESCRIPTION E NR, CNT X NR. CNT L  MJLl CNT X NR. CNT X NR. CNT X NR. CNT X NR. CNT X NR. CNT X














48 Sx during exposure to
grain dust:
Eyes burning A 310 242 78
Stuffy nose B 310 246 79
Throat sore C 310 161 52
48D Worse exposure dusts:
Durum A 281 234 83
Spring B 281 116 41
Rye C 281 136 48
Oats D 281 113 40
Barley E 281 213 76
C o m r 281 15 5
Soybean G 281 22 8
Linseed H 281 2 1
Sunflower I 281 10 4
Beets J 281 5 2
Malt K 281 0













O I A I I C O N T R O L S
TOTAL SMOKER EX-SM NONSM TOTAL SMOKER EX-SM NONSM
m. J£SX % HEj. J5ÏÏL L  WL. J2HI % K L. jzh x s NR. CUT %_ MRT CNT % Nfij. CNT % NRa. CNT %
54 Ever been exposed
to pesticides Y 310 294 95+ 239 49 21
55 Pesticide health







G R A I N C O N T R O L S
K D TOTAL SMOKER KZ-SM NONSH TOTAL SMOKER EX-SM NONSM
S DESCRIPTION t H!L. j m S W ,  .Çiin.l!L CHI % NR. CNT X NR. CNT X_ NRj. CNT % NRj. CNT % NR, _CNT X
56 Where did exposures
happen?
At work A 310 168 54 239 6 3
Home B 310 2 1 239 0 0
Farm C 310 0 0 239 0 0
Other D 310 0 0 239 1 .5
57 What kind of health 
problems did you have?
Weakness A 310 65 21 239 4 2
Fainted B 310 7 2 239 0 0
Dizziness C 310 88 28 239 4 2
Headache D 310 116 37 239 6 3
Convulsions B 310 0 0 239 0 0
Trouble breathing F 310 51 16 239 2 1
Nausea G 310 65 21 239 3 1
Stomach pain H 310 12 4 239 1 5
Diarrhea I 310 12 4 239 0 0
Cramps J 310 5 2 239 0 0
Blurred vision K 310 14 5 239 0 0
Jaundice L 310 0 0 239 0 0





G R A I N
M d m TOTAL
C O N T R O L S
EX-SH NONSM
S DESCRIPTION E NR, s n 5 NR. CNT X NR. CNT % NR. CNT X NR,. CNT % NR, CNT X NR, CNT X NR, CNT %
59 How many times pesti­
cide problems?
0-5 164 84 51 7 5 71
6-10 164 34 21 7 1 14
11-20 164 21 4 7 1 14
21-50 164 14 9 7 0 0
51-100 164 8 5 7 0 0
100-300 164 3 2 7 0 0
60 Couldn't do regular
Job Y 167 28 17 7 2 29
61 Taken to Doctor? Y 167 19 11 7 0 0
62 What pesticides?
Do not know A 310 50 16 239 1 .5
Carbon tet B 310 103 33 239 1 .5
Halathion C 310 52 17 239 1 .5
Methyl Bromide D 310 51 16 239 1 .5
Phostoxin S 310 84 27 239 1 .5





Q c 0 H A I H C O N T R O L S
U 0 --------------- -- ---------------------------------------------------------------------------
E D TOTAL______ SMOKER EX-SH______ NONSH TOTAL________SMOKER EX-SH_______NONSH
_fi DESCRIPTION__________ E IOLl CNT % ffiL CNT %_ fflL. CNT % NRj. CNT % NRj. CNT NR^ CNT % NR^ CNT X NIL _CNT 1_
63A How much trouble with 
dust Illnesses?
None A 310 66 21 153 35 23 92 22 24 65 9 14 239 57 24 106 21 20 70 14 20 63 22 35
Little B 310 137 44 153 70 46 92 40 43 65 27 42 239 119 50 106 47 44 70 40 57 63 32 51
Hoderate C 310 84 27 153 38 25 92 25 27 65 21 32 239 55 23 106 33 31 70 13 19 63 9 14
Much D 310 21 7 153 10 7 92 5 5 65 6 9 239 7 3 106 5 5 70 2 3 63 0 0
Great Deal E 310 2 1 153 1 1 92 0 0 65 1 2 219 1 .5 106 0 0 70 1 1 63 0 0
63B Unable to do usual 
activltlest
None A 309 145 47 152 77 51 92 39 42 65 29 45 239 132 55 106 53 50 70 37 53 63 42 67
One Time B 309 41 13 152 15 10 92 17 19 65 9 14 239 29 12 106 11 10 70 10 14 63 8 13
2-5 Times C 309 103 33 152 52 34 92 29 32 65 22 34 239 67 28 106 35 33 70 20 29 63 12 19
> 5 D 309 20 7 152 8 5 92 7 7 65 5 8 239 11 5 106 7 7 70 3 4 63 I 2
64 Pulmonary problems
Bronchitis A 310 53 17 153 27 18 92 16 17 65 10 15 239 36 15 106 18 17 70 11 16 63 7 11
Emphysema B 310 6 2 153 4 3 92 2 2 65 0 0 239 2 1 106 0 0 70 2 3 63 0 0
Pleuresy C 310 28 10 153 17 11 92 8 9 65 3 5 239 18 8 106 10 9 70 5 7 63 3 5
Tuberculosis D 310 6 2 153 4 3 92 1 1 65 1 2 239 1 5 106 0 0 70 1 1 63 0 0
Cancer E 310 0 0 153 0 0 92 0 0 65 0 0 239 0 0 106 0 0 70 0 0 63 0 0
Chest Surgery T 310 4 1 153 2 1 92 1 1 65 1 2 239 3 1 106 0 0 70 3 4 63 0 0
Chest Injury G 310 11 4 153 6 4 92 2 2 65 3 5 239 10 4 106 6 6 70 2 3 63 2 3








D TOTAL SMOKER EX-SH NONSM TOTAL SMOKER EX--SM NONSM
_S DESCRIPTION e E&i. SSL X N&J. s n  L  WL. SSL % NR, CNT X NR. CNT %_ NR. CNT X NR. CNT % NR. CNT %_
64 CONTINUED:
Sinus trouble H 310 72 23 153 34 22 92 26 28 65 12 18 239 74 31 106 37 35 70 27 39 63 10 16
Farmor's lung I 310 0 0 153 0 0 92 0 0 65 0 0 239 0 0 106 0 0 70 0 0 63 0 0
65A Pneumonia Y 310 68 22 153 29 19 92 24 26 65 24 37 239 60 25 106 32 30 70 18 26 63 10 16
65B Pneumonia I tlmei
0-2 67 59 88 29 24 83 24 22 92 14 13 93 60 46 77 32 22 69 18 16 89 10 8 80
3-5 67 7 10 29 4 14 24 .2 8 14 1 7 60 13 22 32 10 31 18 2 11 10 1 10
6-10 67 1 2 29 1 3 24 0 0 14 0 0 60 1 2 32 0 0 18 0 0 10 1 10
10-30 67 0 0 29 0 0 24 0 0 14 0 0 60 0 0 32 0 0 18 0 0 10 0 0
66A Bronchial asthma Y 310 12 4 153 3 2 92 8 9 65 1 2 239 4 2 106 0 0 70 2 3 63 2 3
66B Age asthma started:
0-10 11 7 64 3 2 67 7 4 57 1 1 100 4 2 50 0 0 0 2 0 0 2 2 10C
11-20 11 2 18 3 0 0 7 2 29 1 0 0 4 0 0 0 0 0 2 0 0 2 0 0
21-30 11 0 0 3 0 0 7 0 0 1 0 0 4 2 50 0 0 0 2 2 100 2 0 0
31-40 11 0 0 3 0 0 7 0 0 1 0 0 4 0 0 0 0 0 2 0 0 2 0 0
41-50 11 2 18 3 1 33 7 1 14 1 0 0 4 0 0 0 0 0 2 0 0 2 0 0
51-60 11 0 0 3 0 0 7 0 0 1 0 0 4 0 0 0 0 0 2 0 0 2 0 0
61-70 11 0 0 3 0 0 7 0 0 1 0 0 4 0 0 0 0 0 2 0 0 2 0 0




U 0 — -----------------— --------------------------------------------------------------------— --------------------------
R D TOTAL______ SMOKER EI-SM______ NONSM TOTAL________SMOKER EX-SH_______NONSM
_ S  D E SC R IPTIO N ______________  E NR^. CNT % NRj. CUT X _  HJL. CNT %  NR^. CNT % NRj. CNT % _  NRj. CNT % NRj. CNT %  N R t  CNT
66D Age asthma stop:
0-10 7 5 71 2 2 100 4 2 50 1 1 100 2 0 0 0 0 0 0 0 0 2 0 0
11-20 7 1 14 2 0 0 4 1 25 1 0 0 2 2 100 0 0 0 0 0 0 2 2 100
21-50 7 0 0 2 0 0 4 0 0 1 0 0 2 0 0 0 0 0 0 0 0 2 0 0
51-70 7 1 14 2 0 0 4 1 25 1 0 0 2 0 0 0 0 0 0 0 0 2 0 0
67 Other health problems: 
Heart A 310 20 6 239 15 6
Blood pressure B 310 49 16 239 33 14
A!lergic C 310 20 6 239 29 12
Kidney D 310 24 8 239 15 6
Liver E 310 17 5 239 13 5
Diabetes r 310 6 2 239 11 5
68 Eczema Y 307 13 4 239 10 4
69 Skin rashes Y 310 92 30 239 72 30
70 Skin rashes > 2 wks Y 92 56 61 72 42 58
70B Skin rash area:
Face A 310 12 4 239 11 5
Bars B 310 6 2 239 6 3
Scalp C 310 7 2 239 10 4









D TOTAL SMOKER EX-SM NONSM TOTAL SMOKER EX-SM NONSM
S DESCRIPTION S NR, CNT % NR. CNT BL. ONT * NR. CNT % NR. CNT %_ NR. CNT % NR. CNT X NRj. CNT %
70B CONTINUED:
Arms E 310 27 9 239 20 8
Chest F 310 11 4 239 13 5
Beck 0 310 16 5 239 13 S
Abdomen H 310 IS 5 239 13 5
Legs I 310 32 10 239 22 9
Feet J 310 16 5 239 11 5
71A Swollen Joints Y 310 96 31 239 72 30
7 IB Which Joints: 
Fingers A 310 37 12 239 30 13
Wrists B 310 25 8 239 11 5
Elbows C 310 34 11 239 18 8
Shoulder D 310 40 13 239 25 10
Spine E 310 12 4 239 8 3
Hips F 310 18 6 239 8 3
Knee G 310 44 14 239 35 15
Ankle H 310 24 8 239 11 5
71C Joints swollen Y 95 48 51 70 37 53
72 Frequent chills Y 309 35 11 239 11 5







G R A I N C 0 N T R 0 L S
B
w
D TOTAL SMOKER EX-SM NONSM TOTAL SMOKER EX-SM NONSM
_S DESCRIPTION E NR. CNT X NR. CNT HL. CNT X NR. CNT X NR. CNT %_ NR. CNT X NR. CNT X NR. CNT X
74 Family diseases:
Chronic bronchitis A 310 15 5 239 9 4
Emphysema B 310 16 5 239 18 8
Asthma C 310 33 11 239 25 10
Hay fever D 310 20 6 239 27 11
Cystic fibrosis E 310 1 .5 239 0 0
Cancer, lung F 310 12 4 239 17 8
Farmer's lung G 310 0 0 239 1 .5
Other lung H 310 11 4 239 8 3
77D Last exposed to work: 
0-3 Days 14 5 36 5 3 60 5 2 40 4 0 0 1 0 0 0 0 0 1 0 0 0 0 0
4-14 Days 14 6 43 5 2 40 5 2 40 4 2 50 1 1 0 0 0 0 1 1 100 0 0 0
28-30 Days 14 3 21 5 0 0 5 1 20 4 2 50 1 0 0 0 0 0 1 0 0 0 0 0
31-180 14 0 0 5 0 0 5 0 0 4 0 0 1 0 0 0 0 0 1 0 0 0 0 0
77 Last exposed to work A 310 218 70
B 310 65 21
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INSTRUCTIONS TO PHYSICIANS ON GRAIN HANDLERS* FIELD STUDY
The physician's assessment of the health status of the patient will include 
an interview during which the salient points of the questionnaire will be
reviewed with particular emphasis on the manifestations related to the
cardiovascular system to the symptoms related to exposure to grain dust and those 
symptoms related to exposure to detectable pesticides.
The questionnaire will be reviewed for completeness by one of two trained 
assistants before you see the worker» but you are required to recheck it to 
assure it is complete. Pay particular attention to the following:
- Check to see that the Consent Form is signed and obtain necessary
permission for release of information from other physicians if necessary.
- Check work history, particularly whether the patient has worked in mining, 
farming, in a foundry, steel mill, with asbestos, in a shipyard, chemical
plant, quarry, grain flour industry, welder, etc.
- Question 13e— be sure that the number of years that he/she has had the
cough is entered.
- Is his/her cough better when non-exposed?
- Question 20— be sure that he/she understands that "only once** means only 
once in a lifetime and not once a day.
- Be sure that he/she enters the number of years on Questions 23 and 24.
I . Interview:
The interview should emphasize the clarification of complaints in the
questionnaire, but answers to questions should not be modified. Questions 46 and 
47 should be verified using Work Sheet provided (Appendix V).
The information you obtain from the patient should be written on the margins 
or at the end of the questionnaire. This anecdotal information will serve to 
clarify interpretation of historical, physical or laboratory findings in
individuals if necessary. Analysis of symptoms felt in relation to his/her work 
should be done to rule out cardiac disease as the cause of the usual symptoms of 
cough, dyspnea, wheezing and chest tightness. Be sure to answer the following 
question:
In your opinion is his dyspnea from heart disease?
Yes _______  No  Not sure ______
- Obtain more details on pesticide exposure symptoms.
- On Question 64d— if he/she has had tuberculosis, did he/she receive 
treatment; did he/she receive a vaccine for tuberculosis?
- On Question 64e— specify age and treatment for the cancer.
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- On Question 64f— specify reason for surgery, what was done, when.
- On Question 64i— how «ras Farmer's Lung disease diagnosed?
- if yes to Question 65a— pneumonia diagnosed by a doctor. Obtain detailed 
history for each pneumonia.
Pneumonia #1: Did he/she have a chest x-ray, to be hospitalized,
cough, phlegm, chest pain, wheezing, dyspnea, sore 
throat, earache, stuffy nose, muscle aches.
Pneumonia #2: Did he/she have a chest x-ray, to be hospitalized,
cough, phlegm, chest pain, wheezing, dyspnea, sore 
throat, earache, stuffy nose, muscle aches.
Pneumonia #3: Did he/she have a chest x-ray, to be hospitalized,
cough, phlegm, chest pain, ««heezing, dyspnea, sore 
throat, earache, stuffy nose, muscle aches.
- Question 67a— type of heart disease or heart trouble. Therapy, if any.
- Questions 67d and 67e— what trouble, «ihen, doctor's diagnosis, what doctor, 
what tests «rere done, «ras he/she hospitalized, ««here.
II. The physical examination «rill include:
a. The measurement of height, «reight, blood pressure and heart rate, which 
will be performed by a technician.
b. The description of the chest configuration as outlined in the physical
examination form.
c. Auscultation of the chest to be done in the upper and lower lung fields
posteriorly while the patient breathes deeply through open mouth
followed by auscultation during forced expiratory maneuvers. These 
«rill be reported as: 1) none, 2) obvious and common, or 3) on forced
expiration only. If present, Whether bilateral and diffuse or
unilateral and localized. Sales will be reported as: 1) none, 2)
bilateral, or 3) unilateral. The anterior or ventral chest will be
auscultated over the four usual precordial areas, that is, the apex of
the heart, the left sternal border, the aortic valve area and the
pneumonic valve area. The findings will be reported as: 1) normal
heart, 2) murmur and specify, 3) abnormal rhythm, or 4) other and 
specify. Also, specify «rhether in your opinion the murmur is 
"functional** rather than "organic** in origin. With the patient then 
lying do«m, palpate the liver at the mid-clavicular line. If palpable, 
the span should be measured by percussion and palpation. If the span 
is greater than 14 cm., hepatomegaly is present. Any other obvious 
physical findings should be reported under "Other Findings."
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PHYSICAL EXAMINATION RECORD 
STUDY ID # BLOOD SAMPLE URINE SAMPLE
/  /  / /  / / / I t  t
WEIGHT / / / t t t Pounds BLOOD PRESSURE / / /  / /  /-/ / /  / /
(SYSTOLIC) (DIASTOLIC)
HEIGHT / / / / / / Inches PULSE RATE / / / / / / Beats/Min
RECORDER ____
CHEST CONFIGURATION (Check ONLY one)
that pertain)
/ / 1. Normal
If NOT Normal:
/ / 2. Kyphoscoliosis
/ / 3. Scoliosis
/ / 4. Pectus Excavatum
/ / 5. Other
AUSCULTATION - POSTERIOR CHEST 
Rhonchi and/or Wheezes (Check ONLY one)
/ / 1. None
Or obvious on deep but not forced 
expiration: (Check ONLY one)
/ / 2. Bilateral-diffuse
/ / 3. Unilateral-localized
Or if ONLY on forced expiration:
/ / 4. Bilateral-diffuse
/ / 5. Unilateral-localized
IV AUSCULTATION - ANTERIOR CHEST (Check ALL 
/ 1. Normal
If NOT Normal:
/ / 2. Murmur (Specify: ______________
/ / 3. Abnormal rhythm
/ / 4. Other (Specify: _______________
V. ABDOMEN (Palpate liver at mid-clavicular line 
If palpable, measure span. If greater than 
14 cm. = hepatomegaly.)
Liver
/ /l. Not palpable
If palpable, span = ________ .  cm
/ 1 2 .  Hepatomegaly absent
/ / 3. Hepatomegaly present
/
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PHYSICAL EXAMINATION RECORD (continued)
Rales (Check ONLY one)
/ / 1. Hone
/ / 2. Bilateral
/ / 3. Unilateral
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FORWARD
This manual contains a description and detailed procedures of the 
standardized techniques used in conducting the on-site pulmonary function 
tests specific to this study. Recorded data will be appropriately filed in 
data storage folders and subsequently measured and transcribed to computer 
input forms in Madison, Wisconsin, following completion of the field testing. 
Frequent on-site measurements and computations on a programmable calculator 
(TI SR-52 with PC 100 Printer) will be performed to spot check technical 
procedures and measurements.
Since prior to 1977 our epidemiological studies were supported by an HHLI 
Specialized Center for Lung Research Grant. Our laboratory had standardized 
pulmonary function testing in accordance with the recommendations of the HHLI, 
Division of Lung Disease, report of workshops on epidemiology of respiratory 
disease, October, 1972, and November, 1973. In addition, for measurements of 
FEV} and FVC we have considered the preliminary information available from 
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I. SPIROMETRY Page
STANDARDS FOR PULMONARY FUNCTION TESTING 
I. Spirometry, FEV^ FVC, and MMF for Studies I & III
1. Instrumentation - Studies I & III (Rolling bar 840 will be used for 
Studies II, IV, & V.)
Standard equipment utilized for these procedures includes:
A. 13.51 chain-linked, water-sealed, spirometer (W. E. Collins), 
with 3 speeds (32, 160, 1920 mm/min).
B. Mouthpieces - large rubber
C. Two-way bypass valve
D. Two 34** lengths of 1 1/2” ID corrugated wire wound flexible 
plastic tubing with 1 3/8** ID rubber coupling ends
E. Recording pens and ink
F. Noseclamp
Uith nose occluded, the subject is connected to the spirometer through 
the rubber mouthpiece attached to a large free breathing bypass valve and 
two lengths of corrugated tubing. Any CO^ absorbent is removed from the 
system to minimize resistance to air flow.
2. Calibration 
Weekly check for:
A. Deformities in spirometer bell
B. Leaks around water seal
C. Accuracy of kymograph drum speed
Forced Expiratory Volume (FEVt) - the volumes exhaled in 1.0 and 3.0 









f. Barometric pressure (mmHg)
o
g. Spirometer temperature ( C)
*b-e optional if recorded elsewhere
2. Seat subject in a comfortable upright posture
3. Loosen any tight clothing
4. Explain test procedure
5. Install nose clip
6. Go onto mouthpiece, breath normally to room air
7. Fill drum approximately 2/3 full
Turn subject into spirometer (kymograph speed of 160 mm/min) and followng 
a few quick breaths request a maximal inspiration — (hold at TLC for ~1 
second while switch is turned to 1920 ml/min paper speed); then request a 
maximal expiration (vigorously encourage subject to breathe out as hard 
and fast as possible).
Repeat steps 8 & 9 until at least three acceptable curves are obtained.
4. Criteria of Acceptability
Acceptability is based upon the technician's observation that the 
subject understood the instructions and performed the test with a smooth, 
continuous exhalation with apparent maximum effort and without: a)
coughing; b) Valsalva maneuver; c) premature expiratory termination (in 
normals, before completion of the breath; in obstructed individuals this 
would be assumed if expiratory time was less that 5 seconds); d) a leak; 
e) an obstructed mouthpiece (e.g.t tongue becoming positioned in front of 
mouthpiece); f) unsatisfactory start of expiration from TLC, characterized 
by excessive hesitation or false starts thus preventing accurate back 
extrapolation to time 0. (Extrapolated volume on the volume time tracing 
(spirogram) must be less than 10% of the FVC); g) excessive variability 
among the three acceptable curves i.e., exceeding + 10% of the reading or 
100 +mm.; Whichever is greater, between the two best curves.
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5. Measurements/Calculations
(a) FEV. - volume of gas exhaled over a given time interval duringW
the performance of a vital capacity maneuver. (Sea Fig- 1) FEV 
1.0 la the volume expired in the first 1.0 sac. of the FEV^. 
FEV 1.0 as well as FEV 2.0 and 3.0 are obtained from the 
spirogram by determining the time intervals on the spirometer 
chart paper. FEV and FEV^ volumes are expressed as a X  of 
total (i.e., FEV 1.0%), the values for Which may be determined 
from different acceptable curves.
FEV 1.0 (*) - FEVX (ml) x 100
FVC (ml)
The maximum FVC and the maximum FEV^ (BTPS) will be computed 
following examination of data from all the acceptable curves even 
if the two values do not come from the same curve. From these 
values the FEV (1%) will be calculated. In addition, the 
maximum FVC and FEV^ from the maximum FVC as well as the ratio 
of this FEV^/FVC X 100 «rill be recorded for purposes of the 
three year follow-up study.
Volumes expressed in absolute terms must be converted from ATPS
to BTPS. FEV  « FEV.__ X BTPS factor.BTPS ATPS
O  T i r o
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I 4 3 . B  a m
Fig. 1 Forced Expiratory spirogram
(to) FEF 25-75% - the average flow rate during the middle two quarters 
of the volume segments of the forced expiratory spirogram (i.e..
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Fig. 2 Forced Expiratory Spirogram 
**A~ represents the intersection of the FEF with the line between 
the first and second quarter of the FTC volume (25%); **B~ is the 
Intersection of the FEF with the line between the third and 
fourth quarter of the FVC volume (75%). Points "A" and "B" are 
determined by measurement or with preset quadrant calipers from 
the point of commencement (0 time) of forced exhalation. Zero 
(0) time is determined by the back extrapolation method (Fig.3). 
Extrapolated volumes that exceed 10% of FVC are suboptlmal and 
should be so noted for subsequent interpretations.
Fig. 3 Back Extrapolation Method of Establishing 0 Time Point
The slope of the line connecting "A" and "B" is the forced aid-expiratory flow 
(FEF 25-75%) which is determined by extending line "AB" until it crosses two 
time lines (i.e., 1 sec. apart). The distance between where the line crosses 
the two time lines represents the FEF 25-75% volume. Therefore:
FEF 25-75%___ - l/sec x 60 * 1/minATPS ------------  -----------
FEF 25-75%____ =FEF 25-75% x BTPS factor =BTPS ATPS ----------------
The FEFg^ ***11 he calculated from the curve producing the largest sum of
FVC and FEV^. In addition, the MHF that corresponds with the largest FVC
will be recorded for purposes of the 3 year follow-up study.
Prediction Values:
Absolute values of FEV^, FVC, and MHF will be compared with the
following prediction equations of Knudson, et al.
FEV^ q <25 years old = .045 Age (yrs) + .046 Ht (cm) - 4.808
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(men) <25 years old =-.027 Age (yrs) = .052 Ht (cm) - 4.203
FVC <25 years old - .078 Age + .05 Ht - 5.508
(men) >25 years old = -.029 Age (yrs) + .065 - .065 - 5.459
MHF >25 years old = .059 Ht (cm) - 5.334
(men) >25 years old = - .031 Age + .045 Ht (cm) - 1.864
For Studies II. IV. and V :
The instrumentation is described under "Flow-volume Curve." Forced 
expiratory volume-time will be obtained using an Ohio 840 Holling Bar 
Spirometer. The FVC-time curve will be displayed on an HP 1046A X-Y-Y 
recorder and measured on the paper record as explained above.
References
Kanner, R.E. and A.H. Morris, eds., Spirometry, Ch. 1, "Clinical Pulmonary 
Function Testing," 1975.
Kory, R.C., J. Rankin, G.L. Snider, and J.F. Tomashefski. Clinical 
Spirometry (recommendations of the section on pulmonary function testing. 
Committee on Pulmonary Physiology, Am. Col. of Chest Phys.), Pis♦ of the 
Chest. (43):214-219, 1963.
Frayser, R . and J . C . Ross. Clinical Sp irometry. Laboratory Procedure 
Manual. Dept. Medicine, Indiana Univ. School of Medicine,:11-19, 1966.
Knudson, R.S., Slatin, R.C., Lebowitx, M.D., Burrows, B. The maximal 
expiratory flow volume curve, normal standards, variability and effects of 
age. Am. Rev. Resp. Piv. 113:587-600, 1976.
National Heart and Lung Institute, Report on Workshop on Standardization 
of Methods used in Epidemiologic Studies, 1973.
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Ha. CLOSING VOLUME - NITROGEN METHOD
1, Instrumentation: Standard equipment utilized for this procedure
includes:
A. Wedge Spirometer (Med. Science 570)
B. Nitralyser (Med. Science 505)
C. XYY recorder (Hewlett-Packard 7046A)
D. Two-way bypass valve
E. Tubing (corrugated) 24-30 length 1-7/8 ID
F. Mouthpiece - large rubber
G. O^ cylinder (1001 °2^' pressure regulator
H. Recording paper (Hewlett-Packard 9270-1024)
I. Recording pens
J. Nose clamp
With nose occluded, the subject is connected to the Wedge spirometer 
through a large rubber mouthpiece, corrugated tubing and bypass valve. The 
output of the spirometer is monitored by a Nitralyser connected to one axis of 
the XYjY^ recorder allowing for simultaneous recording of the flow volume 
and N^ concentration curve.
2. Calibration:
A. recorder: according to Ch. V, in Maintenance,
Performance, Checks and Adjustments of the Operating and Service
Manual for XY„Y4 Recorder 7046A.1 2
B. Nitralyser: Weekly with concentrations ranging from 0-80% dry 
N from calibrated tanks. (Monthly calibrations may prove 
adequate.)
C. Wedge Spirometer: Calibration of volume (I) + N^
concentration (%), is performed against a built-in electronic 
reference and displayed on each subject*s record of CV tracings.
3. Procedure
A. Flush the Wedge Spirometer with 100% O^ until N^ concentration 
reads 0.
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B. Install noeeclip and have subject come onto the mouthpiece with 
the two-way valve turned to room air.
C. The subject takes a deep breath and exhales to residual volume(RV).
D. At RV the subject is turned into the spirometer and slowly 
inspires a vital capacity breath of pure 0^ and, without breath 
holding, slowly expires a second time to RV.
During inhalation of 0^ the channel of the recorder is switched from .5 
V/cm to 25 mv/cm. The subject is instructed to maintain expiratory flow rate 
(monitored from the display channel) at 0.4 Ips.
E. At the end of the second expiration to RV, the subject is turned 
into room air.
F. The operator urges the subject repeatedly at both extremes of vital 
capacity; during exhalation of the measurement, however, it must 
be only after the Phase IV deflection is apparent (See Fig. 2).
G. A minimum of 3 and maximum of 6 measurements are made; the number 
of measurements determined by visual acceptance of the curves.
H. Complete 0^ washout is not necessary between measurements. This 
necessitates accurate P.N measurements. A delay in repeatingA £
the test is advised if, during the preliminary air breathing 
phase, and differ by m°re than 5X.
4. Criteria for Acceptability of Sinule Breath Closing Volume Curves
The following criteria must be met for acceptability, failure to
satisfy any one of these leads to rejection of the curve:
A. Mean expiratory flow after the first 500 ml is expired must equal
or be less than 0.5 lps (the subject is instructed to aim for 0.4 
lps).
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B. Except for the first 500 ml of expiration during closing volume 
measurement, expiratory flow transients must not exceed 0.7 lps. 
Unacceptable flow transients are defined as deviation from the 
required flow which persists during expiration of more than 300 ml.
C. Difference between inspired and expired VC must be less than 5%-
D. Differences in VC between blows must not exceed 10%.
E. There must not be a step change in the expired concentration 
with continued cardiogenic oscillations after the step. The 
causes of such step changes are obscure but are probably not
related to airway closure. If such curves are accepted the onset
of Phase IV will frequently be read as the volume at which the 
step occurs.
5. Measurements/Calculations
Ideally on all subjects 3 acceptable tracings will be obtained. The 
mean of the 3 values of each measurement is taken as the final value. 
When only 2 readable tracings are obtained, the mean of the 2 values 
is used. When only one readable tracing is obtained, the subject is 
discarded from the series. Readers must keep a careful track of the 
number of individuals with 3, 2, 1, and 0 readable curves. Figure 4 
depicts a sample closing volume tracing.
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CLOSING VOLUME AND CLOSING CAPACITY
j*————,oc*—
|>------------------------- TD TPL (JUNG C fFU C IT Y  ___________________________ J
n o tc u » . « a J c
------------------------------  V IT P L  O F R C IT V  ____  J c RV J
A E S i a ! ^  C f v - r c t r t
It—  - ™c _____ 4
Pig* * - Characteristic chans** in expired nitrosen concentration
which occur during a vital capacity maneuver following an
inhalation of 100% oxygen.
A. Closing Volume (CV)
The onset of phase IV should be determined by the best-fit line 
drawn by aya through the latter half of phase III. The point of 
final departure from this line is the onset of phase IV. In some 
sub j ects there is a sharp drop in N^ concentration af ter the 
onset of phase IV. Occasionally this can intersect the line dr a m  
throush phase III. Under these circumstances the onset of phase 
IV is taken as the first definite point of departure of the N^ 
tracing from the best-fit line. The closins volume is the volume 
from the onset at phase IV to residual volume (RV). CV is
expresses as %  of the expired vital capacity (VC).
The slope of phase III Is determined by the best-fit line, between 
7OX VC and the onset of phase IV. The slope is reported as the 
angle formed by the line of best fit with the horizontal axis.
The analysis of these curves cannot always be made in a totally objective 
manner. On some curves in particular, the onset of phase IV is difficult to 
determine and when the same reader blindly reads such curves twice, there is 
not very good agreement between the two measurements. This appears to be due 
to differences between individuals, because when a subject generates such a 
curve, it is likely that all curves that he generated will be difficult to 
analyze. On the other hand, if a subject generates 3 curve which is easy to 
analyze, in all likelihood, all curves obtained from him will be easy to 
analyze. Obviously, curve readers will have to use good judgment and they may 
decide that some curves, although conforming to the criteria of acceptability, 
are unreadable and therefore must be rejected. It is impossible at present to 
establish a set of rigid rules governing such cases.
Prediction Values;
For purposes of comparison with general population studies, CV and Phase 
III slope values will be compared with the predictions of Buist.
Buist: Closing Volume:
CV/VC % = 0.318 Age (yrs) + 1.919 ± SEE 4.61 (HEN AND WOMEN)
Phase III Slope:
A H2/L « 0.710 + 0.010 Age (yrs) + SEE 0.43 (Men)
A H2/I* * 1.036 + 0.009 Age (yrs) + SEE 0.57 (Women < 60)
A H2/L * 1.777 + 0.058 Age (yrs) ± SEE 1.30 (Women > 60)
B. Slope of phase III
REFERENCES
Suggested Standardized Procedures for Closing Volume Determinations 
(Nitrogen Method), Division of Lung Diseases, National Heart and Lung Assoc. 1973 
Buist, A.S. and B.B. Ross. Predicted values for closing volume using a 
modified single breath test. Am. Rev. Resp. Pis.. 107:744-752, 1973.
Buist, A.S. and B.B. Ross. Quantitative analysis of the alveolar plateau in 





A. An Ohio 840 So11ins Bar Spirometer
B. Hewlett-Packard X-Y Recorder HP 7046A for volume-tise curves.
C. Hewlett-Packard X-T Recorder BP 7046A for flow volume curves,
(slotting speed T axis « 76 cai/sec and sccelermtion T axis - 6350 
cm/sec).
D. Larga base flexible plastic tubing and large rubber mouthpiece.
If during the performance of a forced vital capacity maneuver 
expired airflow is plotted against expired (or lung) volume, the 
resultant relationship has a characteristic configuration as 
depicted in Fig. 5. Expired flows Increase readily to a peak 
and then decrease relatively linearly with decreasing lung 
volume. Obstructive and restrictive lung disease results in 
flow patterns different from the normal response (Fig. S), 







Fig 5 - Schematic representation of typical maximal expiratory flow volume 
curves from a normal subjact and from patients with restrictive and 
obstructive lung disease. Airway obstruction results in low expired flows 
both in absolute terms and relative to the lung volume. In contrast, 
restrictive disease results in low flow in absolute terms, but normal or 
slightly high flow when corrected for lung volume.
With nose occluded, the subject is connected to the spirometer through a 
large rubber mouthpiece and corrugated tubing. Simultaneous monitoring of 
expired air flow against: a) lung volume and b) time are traced on the XY
axis of individual recorders.
2. Calibration:
Initial calibration of volume is done using the 1 liter glass syringe 
previously checked against a 13 liter Collins spirometer. Flow rate is 
determined with a Fisher rotometer which has been previously calibrated 
against a Tissot spirometer with room air. Individual calibration will be 
done by the operator for each patient, using the function known on the 
Ohio 840 spirometer.
3. Procedure:
A. Set function knob at operate, BTPS at the appropriate setting, and
piston variation knob at 5 liters.
B. With nose occluded, have subject go onto mouthpiece and breathe
normally on room air.
C. Following 2-3 normal breaths, instruct subject to inspire maximally
(TLC).
D. Lower pens of both recorders to contact surface and request a maximal
effort of fast exhalation followed by a maximal inspiration.
E. Disconnect subject; remove nose clip; let subject relax and flush
spirometer.
F. Repeat steps A-E until three acceptable curves have been obtained.
4. Criteria for Acceptability of Measured Data:
A. Inspired and expired volumes must check within 5% and duplicate 
curves within 5%.
B. Three acceptable curves are required.
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5. Measurements/Calculations:
Measurement of maximum instantaneous flow over portions of the expiratory
volume are determined by the linear distances (mm) of the excursion
height, converted to volume (1) with the appropriate conversion factor
determined from the electrical calibration. FEV^, FVC, and MMF will be
measured as explained in "Spirometry** section. These values will be used
in Studies II, IV, and V. Measurements of maximum instantaneous flows
will be made on three acceptable vital capacity loops that do not vary by
more than ± 5% (that is, not less than 5% of the largest EVC). Flow will
be measured after a volume equal to 5OX and to 75X of the EVC has been
expired. V f|gvr50 and V^^75 corresponding to: I) the largest EVC and,
II) the mean of the two or three acceptable curves (II) will be
measured and recorded. V by method (I) trill be used in studies I, IV,max
V, and by method (II) in studies II and III.
Prediction Values:
Values for VC and MEF flow measured with the rolling bar spirometer in
these studies will be compared with the following predicted values of
Knudson et al.
VmaxSO Table:
<25 years old 0.081 Age + 0.051 Ht - 4.975
>25 years old 0.015 A*e + 0.069 Ht - 5.400
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Vmax75 Table:
<25 y«ars + .032 Ht - 2.455
>25 years old -0.012 Age + .044 Ht - 4.143
NOTE: Applies to Studies II, IV, and V - when Ohio 840 output was taped for
later display and analysis. Regarding Instrumentation: add 1) 4
channel Hewlett-Packard tape recorder (multiple speed); 2) Tetronix 
storage oscilloscope.
3.D Add "Turn on tape recorder, identify patient and time of day,'* 
clear storage oscilloscope screen.
E.E Add -Turn off tape recorder.”
Additions to Above:
Study I . FEV^ and FVC measured from Ohio 840 records will be compared 
to those obtained on Collins spirometer and used for future prospective 
studies.
Study II. Add to above instrumentation procedures and measurement: 
During Study II flow and volume signals from Ohio 840 spirometer were also 
recorded on a Superscope 301A cassette recorder. The taped data were analyzed 
using a micro-processor based on an Intel 8080 system with 4 analog to digital 
channels and 4 digital to analog channels and a 2K circulating memory for each 
channel. The data was displayed on a two channel oscilloscope with cursor 
signal on the two channel. The operator used the cursor, under control of a 
basic program, to mark the curves to be analyzed.
Studies IV and V . Add to above technique description: Flow and volume
from Ohio 840 spirometer was displayed on a Tetronix 411 storage oscilloscope 
and recorded on magnetic tape using a Hewlett-Packard 3960 instrumentation 
recorder at speed of 3.75 ms/sec. From the taped data played back at 15/16 
ms/sec we obtained a paper record using a Hewlett-Packard X_Y_Y 7046A recorder 
to measure FVC, v 75» an(* ^ V5q He_°2'
Page 267
III. SINGLE BREATH CARBON MONOXIDE DIFFUSING CAPACITY
1. Instrumentation
Equipment required:
A. 30 liter test bag for gas containing approximately 0.2% CO, 10%
He, 21% 02 , 69% M2
B. A bag-in-box respirometer (V. E. Collins)
C. Infared CO analyzer, or gas chromatograph
D. Linear He analyzer (15% full-scale)
E. Solenoid valve for direction of expiratory volume into a 5 liter
sample bag or to room air
F. Mouthpiece - large rubber
G. 9 liter Collins Spirometer
H. Gas Cylinder and regulator
I. Recording supplies - paper, pens, ink
J . Stopwatch
K. 5 liter rubber sample bags 
The measurement of diffusion capacity is the rate at which CO disappears 
from the lung into the blood. The nature of this disappearance beginning at 
the initiation of inspiration is exponential with time, the slope of the curve 
being dependent upon the diffusivity of the CO molecule along the whole 
diffusion pathway from alveolus to hemoglobin molecule.
The bag-in-box system (See Fig. 6) is completely flushed and the bag 
filled wittr the test gas mixture from which a sample is analyzed. The subject 
is seated, nose occluded, and kymograph drum speed set at 160 ron/min. The 
subject inspires to TLC, holds breath, goes onto the mouthpiece, exhales to 
RV, then inspires to TLC as rapidly as possible and holds his breath for 8-12 
secs. He then exhales rapidly to RV during which the first 800-1000 ml. of VC 
is expired to room air and the remainder directed to a collection bag for 
subsequent analysis. From the changes in gas concentration between inspired
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A -  30 litre bag of test gas 
B -  rigid box 
C -  stopcock for filling A 
V -  solenoid valve permitting expira­
tion into the spirometer (s) and 
inspiration from the bag (A) via 
flexable rubber tubing
E -  large bore -  3 -  way valve 
P -  mouthpiece 
F -  5 litre sample bag 
S -  8 litre recording soirometer 
D -  kymograph drum revolving 
2*66 mm/sec.
T -  thermometer
and expired gas and the associated spirometric tracing, the D.CO and He 
dilution lung volumes may be calculated.
2. Calibration
(1) Testing for leaks:
Check Spirometer weekly for:
A. Deformities in spirometer bell
B. Leaks around water seal
C. Accuracy of kymograph drum speed
D. Leaks in the 30 liter test gas bag
E. Solenoid valve operation
(2) CO and He meters
Calculation of single breath D requires calculations of 
ratios of two measurements of He concentration and two 
measurements of CO concentration. Since only the ratios of He 
and CO are important, precise measurements of either He and CO 
concentration is not essential.
CO meter calibration and He meter linearity procedure:
A. Scales should read zero with no power, adjust mechanical 
zeros as required
B. Following several hours of warm-up, flush system with room 
air and zero both instruments
C. Introduce sample of test gas and adjust CO analyzer gain
controls to approximately 90% of full scale deflection. 
Thus, a slightly higher C0% (e.g., 0.3) will not read
greater than 100% full scale. Once set, do not alter gain 
control further.
Whenever a non-linear CO analyzer is used, it is necessary to 
carefully construct a calibration curve from which meter
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deflections can be used to determine the actual concentration of 
CO in the test sample. Once the calibration curve is 
established, the gain adjustment of the reference gas should 
always be set at the identical reference value.
Alternately, if CO samples are analyzed using gas 
chromatography, then the recorded peak heights of reference gas 
curves are used to establish a proportionality for determination 
of test sample concentrations.
With 10% He, the He meter should read 8-12% with appropriate
adjustment of the gain control as required.
K. Repeat zero and test gas checks; readjust zero and upper
scale deflections as necessary. Verify further with test gases
of different concentrations.
3. Procedure
(1) Check depletion level of CO^ absorber system
(2) Flush system rebreathing circuit leaving test gas bag completely 
evacuated
(3) Fill the reservoir balloon (bag-in-box) with test gas
(4) Seat subject and occlude nose
(5) Set kymograph speed at 160 mm/min
(6) Have subject inspire to TLC, go onto mouthpiece, exhale to RV, 
then inspire to TLC as rapidly as possible. Hold breath at end 
of inspiration for approximately 10 secs then expire forceably 
to RV
(7) After discarding the initial “dead space** (800-1000 ml portion) 
of the expired volume into room air, activate the solenoid 
switch and collect the remainder of the expirate.
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(8) Have subject come off mouthpiece and breath room air
(9) Clamp, remove alveolar sample balloon and analyze contents.
(10) Flush rebreathing circuit thoroughly
(11) Repeat steps (1-10) following a minimum of 5 minutes before
retesting to insure complete washout of CO and He from lungs.
Repeat test 3 times.
4. Criteria for acceptability for single breath D .L»
Acceptable tracings will have a sharp and rapid inspiration,
level hold for 8-10 seconds from the beginning of inspiration to
start of sample collection. Rapid expiration of the appropriate
volume will show about the same vital capacity and expired gas values
from trial to trial.
5. Measurements/Calculations:
D CO is determined according to the following equation:
D CO (ml/min/mmHg) = VA x 60 In F C09
I* X  A
(PB - 47)t FAC0t
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where:
F .co« = FtC0 * F.He A O  I ~A—
FjHe
where: VISTPD = volume inspired corrected to STPD
VD = assumed dead space volume of .150 1 
FjHe = X inspired He 
FeHe = X expired He (F He)A
60 = # secs in one min.
Bp-47 = Barometric pressure - water vapor pressure at body 
otemperature of 37 C.
t = time in secs of breath held 
FjCO - X inspired CO 
F^CO^ = X expired CO
in = natural log raised to power of expression in 
parenthesis 
Prediction Values:
For purposes of comparison with general population studies, DL values 
will be compared with the following predictions of Ogilvie, et al. 
and Rankin, et al.
Ogilvie:
DL (ml/min/tnra) = 18.85 surface area - 6.8 
Rankin:
DL (ml/min/mm) = 2.0474 Ht (in.) - .166 Age (Yrs) - 102.62
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HELIUM-OXYGEN FLOW VOLUME TEST
Ins trumentat ion
A. An Ohio 840 Spirometer
B. Esterling Angus X-Y Recorder
C. Ohio Demand Valve
D. Large bore 3-way stopcock
E . Appropriate tubing and connectors
Following completion of three flow volume loops, the subject inspires 
four slow VC breaths of an 80% Helium/20% mixture. At RV of the 
fourth breath the subject is turned into a spirometer containing the same 
80% Helium/20% 0^ gas mixture, and instructed to inspire to TLC followed 
by a maximal forced expiration. Following this maneuver, the subject 
returns to the He/O^ circuit for several more breaths and the process is 
repeated.
Calibration
Initial calibration of volume is done using the 1 liter glass syringe 
previously checked against a 13 liter Collins spirometer. Flow rate is 
determined with a Fisher rotometer which has been previously calibrated 
against a Tissot spirometer both with air and with the 80% Helium/20% 
mixture. Individual calibration will be done by the operator for each 
patient, using the function knob on the Ohio 840 spirometer.
Procedure
A. Set function knob at operate, BTPS knob at the appropriate 
temperature setting, and piston variation knob at S liters.
B. Have subject perform three flow volume loops (see Section 11a).
C. Flush spirometer and fill with 80% He, 20% C^ mixture.
D. Tura 3-wiy stopclock eonnectlns subject to the Inspirad s u
mixture vlt the dwiand nlvi.
X. Xeguost_four slow dttp breaths to TLC explrins to XV each tine.
r. At the and of «xpiration, turn subject into splrooeter with tito 3 - w y
stopcock.
G. Itqutst a tudaal inspira tloa (to TLC) f o lloved by • m t í m I foreed
«xplration (to 17).
H. Satura subject to Ha/O^ mixtura for aeveral mora breaths («hila
apiro— tar is rinsed) and rapaat atapa C-C.
4. Crltrl» of Aee«nt«bllltr
A ■Inlum of thraa aeeeptable tracins* ara required. Tha CVC and ZVC 
must corraspond within 10% of aaeh other. The agraenent between tha 
heliun-oxygen curva and tha curva on roo* air a u t  be withln SI of each 
other in regard to EVC. Zf the curves are aot identical, they are lined 
up at XV. Zf aftar a sroup of test runa tbere la ltek of agreeoent in 
XTC, the loop that has tha largeat XVC, aeetlng the requireaent of XVC/IVC 
beins within 101 of each other» la ehosea as the teat run.
5. Heasuracents/Calculatlons;
Tha hellua/oxygen curve is superiaposed on the rooa air curve at XV (Fig.
7). The point of lntersection of flow is found. The voluae at which the
flow ratas were identical (laovolune point) on both Re + 0^ air» that
is. independent of density, is identified and expressed as a percent of




Hutcheon, M., P. Griffin, H. Levison, and N. Zamel. Volume of isoflow. A
new test in detection of mild abnormalities of lung mechanics. Amer. Rev. 
Resp. Pis.. 110:458, 1974.
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I. Hemoglobin Determination.
Quantitative estimation of hemoglobin is used as a routine test to detect 
the existence and/or degree of anemia. In the hemoglobin determinations red 
blood cells are lysed to release the hemoglobin fraction. The hemoglobin is 




Sodium bicarbonate 1.0 gn
Potassium ferricyanide 0.2 gm
Potassium cyanide 0.005 gm
Dissolve in distilled water and dilute to one liter. Store in a dark
bottle. The solution is stable for one month if protected from light and
evaporation.
Caution: Cyanide salts and solutions are poisonous and should be
handled carefully. Pipette solutions with a bulb. Mix solutions by 
swirling. If any of the compounds are spilled, clean their, up quickly and 
carefully. When disposing of solutions in the sink, wash down generously with 
cold water.
Method for Cyanmethemoglobin Determination.
A. Calibration of Fisher hemoglobin detector.
Use the commercial standard (Hycel). The undiluted standard in this 
method represents 20 gm. percent of hemoglobin.
1. Prepare cuvettes as follows:
Volume of Volume of
Standard Drabkin*s Reagent Gm X Hgb
6 ml 2 ml 15
2 ml 6 ml 5
2. Set the Hi control knob on the machine at 15 with the 15 gm X
standard and the Lo knob at 5 with the 5 gm X standard.
3. Read the Fisher artificial standards (in sealed tubes) against
the hemoglobin standards.
4. Plainly label the Fisher standard tubes with the values thus 
obtained,
B. Hemoglobin Method.
1 . Dispense 5 ml of Drabkin’s Reagent in Fisher cuvettes.
2. Add 0.02 ml of Whole blood to the solution (1-25- ml dilution).
3. Set the Hi and Lo knobs at the values indicated on the sealed 
artificial standards provided with the instrument.
4. Insert the cuvette with test sample and determine the hemoglobin 
in gm I on the direct reading scale.
II. Oxyhemoglobin Determination.
In this measurement hemoglobin is converted to oxyhemoglobin in the
presence of dilute or weak alkali solutions. This determination measures 
active hemoglobin; hence, the values may be lower than cyanmethemoglobin in 
the same samples.
Reagents.
A. 0.04% Ammonium Hydroxide
Dilute 0.4 ml of concentrated NH4OH to 1.0 liter using 
distilled water
Method for oxyhemoglobin determination.
1. Calibrate the detector as described previously.
2. Dispense 5.0 ml of 0.04% VH4OH into cuvettes.
3. Add 0.02 ml of capillary or venous blood.
4. Mix well.
5. Read immediately or within 24 hours.
III. Hematocrit Determinations.
Method
1. Select capillary tubes approximately 7 cm long with a 1.0 mm 
internal diameter.
2. Using capillary action fill the tube with blood to within 1.0 cm 
of the end.
3. Plug one end with plasticine.
4. Centrifuge the tubes in a microhematocrit centrifuge at 5000 xg 
for 10 minutes.
5. Measure the length of the blood column, including the plasma.
Normal values.
Hemoglobin
Adult females 12-16 gm X 
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Rationale:
The presentation of a foreign substance to the immune system elicits the 
production .of antibodies Which are directed toward the foreign substance. The 
nature of the antibody produced, in part, determines the immunopathology of 
the disease. The production of antibodies of the IgE class would result in 
immediate allergic reactions upon subsequent challenge. Conversely, the 
production of antibodies of the IgG class and, occasionally of the IgM class, 
would favor the elicitation of a hypersensitivity pneumonitis reaction in the 
lung on re-exposure to the foreign substance.
It is possible to ascertain the presence of antigen specific IgE
antibodies which evoke allergic reactions by intradermal skin testing
(Appendix XI) and the presence of IgM or IgG antibodies directed toward
specific antigens by precipitation (Appendix XII). The determination of both 
the allergic antibody and the precipitating antibodies depend heavily on the 
preparation of extracts from organic material. Extracts from organic material 
can be prepared from pulverized washed grains, grain dusts, pulverized grain 
insects and from culture filtrates of bacteria and fungi known to cause
hypersensitivity pneumonitis.
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Settled dust I-Rafter 
Dust
Settled dust II- 
Holding tank 





B 0.85% Saline 
C Whatman Ho. 1 filter paper 
D Dialysis tubing
E Coca's non-allergenic buffer (Hollister-Steir Laboratory)
F Glycerine
G Sterile dropper vials - 2.0 ml (Greer Laboratories)
H 0.1 M borate citrate buffer pH 8.4 (Appendix XII).
Methods:
1. Preparation of saline extracts of grain, respirable grain dust, insects 
and mites.
a. It is necessary to prepare a fine powder of intact grains and insects. 
Intact grains can be pulverized in a Ball mill, whereas insects and 
nites can be ground into a fine powder with a mortar and pestle. The 
growth conditions for insects and mites are shown in Table I.
b. The powder is suspended in 0.85% saline in a 1:10 W/V ratio and incu­
bated with constant agitation at 4*C for 24 hours.
c. The mixture is allowed to settle for 2 hours at 4*C and the supernatant
fluid removed.
d. The supernatant fluid is filtered through a Buchner filter using 


















e. The effluent is placed in dialysis tubing and dialyzed against 
running, cold tap water for 24 hours.
f. After dialysis, the extract is concentrated to 20-50 ml. in the 
dialysis tubing by perevaporation.
g. The concentrated extract is placed in a new dialysis tubing and 
dialyzed against 0.85% saline at 4*C for 24 hours.
h. The extract is lyophilized by conventional methods.
i. The protein content of each extract is determined by Micro-Kj eldahl
protein determinations (A10.1). Results are expressed as protein 
nitrogen units per mg. of lyophilized material.
j. Store lyophilized extracts in a -20*c freezer.
2. Preparation of saline extracts from culture filtrates of bacteria and
fungi.
a. The broth cultures of each organism are grown as shown in Table II.
b. The broth culture is centrifuged at 1000 xg for 30 minutes at 4*C.
c. The supernatant fluid is carefully decanted into a beaker without
disturbing the precipitate.
d. The supernatant fluid is filtered through Whatman Ho. 1 filter paper 
using a Buchner funnel.
e. The effluent is placed in dialysis tubing and dialyzed against cold, 
running tap water for 24 hours.
f. The remaining steps of the procedure are identical to those described 
for preparation of grain, respirable grain dusts and insects and 
mites.
3. Preparation of immediate skin test reagents.
a. Remove extracts of grain, grain dusts, and insects from the freezer.
b. Using sterile technique, prepare 50 ml of sterile Coca's buffer 
containing 50% glycerine v/v.
c. Using the PNU/mg determinations, weigh out 200,00 PHU of each 
lyophilized extract.
d. Add each extract to separate sterile dropper bottles. Label each 
bottle with the name of the extract and the date.
e. Using sterile technique, add 2.0 ml of the Coca's buffer with 50% 
glycerine. Hote that the fluid concentration is 100,000 PNU/ml.
f. Solubilize the extracts by gentle agitation.
g. Store the reconstituted extracts at 4*C.
4. Preparation of extracts for determination of precipitating antibodies.
a. Remove lyophilized extracts of grain, respirable grain dust, insects 
and the culture filtrates of bacteria and fungi from the freezer.
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b. Weigh out 15 mg of each of the extracts.
c . Place extract in a small 2.0 ml screw-topped vial. Label the vial 
with the name of each extract and the date.
d. Add 1.0 ml of the 0.1 ml borate citrate buffer pH 8.4 to each vial 
and replace the screw top. Note that the final concentration of 
antigen is 15 mg/ml.
e. Store the reconstituted extracts in a refrigerator.
Normal or Reference Values:
The reference values, in terms of protein nitrogen units (PNU) for grain, 
respirable grain dusts, insects and settled dusts are shown below.
Intact Crains Respirable Dust
PNU/ jig Protein/ PNU/ yg Protein/
MG ur of Solid mg UK of Solid
Durum Wheat 12000 760 5600 350
Spring Wheat 12600 790 5800 325
Barley 12600 790 4300 270
C o m 8200 515 3600 225
Rye 8000 500 5000 310
Oats 11300 710 5000 310
Sunflowers 12700 790 2900 180





Settled Dust I -- -- 5300 300
Settled Dust II _ ___ 4600 290
Settled Dust III 5100 32
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Limitations of the Procedure:
Most organic antigens can be extracted into saline and this method has 
proven suitable for extraction of antigenic material from culture filtrates of 
bacteria and fungi known to cause hypersensitivity pneumonitis. One must be 
aware, however, that the metabolic antigens produced by bacteria and fungi
differ quantitatively and qualitatively during growth. Therefore, careful 
consideration must be given to the dynamics of antigen production by each 
organism and the cultures must be harvested during peak antigen production. 
The quantitation of antigens can be achieved by two dimensional cross- 
imraunoelectrophoresis using a human serum with known serological reactivity to 
the metabolic antigens (A10.2). Samples of culture fluids can be assayed at 
weekly intervals and the cultures harvested when there is an increase in the
length of precipitin arcs or in the numbers of precipitin arcs. Since there
is some batch to batch variation in serological reactivity of culture 
filtrates from bacteria and fungi, it is necessary to produce enough of each 
extract to test on control populations with the same batch of antigen extract.
There is also variation in serological reactivity within strains of the 
same species of bacteria or fungi and/or the immune response to these 
organisms is strain specific. These phenomena have been observed in 
precipitin analyses using extracts from A. fumigatus, Pénicillium and the 
thermophillic actinomycetes. It is, therefore, necessary to include in the 
screening panel for precipitating antibodies several extracts of different
strains of the same species of certain bacteria and fungi.
Extracts of the thermophillic bacteria and certain fungi were not included 
in the panel used to ascertain immediate skin test reactivity. Many of these 
extracts, particularly the thermophillic bacteria, evoke toxic skin reactions 
which render them useless in determining skin reactions. Moreover, these 
agents usually evoke hypersensitivity pneumonitis which lacks a true allergic 
immunological component. Hence, even if the extracts were suitable for use in 
immediate skin tests, one would expect negative skin tests with these extracts.
The use of saline extracts of grain and respirable grain dusts for 
immediate skin tests has a major limitation. Many of the proteins of grain 
are insoluble in saline, including the entire gluten complex consisting of 
both gliadin and glutenin. Approximately 80% of the endosperm protein is 
associated with the gluten complex (A10.3). The endosperm constitutes 70% of 
the total protein in the grain. Only the albumin and globulin fraction are 
extracted with saline. Hence, the saline extracts of grain used for skin 
tests measures the presence of atopy to albumin or globulins and not the 




A10.1 Rabat, EA and Mayer, MM: Experimental Immunochemistry, C.C. Thomas Co.,
Springfield, XL, 1961, p. 476.
A10.2 Weeke, B: Crossed Immunoelectrophoresis, Scand. J. of Immunol., 1973,
2(Suppl 1):47.
AIO.3 Nerxheimer, H: The hypersensitivity to flour of bakers apprentices.
Acta. Allergol. (KbH), 1973, 28:42.
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Confused Flour Beetle 
Adults and Larvae




















with 5% Brewers Yeast
Purina Lab Chow
with 5% Brewers yeast
8 Purina Lab Chow*
3 Wheat Germ 
3 Dry Milk 
1 Brewers yeast 
1 Meat & Bone Meal
3 Brewers Yeast*
1 Wheat Germ
3 Brewers Yeast 
1 Wheat Germ
3 Brewers Yeast 
1 Wheat Germ
♦weight:weight ratio
All insects were maintained at 27—1*C and 60% relative humidity with a 
16:8 Light:Darkness photo ratio. All insects were screened from the growth 
medium and then examined microscopically for remaining media. When necessary, 
the insects were rescreened and further separated from remaining media. The 
insects were then promptly frozen and stored in a -40*C freezer.
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200 Boom temp 4
200 Room temp 5
200 Room temp 5
200 37*C 5
200 Room temp 5
200 Room temp 5
200 Room temp 5
200 Room temp 5
200 Room temp 5
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M. faeni-U.W.













































♦Isolated from sputum cultures 
♦♦American type culture collection 
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RATIONALE
It is possible to reproduce both allergic and cell mediated immune 
reactions by introducing small amounts of antigenic material into the skin. 
Based on the time course of the reaction, the skin tests can be classified as 
immediate reactions which occur within 20 minutes and delayed reactions which 
are noted after 24-48 hours. Although both skin test reactions have similar 
morphologies, the immunological mechanisms which mediate the reactions are 
different. The immediate skin test reaction is due to the interaction of 
allergens with antibodies of the IgE class which are bound to mast cells and 
basophils in the skin. The allergen antibody complex intiates the release of 
histamine, SRS-A and other mediators from the mast cells and basophils. The 
pharmacologically active agents increase vasoconstriction and increase 
vascular permeability which results in a localized area of edema called a 
wheal which is surrounded by a less defined area of redness called an 
erythema. Since allergen specific IgE is only found in allergic individuals, 
the immediate skin test is a direct measure of the allergic or atopic status 
of the test subject. Moreover, in respiratory allergies, skin tests are often 
positive when respiratory challenge fails to reproduce the disease (All.l).
The prick test is the method of choice for determining immediate skin 
test reactivity in large population studies. The method is reasonably safe 
with minimal systemic antigen absorption. Moreover, one can perform large 
numbers of tests without discomfort to the test subject. Unlike the 
intradermal tests, nonspecific reactions seldom occur with the prick test.
The delayed skin reaction is the result of the interaction between 
sensitized lymphocytes and antigen introduced into the skin. The sensitized
lymphocytes are, in effect, memory cells which remember previous exposure to 
selected bacterial, viral and fungal agents (i.e. tuberculosis, mumps, 
streptococcal infection, Candida and trichophyton infections). Upon 
introduction of these antigens into the skin, sensitized lymphocytes localize 
in the skin test area and release small molecular migration and metabolic 
activity of other cell types including the peripheral blood monocytes. 
Monocytes with increased metabolic activity are localized in the skin test 
area and initiate an acute inflammatory response. The inflammatory response 
results in localized swelling called induration surrounded by an area of 
erythema. Hence, the delayed skin test reaction to selected antigens is a 
measure of the functional status of the cell mediated immune system. It 
follows that the delayed skin reactivity reaction is useful in determining 
whether there is decreased delayed hypersensitivity if reactions are observed 
it would suggest that exposure to environmental agents caused an 
immuno-suppresive effect.
Principle;
The immediate skin tests measure the allergic sensitivity to common 
areo-allergens and possible occupation-related environmental allergens. 
Conversely, the delayed skin tests measure the status of the cell 
mediated immune system as measured by the capacity to mount an 




I . Immediate Skin Tests








1 .0% histamine in 










Adult grain & rice 
weevils - mix 
Adult confused flour, 
blank carpet and 
dermestid beetle - 
Mold, house & grain
Grain smut mite -- mix
Insect Grains Airborne Grain Dust Settled dust
Durum wheat Durum wheat Settled Dust I
Spring wheat Spring wheat Settled Dust II
Barley Barley Settled Dust III
C o m C o m
Rye Rye
Oats Oats
Sunflower seeds Sunflower seeds
Small seeds
Soybeans
Positive Control Negative Control
Diluting fluid with 50% glycerine
b. Sterile stainless steel needles
c. Alcohol impregnated pads
d. 2x2 gauze pads
e . Magic markers
f. Drug box with resuscitation equipment and adrenalin (1:1000 V/V)
♦Purchased from Greer Laboratories, Lenoir, NC
mix
a. Skin test panel for delayed skin testing 
PPD - tine te3t
SK/SD - 4U/IU in - 0.1 ml 
Mumps - 0.1 ml of stock 
Candida - 10 PHU in 0.1 ml
Trichophyton - 1:1000 dilution in '0.1 ml using A 1:10 w/v 
stock solution
b. Tuberculin syringes with 27 gauge needles
c. Alcohol impregnated pads
d. 2x2 gauze pads
e. Corticosteroid impregnated tape 
Methods:
A. Immediate skin tests
1. Subject removes shirt or blouse and lies face down in a horizontal 
position.
2. The back is cleansed with alcohol impregnated pads.
3. Using a magic marker, the numbers 1-10 are painted in two columns 
approximately 3M from and on either side of the spine. The numbers should 
begin near the shoulder and terminate near the waist. By placing extracts 
on either side of both columns, it is possible to test 40 different 
extracts.
4. The skin test reagents are placed in rack rows of 10. The initial sample 
in the first row should be the positive histamine control and the last 
sample in the test panel should be the negative control.
5. Using the column of numbers nearest the technician, a single drop of 
extract numbered 1 -1 0 is placed on the back.
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II. Delayed Skin tests
6 . Using the opposite side of the same numerical column, a drop of extracts 
11-20 are placed on the hack, beginning at the shoulder and working 
downward.
7. With a sterile needle the skin is gently scratched beneath each drop. The 
needle is directed so that the skin is slightly raised as the needle 
punctures the skin. Clean the needle with a 2x2 gauze pad between tests.
8 . Wipe the back clean of extracts 1-20 using 2x2 gauze pads.
9. Using the column of numbers farthest from the technician, place drops of 
extracts 21-30 on the back.
10. Using the opposite side of the same column of numbers, place a drop of 
extracts 31-40 on the back.
11. Repeat step 7.
12. Repeat step 8 .
13. The subject is given a laboratory timer and asked to report back to the 
technician after 20 minutes.
14. The largest axis of the wheal and erthyema is determined using a ruler 
graduated in millimeters.
B. Delayed skin tests
1. Sterile 1.0 ml tuberculin syringes are loaded with 0.15 ml of each 
antigen. Bubbles are removed from the barrel by gentle agitation. The 
plunger is then pressed until only 0 .1 ml remains in the syringe barrel 
and the needle.
2. Ask the test subject to roll up sleeves to the elbow.
3. Cleanse the forearms with alcohol impregnated pads and allow to dry.
4. Using the left forearm, inject intradermally 0.1 ml of three compounds 
(Candida, mumps, PPD) in alphabetical order beginning near the elbow joint.
5. Using the right forearm, inject 0.1 ml of the remaining two compounds 
(SK/SD and trichophyton) in alphabetical order, beginning near the elbow.
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6 . The test subject is asked to return in 48 hours.
7. The longest axis of the induration and erythema is determined using a
ruler graduated in millimeters.
Homtal or Reference Values:
In the course of the study, a positive immediate skin test reaction was 
considered to be a wheal >3.0 HM and/or erythema greater than 5.0 HM. Positive 
control histamine induced skin reactions were greater than 5.0 MM wheal.
Because of the variability in the potency of allergenic extracts, it is 
impossible to give reference value for the frequency of positive imaediate skin 
tests in a population. Hence, for scientific validity the frequency of 
immediate skin tests in a test population should be compared to the frequency 
of skin tests in a similar-sized control population.
When the delayed skin tests were used in the study the induration and
erythema was measured after 48 hours. The criteria for positive delayed skin
reactions were:
Antigen Induration Erythema
Candida > 5.0 MM > 15.0 MM
PPD > 10.0 MM
SK/SD > 5.0 MM
Trichophyton > 5.0 MM
The frequency of delayed skin reactions to intermediate strength antigens 









The use of the prick test for skin testing has one disadvantage. The 
prick test is less sensitive than intracutaneous skin testing. Hence, allergy 
cannot be ruled out on the basis of a negative prick test (All.3).
Conversely, persons with some skin conditions will respond to all skin 
test reagents. These individuals usually present with skin demography of 
several types. These individuals can be identified by virtue of the fact that 
they will also have a positive response to the diluting fluid. Although the 
individuals should be excluded from the data pool, it is sometimes possible to 
demonstrate true allergic reactions which are greater than reactions observed 
with the diluting fluid (All.3).
It is also possible that some individuals will not respond to the positive 
histamine control. This may be due to certain medications ingested by the 
subject or poor technique (All.3). If the subject has taken medications which 
influence histamine action, he should be excluded from the data pool.
The delayed skin tests also have several theoretical and practical limi­
tations. First, it is conceivable that the test population has not been 
exposed to the test antigen(s). Hence, one would observe a decreased frequency 
of positive reactions within the population. It is necessary, therefore, to 
determine the frequency of positive delayed skin test reactions in control 
population of similar size from the same geographic area. Second, certain 
immunopathological processes preclude demonstration of a positive delayed skin 
test. Hence, persons with atopic dermatitis should be excluded from the 
study. Third, persons receiving corticosteroid therapy, which depresses the 
inflammatory response, should also be excluded from the study. Fourth, a 
strong immediate response (20 minutes) at the reaction site may yield a false 
negative delayed reaction. Hence, subjects with a strong immediate response 
should be excluded from consideration in the analyses of the data (All.2).
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There are problems that arise with determination of skin test frequency 
within a population. The first problem is associated with the shelf life of 
immediate skin test reactions. The shelf life of reconstituted prick 
allergenic extracts is 18 months in SOI glycerine when stored at refrigerated 
temperatures. Therefore, for accurate determinations of immediate skin test 
reactivity in test and control populations, one must test both populations with 
the Same Lot of allergenic extracts within 18 months. It is not advisable to 
change lots of allergenic extracts during the course of the study. There is 
considerable variation in the allergenic potency of immediate skin test 
reagents ««hen different lots of the same allergic extract are compared.
Although the prick test is considered to be a safe, rapid method for 
determining atopic status, one must be aware that systemic allergic reactions 
may occur in a small number of individuals. Therefore, a physician should be 
available in an emergency. Moreover, the skin testing facility should be 
equipped with a drug box containing the necessary resuscitation equipment and 
aqueous adrenalin (1:1000 V/V).
The serological reactivity of some delayed skin test reagents is not well 
standardized (i.e. SK/SD, Trichophyton and Candida). In this case, it is 
necessary to determine the concentration necessary to evoke delayed 
hypersensitivity reactions in number of normal controls prior to the start of 
the population study.
The lack of antigen standardization creates another problem. Some 
individuals will have massive delayed hypersensitivity reactions to low doses 
of SK/SD (4U/IU). These reactions include induration greater than 40 HM, 
sloughing of the epidermis and swelling of the entire forearm with associated 
joint pains. Although this problem is not serious, it does cause a great
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Trouble Shooting:
degree of apprehension among other participants in the study. Should these 
accelerated reactions occur« a physician should be consulted and the reaction 
site covered with corticosteroid impregnated tape.
With respect to potency and shelf life, the same problems apply to the 
delayed skin test reagents that were outlined for the immediate skin test 
reagents. Care should be taken to insure that both the test and control 
population are tested with the same lot of antigen within the shelf life of the 
reagent.
There are problems associated with the determination of positive skin 
tests. To abrogate the variability in actually reading the positive skin 
tests, it is necessary to insure that the same individual(s) read the skin test 
during the course of the study. It is also necessary to make a prior criterion 
for a positive skin test, in terms of the size of the wheal or induration, for 
each antigen before initiating the study. Obviously, this criterion will 
depend on the sensitivity of the person reading the skin test.
Interpretation
Patterns of immediate skin test reactivity is difficult to interpret. In 
some industries, the more allergic individuals are forced out of the work 
environment. Hence, there is a survivor working population which will have 
overall patterns of immediate skin test reactivity which are lower than a 
control population from the same geographic area. Moreover, some individuals 
may have positive skin tests to specific allergens but no clinical episodes of 
asthma associated with exposure to the same allergens used in the skin tests.
The concept of a survival population is difficult to establish because of 
the limited number of individuals working in an industry. However, comparison 
of the skin test frequencies in: (a) control population; (b) currently
working; and (c) non-working people who left the industry, should establish 
whether atopic sensitivity played a role in the decision to leave the industry, 
and Whether occupation related allergenic activity was observed in the 
non-working group.
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The relationship of positive skin tests to occupation-related allergens 
and occupation-related asthma must be confirmed. This can be achieved by 
demonstrating * strong correlation between a positive skin test to 
occupation-related allergens and a history of occupational asthma provoked by 
the same agent.
The presence of anergy to delayed skin test with a population can be 
assessed by several techniques as described by Spitler (All.2):
1. Positive responses to fewer than two of the five skin test antigens in 
an individual.
2. The total sum of induration to all five skin test antigens is less 
than 10 HM.
REFERENCES
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Precipitating Antibody Determination
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BATTOMAT.K
Exposure to a foreign antigen elicits the production of antibodies 
directed toward the antigen. If the antigen is a soluble molecule, the 
reaction between antibodies and antigen can be determined by precipitation 
reactions. The precipitated reaction is a two stage chemical which takes 
place in a liquid or gel matrix. The first stage the antibody reacts with 
antigenic determinants on the antigen. Since both the antigen and the 
antibody are charged molecules, the reaction is dependent on pH and ionic 
strength of the buffer used in the reaction. Hence, precipitation reactions 
are carried out in buffered media containing electrolytes. When the primary 
reaction has reached an equilibrium, a secondary reaction takes place. This 
reaction is possible since only one antigen combining site on the divalent 
antibody is reacted with antigen during the primary stage of antigen-antibody 
interaction. The second unbound antibody receptor now attaches to additional 
antigenic determinants on the antigen. This results in lattice formation 
between multiple antibodies and antigenic determinants. Visible precipitation 
then occurs because the lattice formation is large enough to be insoluble in 
the buffered media.
The precipitation reaction occurs only when there are optimal interactions 
between antigen and antibody. Hence, the reaction is dependent directly on 
the concentration of both antigen and antibody. If there is excess antibody 
relative to the amount of antigen in the system, visible precipitation will 
not be observed. Under this condition, the antibody will complex with two 
antigenic determinants. Because the antibody has complexed with two antigenic 
determinants, it Is unable to react with additional antigenic determinants 
necessary for lattice formation. Conversely, if there is excess antigen 
relative to antibody in the system there will also be no visible
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precipitation. The lack of visible preciptation is due to the fact that there 
are two antibodies to combine with all the receptor sites necessary for 
lattice formation.
Precipitation reactions in agarose gels are widely used in immunology to 
detect the presence of antibodies to soluble antigens. The reaction is 
identical to precipitation reactions in liquid media. Inwells are cut in 
solidified agarose. Antibody is placed in one well and antigen is placed in 
another well. During the incubation period, the antibodies and antigen 
diffuse toward each other and interact in a manner described previously. When 
optimal concentrations are achieved, lattice formation takes place and a 
precipitate forms that is visible through the agar as a white line.
Using immunodiffusion techniques careful consideration oust be given to 
the size of the wells and the distance between wells. If proper sized wells 
are used, the optimal interactions between antigens and antibodies will not be 
achieved, and no visible precipitation will occur. Moreover, if the wells are 
too far apart for optimal interactions to occur, no visible precipitation will 
occur. Therefore, the immunodiffusion technique must be standardized from 
laboratory to laboratory to yield reproducible results.
The determination of precipitating antibodies directed against organic 
molecules by immunodiffusion techniques is often helpful in the diagnosis of 
certain lung diseases. Subjects with a history of hypersensitivity 
pneumonitis (HP) often have precipitating antibodies to the etiological agent 
in their serum (A12.1). Hence, the presence of precipitating antibodies to 
extracts of thermophillic actinomycetes is used to support a tentative 
diagnosis of HP. The presence of precipitins alone, without a clear clinical 
history of the disease, cannot be used to diagnose HP.
The determination of precipitating antibodies to occupation-related anti­
genic material is also useful determining the relative exposure of industrial
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populations to agents which may cause HP. Again, the frequency of precipitins 
in the test population mist be compared to frequency in control populations. 
REAGENT
1. Panel of extracts used for determination of precipitating antibodies 
(Appendix X)
2. Pre-cleaned microscope slides
3. 0.1 M borate citrate buffer pH 8.4
a. 6.19 g boric acid
b. 9.54 g sodium tetraborate
c. 4.38 g sodium chloride
d. Dissolve in 1.0 liter of deionized, distilled water
e. Add 1.0 g of citric acid
f. Adjust the pH to 8.4
4. Agarose
5. 0.1% Agarose for precoating slides
a. 0 .1 g of agarose in 100 ml deionized distilled water
b. Bring to a boil
c. Cool to 56°C in a water bath
d. Add 0.5% glycerol and stir
6 . 1 .0% agarose for agar slides








1. Pre-coating microscope slides
a. Place 0.1% agarose suspension in a beaker and place in a water
bath on a hot plate.
b. Bring the agarose suspension to a boil.
c. Pour the liquid agarose into a Cop 1 in jar large enough to immerse
microscope slide.
d. Using a pair of tweezers, quickly immerse microslides in the
Cop 1 in jar. Be sure that the entire slide is beneath surface of 
the liquid.
e. Immediately remove the microscope slides and place at a 45 degree 
angle.
f. Let the slides air dry.
g. Wrap the slides in groups of six in paper towels. Be sure that
the wrapping process prevents slide to slide interaction.
h. Secure the paper with a rubber band. Mark each pack with the date.
i. Store at room temperature.
2. Preparation of gel diffusion plates
a. Mark six slides with the numbers 1-6 using a diamond point pen.
b. Place the six slides in an immunoframe on a leveling table. Be
sure that the slides are in numerical sequence, and that the 
slides are level.
c. Weigh out 0.5 g of agarose.
d. Suspend the agarose in 50 ml of 0.1 M borate citrate buffer pH 8.4.
e. Place the agarose suspension in a water bath on a hot plate.
f. Bring the mixture to a boil.
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g . Let the liquid cool to 56 °C in a waterbath. Keep the molten 
agarose in the water bath.
h. "Place 10 si of the molten agar onto the three microscope slides on
one side of the issnunoframe.
i. Place another 10 ml onto three slides in the other side of the 
immunoframe.
j. Allow the agar to harden at room temperature for IS minutes.
k. Place the agar-coated microscope slides in a humid chamber for 30
minutes.
1 . Repeat steps a-k for a second set of slides.
Cutting the gel diffusion wells
a. Using an LKB gel cutter, prepare two well patterns per microscope 
slide. Each pattern should contain six peripheral (2.0 KM in 
diameter) wells separated from a central well (6.0 MM in diameter 
by 3.0 MM).
b. Remove one imctunoframe with agarose-coated slides from the humid 
chamber.
c. Place the well cutter over the agarose-coated slides and press the 
plunger.
d. Repeat the process until two patterns have been cut in each of the 
six microscope slides.
e. Gently remove the agarose from the wells using a capillary pipette 
attached to a water aspirator. Make sure that the wells are 
straight and free of agarose fragments.
f. Place the microscope slides in the humid chamber.
4. Immunodiffusion analyses
a. Remove the panel of extracts used to detect precipitating 
antibodies from the refrigerator. Allow to wane to room 
temperature.
b . Place the extracts in groups of six in test tube rack and remove 
the caps.
c . Place a capillary pipette with a rubber bulb in each of test 
extracts.
d. Make a master list of the extracts as they appear in each group of 
six.
e. Remove the agarose-coated slides from the humid chamber.
f. Begin with the first pattern of microscope slide #1. Add 
approximately 10 yl of the first six extracts to wells 1-6. Be 
careful not to overfill the wells. If overfilling occurs, blot 
with disposable wiper.
g. Repeat the procedure with the second well pattern on the first 
slide using the next set of six extracts.
h. Repear until all of the wells are filled in all six microscope 
slides.
i. Place a sample of undiluted test serum into the center well of 
each pattern. Make sure the well is filled (approximately 50 
yl). Do not overfill.
j. Place the slides in a humid chamber.
k. Examine for precipitin lines at 24 and 48 hours.
LIMITATIONS
Although the immunodiffusion method described previously is as sensitive 
as other immunodiffusion methods (e.g., gel template method) and more
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sensitive than the counter immunoelectrophoresis method, immunodiffusion does 
have severer limitations. First, it is less sensitive than other methods used 
to detect the presence of specific antibodies. However, the more sensitive 
methods do not readily lend themselves to large population studies using many 
different antigens and test sera. Secondly, the large antibody well used in 
the immunodiffusion method is not commercially available and must be
manufactured by the individual investigator. Third, serum lipoproteins may 
precipitate around the antiserum wells and inhibit the visualization of 
precipitin lines. Fourth, some of the precipitin lines observed in
immunodiffusion method may not be classical antigen-antibody interactions. 
Reactions between acid proteins of the antigen can form precipitin lines in 
gels (A12.2). Conversely, interactions between basic proteins in serum (i.e., 
lysozyme) and acidic proteins in antigen preparations can also initiate 
non-specific precipitation in gels. Reactions of C-reactive protein, a serum 
complement produced during an inflammatory response, and C-polysaccharide also 
produce non-specific precipitation in gels. C-polysaccharide is produced by 
several bacteria and some species of aspergillus (A12.3). It is also 
conceivable that certain antigenic extracts contain a protein similar to 
C-reactive protein. Hence, interaction between antibodies and substances
analogous to C-reactive protein initiate precipitation. Some non-specific 
precipitation has also been demonstrated after non-specific interaction 
between non-antibody serum proteins and teichoic acids of bacterial cell wall 
(A12.4), and serum alpha macroglobulin and certain antigens. Hon-specific 
precipitation should be suspected in large population studies if 40-50% of the 
test and control populations demonstrate serological reactivity to specific 
antigens.
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Some types of non-specific precipitation can be prevented by use of
reactant modifiers or changes in the buffer system, or the use of agarose as
the supporting matrix. Non-specific precipitation of serum lipoproteins can 
be prevented by using 1.0 M glycine in the agar gels (A12.5). The interaction 
of acidic-basic proteins can be prevented by the absence of NaCl in the buffer 
(A12.6). The use of the clotting agent citrate may prevent the CA 
requiring interaction between C-reactive protein and C-polysaccharide. The 
citrate also prevents precipitation of serum lipoproteins in agar (A12.7, 
A12.8).
If changes in buffers or addition of reactant modifiers fail to alter the 
precipitin lines, one must use other immunological methods to demonstrate the 
nature of the immunological reaction. To determine whether a-2 
macroglobulin-antigen interactions result in precipitin lines,
immunoelectrophoresis techniques can be employed (A12.9). Wells are cut on
either side of a trough and test sera is placed in one well and normal serum
is placed in the other well. After electrophoresis, the antigen extract is 
placed in the trough and allowed to diffuse toward the electrophoresed serum 
components. If the reaction is due to reactions between a-2 macroglobulin 
and antigen, a line of precipitation will be observed in the a -2 region with 
both the test and control sera; no line will be observed in the antibody 
containing a region. Conversely, if the antigen is interacting with 
antibodies, the line of precipitation will be observed in the y region. The 
specificity of the reaction may or may not be determined by the reaction. If 
the reaction is non-specific, lines of precipitation will be observed in the 
y electrophoretic region of both the test and control sera. If the reaction 
is specific, a reaction will only be observed in the y electrophoretic region 
of the test serum.
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It is best, however, to actually demonstrate the antigen-antibody reaction 
observed in immunoelectrophoresis as the result of antibody binding to antigen 
via the F (ab)^ portion of the molecule. This can be achieved by isolating 
the IgG fraction of test sera by salt fractionation (A12.10. A12.ll). The 
isolated IgG is then treated with pepsin which digests the Fc portion of the 
antibody but has no effect on the F (ab)^ portion of the antibody (A12.12, 
A12.13). Since C-reactive protein antibody interactions occur in the Fc 
portion of the antibody, pepsin digestion, in effect* will prevent 
non-specific interactions from occurring via the Fc receptor. After column 
chromatography, to separate the F (ab^ and Fc fragments, the F (ab)^ 
fragments are concentrated and tested in the immunodiffusion system against 
the same antigen. The presence of a precipitin line proves that the reaction 
is the consequence of classical antigen-antibody reaction since the antibody 
preparation lacVs other serum proteins which can give false positive reactions 
and the reaction can only occur via the F (ab)^ portion of the antibody.
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INTERPRETATIONS
1. Presence of a precipitin line:
The demonstration of a precipitin line indicates the previous exposure 
to the antigen. The presence of a precipitin line to specific 
antigens should be correlated with clinical history, pulmonary 
function changes and/or x-ray changes to determine if there is an 
association with lung disease.
2. Negative precipitin lines:
The lack of a precipitin line does not preclude exposure to the 
antigen. Two explanations for the lack of precipitin lines can be put 
forth. First, the test panel may not contain the proper antigen. 
Second, the precipitating antibodies are present in small concentra­
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RATIONALE
Several constituents of serum can be measured in vitro by immunochemical 
techniques. The proteins include immunoglobulins (G, A, H) complement 
component (C3) and alpha^-antitrypsin (AAT). The usual way to quantitate
these proteins is radial immunodiffusion (RIO). In this technique, 
heterologous antibody directed toward the protein is distributed evenly within 
a solidified matrix. Wells are then cut into the agar and the test protein 
(antigen) is placed in the wells. The antigen diffuses radially from the 
wells into the matrix containing antibodies. When optimal concentration of
antigen and antibody are attained (Appendix XII) a visible precipitate, in the 
form of a ring, is observed. Since the antibody concentration is fixed in the 
reaction, the point of optimal concentration of antigen-antibody necessary for 
precipitation is dependent solely on the concentration of antigen in the 
system. Hence, the larger the diameter of the precipitin ring the higher the 
concentration of antigen.
Two different radial immunodiffusion methods can be used to quantitate 
serum protein. In the timed technique the diameter of the precipitin ring is 
determined as it is still expanding (A13.1). Theoretically, the timed method 
is feasible since, as more antigen diffuses from the well, the precipitin ring 
will dissolve in antigen excess and will reappear at a more distinct point. 
Since the timed method requires less incubation time, it can be used When 
quick results are needed. The second method used to quantitate serum proteins 
is the limit diffusion method. In this method, the diameter of the ring is 
determined at the conclusion of the reaction when the precipitin ring has 
stopped expanding (A13.2).
The relationship of the antigen concentration to the diameter of the ring 
is different'when the timed and limit diffusion method are compared. In the
timed reaction, an approximate linear plot is observed when the log of the
antigen concentration is plotted versus ring diameter. Conversely, in the
2
limit diffusion technique, the relationship between the diameter squared (D) 
and the antigen concentration is linear.
The limit diffusion method is the method of choice for quantitation of 
serum proteins. This method has been found to be highly accurate and is not 
influenced by environmental factors (i.e. temperature changes) which may alter 
the results of timed tests (A13.3).
The quantitation of serum proteins is useful for several reasons. 
Determination of levels of IgG, IgA, IgM and C3 can be used in assessing the 
immunological status of test populations in cases where immunosuppression is 
suspected. Conversely, alpha^ and antitrypsin is the major serum protein 
which inhibits trypsin activity in the lungs. Hence, the lack of AAT may 
predispose individuals to syndromes involving this trypsin-induced auto­
digestion of the lungs.
REAGENTS
1. Commercially available (Calbiochem/Behring) Limit Diffusion Radial 
Immunodiffusion Plates for Determination of: IgG, -IgA, IgM, C3, 
alpha^ antitrypsin.
2. 0,85% saline




6 . Calibrated magnifier
7. Accuracy control for each protein
8 . Internal standard




A. Remove the test samples and the internal control from the freezer.
The method for obtaining samples is described in Appendix XIV.
B. Allow the samples to reach room temperature.
C. Make the appropriate dilutions of the test samples in 0.85% normal
saline according to the manufacturer directions.
1. IgG - 1:10
2. IgA - undiluted
3. IgM - undiluted
4. C3 - 1:2
5. AAT - 1:10
D. Make a master list of the samples relating the sample to the plate and 
well number.
E. Remove the RID plates, accuracy control and protein reference 
standards from the refrigerator. Carefully, remove from the aluminum 
foil envelope as directed by the manufacturer.
F. Remove the lids of the RID plates and allow them to stand open for 5 
minutes at room temperature.
G . To the first well on plates 1 and 3, add 5 yl of Standard Solution 
No. I.
H. To the second well on plates 1 and 3 add 5 yl of Standard Solution 
No. II.
I. To the third well on plates 1 and 3 add 5 yl of Standard Solution 
No. III.
J. Add 5 yl of the accuracy control to well 4 on plates 1 and 3 and
well number 1 on plate 2 .
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K. Add 5 vX of the internal control to well 5 on plates 1 and 3 and 
well number 2 on plate 3.
L. Place test serum samples (5 ill) in the remaining wells.
M. Replace the lid of the RID plate and replace in the aluminum foil 
envelope.
H. Seal the envelope with scotch tape to prevent loss of moisture.
2. Incubation at Room Temperature
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A. IRC 50 hours
B. ISA 50 hours
C. IgM 80 hours
D. C3 48 hours
B. AAT 48 hours
3. Calibration Curves
A. Remove the plates from the foil packages.
B. Using a calibrated magnifier, measure the diameter of the precipitin
rings for each standard protein solution and internal and accuracy
control. The measurement must be accurate to 0.1 mm.
C. Determine the mean and standard deviation for each standard protein
solution and the controls. The variability from plate to plate should
be less than 0.5 mm.
2
D. Calculate the diameter squared for each mean value (D) .
2
E. Using linear graph paper plot the (D) of the protein standards, I,
II and III (ordinator) against the concentrations (abscissa). The
plot should result in a straight line which intercepts the ordinate at
2 2 11 + 3.4 mm . If the intercept value is greater than 14.5 mm or
2
less than 7.5 mm , the test must be repeated.
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Determination of Internal Accuracy and Reproducibility
2
A. Calculate the diameter squared (D) of the accuracy control and the 
internal control.
B. Determine the concentration of the controls from the protein reference 
calibration curve. The protein concentration of the accuracy control 
should be less than the standard deviation of the mean value supplied 
from the manufacturer. The internal control should not vary more than 
2.5%.
Determination of Protein Test Sera
2
A. Calculate the diameter squared (D) for each test sample.
B. Determine the protein concentration from the standard reference curve. 
Conversion Formulae
A. To convert mg/100 ml to I.U./ml:
1. IgG mg/100 ml x 11.5 - I.U./ml
100
2. IgA mg/100 ml x 59.5 - I.U./ml
100
3. IgM mg/100 ml x 115 - I.U./ml
100




















There are several practical and theoretical limitations of the RIO test. 
Both timed and end point diffusion plates are commercially available, but the 
end point diffusion method should be used. These plates should be prepared by 
the method of Nancini, Carbonara and Heremans (A13.2). When there is a 
question of reaction kinetics, the manufacturer should be consulted. Moreover, 
the RID method must be used as the manufacturer specifies. Radial immuno­
diffusion plates designed for timed diffusion cannot be used to determine end 
point diffusion.
There are also several technical factors which may influence the results 
of RID. First, it is conceivable that there may be batch to batch variation 
in the serological reactivity of antibody in the RID plates; therefore, one 
must use the same lots of plates to test both test and control populations. 
Second, there may be some plate to plate variation in antibody reactivity in 
RID plates. The use of an internal standard and accuracy control on every 
plate can be used to detect plate to plate variation. Usually, the diameter 
of the accuracy control and internal standard will be 2.0 + 1.0%. Lastly, to 
insure the accuracy of the standard reference curve, a three point reference 
protein curve should be run on every third plate.
Several sources of error can be ascribed to the filling of the wells. If 
the wells are not completely filled with a constant amount of antigen or the 
antigen is spilled outside the wells, the results will be spurious. If the 
wells contain air bubbles, the results will be invalid.
The determination of serum proteins by immunodiffusion technique detects 
only the presence of the test protein and not the functional capacity. Hence, 
if functional abnormalities of the serum proteins are suggested, more
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sophisticated immunological tests must be employed. For example, increases in 
a specific immunoglobulin may suggest a monoclonal gammopathy. but clinical 
interpretation would depend on total serum protein levels and serum 
electrophoresis patterns. Conversely, decreased Immunoglobulin levels may 
suggest an immunosuppression or immunodeficiency, but clinical interpretation 
will depend on assessment of the antibody mediated immune system.
INTERPRETATION
The data are difficult to interpret because certain disease conditions 
and/or environmental stimuli may increase or decrease the levels of serum 
proteins. Moreover, the levels of serum proteins may be altered by increases 
in synthetic rate or decreases in the metabolic rate. It is conceivable, 
therefore, that decreases in complement C3 may be due to an increase in 
catabolism rather than consumption in an antigen-antibody reaction or an 
immune defect in synthesis.
The AAT levels in serum present a unique problem. Decreased levels of AAT 
may be due to a genetically determined partial or total inhibition of 
synthesis of AAT. Hence, it is necessary to determine the P^ phenotype and 
the trypsin inhibitory capacity of (TIC) serum samples with less than 60% of 
the normal mean value for AAT. Phenotyping and TIC determinations and beyond 
the scope of most laboratories and should be done only in regional reference 
centers. Using these techniques the presence of the MZ or ZZ phenotype with 
decreased trypsin inhibitory capacity may suggest a propensity to develop 
emphysema. The data should, however, be evaluated in conjunction with 
familial and clinical history and possible exposure to agents which induce 
emphysema.
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Determination of Factor 8 Level and Activation
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The complement system is a group of nine blood proteins which interact in 
a cascading effect. The complement cascade can be initiated by two mecha­
nisms. In the classical pathway, antigen-antlbody complex initiate the 
reaction, and the complement proteins interact in a defined manner 
(Cl,42356789). The second pathway, which does not require the presence of 
antibody-antigen complexes, is termed the alternate pathway. The interactions 
of complement proteins with certain microbial or viral antigens are the 
results of direct interaction of C3 with the antigen (C356789). As a 
consequence of complement interaction by either the classical or alternate 
pathway, soluble complement components are liberated which can initiate the 
release of histamine from mast cells, initiate chemotaxis of phagocytic cells 
and increase phagocytosis by phagocytic cells.
It is possible to demonstrate activation of the classical or alternate 
complement pathway by in vitro methods. These methods are predicated on the 
fact that the electrophoretic mobility of intact complement components and 
complement fragments differ in an agarose matrix. Since complement protein C3 
is necessary for both the classical and alternate pathways, the demonstration 
of products of C3 unique to either the classical or alternate pathway can be 
used to measure complement activation.
Activation of intact C3 (1C) by the classical pathway liberates four 
major fragments: C3a, C3bt C3c (^A) and C3d (a2d). The C3d (a2d)
remains in the serum. Since the C3d (a2d) fragment has a slower 
electrophoretic mobility than intact C3 (1) it is possible to separate 
intact C3 (1C) from the C3d and (<*2d) in an electrical field using 
immunoelectrophoresis or cross-immunoelectrophoresis.
Rationale:
Activation of C3 by the alternate pathway liberates different complement 
products. Complexes of C3b, C3 proactivator convertase (Factor D) and C3 
proactivator (Factor B) initiate the cleavage of C3 proactivator (Factor B) 
into two prof actors Ba and Bb (C3 activator). The Ba fragment is quickly 
metabolized Whereas factor Bb (C3 activator) remains in serum. Under an 
electrical potential, intact C3 proactivator (Factor B) migrates in the B-2 
region and the Bb fragment (C3 activator) migrates in the a region. Hence, 
intact C3 proactivator (Factor B) and presence of the Bb fragment (C3 
activator) can be ascertained by Immunoelectrophoresis.
Reagents:
1. 10 ml Vacutainer tubes (EDTA or serum separation tubes)
2. Vacutainer holders
3. Tourniquets
4. Multiple sample Vacutainer needles
5. Alcohol impregnated pads
6. Sterile 2 x 2  gauze pads
7. Agarose
8. 0.1% Agarose with glycerol
a) O.lg of Agarose in distilled water
b) Bring to a boil
c) Cool to S6°C in a water bath
d) Add 0.51 v/v glycerol and stir
9. Stock barbital buffer pH 8.6 (2x)
a) 2.466g of barbituric acid
b) 9.76g of sodium barbital
c) Suspend to 1.0 liter
10. Working buffer for positive control (lx)— Buffer A
a) Dilute 5.0 ml of stock buffer with 5.0 ml of deionized, distilled water.
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11. 0.2M EDTA
a) 76g of EDTA tetrasodium salt A
b) 74.4g of EDTA disodium dihydrate
c) Dissolve in 900 ml of deionized, distilled water
d) Adjust the pH to 8.6
e) Adjust concentration to 1.0 liter
12. Working buffer for agarose preparation and electrophoresis (lx)— Buffer B
a) 500 ml of stock barbital buffer
b) 400 ml of deionized distilled «rater
c) 100 ml of 0.2m EDTA




17. Gel cutter and knife
18. Control sera
a) Plasma samples recovered from blood drawn in heparin and stored at 
-70°C





21. Provials - 20 ml (Cooke Scientific)
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Methods:
1. Preparation of blood samples.
a. The arm is cleansed with alcohol impregnated pads.
b. Venipuncture is performed without traumatizing the skin or vein using a 
Vacutainer and either 10.0 ml EDTA or serum separation tube.
c. Plasma is obtained from EDTA tubes by centrifugation at room 
temperature for 10 minutes. Blood in serum separation tubes is allowed 
to clot for 5 minutes and centrifuged for 10 minutes at room 
temperature.
d. Serum or plasma is recovered and aliquoted into 2.0 ml provials. Vials 
are labeled with subject’s name or identification number.
e. Samples are immediately stored at -70°C.
2. Precoating of microscope slides.
a. Place 0.1% agarose suspension in a beaker and place in a water bath on 
a hot plate.
b. Bring the agarose suspension to a boil.
c. Pour the liquid agarose into a Coplin jar large enough to immerse 
microscope slide.
d. Using a pair of tweezers, quickly immerse microslides in the Coplin 
jar. Be sure that the entire slide is beneath surface of the liquid.
e. Immediately remove the microscope slides and place at a 45 degree angle.
f. Let the slides air dry.
g. Wrap the slides in groups of six in paper towels. Be sure that the 
wrapping process prevents slide to slide interaction.
h. Secure the paper with a rubber band. Mark each packet with the date.
i. Store at room temperature.
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3. Preparation of gel diffusion plates.
a. Mark six slides with the numbers 2-6 using a diamond point pen.
b. Place the six slides in an immunoframe on a leveling table. Be sure
that the slides are in numerical sequence and that the slides are level.
c. Weigh out 0.5g of agarose.
d. Suspend the agarose in 50 ml of the working barbital buffer (Buffer B).
e. Place the agarose suspension in a water bath on a hot plate.
f. Bring the mixture to a boil.
g. Let the liquid cool to 56°C in a waterbath. Keep the molten agarose 
in the water bath.
h. Place 10.1 ml of the molten agar onto three microscope slides on one 
side of the immunoframe.
i. Place another 10 ml onto three slides on the other side of the 
immunoframe.
j . Allow the agar to harden at room temperature for 15 minutes.
k. Place the agar-coated microscope slides in a humid chamber for 30 
minutes.
1. Repeat steps a-k for a second set of slides.
4. Gel patterns.
a. With a gel punch, cut two wells and a trough in the agar. The size of 
the wells will differ for each system and the correct size must be 
determined in each laboratory.
b. Remove the plugs from the well with a capillary pipette by gentle 
suction using a water aspirator.
c. Place the slides in a humid chamber.
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Preparation of positive and negative controls.
A. Positive Control.
1. Weigh out 10 mg of inulin.
2. Resuspend the inulin in 1.0 ml of working barbital buffer which 
lacks EDTA (Buffer A).
3. Pipette 20 pi of the inulin suspension into a tube containing 20 
111 of fresh normal human serum or normal human plasma drawn in 
heparin and stored at -70°C.
4. Incubate for 30 minutes at 37°C.
5. Centrifuge at lOOOxg for 10 minutes at room temperature.
6. Recover supernatant fluid for use as a positive control.
B. Negative Control.
1. Fresh normal serum drawn in EDTA or frozen serum drawn in EDTA and 
ostored at -70 C.
Electrophoresis.
a. Prepare 1.0 liter of 1 working barbital buffer (Buffer B).
b. Cut filter paper strips (Reeve Angel No. 3) in strips approximately 2 
inches wide and 3 inches long.
c. Remove test serum samples from the freezer and thaw.
d. Arrange the sera in groups of 10 samples and make a master list of the 
sample order.
e. Remove the agarose-coated slides from the humid chamber.
f. Add 4.0 pi of the positive control to the top well of slide number 1.
g. Add 4.0 pi of the negative control to the bottom well of slide number.
h. Add the test samples to the wells on each of the remaining slides.
i. Fill the electrophoresis chamber with the working barbital buffer 
solution (Buffer B).
j. Place the imntunoframe in the electrophoresis chamber.
k. Place the filter paper strips on each end of the imntuno frame. Let hang 
into the buffer vessels of the electrophoresis chamber.
7. Electrophoresis Conditions.
a . For determination of C3 activator t samples are electrophoresed at 
250V. The current should be between 6-9m Amps with a running time of 
75 minutes.
b. For determination of C3 activation, samples are electrophoresed at 50V 
for 3-6 hours. The current should be between 2-4m Amps.
8. Antiserum Placement.
a. Remove the immunoframe from the electrical field.
b. Remove the agarose from the trough with a gel knife.
c. Fill the trough with 80 yl of diluted anti-C3 proactivator or anti-C3 
(BjA/BjC). The proper dilution of antiserum will vary depending on 
the source.
9. Incubation.
a. Return the immunoframes to the humid chamber and incubate at room 
temperature for 24-48 hours.
10. Results.
a. For determination of' C3 activator, a positive reaction is denoted by a 
precipitin arc in the a region (Factor Bb) and a precipitin arc in 
the B region (C3PA). A negative reaction is denoted by a single 
precipitin arc in the B region.
b. For determination of C3 activation, a positive reaction is denoted by a 




The determinations of complement conversion products have several 
limitations. The validity of the system depends on the ability of the 
antisera to recognize the presence of unique antigens of complement products. 
In the determination of C3d (a2d) this presents a problem in that antiserum 
to C3d (a2d) is not readily available. Antiserum to intact C3 (B1A/B1C)
must be used with the assumption that the antisera will recognize the D 
antigen Which is present on intact C3, C3b and C3c (B1A). Although the
presence of C3b and C3c (la) in the immunoelectrophoretie system does denote 
complement activation, it is unlikely that C3b and C3c (1A) will be 
demonstrated because of rapid metabolism. Therefore, the antiserum must have
the capacity to recognize the D antigen. Commercially available antisera to
B1A/B1C differ significantly in their ability to recognize the D antigen, and 
is necessary to screen several lots of antisera from several companies in 
order to find one which will work in the system.
Antisera used to detect activation of the alternate pathway present little 
problem. Antiserum to Factor B (C3 proactivator) trill react with intact 
Factor B and the Ba and Bb fragments due to the fact that the major antigenic 
determinants are the Ba and Bb molecules which are present on intact Factor B 
(C3 proactivator) and the fragments. The most reliable source of the anti- 
Factor B antiserum is, however. Dr. Otto Goetze of the Scripps Institute.
In determination of activation of C3 by the classical pathway, two methods 
are available. Conventional immunoelectrophoresis is suitable for large 
population studies if adequate separation can be achieved in the electrical 
field. The method is less sensitive, however, than the cross- 
immunoelectrophoresis which detects as little at 5X conversion (A14.1, A14.2). 
The choice of method, therefore, depends on the individual investigator.
The demonstration of complement conversion products may he affected by 
technical parameters. Complement can be activated in blood samples by 
interactions, between plasmin and Cl or a direct effect of plasmin on C3. 
Hence, it is suggested that blood be drawn in EDTA, which prevents complement 
interactions or in serum separation tubes which also inhibit complement
activation. In addition, some lots of agarose will activate complement during 
electrophoresis. This phenomenon, however, can be prevented by adding small 
amounts of EDTA to the agaroe and the buffers used in electrophoresis.
The use of agar as the electrophoretic matrix is not recommended because 
of electro-osmotic effect; all charged proteins will be carried to the cathode 
thus altering the normal electrophoretic pattern. Agarose has little
electro-osmosis and no affinity for acidic or basic proteins. Hence, proteins 
migrate more homogeneously with greater resolution.
Interpretations
1. Activation of the classical pathway.
Demonstration of complement fragments liberated by the classical
pathway suggests that an antigen-antibody reaction has taken place.
2. Activation of the alternate pathway.
Demonstration of complement fragments liberated by the alternate
pathway suggests that complement has been activated without antigen 
antibody interaction.
3. Lack of complement activation by either pathway.
The failure to demonstrate complement activation does not preclude the 
possibility that complement has been activated. If the reaction takes 
place in other areas of the body (i.e. lungs) the conversion products 
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for Airborne Dust Levels
Environmental Studies:
Airborne dust levels: These studies were performed by NIOSH Personnel.
Method of collection of respirable and total personal dust samples were:
1) “Respirable, personal dust samples were collected utilizing an air 
sampling train consisting of a 10 mi nylon cyclone respirable dust sample 
assembly connected to a personal air pump by a 2 ft. length of 1/4" 
diameter tygon tubing. Each pustp was calibrated to provide an ail* 
sampling flow rate of 1.7 + 0.1 L/min. over a full work shift. The dust 
samples were collected in a two-piece filter cassette holder (supplied 
with the cyclone containing a 37 mm diameter pore size DM-800 Gelman 
filter supported on a cellulose back-up pad. The samplers were placed on 
each worker studied immediately after his pre-shift medical examination 
and removed just prior to his post-shift medical examination conducted by 
the University of Wisconsin laboratory for gravimetric analysis and 
mycological evaluation. All gravimetric analyses (including pre- and post­
weights) and filter cassette assemblies were conducted by the University 
of Wisconsin» Department of Plant Pathology Laboratory personnel.**
"Personal total dust samples were collected in the same manner as the 
respirable dust samples except the cyclones were not used and FWSB 5.0 um 
MSA filters were used instead of DM-800*s. In addition, the Utah 
Biomedical Test Laboratory (UBTL) provided the two-piece filter cassette 
used and conducted pre- and post-weighing for analysis. Pump flow rates 
for all total dust samples were 2.0 + 0.1 L/min.**
"Sampling error is 0-5% for both respirable and total air sampling.**
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b. "Respirable dust concentrations of Superior city workers were 
determined using a 37 millimeter diameter acrylic copolymer 0.8 
micrometer pore size filter (DM-800, Gelman) desiccated and preweighed 
to the nearest 0.001 milligram, supported by a cellulose backup pad and 
sealed with cellulose bands into a two-piece 37 mm filter cassette. 
Prepared filter cassettes were uncapped and securely placed into a 10 
mm nylon cyclone assembly attached by 0.7S m long tygon tubing to 
personal sampling pumps equipped with pulsation flow dampers (Model G, 
MSA). Sampling pumps were periodically monitored over the shift to 
insure a flow rate of 1.7 Lpm + 0.1 Lpm. At the end of sampling, 
filter cassettes were removed from the cyclones, capped, taped and hand 
carried back to the laboratories for desiccation and re-weighing.**
"Total dust sampling was conducted in a similar manner to respirable 
dust sampling except cyclones were not used, and the sampling pumps 
were calibrated at the flow rate of 2 Lpm + 0.1 Lpm.**
"Ten percent of the filters used in a sampling day were used as 
controls and treated identically to sampling filters except no air was 
drawn through the filters."
Notice of Related Work:
The mycological and entomological contaminations of grain and grain Dust 
were examined independently under a separate N10SH contract (Ho. 210-77-0150) 
entitled "Combined Mycological/Entomological Evaluation of Grain dust 




Chest Radiograph Reading Form 
Field Operations Manual 






0. Not done (reason^______ _ _________________________________________ )
1. Adequate
2. Deficient, but acceptable 
3 - Inadequate
B. THORACIC CAGE (May be more than one)
1. Normal
2 . Kyphoscoliosis
3. Abnormal rib fracture (specify)
a) old b) new
4. Abnormal degenerative arthritis of spine
5. Abnormal - other (specify________________________________________ )
C. HEART
1. Normal
2 . Abnormal - enlarged







3. Questionable abnormality 
E-l Type of Lesion (only one)
1. Increase in lung markings a) localized b) diffuse-bilateral
2. Reticulonodular pattern a) localized b) diffuse-bilateral
3. Reticulo-linear pattern a) localized b) diffuse-bilateral
4. Nodular (many rounded opacities less than 3mm)
a) localized-unilateral
b) diffuse-bilateral
IF localized, circle location: RU LU
RM or LM or R hilum area (RHA) 
RL LL L hilum area (LHA)
IF yes to 1, 2, 3 or 4:
Severity of above lesions (degree of profusion of lesions)
0. Minimal or questionable
1. Definitely present, but few
2 . Numerous opacities, but lung markings still present
3. Very numerous, obscuring vascular pattern
5. Module, non-calcifled (3 mm - 2.5 cm)
a) single _______________
b) more than one ___________________, circle location: RU, RM, RL,
La, LM, LL, RHA, LHA
6. Vodule calcified (3 mm - 2.5 cm)
a) single ______________
b) more than one __________________ , circle location:RU. RM, RL,
LU, LL, RHA, LHA
7. Mass 2.5 cm, circle location: RU, RM, RL, LU, LM, LL, RHA, LHA
F. PLEURA
1. Hormal





2. Abnormal - flat (hyperinflated lungs)
3. Abnormal - other (specify ____________________________________ )





A Manual and Automated Procedure for Measuring Serum 
Cholinesterase Activity and Identifying Enzyme Variants
ALANINE AMINOTRANSFERASE (ALT) 




(Glutamate-pyruvate transaminase - GPT)
Principle
This procedure utilizes the Calbiochem Single Tial Reagent (S.V.H.) 
system. (Catalog number 869302)
In this reaction, a-ketoglutarate and L-alaninef in the presence of ALT. 
yield L-glutamate and pyruvate. The latter is reduced by lactate dehydrogen­
ase (LDH) to L~l*ctate; simultaneously a m o la r equivalent of NADH is oxidized. 
The rate of change in absorbence at 340 nm is proportional to the activity of 
the ALT in the sample.
Specimen:
Serum. Hemolysis does not interfere but do not use specimen with 
appreciable hemolysis. GPT (ALT) activity is 7 times higher in RBC's than 
serum.
Reagents: (Note A)
1. TES buffer 0.08 moles/L
2. L-Alanine 0.56 moles/L
-23. a-ketoglutarate 2*0 x 10 moles/L
4• NADH 2.0 x 10~* moles/L
5. LDH (animal) 720 IU/L
6. pH 7.5
7. Non-reactive stabilizers
Reconstitute by adding 15 ml double distilled water to vial. One vial 
will be sufficient for 5 tests. Substrate is stable 72 hours when stored 
between 2° and 8°C.
If reagent shows initial absorbence reading of less than 1:1. or evidence 
of bacterial contamination, discard.
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Procedure:
1. Set up Coleman 124D spectrophotometer; (see general instructions under 





Reference Cell: dichromate (Bote C)
2. Determine total number of assays. Each patient is done in duplicate and 
in separate runs. There must be at least one control per run. A "run" is 
comprised of 4 assays monitored sequentially at 15 second intervals.
3. Reconstitute appropriate number of GPT vials. Mix vials gently by 
inversion to dissolve but D0H*T SHAKE. You will need 3 ml substrate per 
assay.
4. After solution is complete, pour all vials (if more than one is reconsti­
tuted) into a larger container and swirl to mix. This will eliminate 
vial-to-vial variation in the run.
5. Pipette 3 ml pooled substrate solution (step 4) into disposable cuvettes 
and place in a 30°C «rater bath for 5-8 minutes to bring to reaction 
temperature. Do not pre-incubate more than eight cuvettes at a time.
6. Add 0.200 ml of control or specimen (Eppendorf Pipet). Cap cuvet. Mix 
well by inversion, tap to remove bubbles. Remove cap. Wipe cuvet and 
place in holder #1 making sure clear sides of cuvet are in the light path.
7. Repeat step 6 until all four positions in the cell chamber are filled, 
inserting 2nd and 3rd and 4th cuvets in a counter-clockwise manner. (See 
notes B & C)
8. When the final cuvet is in place, activate cell programmer by switching 
from manual to auto mode. Switch recorder to "chart" position.
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9. Allow recorder to chart change in absorbence for several minutes. Refer 
to section on calculations to determine patient and control results. (See 
note E & F)
Hotes:
A. If bottle does not have a vacuum or shows evidence of moisture, do not use.
B. Remove cover only long enough to place cuvette in position in order to 
maintain 30°C in well.
C. Offset may have to be used to get some of the samples on the chart. If 
that still doesn't work, switch to 0-2 scale settings and see note in 
calculation section.
D. This test should be run only after one is familiar with kit information 
supplied by Calbiochem (Document Ho. L03426, 4/1/78).
E. If AA is greater than . 390/min, the activity is greater than 1000 mU/ml 
and the sample should be diluted with saline and rerun.
F. Elevated levels of ALT (GPT) may be substantially reduce HADH before 
initial absorbence is recorded. If a sample gives an initial reading of
0.6 or less dilute with saline and rerun.
G. Dichromate solution: Use reagent #PD3 from Oxford Spectrocheck set. 
Dilute 1:100 as directed on vial. Cover reference cuvette with parafilm 
so that it may be reused.
Calculations:
AA/min x total volume x 1000
= mU/ml
mM absorptivity x sample vol. x light path x min
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mM absorptivity * 6.22 G 340 run for HADH
Page 349
AA/min x 3.2 ml x 1000 
(.22 x 0.2 ml x 1 x 1 = 2572 x AA/min = mU/ml
When reading from the chart let each square represent a unit of 
absorbence; then
AA x 2.572 = mU/ml 
when a line is extrapolated to cover a 10 minute period.
Hote: If using 0-2 scale because of lipemic specimens, use:
AA x 5.144 % mU/ml
(also use a 10 minute line)
Expected Values: (taken from kit literature)
Male: 1-25 mU/ml @ 30°C
Female: 2-24 mU/ml @ 30°C 
References:
See kit insert, Calbiochem Doc. Ho. L03426.
This reduces to:
GAMMA-GLUTAMYL-TRANSPEPTIDASE (GCTP)
The assay is based on the transfer of the glutamyl group from 
L-Y-glutamyl-p-nitroanilide to glycy1-glycine in the presence of GGTP. The
rate of p-nitroaniline formation measured at 405 nm is proportional to the
GGTP concentration in the sample. (Sigma Technal Bulletin #415, 1/77).
Specimen:
Plasma: Blood is drawn into a tube containing either heparin or EDTA and
centrifuged to obtain plasma. (See note D)
Serum: Blood is drawn into a plain tube and allowed to clot. The serum
is separated from the clot as soon as possible. (See note D)
Storage: GGTP is stable in serum for at least 1 week at 4°C and 2
months at -18°C. A minimum of 1 ml is needed for analysis.
Instrument Settings:
Allow a 30 minute warm-up for instrumental system (Coleman 124D
spectrophotometer and attachments).
1. Spectrophotometer:
a. Wavelength: 405 nm
b. Slit width: 1.0 nm
c. Read absorbence on 0-1 scale.
d. Place dichromate solution in reference. Set zero to keep readings
on chart (1:100 dilution of stock #PD-3) (Hote A).
e. Tungsten lamp: on
f. Mirror towards tungsten lamp
2. Recorder:
a. Chart speed (20)
b. Range (10)





b. Measurement period - 15 seconds
c. Manual, initially, then to auto for readings
4. Scale Expander:
a. All offset dials to 0
b. High readings can be offset by turning appropriate knob to make 
readings stay on recorder.
5. Constant Temperature Circulating Water Bath:
o oa. Set temperature 30.0 C (31 C on thermometer) (See Hote E).
b. Turn tap water on slowly.
6. Water Bath for Incubation 
Set at 30°C.
Reagent Composition:
GCTP substrate: (Sigma stock #445-5
L-Y-glutamyl-p-nitro anilide 
Glycylglycine 




Add 15.5 ml A.M.P.D. buffer to substrate vial. Shake vigorously for a few 
seconds and place in 37°C water bath 2-3 minutes until substrate is 
dissolved. Each vial contains enough substrate for 5 tests. Reagent is 






1. Determine total number of assays: each patient is done in duplicate
and at least one control in each run; a "run" consists of four assays 
being monitored sequentially at 15 second intervals.
2. Prepare the appropriate number of GGTP substrate vials. Pour all 
vials into a larger container and swirl to mix. This eliminates any 
vial-to~vial variation.
3. Pipet 3 ml of the pooled substrate into disposable square cuvettes 
and place in a 30°C water bath 5-8 minutes to bring to reaction 
temperature. Do not pre-incubate more than 8 vials at one time.
4. Add 200 vL sample to a cuvet with an Eppendorf pipet. Cap and 
invert several times to mix. Tap to remove any air bubbles. Remove 
cap, wipe cuvet and place in holder #1. (Clear sides of cuvet in 
light path.)
5. Repeat step 4 with 2nd, 3rd & 4th cuvettes, placing them in holders in 
a counter-clockwise manner. (Note B)
6. Switch cell programmer from manual to auto mode and immediately switch 
recorder to "chart” position.
7. Allow recorder to trace changes in absorbence for several minutes. 
Refer to calculations for how to determine patient and control 
results. (Note C)
Notes:
A. This is the same blank used in the ALT & AST procedures. If a sample is
unusually lipemic or icteric, 200 |iL of sample should be added to a
cuvet containing the dichromate solution and this mixture should be used
as a blank for that sample (to keep the readings on the chart).
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B. Remove top from cuvet well only long enough to place each cuvet in its 
holder in order to maintain temperature in well.
C. If A is greater than 0.125/min, dilute the sample with saline and rerun.
D. Fluoride, oxalate and citrate have been found to inhibit GGTP activity. 
Falsely elevated levels occur in patients talcing antiepileptic drugs, such 
as phenytoin and barbiturates.
E. The heating unit of the constant temperature water bath is usually set at
o31 C depending on room temperature. The circulating water will cool as
it warms the cell chamber. The temperature of the cell chamber can be
checked periodically by placing tight fitting styrofoam material on the 
top of the cell chamber and then pushing a thermometer through this 
material.
Calculations:
mU/ml = AA/min x total volume x temp, correction factor 
micromolar extinction factor x sample volume 
mU/ml = AA/min x 3.2 x 0.8
.0099 x 0.2
mU/ml * &A x 1293
Note: When reading from chart, let each square represent a unit of
absorbence. Extrapolate a line for a 5 minute reading, then AA
(5 minutes) x 2586 = mU/ml.
Controls:
Controls consist of two levels of unassayed control material (Hyland 
Scan I & II). Control limits are +2.0 standard deviations or other range as
indicated in the current Scan Control Data Book. Unknowns are to be assayed
in duplicate but not within the same run of four. There must be one control
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in each run of four. If control values are not acceptable, check wavelength, 
slit width, cuvets, reaction temperature, pipetting, age of reagents, storage 
of reconstituted reagents, manual reading of reaction curves, and finally 
reconstitute new controls.
Honnal Range:
Adults: up to 30 mU/ml 
Reference:
Sigma Technical Bulletin Vo. 415, January, 1977.
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CREATININE
Creatinine reacts with picrate under alkaline conditions (Jaffe reaction) 
to give a yellow-red solution which is measured photometrically at 505 nm.
The determination is made on diluted urine or on protein-free filtrate 
(dialysate) of plasma or serum.
The method employed is a modification of the procedure of Folin and Wu 
taken from the text "Hawk*s Physiological Chemistry.**
Creatinine clearance is a sensitive measure of glomerular filtration 
rate. Relatively minor changes in serum creatinine are accompanied by changes 
in creatinine clearance which are more dramatic, especially in the early phase 
of kidney disease.
Specimen:
Creatinine may be determined in any biological fluid, but plasma, serum, 
amniotic fluid, and urine are the specimens most commonly employed. Plasma 
and serum are preferred to whole blood since considerable amounts of 
noncreatinine chromogens are present in red cells. If kept for a few days, 
specimens for creatinine are best stored at refrigerator temperatures; if kept 
for longer periods, they should be frozen. Aqueous solutions of creatine and 
creatinine very slowly approach a state of equilibrium with respect to each 
other. Creatinine is formed rather quickly from creatine in either alkaline 
or acid solutions.
When performing a creatinine clearance, a precisely timed urine specimen 
and serum sample is required. The blood is generally collected in the middle 
of the urine collection period. Submit a 50-100 ml aliquot of the well-mixed 
24 hour urine collection with a record of the total volume.
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Principle:
1. Hyland Scan I and II (serum)
2. 2 levels of frozen serum pools
3. 2 levels of frozen urine pools
4. Occasional assayed lyophilized urine material from Hyland 
Reagents:
1. Saline, 9.0 grn HaCl 1000 ml double distilled water 
Add 0.5 ml Brij-35-mix
Stable indefinitely at room temperature.
2. Sodium Hydroxide, 0.5 H
20 gm/1000 ml double distilled water. Stable indefinitely at room 
temperature.
3. Saturated Picric Acid
13 gm/1000 double distilled water. Stable indefinitely. (See note 1)
a. To 13 gm of reagent grade picric acid in a one liter volume 
flask. Add distilled water to the mark.
b. Allow the excess picric acid to remain in contact with the water 
and shake occasionally.
c. Filter and store in a polyethylene bottle:
4. Stock creatinine standard (1 mg/ml)
1000 gm/1000 ml 0.1 H HC1 (Stable 1 year at room temperature)
5. Working creatinine standards:
Dilute stock creatinine standard with 0.2 H HC1.
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Controls:
ml stock Dilute to; mg creatinine/100 ml
0.5 100 ml 0.5











1. Sampler II - (run at 60 per hour)
2. Proportioning Pump
o3. Dialyzer (37 C - Type C Membrane)
4. 40 ft. time delay coil (Room temperature)
5. Colorimeter (505 mu - 15 mm tubular flow cell)
6. Recorder
(See attached flow diagram)
The sample stream segmented with air, is diluted with 0.9% sodium 
chloride. This combined stream enters the sample side of the dialyzer. The 
recipient stream consists of water segmented with air. (See notes 3, 4, & 5)
After emerging from the dialyzer it is joined with a stream formed by a
combination of saturated picric acid and 0.5 normal sodium hydroxide. The
streams are mixed, sent through a time delay coil and then go into the
colorimeter. The developed color is read at 505 nm using a 15 mm tubular flow
-Harm up time of colorimeter - 20 min.
-Time to bring up reagents - 20 min.
-Set Baseline at 95% T
-Keep wash line separate from picric acid and VaOH line.
-Serum samples should be mixed and centrifuged before being placed on 
sampler.
-Results that are higher than the 10 mg/dl standard should be diluted and 
repeated. Multiply result by appropriate dilution factor.
Plate format:
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1. 0.5 mg/dl 13. Frozen Pool #1
2. 1.0 M 14. Frozen Pool #2
3. 2.0 15. Water
4. 3.0 * * 16. Serum specimens
5. 4.0 17. Water
6 .  5.0 H 18. Urine Pool #1
7. 7.0 « • 19. Urine Pool #2
8 .  10.0 99 20. Water
9. Hater 21. Urine specimens




1. Sigma Stock #925-40 (As a safety precaution, aqueous picric acid 
should be purchased, as the dry powder can be explosive)
2. A is obtained from a surface-area monogram. (p. 916, Hawk*s 
Physiological Chemistry. See attached monogram).
3. For optimal bubble pattern and low noise use 0.5 ml of Brij-35 per 
liter of saline and distilled water recipient.
4. The noise with serum may sometimes be due to the formation of a pre­
cipitate. If this occurs, it is advisable to try a different lot of 
picric acid. It may also be helpful to clean the picric -sodium hy­
droxide lines and coils as well as the flow cell with 10% acetic acid.
5. When running the creatinine determination a check should be made of 
the noise. This can be done by continually aspirating a 5 mg/100 ml 
creatinine standard. The noise level should be no greater than ±0.5 
transmission line. If the noise level is greater, a check of the 
manifold and dialyzer should be made to insure that a good bubble 
pattern is being obtained. Noise is generally related to a poor 
bubble pattern which gives poor proportioning of reagents.
Calculations:
1. Serum or Plasma - these are read directly from a standard curve.
Results are reported in mg/dl.
2. Urine results are reported in gm/24 hr vol. Samples are generally 
diluted 1:30 before analysis.
mg/100 ml x 30 x .. . . x ^ ^  = gm/24 hr volaliquot vol
24 hr vol 1000 mg
where mg/100 ml is the reading from standard curve and 30 is the dilution
factor
3. Creatinine clearance is calculated as follows:
C = UV x 1.73
P A
where U = mg creatinine/ml urine 
V * ml urine/min 
P s mg creatinine/ml serum
A = body surface area of individual being tested.
(See Note 2 or attached nomogram)
C * ml serum cleared/min/std surface area
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Normal Ranges:




Female 0.8-1.8 gm/24 hr vol





1. Technicon Autoanalyzer Methodology Method File H-11B
2. Fundamentals of Clinical Chemistry. Horbert Tietz, 1976 p.996-998
3. Hawk*s Physiological Chemistry. Edited by Bernard L. Oser, Fourteenth 
Edition 1965.
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